Browse Plants
Access Plants in Each Plant Family

Plant Family No. of Plant Genus No. of Plants No. of Medicinal Plants No. of Food Plants No. of Human Edible Plants No. of Agricultural Plants No. of Garden Plants No. of Drug-producing Plants
Fabaceae 190 653 225 28 136 3 3 0
Myrtaceae 20 79 18 7 14 0 0 0
Hypericaceae 5 47 17 1 5 0 1 0
Asteraceae 316 1044 218 20 118 0 14 1042
Annonaceae 34 107 25 4 20 0 0 0
Rubiaceae 69 179 66 2 30 0 1 0
Cupressaceae 18 56 11 1 8 0 1 0
Ranunculaceae 20 214 97 0 20 0 0 0
Lamiaceae 77 428 152 18 66 0 7 0
Rutaceae 65 257 89 8 46 0 2 0
Cervantesiaceae 2 3 1 0 3 0 0 0
Torricelliaceae 2 2 0 0 0 0 0 0
Meliaceae 26 77 15 0 18 0 0 0
Proteaceae 10 15 3 1 3 0 0 0
Ebenaceae 3 22 8 0 11 0 1 0
Pinaceae 7 67 15 2 27 0 7 0
Polygonaceae 14 55 36 4 20 0 0 0
Crassulaceae 11 35 12 1 2 0 0 0
Scenedesmaceae 1 1 0 0 0 0 0 0
Nymphaeaceae 3 5 2 1 2 0 0 0
Pteridaceae 9 47 20 0 3 0 2 0
Gentianaceae 11 77 33 1 6 0 0 0
Primulaceae 11 60 34 1 11 0 2 0
Rosaceae 38 146 66 22 63 0 7 0
Betulaceae 5 19 4 0 4 0 1 0
Oleaceae 9 39 23 2 8 0 2 0
Euphorbiaceae 37 167 52 1 24 0 1 167
Orchidaceae 33 72 24 0 5 0 0 0
Moraceae 10 54 24 4 26 0 0 0
Solanaceae 29 125 46 8 20 0 2 123
Malvaceae 32 64 42 7 23 0 2 0
Plantaginaceae 21 61 22 3 10 0 1 61
Polemoniaceae 3 3 1 0 0 0 0 0
Apocynaceae 47 162 66 0 23 0 3 162
Asparagaceae 24 70 32 1 27 0 1 0
Poaceae 37 58 30 9 12 0 0 0
Chenopodiaceae 18 29 10 4 7 0 0 0
Celastraceae 21 78 21 0 15 0 0 0
Boraginaceae 19 48 13 1 7 0 0 0
Burseraceae 5 21 8 0 8 0 0 0
Lythraceae 11 18 9 1 8 0 2 0
Salicaceae 12 43 14 0 12 0 2 0
Caprifoliaceae 10 45 18 1 6 0 0 0
Campanulaceae 10 27 9 0 4 0 1 0
Stemonaceae 2 8 4 0 1 0 0 0
Smilacaceae 1 7 4 0 2 0 0 0
Linaceae 1 4 1 1 0 0 0 0
Pittosporaceae 2 7 0 0 4 0 0 0
Vitaceae 6 15 6 1 3 0 1 0
Lauraceae 23 106 31 3 16 0 2 0
Dipterocarpaceae 9 17 4 0 1 0 0 0
Apiaceae 60 166 89 13 34 0 0 166
Hyacinthaceae 12 21 2 0 2 0 0 0
Begoniaceae 1 2 1 0 0 0 0 0
Lardizabalaceae 5 8 5 0 4 0 1 0
Menispermaceae 29 69 32 0 12 0 0 0
Thymelaeaceae 12 35 14 0 1 0 1 0
Rhamnaceae 15 39 16 0 7 0 0 0
Aquifoliaceae 1 17 9 0 4 0 0 0
Orobanchaceae 19 36 16 0 7 0 0 0
Cyperaceae 8 15 6 0 3 0 0 0
Zingiberaceae 13 59 30 5 18 0 0 0
Chloranthaceae 3 8 4 0 1 0 0 0
Berberidaceae 11 65 32 0 14 0 1 0
Xyridaceae 1 3 1 0 0 0 0 0
Asphodelaceae 12 32 8 0 7 0 0 0
Polygalaceae 6 26 13 1 2 0 0 0
Araliaceae 13 50 22 2 10 0 0 0
Heliotropiaceae 4 21 5 0 2 0 0 0
Iridaceae 5 27 12 1 7 0 2 0
Paeoniaceae 1 8 5 0 1 0 1 0
Verbenaceae 6 17 7 1 6 0 2 0
Papaveraceae 20 100 46 1 10 0 0 98
Dioscoreaceae 1 25 17 0 8 0 0 0
Pentaphylacaceae 4 4 1 0 1 0 1 0
Brassicaceae 25 56 20 12 18 0 1 0
Araucariaceae 2 5 0 0 2 0 0 0
Piperaceae 3 54 22 2 12 0 0 0
Myricaceae 2 7 2 0 1 0 0 0
Rhabdodendraceae 1 1 0 0 0 0 0 0
Geraniaceae 4 16 7 0 6 0 1 0
Taxaceae 6 27 11 0 9 0 3 27
Amaranthaceae 6 17 12 0 4 0 1 0
Peraceae 1 1 0 0 0 0 0 0
Sarcolaenaceae 1 1 0 0 0 0 0 0
Adoxaceae 3 22 7 2 4 0 1 0
Amaryllidaceae 19 84 25 8 12 0 2 0
Cornaceae 2 12 6 0 6 0 0 0
Moringaceae 1 1 1 1 0 0 0 0
Plumbaginaceae 4 10 7 0 1 0 0 0
Pandaceae 1 1 0 0 1 0 0 0
Simaroubaceae 12 24 6 0 6 0 0 0
Sapindaceae 17 40 17 3 17 0 2 0
Scrophulariaceae 8 31 6 0 4 0 0 0
Acanthaceae 17 42 19 0 10 0 1 0
Cunoniaceae 3 3 1 0 1 0 0 0
Ulmaceae 2 6 3 0 3 0 0 0
Convolvulaceae 13 41 24 2 12 0 0 0
Clusiaceae 8 47 12 1 26 0 0 0
Magnoliaceae 3 34 20 0 5 0 2 0
Fagaceae 5 32 7 1 18 0 5 0
Ericaceae 15 62 25 4 12 0 2 0
Bignoniaceae 20 38 12 0 7 0 0 0
Elaeagnaceae 2 6 2 1 4 0 0 0
Mniaceae 3 5 0 0 0 0 0 0
Nyctaginaceae 4 4 4 0 1 0 1 0
Xanthorrhoeaceae 5 11 4 1 2 0 0 0
Marattiaceae 1 2 1 0 2 0 0 0
Liliaceae 3 33 15 0 8 0 0 0
Cleomaceae 4 6 1 0 1 0 0 0
Actinidiaceae 1 12 7 2 4 0 0 0
Scapaniaceae 3 7 0 0 0 0 0 0
Aristolochiaceae 2 28 18 0 3 0 0 0
Polypodiaceae 12 24 13 0 4 0 0 0
Buxaceae 3 18 9 0 2 0 2 0
Lomariopsidaceae 1 1 0 0 1 0 0 0
Zygophyllaceae 2 3 2 0 1 0 0 0
Cucurbitaceae 22 44 25 9 11 0 0 0
Saxifragaceae 8 23 8 0 7 0 0 0
Theaceae 1 6 6 2 1 0 2 0
Jungermanniaceae 2 3 1 0 0 0 0 0
Platanaceae 1 1 0 0 1 0 0 0
Cordiaceae 1 6 0 0 1 0 0 0
Araceae 15 26 8 0 8 0 0 0
Cactaceae 17 21 4 0 11 0 0 0
Bonnetiaceae 1 1 0 0 0 0 0 0
Combretaceae 6 15 5 0 4 0 0 0
Acoraceae 1 4 3 1 1 0 0 0
Selaginellaceae 1 15 11 0 1 0 0 0
Viscaceae 2 7 4 1 1 0 0 0
Cycadaceae 1 4 2 0 2 0 1 0
Ephedraceae 1 19 9 0 5 0 0 18
Hydrangeaceae 2 6 3 0 2 0 1 0
Loganiaceae 3 35 6 0 7 0 0 0
Podocarpaceae 6 29 5 0 5 0 1 0
Rhizophoraceae 6 14 9 0 4 0 0 0
Styracaceae 1 10 5 0 3 0 0 0
Loranthaceae 6 8 3 0 3 0 0 0
Melanthiaceae 6 20 6 0 0 0 0 0
Onocleaceae 1 2 2 1 1 0 0 0
Ochnaceae 1 1 0 0 0 0 0 0
Lycopodiaceae 7 16 9 0 0 0 0 0
Violaceae 1 5 2 1 1 0 0 0
Putranjivaceae 1 4 1 0 0 0 0 0
Calophyllaceae 4 21 2 1 3 0 0 0
Arecaceae 11 15 6 2 5 0 1 0
Dryopteridaceae 5 19 9 0 3 0 0 0
Grossulariaceae 1 4 2 1 1 0 0 0
Urticaceae 6 12 7 0 4 0 0 0
Phyllanthaceae 10 27 14 0 4 0 0 0
Juglandaceae 5 12 6 3 4 0 1 0
Hypoxidaceae 2 3 2 0 2 0 0 0
Santalaceae 2 3 1 0 1 0 0 0
Plagiochilaceae 1 2 0 0 0 0 0 0
Metzgeriaceae 1 1 0 0 0 0 0 0
Dicksoniaceae 1 1 1 0 0 0 0 0
Quillajaceae 1 1 0 0 0 0 0 0
Caulerpaceae 1 4 0 0 3 0 0 0
Krameriaceae 1 3 0 1 0 0 0 0
Aceraceae 2 3 0 0 0 0 0 0
Passifloraceae 3 12 4 3 5 0 1 0
Erythroxylaceae 1 4 0 0 0 0 0 0
Namaceae 3 4 0 0 1 0 0 0
Monostromataceae 1 2 1 0 0 0 0 0
Sapotaceae 9 10 2 2 7 0 0 0
Schisandraceae 3 30 19 2 5 0 0 0
Ceratophyllaceae 1 1 0 0 0 0 0 0
Droseraceae 2 8 4 0 1 0 0 0
Tropaeolaceae 1 2 1 1 0 0 1 0
Balanopaceae 1 1 0 0 0 0 0 0
Coriariaceae 1 5 2 0 0 0 0 0
Anacardiaceae 12 27 12 3 11 0 0 0
Caryophyllaceae 18 30 16 0 6 0 1 0
Tamaricaceae 2 9 4 0 3 0 0 0
Melastomataceae 5 5 3 0 0 0 0 0
Thelypteridaceae 7 8 3 0 0 0 0 0
Trochodendraceae 1 1 0 0 0 0 0 0
Elaeocarpaceae 3 5 0 0 1 0 0 0
Cannabaceae 3 6 4 2 1 0 0 6
Mamiellaceae 1 1 0 0 0 0 0 0
Udoteaceae 2 5 0 0 0 0 0 0
Gnetaceae 1 6 2 0 1 0 0 0
Aytoniaceae 3 3 1 0 0 0 0 0
Nepenthaceae 1 1 0 0 0 0 0 0
Capparaceae 2 5 2 1 3 0 0 0
Bryaceae 2 4 1 0 0 0 0 0
Conocephalaceae 1 2 1 0 0 0 0 0
Dilleniaceae 3 7 2 0 2 0 0 0
Petiveriaceae 2 2 0 0 1 0 0 0
Ptilidiaceae 1 1 0 0 0 0 0 0
Nyssaceae 2 3 2 0 0 0 0 0
Pandanaceae 1 1 1 0 1 0 0 0
Aizoaceae 5 8 3 1 4 0 0 0
Athyriaceae 1 1 1 0 1 0 0 0
Velloziaceae 2 5 0 0 0 0 0 0
Balsaminaceae 1 3 2 0 1 0 1 0
Solenostomataceae 1 1 0 0 0 0 0 0
Onagraceae 4 4 2 0 3 0 0 0
Linderniaceae 1 1 1 0 0 0 0 0
Dumortieraceae 1 1 1 0 0 0 0 0
Hymenophyllaceae 1 1 0 0 0 0 0 0
Alismataceae 3 4 1 0 3 0 0 0
Balanophoraceae 1 6 3 0 1 0 0 0
Resedaceae 3 3 1 0 1 0 0 0
Bromeliaceae 3 3 1 0 1 0 0 0
Typhaceae 2 6 4 1 5 0 0 0
Potamogetonaceae 1 2 1 0 0 0 0 0
Gleicheniaceae 3 5 2 0 1 0 0 0
Portulacaceae 1 3 3 1 2 0 0 0
Phytolaccaceae 1 6 2 1 2 0 0 0
Cynomoriaceae 1 1 1 0 1 0 0 0
Davalliaceae 4 6 2 0 0 0 0 0
Daphniphyllaceae 1 5 2 0 0 0 0 0
Osmundaceae 1 1 1 0 0 0 0 0
Garryaceae 2 3 0 0 0 0 0 0
Equisetaceae 1 4 3 0 1 0 1 0
Dasycladaceae 2 2 0 0 0 0 0 0
Eupteleaceae 1 1 1 0 1 0 0 0
Staphyleaceae 3 4 3 0 1 0 0 0
Gesneriaceae 5 5 1 0 0 0 0 0
Myristicaceae 7 21 5 2 5 0 0 0
Stilbaceae 1 2 0 0 0 0 0 0
Dunaliellaceae 1 2 0 0 1 0 0 0
Commelinaceae 4 4 2 0 2 0 0 0
Molluginaceae 2 5 4 0 4 0 0 0
Siparunaceae 2 2 0 0 0 0 0 0
Anthocerotaceae 1 1 0 0 0 0 0 0
Zosteraceae 1 1 1 0 0 0 0 0
Halimedaceae 1 1 0 0 0 0 0 0
Gyrostemonaceae 1 1 0 0 0 0 0 0
Symplocaceae 1 6 2 0 0 0 0 0
Frullaniaceae 1 3 1 0 0 0 0 0
Calceolariaceae 1 1 0 0 0 0 0 0
Chlamydomonadaceae 1 2 0 0 0 0 0 0
Caricaceae 2 4 2 1 0 0 0 0
Ulvaceae 1 4 3 0 2 0 0 0
Picrodendraceae 1 1 0 0 0 0 0 0
Musaceae 1 3 1 0 0 0 0 0
Malpighiaceae 2 3 0 0 1 0 0 0
Pontederiaceae 1 1 1 0 1 0 0 0
Colchicaceae 5 11 1 0 0 0 0 0
Limeaceae 1 1 0 0 0 0 0 0
Canellaceae 2 3 1 0 0 0 0 0
Gomortegaceae 1 1 0 0 1 0 0 0
Datiscaceae 1 1 0 0 0 0 0 0
Codiaceae 1 3 1 0 1 0 0 0
Jackiellaceae 1 1 1 0 0 0 0 0
Aspleniaceae 1 5 2 0 1 0 0 0
Pedaliaceae 3 3 2 0 3 0 0 0
Cyatheaceae 1 1 1 0 0 0 0 0
Cymodoceaceae 1 1 0 0 0 0 0 0
Phrymaceae 3 4 1 0 0 0 0 0
Oxalidaceae 2 5 4 1 1 0 0 0
Lunulariaceae 1 1 0 0 0 0 0 0
Ancistrocladaceae 1 3 1 0 0 0 0 0
Cistaceae 1 1 0 0 0 0 0 0
Lophocoleaceae 2 2 0 0 0 0 0 0
Lygodiaceae 1 3 2 0 2 0 0 0
Nitrariaceae 2 4 3 0 1 0 0 0
Salviniaceae 1 1 1 0 0 0 0 0
Brachytheciaceae 2 2 0 0 0 0 0 0
Lentibulariaceae 2 3 0 0 2 0 0 0
Calyceraceae 1 1 0 0 0 0 0 0
Thesiaceae 1 2 1 0 0 0 0 0
Posidoniaceae 1 1 0 0 0 0 0 0
Herbertaceae 1 2 0 0 0 0 0 0
Pseudolepicoleaceae 1 1 0 0 0 0 0 0
Didiereaceae 1 2 0 0 0 0 0 0
Restionaceae 2 2 0 0 0 0 0 0
Hernandiaceae 1 3 2 0 0 0 0 0
Chrysobalanaceae 4 4 0 0 2 0 0 0
Ophioglossaceae 3 4 3 0 2 0 0 0
Saururaceae 2 3 3 0 2 0 0 0
Monimiaceae 3 4 0 0 0 0 0 0
Icacinaceae 2 2 1 0 0 0 0 0
Polytrichaceae 2 4 1 0 0 0 0 0
Akaniaceae 1 1 1 0 0 0 0 0
Gelsemiaceae 1 2 1 0 1 0 0 0
Dioncophyllaceae 2 2 0 0 0 0 0 0
Achariaceae 4 6 1 1 2 0 0 0
Nelumbonaceae 1 2 1 1 0 0 1 0
Hamamelidaceae 2 2 1 0 0 0 0 0
Sarraceniaceae 1 2 1 0 0 0 0 0
Lecythidaceae 3 3 1 0 3 0 0 0
Blechnaceae 5 6 2 0 0 0 0 0
Phellinaceae 1 1 0 0 0 0 0 0
Sabiaceae 2 4 1 0 0 0 0 0
Corsiniaceae 1 1 0 0 0 0 0 0
Plagiogyriaceae 1 2 1 0 0 0 0 0
Calycanthaceae 2 3 3 0 1 0 0 0
Zamiaceae 3 4 0 0 1 0 0 0
Altingiaceae 1 2 2 0 1 0 0 0
Dennstaedtiaceae 4 8 6 0 3 0 0 0
Paulowniaceae 1 1 1 0 1 0 1 0
Aptandraceae 1 2 1 0 1 0 0 0
Hippocastanaceae 1 1 1 0 1 0 0 0
Anastrophyllaceae 1 1 0 0 0 0 0 0
Austrobaileyaceae 1 1 0 0 0 0 0 0
Menyanthaceae 1 1 1 0 0 0 0 0
Splachnaceae 1 1 1 0 0 0 0 0
Ginkgoaceae 1 2 1 1 0 0 1 0
Melianthaceae 2 4 1 0 2 0 0 0
Griseliniaceae 1 2 0 0 1 0 0 0
Cladophoraceae 1 1 0 0 0 0 0 0
Ehretiaceae 1 1 0 0 1 0 0 0
Lepidoziaceae 2 3 0 0 0 0 0 0
Nothofagaceae 2 2 0 0 0 0 0 0
Eucommiaceae 1 1 1 0 1 0 0 0
Casuarinaceae 1 1 1 0 1 0 0 0
Hydrodictyaceae 1 1 0 0 1 0 0 0
Targioniaceae 1 1 0 0 0 0 0 0
Picramniaceae 1 1 0 0 0 0 0 0
Gunneraceae 1 1 0 0 0 0 0 0
Chlorellaceae 1 1 0 0 0 0 0 0
Calypogeiaceae 1 1 0 0 0 0 0 0
Loasaceae 2 2 0 0 1 0 0 0
Aulacomniaceae 1 1 1 0 0 0 0 0
Woodsiaceae 1 1 0 0 0 0 0 0
Hylocomiaceae 1 1 0 0 0 0 0 0
Bixaceae 1 1 1 0 0 0 0 0
Atherospermataceae 3 3 0 0 0 0 0 0
Lejeuneaceae 1 1 0 0 0 0 0 0
Adelanthaceae 1 1 0 0 0 0 0 0
Stachyuraceae 1 2 0 0 0 0 0 0
Bryopsidaceae 1 1 0 0 0 0 0 0
Centroplacaceae 1 1 0 0 0 0 0 0
Characeae 1 1 0 0 0 0 0 0
Cercidiphyllaceae 1 1 1 0 0 0 0 0
Diapensiaceae 1 1 1 0 0 0 0 0
Dipentodontaceae 1 1 0 0 0 0 0 0
Podostemaceae 1 1 0 0 0 0 0 0
Nartheciaceae 2 2 0 0 0 0 0 0
Gyrothyraceae 1 1 0 0 0 0 0 0
Juncaginaceae 1 1 1 0 0 0 0 0
Amphorogynaceae 1 1 0 0 0 0 0 0
Hypnaceae 1 1 0 0 0 0 0 0
Botryococcaceae 1 1 0 0 0 0 0 0
Microteaceae 1 1 0 0 0 0 0 0
Salvadoraceae 1 1 1 0 1 0 0 0
Bartramiaceae 1 1 1 0 0 0 0 0
Alstroemeriaceae 1 1 0 0 1 0 0 0
Welwitschiaceae 1 1 0 0 0 0 0 0
Leucobryaceae 1 1 0 0 0 0 0 0
Ricciaceae 1 1 0 0 0 0 0 0
Goupiaceae 1 2 0 0 0 0 0 0
Trichocoleaceae 1 1 0 0 0 0 0 0
Marchantiaceae 1 1 1 0 0 0 0 0
Eriocaulaceae 1 1 0 0 0 0 0 0
Pelliaceae 1 1 0 0 0 0 0 0
Radulaceae 1 2 0 0 0 0 0 0
Cystopteridaceae 1 1 0 0 0 0 0 0
Winteraceae 2 2 0 0 1 0 0 0
Taccaceae 1 2 2 0 1 0 0 0
Simmondsiaceae 1 1 0 0 1 0 0 0
Costaceae 1 2 1 0 0 0 0 0
Haematococcaceae 1 1 0 0 0 0 0 0
Clethraceae 1 1 0 0 0 0 0 0
Oocystaceae 1 1 0 0 0 0 0 0
Philydraceae 1 1 1 0 0 0 0 0
Biebersteiniaceae 1 1 0 0 0 0 0 0
Fouquieriaceae 1 1 0 0 0 0 0 0
Myliaceae 1 1 0 0 0 0 0 0
Cibotiaceae 1 1 1 0 1 0 0 0
Caryocaraceae 1 1 0 0 1 0 0 0
Escalloniaceae 1 1 0 0 0 0 0 0
Crossosomataceae 1 1 0 0 0 0 0 0
Psilotaceae 1 1 1 0 0 0 0 0
Porellaceae 1 1 0 0 0 0 0 0
Juncaceae 1 1 1 0 1 0 0 0
Lanariaceae 1 1 0 0 0 0 0 0
Muntingiaceae 1 1 1 0 0 0 0 0
Hydrocharitaceae 1 1 1 0 0 0 0 0
Bruniaceae 1 1 0 0 0 0 0 0
Marsileaceae 1 1 1 0 0 0 0 0
Access Plants in Each Plant Usage Class (Click the Pie Chart Sections)

Access Plants That Show Activities on Each Target Protein

Target Category Target Gene Symbol Target Name No. of Plants No. of Medicinal Plants No. of Human Edible Plants No. of Agricultural Plants No. of Garden Plants No. of Drug-producing Plants
Nuclear hormone receptor subfamily 1 RORB Nuclear receptor ROR-beta 2 1 1 0 0 0
Lysine demethylase KDM4E Lysine-specific demethylase 4D-like 649 287 199 0 18 145
Protein Kinase SGK1 Serine/threonine-protein kinase Sgk1 1 0 1 0 0 1
Small molecule receptor (family C GPCR) GRM8 Metabotropic glutamate receptor 8 142 111 25 0 8 22
Unclassified protein MEN1 Menin 1 1 1 0 0 1
Transferase PIK3CD PI3-kinase p110-delta subunit 1 0 0 0 0 0
Protein Kinase PLK4 Serine/threonine-protein kinase PLK4 2 0 2 0 0 1
Protein Kinase STK25 Serine/threonine-protein kinase 25 1 0 1 0 0 1
Hydrolase FAAH Anandamide amidohydrolase 11 8 4 0 1 0
Hydrolase CES2 Carboxylesterase 2 40 18 4 0 0 7
Enzyme SCD Acyl-CoA desaturase 11 6 5 0 1 1
Protein Kinase CIT Citron Rho-interacting kinase 1 0 1 0 0 1
Isomerase PTGES Prostaglandin E synthase 55 40 24 0 3 9
Protein Kinase MAP2K7 Dual specificity mitogen-activated protein kinase kinase 7 3 2 3 0 0 1
Transferase TERT Telomerase reverse transcriptase 22 15 9 0 0 6
Protein Kinase CHEK1 Serine/threonine-protein kinase Chk1 15 9 4 0 1 4
Small molecule receptor (family A GPCR) FFAR1 Free fatty acid receptor 1 549 288 166 1 17 139
Protein Kinase IKBKB Inhibitor of nuclear factor kappa B kinase beta subunit 1 0 1 0 0 1
Protein Kinase AURKA Serine/threonine-protein kinase Aurora-A 38 25 16 0 0 6
Protein Kinase GAK Serine/threonine-protein kinase GAK 3 1 2 0 0 1
Protein Kinase DCLK1 Serine/threonine-protein kinase DCLK1 1 0 1 0 0 1
Protein Kinase CHUK Inhibitor of nuclear factor kappa B kinase alpha subunit 1 0 1 0 0 1
Transporter NPC1 Niemann-Pick C1 protein 152 51 39 0 2 54
Protein Kinase MUSK Muscle, skeletal receptor tyrosine protein kinase 1 0 1 0 0 1
SLC superfamily of solute carriers SLC22A2 Solute carrier family 22 member 2 5 3 1 0 1 0
SLC superfamily of solute carriers SLC22A1 Solute carrier family 22 member 1 3 1 1 0 0 0
Protein Kinase MAPK13 MAP kinase p38 delta 1 0 1 0 0 1
Histone deacetylase HDAC3 Histone deacetylase 3 1 0 0 0 0 0
Protein Kinase PDPK1 3-phosphoinositide dependent protein kinase-1 2 0 2 0 0 1
Peptide receptor (family A GPCR) MLNR Motilin receptor 1 1 0 0 0 0
Protein Kinase DAPK3 Death-associated protein kinase 3 2 0 2 0 0 1
Protein Kinase MAP3K7 Mitogen-activated protein kinase kinase kinase 7 3 2 3 0 0 1
Protein Kinase RIPK2 Serine/threonine-protein kinase RIPK2 3 1 2 0 0 1
Hydrolase MGAM Maltase-glucoamylase 10 6 4 0 0 1
Lyase CA12 Carbonic anhydrase XII 2498 986 700 3 66 589
Protein Kinase DYRK3 Dual-specificity tyrosine-phosphorylation regulated kinase 3 6 3 5 0 0 1
Oxidoreductase AKR1B10 Aldo-keto reductase family 1 member B10 245 103 85 0 7 69
Protein Kinase NUAK1 NUAK family SNF1-like kinase 1 295 115 94 0 5 71
Protein Kinase JAK2 Tyrosine-protein kinase JAK2 10 5 4 0 0 2
Transcription factor MITF Microphthalmia-associated transcription factor 8 5 2 0 0 0
Protein Kinase ROCK2 Rho-associated protein kinase 2 8 3 3 0 0 2
Protein Kinase ULK1 Serine/threonine-protein kinase ULK1 1 0 1 0 0 1
Enzyme ERN1 Serine/threonine-protein kinase/endoribonuclease IRE1 1 0 1 0 0 1
Nuclear hormone receptor subfamily 1 NR1I2 Pregnane X receptor 11 8 5 0 1 2
Unclassified protein GMNN Geminin 64 36 16 0 5 20
Protein Kinase RPS6KA5 Ribosomal protein S6 kinase alpha 5 1 0 1 0 0 1
Cysteine protease USP2 Ubiquitin carboxyl-terminal hydrolase 2 39 27 21 0 2 12
Protein Kinase RPS6KA4 Ribosomal protein S6 kinase alpha 4 1 0 1 0 0 1
Protein Kinase STK16 Serine/threonine-protein kinase 16 1 0 1 0 0 1
SLC superfamily of solute carriers SLC22A3 Solute carrier family 22 member 3 16 6 3 0 0 2
Transient receptor potential channel TRPA1 Transient receptor potential cation channel subfamily A member 1 200 93 52 0 3 32
Protein Kinase PAK3 Serine/threonine-protein kinase PAK 3 1 0 1 0 0 1
Phosphodiesterase 5 PDE5A Phosphodiesterase 5A 11 9 6 0 0 0
Phosphodiesterase 9 PDE9A Phosphodiesterase 9A 1 0 1 0 0 1
Protein Kinase STK17B Serine/threonine-protein kinase 17B 1 0 1 0 0 1
Protein Kinase STK10 Serine/threonine-protein kinase 10 1 0 1 0 0 1
Protein Kinase PRKD3 Protein kinase C nu 2 0 2 0 0 1
SLC superfamily of solute carriers SLCO2B1 Solute carrier organic anion transporter family member 2B1 2 2 2 0 0 1
Transferase TNKS Tankyrase-1 49 28 17 1 2 7
ATP-binding cassette ABCB11 Bile salt export pump 9 7 3 0 0 4
Protein Kinase MAP3K6 Mitogen-activated protein kinase kinase kinase 6 1 0 1 0 0 1
Phosphodiesterase TDP2 Tyrosyl-DNA phosphodiesterase 2 14 11 4 0 1 2
Nuclear hormone receptor subfamily 3 ESRRB Estrogen-related receptor beta 166 96 45 1 8 16
Protein Kinase MAP4K4 Mitogen-activated protein kinase kinase kinase kinase 4 9 3 4 0 0 2
Protein Kinase LATS1 Serine/threonine-protein kinase LATS1 1 0 1 0 0 1
Hydrolase ABHD16A Protein BAT5 3 3 2 0 1 0
Protein Kinase PAK4 Serine/threonine-protein kinase PAK 4 1 0 1 0 0 1
Protein Kinase CHEK2 Serine/threonine-protein kinase Chk2 6 1 3 0 0 2
Oxidoreductase ALDH1A1 Aldehyde dehydrogenase 1A1 244 85 69 0 9 53
Oxidoreductase DHFR Dihydrofolate reductase 1 0 0 0 0 0
Oxidoreduction-driven transporters COX2 Cytochrome c oxidase subunit 2 14 7 3 0 0 9
Protein Kinase ABL1 Tyrosine-protein kinase ABL 4 2 2 0 0 2
Protein Kinase EGFR Epidermal growth factor receptor erbB1 312 125 100 0 5 72
Serine protease F2 Thrombin 93 41 32 0 4 17
Serine protease F10 Coagulation factor X 153 53 49 0 5 37
Aspartic protease REN Renin 1 1 0 0 0 0
Hydrolase ADA Adenosine deaminase 8 5 3 0 0 4
Lyase CA1 Carbonic anhydrase I 243 97 75 0 4 57
Lyase CA2 Carbonic anhydrase II 1492 618 423 1 35 357
Other cytosolic protein HRAS Transforming protein p21/H-Ras-1 1 0 1 0 0 0
Secreted protein TNF TNF-alpha 1 1 1 0 0 0
Structural protein LMNA Prelamin-A/C 2393 1053 661 3 54 567
Secreted protein TTR Transthyretin 691 287 204 0 18 193
Nuclear hormone receptor subfamily 3 ESR1 Estrogen receptor alpha 521 255 133 1 13 88
Oxidoreductase ND4 NADH-ubiquinone oxidoreductase chain 4 26 15 3 0 0 3
Metallo protease MMP1 Matrix metalloproteinase-1 439 271 137 0 19 115
Oxidoreductase HMGCR HMG-CoA reductase 1 1 0 0 0 1
Protein Kinase RAF1 Serine/threonine-protein kinase RAF 4 2 2 0 0 2
Hydrolase FUCA1 Alpha-L-fucosidase I 2 1 0 0 0 0
Nuclear hormone receptor subfamily 3 NR3C1 Glucocorticoid receptor 117 46 32 0 1 31
Surface antigen PRNP Prion protein 2 1 0 0 0 0
Transferase TK1 Thymidine kinase, cytosolic 76 30 20 0 2 16
Secreted protein SHBG Testis-specific androgen-binding protein 12 9 6 0 0 0
Protein Kinase ERBB2 Receptor protein-tyrosine kinase erbB-2 3 1 2 0 0 1
Protein Kinase NTRK1 Nerve growth factor receptor Trk-A 1 0 1 0 0 1
Transcription factor TP53 Cellular tumor antigen p53 330 196 106 1 14 99
Cytochrome P450 family 1 CYP1A1 Cytochrome P450 1A1 2032 794 550 1 47 509
P-type ATPase ATP1A1 Sodium/potassium-transporting ATPase alpha-1 chain 15 9 7 0 1 5
Membrane receptor APP Beta amyloid A4 protein 300 196 84 0 10 80
Oxidoreductase ALDH2 Aldehyde dehydrogenase 41 24 15 0 1 6
Cytochrome P450 family 17 CYP17A1 Cytochrome P450 17A1 2 1 1 0 0 0
Secreted protein SERPINE1 Plasminogen activator inhibitor-1 1 1 1 0 1 0
Protein Kinase PRKCG Protein kinase C gamma 13 7 9 0 1 7
Oxidoreductase MPO Myeloperoxidase 27 13 5 0 2 8
Cytochrome P450 family 1 CYP1A2 Cytochrome P450 1A2 2002 784 539 1 44 499
Enzyme ALPL Alkaline phosphatase, tissue-nonspecific isozyme 521 209 154 0 14 116
Transcription factor JUN Proto-oncogene c-JUN 6 5 0 0 0 6
Protein Kinase PRKCB Protein kinase C beta 12 7 8 0 1 7
Serine protease HPN Serine protease hepsin 1 1 0 0 0 1
Protein Kinase INSR Insulin receptor 296 115 95 0 5 71
Protein Kinase LCK Tyrosine-protein kinase LCK 30 17 7 0 0 4
Protein Kinase FYN Tyrosine-protein kinase FYN 41 26 14 0 1 2
Hydrolase BCHE Butyrylcholinesterase 22 15 5 0 1 1
Nuclear hormone receptor subfamily 3 PGR Progesterone receptor 33 22 12 0 1 10
Protein Kinase CDK1 Cyclin-dependent kinase 1 1333 555 392 0 35 304
Enzyme PYGL Liver glycogen phosphorylase 5 2 1 0 0 0
Enzyme POLB DNA polymerase beta 1587 666 463 0 41 364
Hydrolase LPL Lipoprotein lipase 3 3 2 0 1 0
Serine protease EPHX1 Epoxide hydrolase 1 1 1 1 0 0 0
Isomerase P4HB Protein disulfide-isomerase 58 15 17 0 1 17
Protein Kinase FES Tyrosine-protein kinase FES 2 0 2 0 0 1
Protein Kinase CSF1R Macrophage colony stimulating factor receptor 7 4 4 0 0 2
Aspartic protease CTSD Cathepsin D 1 0 0 0 0 0
Cysteine protease CAPN1 Calpain 1 20 5 1 0 0 11
Lyase CA3 Carbonic anhydrase III 13 6 2 0 0 0
Serine protease PRSS1 Trypsin I 1 1 1 0 1 0
Small molecule receptor (family A GPCR) ADRB2 Beta-2 adrenergic receptor 22 8 4 0 2 5
Cysteine protease CTSL Cathepsin L 2 1 0 0 0 1
Cysteine protease CTSB Cathepsin B 6 4 2 0 0 2
Other cytosolic protein HSP90AA1 Heat shock protein HSP 90-alpha 27 8 4 0 0 12
Protein Kinase YES1 Tyrosine-protein kinase YES 1324 552 391 0 35 304
Protein Kinase LYN Tyrosine-protein kinase Lyn 3 1 2 0 0 1
Protein Kinase RET Tyrosine-protein kinase receptor RET 12 5 5 0 0 3
Protein Kinase IGF1R Insulin-like growth factor I receptor 1485 610 429 0 38 359
Transcription factor GLI1 Zinc finger protein GLI1 36 7 11 0 1 13
Small molecule receptor (family A GPCR) CHRM2 Muscarinic acetylcholine receptor M2 35 26 10 0 1 16
Small molecule receptor (family A GPCR) CHRM4 Muscarinic acetylcholine receptor M4 23 17 8 0 1 6
ATP-binding cassette ABCB1 P-glycoprotein 1 153 62 46 0 6 40
Secreted protein SERPINA6 Corticosteroid binding globulin 39 21 13 0 1 10
Nuclear hormone receptor subfamily 3 NR3C2 Mineralocorticoid receptor 28 19 11 0 1 10
Other cytosolic protein HSP90AB1 Heat shock protein HSP 90-beta 1 1 1 0 0 0
Metallo protease MMP2 Matrix metalloproteinase-2 508 293 164 0 20 135
Metallo protease MMP3 Matrix metalloproteinase 3 6 1 1 0 0 4
Protein Kinase MET Hepatocyte growth factor receptor 1454 600 426 0 37 345
Small molecule receptor (family A GPCR) ADRB1 Beta-1 adrenergic receptor 25 10 6 0 2 5
Protein Kinase HCK Tyrosine-protein kinase HCK 13 6 5 0 0 3
Cytochrome P450 family 3 CYP3A4 Cytochrome P450 3A4 544 278 143 0 14 99
Small molecule receptor (family A GPCR) HTR1A Serotonin 1a (5-HT1a) receptor 125 65 34 0 9 30
Small molecule receptor (family A GPCR) CHRM5 Muscarinic acetylcholine receptor M5 33 26 10 0 1 16
Small molecule receptor (family A GPCR) ADRA2A Alpha-2a adrenergic receptor 100 52 27 0 3 34
Protein Kinase ROS1 Proto-oncogene tyrosine-protein kinase ROS 8 3 3 0 0 2
Transferase GSTP1 Glutathione S-transferase Pi 271 167 57 0 10 60
Protein Kinase PDGFRB Platelet-derived growth factor receptor beta 4 2 2 0 0 2
Protein Kinase FGR Tyrosine-protein kinase FGR 1 0 1 0 0 1
Transferase POLA1 DNA polymerase alpha subunit 8 5 4 0 0 1
Oxidoreductase ALOX5 Arachidonate 5-lipoxygenase 154 75 42 0 5 27
Metallo protease LTA4H Leukotriene A4 hydrolase 1 1 1 0 1 0
Small molecule receptor (family A GPCR) ADORA3 Adenosine A3 receptor 221 117 77 0 4 55
Other cytosolic protein HSPA1A Heat shock 70 kDa protein 1 294 115 93 0 5 70
Transcription factor GLI2 Zinc finger protein GLI2 10 6 1 0 0 1
Secreted protein CXCL8 Interleukin-8 18 10 6 0 0 13
Hydrolase GAA Lysosomal alpha-glucosidase 21 11 9 0 0 10
Nuclear hormone receptor subfamily 3 AR Androgen Receptor 49 28 16 0 1 14
Nuclear hormone receptor subfamily 1 RARA Retinoic acid receptor alpha 3 1 2 0 0 0
Miscellaneous ion channel BCL2 Apoptosis regulator Bcl-2 254 102 74 0 9 50
Cytochrome P450 family 2 CYP2C8 Cytochrome P450 2C8 1 1 1 0 0 0
Cytochrome P450 family 2 CYP2D6 Cytochrome P450 2D6 179 106 43 0 2 65
Other cytosolic protein MAPT Microtubule-associated protein tau 187 107 55 0 8 35
Protein Kinase KIT Stem cell growth factor receptor 11 4 3 0 0 5
Nuclear hormone receptor subfamily 1 RARB Retinoic acid receptor beta 2 1 1 0 0 0
Nuclear hormone receptor subfamily 1 THRA Thyroid hormone receptor alpha 1 0 0 0 0 0
Nuclear hormone receptor subfamily 1 THRB Thyroid hormone receptor beta-1 113 55 36 0 9 31
SLC superfamily of solute carriers SLC2A1 Glucose transporter 26 7 3 0 0 12
Enzyme UMPS Uridine 5'-monophosphate synthase 3 2 2 0 0 1
Small molecule receptor (family A GPCR) CHRM1 Muscarinic acetylcholine receptor M1 34 27 10 0 1 16
Other cytosolic protein BCR Bcr/Abl fusion protein 1 0 1 0 0 1
Protein Kinase PIM1 Serine/threonine-protein kinase PIM1 1374 573 402 0 38 315
Protein Kinase FGFR1 Fibroblast growth factor receptor 1 12 5 5 0 0 3
Isomerase TOP1 DNA topoisomerase I 28 19 12 0 1 8
Isomerase TOP2A DNA topoisomerase II alpha 405 179 113 0 13 89
Nuclear hormone receptor subfamily 1 VDR Vitamin D receptor 2 1 0 0 0 0
Nuclear hormone receptor subfamily 3 ESRRA Estrogen-related receptor alpha 166 96 45 1 8 16
Cytochrome P450 family 2 CYP2A6 Cytochrome P450 2A6 86 33 26 1 1 38
Cytochrome P450 family 19 CYP19A1 Cytochrome P450 19A1 496 185 144 0 11 112
Cytochrome P450 family 2 CYP2C9 Cytochrome P450 2C9 243 118 68 0 5 55
Protein Kinase CDK4 Cyclin-dependent kinase 4 1 0 0 0 0 0
Oxidoreductase IMPDH2 Inosine-5'-monophosphate dehydrogenase 2 1 0 0 0 0 0
Metallo protease ACE Angiotensin-converting enzyme 2 2 1 0 0 0
Protein Kinase SRC Tyrosine-protein kinase SRC 333 128 99 0 6 86
Metallo protease PEPD Xaa-Pro dipeptidase 7 2 2 0 1 0
Nuclear hormone receptor subfamily 1 RARG Retinoic acid receptor gamma 2 1 1 0 0 0
Surface antigen F3 Coagulation factor III 726 309 210 0 19 160
SLC superfamily of solute carriers SLC5A1 Sodium/glucose cotransporter 1 61 20 13 0 2 13
Small molecule receptor (family A GPCR) ADRB3 Beta-3 adrenergic receptor 29 14 8 0 2 5
Oxidoreductase HSD17B1 Estradiol 17-beta-dehydrogenase 1 752 307 221 0 20 206
Aspartic protease CTSE Cathepsin E 1 0 0 0 0 0
Enzyme MIF Macrophage migration inhibitory factor 61 26 21 0 2 7
Transferase FDPS Farnesyl diphosphate synthase 1 1 0 0 1 0
Small molecule receptor (family A GPCR) DRD2 Dopamine D2 receptor 124 72 31 0 6 29
Protein Kinase INSRR Insulin receptor-related protein 1 0 1 0 0 1
Enzyme PKM Pyruvate kinase isozymes M1/M2 14 13 7 0 1 1
Oxidoreductase TYR Tyrosinase 15 14 9 0 0 1
Metallo protease MMP9 Matrix metalloproteinase 9 483 284 153 0 21 128
GABA-A receptor GABRA1 GABA receptor alpha-1 subunit 3 2 1 0 0 1
Oxidoreductase IDO1 Indoleamine 2,3-dioxygenase 8 8 3 0 2 0
Oxidoreductase DAO D-amino-acid oxidase 4 4 0 0 1 2
Protein Kinase BRAF Serine/threonine-protein kinase B-raf 4 2 2 0 0 2
Metallo protease CPA1 Carboxypeptidase A1 4 2 2 0 0 0
Metallo protease CPB1 Carboxypeptidase B 1 0 1 0 0 0
Fatty acid binding protein family FABP4 Fatty acid binding protein adipocyte 510 278 186 0 19 134
Oxidoreductase AKR1B1 Aldose reductase 487 212 153 0 6 124
Enzyme HPGD 15-hydroxyprostaglandin dehydrogenase [NAD+] 295 116 94 0 5 70
Cytochrome P450 family 11 CYP11B1 Cytochrome P450 11B1 1 0 0 0 0 0
Oxidoreductase NQO1 Quinone reductase 1) 4 4 0 0 1 0
Protein Kinase PHKG2 Phosphorylase kinase gamma subunit 2 2 0 2 0 0 1
Oxidoreductase ALOX15 Arachidonate 15-lipoxygenase 695 365 210 1 19 176
Oxidoreductase NQO2 Quinone reductase 2 149 68 41 0 1 27
Oxidoreductase CBR1 Carbonyl reductase [NADPH] 1 166 59 45 0 3 42
Hydrolase PNLIP Pancreatic lipase 3 3 2 0 1 0
Protein Kinase PDGFRA Platelet-derived growth factor receptor alpha 4 2 2 0 0 2
Peptide receptor (family A GPCR) TSHR Thyroid stimulating hormone receptor 597 384 188 0 17 149
Protein Kinase FER Tyrosine-protein kinase FER 2 0 2 0 0 1
Protein Kinase PRKCA Protein kinase C alpha 77 27 21 0 1 23
Protein Kinase PRKACA cAMP-dependent protein kinase alpha-catalytic subunit 1 0 1 0 0 1
Protein Phosphatase PTPN2 T-cell protein-tyrosine phosphatase 19 4 2 0 0 9
Unclassified protein XBP1 X-box-binding protein 1 19 4 1 0 0 10
Protein Kinase FLT1 Vascular endothelial growth factor receptor 1 12 5 5 0 0 3
Protein Phosphatase PTPN1 Protein-tyrosine phosphatase 1B 22 9 11 0 1 5
Enzyme ALOX12 Arachidonate 12-lipoxygenase 1396 580 414 0 36 319
Small molecule receptor (family A GPCR) ADRA2B Alpha-2b adrenergic receptor 275 200 70 0 13 57
Small molecule receptor (family A GPCR) ADRA2C Alpha-2c adrenergic receptor 70 40 21 0 0 19
Cytochrome P450 family 11 CYP11B2 Cytochrome P450 11B2 1 0 1 0 0 1
Protein Kinase EIF2AK2 Interferon-induced, double-stranded RNA-activated protein kinase 2 0 1 0 0 1
Protein Kinase CSNK2A2 Casein kinase II alpha (prime) 1 0 1 0 0 1
Nuclear hormone receptor subfamily 2 RXRA Retinoid X receptor alpha 4 2 1 0 0 0
Transcription factor NFKB1 Nuclear factor NF-kappa-B p105 subunit 1166 541 334 1 31 297
Small molecule receptor (family A GPCR) CHRM3 Muscarinic acetylcholine receptor M3 39 32 10 0 1 21
Threonine protease PSMB1 Proteasome component C5 132 56 43 0 2 23
Membrane receptor ITGAL Leukocyte adhesion glycoprotein LFA-1 alpha 25 15 10 0 2 5
Protein Kinase MAK Serine/threonine-protein kinase MAK 1 0 1 0 0 1
Cytochrome P450 family 2 CYP2B6 Cytochrome P450 2B6 67 57 5 0 5 17
Cytochrome P450 family 3 CYP3A5 Cytochrome P450 3A5 2 2 0 0 0 2
Oxidoreductase IMPDH1 Inosine-5'-monophosphate dehydrogenase 1 1 0 0 0 0 0
Oxidoreductase MAOA Monoamine oxidase A 396 184 128 0 6 113
Small molecule receptor (family A GPCR) CNR1 Cannabinoid CB1 receptor 95 30 28 0 2 33
Protein Kinase EPHA1 Ephrin type-A receptor 1 1 0 1 0 0 1
Small molecule receptor (family A GPCR) DRD1 Dopamine D1 receptor 686 308 202 0 13 168
Protein Kinase FGFR2 Fibroblast growth factor receptor 2 1 0 1 0 0 1
Small molecule receptor (family A GPCR) DRD4 Dopamine D4 receptor 49 35 14 0 1 15
Small molecule receptor (family A GPCR) DRD5 Dopamine D5 receptor 124 63 38 0 2 32
Potassium channels KCNA3 Voltage-gated potassium channel subunit Kv1.3 43 7 12 0 1 9
Hydrolase ACHE Acetylcholinesterase 1850 754 509 0 45 445
Transferase UGT1A1 UDP-glucuronosyltransferase 1-1 6 5 3 0 0 0
Protein Kinase FGFR4 Fibroblast growth factor receptor 4 2 1 2 0 0 1
Protein Kinase FGFR3 Fibroblast growth factor receptor 3 2 0 2 0 0 1
Protein Kinase PRKACB cAMP-dependent protein kinase beta-1 catalytic subunit 1 0 1 0 0 1
Lyase CA4 Carbonic anhydrase IV 1540 630 459 2 42 350
Enzyme CES1 Acyl coenzyme A:cholesterol acyltransferase 1356 483 352 0 29 332
Oxidoreductase PTGS1 Cyclooxygenase-1 144 62 38 0 3 39
Lyase CA6 Carbonic anhydrase VI 105 47 26 0 3 23
Glycine receptor GLRA1 Glycine receptor subunit alpha-1 6 3 2 0 1 0
Protein Kinase RPS6KB1 Ribosomal protein S6 kinase 1 2 0 2 0 0 1
Protein Kinase JAK1 Tyrosine-protein kinase JAK1 2 1 1 0 0 1
Hydrolase AHCY Adenosylhomocysteinase 1 1 1 0 0 0
SLC superfamily of solute carriers SLC6A2 Norepinephrine transporter 78 66 8 0 5 16
GABA-A receptor GABRR1 GABA receptor rho-1 subunit 57 33 19 0 4 19
Cytochrome P450 family 5 TBXAS1 Thromboxane-A synthase 26 15 6 0 0 9
Protein Kinase PRKCH Protein kinase C eta 3 2 3 0 1 2
Protein Kinase CDK2 Cyclin-dependent kinase 2 10 3 3 0 0 1
Peptide receptor (family A GPCR) CXCR1 Interleukin-8 receptor A 1 1 0 0 0 1
Small molecule receptor (family A GPCR) ADRA1D Alpha-1d adrenergic receptor 86 32 27 0 3 25
Small molecule receptor (family A GPCR) PTAFR Platelet activating factor receptor 3 3 2 0 1 0
DNA methyltransferase DNMT1 DNA (cytosine-5)-methyltransferase 1 101 43 32 0 5 21
Oxidoreductase MAOB Monoamine oxidase B 297 115 82 0 5 62
Protein Kinase MAPK3 MAP kinase ERK1 3 2 1 0 0 1
Protein Kinase MARK3 Serine/threonine-protein kinase c-TAK1 9 3 4 0 0 2
Serine protease DPP4 Dipeptidyl peptidase IV 1269 561 367 2 34 298
Enzyme APEX1 DNA-(apurinic or apyrimidinic site) lyase 706 311 211 0 20 156
Phosphodiesterase 4 PDE4A Phosphodiesterase 4A 1 1 1 0 0 0
Threonine protease PSMB5 Proteasome Macropain subunit MB1 202 84 61 0 9 40
Small molecule receptor (family A GPCR) HTR1D Serotonin 1d (5-HT1d) receptor 53 36 8 0 5 10
Small molecule receptor (family A GPCR) HTR1B Serotonin 1b (5-HT1b) receptor 53 36 8 0 5 10
Small molecule receptor (family A GPCR) HTR2A Serotonin 2a (5-HT2a) receptor 83 60 18 0 8 22
Transferase CHAT Choline acetylase 1 1 0 0 0 0
Small molecule receptor (family A GPCR) HTR2C Serotonin 2c (5-HT2c) receptor 77 56 15 0 6 19
Protein Kinase MAPK1 MAP kinase ERK2 393 287 114 0 16 75
Small molecule receptor (family A GPCR) HTR1E Serotonin 1e (5-HT1e) receptor 39 23 5 0 5 8
Oxidoreductase HSD11B1 11-beta-hydroxysteroid dehydrogenase 1 199 74 56 0 2 38
Small molecule receptor (family A GPCR) ADORA2A Adenosine A2a receptor 221 117 77 0 4 55
Protein Kinase EPHA2 Ephrin type-A receptor 2 1 0 1 0 0 1
Protein Kinase EPHA3 Ephrin type-A receptor 3 1 0 1 0 0 1
Protein Kinase EPHA8 Ephrin type-A receptor 8 1 0 1 0 0 1
Protein Kinase EPHB2 Ephrin type-B receptor 2 1 0 1 0 0 1
Protein Kinase LTK Leukocyte tyrosine kinase receptor 8 3 3 0 0 2
Cysteine protease CASP1 Caspase-1 21 13 9 0 0 14
Enzyme NOS3 Nitric-oxide synthase, endothelial 8 6 5 0 1 1
Enzyme NOS1 Nitric-oxide synthase, brain 9 6 5 0 1 1
Protein Kinase TYK2 Tyrosine-protein kinase TYK2 2 1 1 0 0 1
Protein Phosphatase CDC25A Dual specificity phosphatase Cdc25A 31 18 4 0 1 1
Protein Phosphatase CDC25B Dual specificity phosphatase Cdc25B 578 231 155 0 15 123
Protein Kinase AXL Tyrosine-protein kinase receptor UFO 1356 562 395 0 36 318
Small molecule receptor (family A GPCR) ADORA1 Adenosine A1 receptor 223 118 78 0 4 55
Peptide receptor (family A GPCR) AGTR1 Type-1 angiotensin II receptor 1 1 1 0 0 0
Small molecule receptor (family A GPCR) HTR1F Serotonin 1f (5-HT1f) receptor 39 23 5 0 5 8
SLC superfamily of solute carriers SLC5A2 Sodium/glucose cotransporter 2 62 20 13 0 2 14
GABA-A receptor GABRA5 GABA receptor alpha-5 subunit 3 2 1 0 0 1
SLC superfamily of solute carriers SLC6A4 Serotonin transporter 83 67 10 0 6 22
Protein Kinase AKT1 Serine/threonine-protein kinase AKT 2 1 1 0 0 1
Protein Kinase AKT2 Serine/threonine-protein kinase AKT2 2 1 1 0 0 1
Enzyme ATIC AICAR transformylase 1 0 0 0 0 0
Peptide receptor (family A GPCR) CCKBR Cholecystokinin B receptor 1 1 0 0 0 0
Nicotinic acetylcholine receptor CHRNA3 Neuronal acetylcholine receptor subunit alpha-3 7 6 3 0 1 3
Protein Kinase GRK4 G protein-coupled receptor kinase 4 1 0 1 0 0 1
Hydrolase CDA Cytidine deaminase 122 61 45 0 3 27
Cytochrome P450 family 2 CYP2C19 Cytochrome P450 2C19 320 121 87 0 7 85
ATP-binding cassette ABCC1 Multidrug resistance-associated protein 1 1 0 0 0 0 0
GABA-A receptor GABRA3 GABA receptor alpha-3 subunit 3 2 1 0 0 1
Serine protease EPHX2 Epoxide hydratase 6 4 4 0 1 1
Protein Kinase GRK5 G protein-coupled receptor kinase 5 8 3 3 0 0 2
Small molecule receptor (family A GPCR) HTR7 Serotonin 7 (5-HT7) receptor 125 66 34 0 8 31
Small molecule receptor (family A GPCR) CNR2 Cannabinoid CB2 receptor 554 221 172 0 13 151
Peptide receptor (family B GPCR) CRHR1 Corticotropin releasing factor receptor 1 1 1 0 0 1 0
Lyase CA5A Carbonic anhydrase VA 76 28 15 0 2 22
Enzyme NOS2 Nitric oxide synthase, inducible 2 1 1 0 0 0
Small molecule receptor (family A GPCR) ADRA1A Alpha-1a adrenergic receptor 88 38 31 0 4 27
Oxidoreductase PTGS2 Cyclooxygenase-2 259 114 64 0 6 61
Small molecule receptor (family A GPCR) HRH1 Histamine H1 receptor 21 11 9 0 1 7
Small molecule receptor (family A GPCR) ADRA1B Alpha-1b adrenergic receptor 27 11 6 0 2 9
Peptide receptor (family A GPCR) OPRM1 Mu opioid receptor 37 15 6 0 2 13
Nuclear hormone receptor subfamily 1 RORA Nuclear receptor ROR-alpha 2 1 1 0 0 0
Small molecule receptor (family A GPCR) DRD3 Dopamine D3 receptor 162 85 35 0 8 48
Voltage-gated sodium channel SCN1A Sodium channel protein type I alpha subunit 9 5 3 0 0 2
Voltage-gated sodium channel SCN4A Sodium channel protein type IV alpha subunit 9 5 3 0 0 2
Enzyme GCK Hexokinase type IV 1 0 1 0 0 1
Protein Kinase GRK3 Beta-adrenergic receptor kinase 2 1 0 1 0 0 1
Transcription factor AHR Aryl hydrocarbon receptor 863 342 242 1 26 184
Protein Kinase FLT4 Vascular endothelial growth factor receptor 3 5 2 3 0 0 2
Protein Kinase KDR Vascular endothelial growth factor receptor 2 1588 640 448 0 40 392
Protein Kinase MAP2K2 Dual specificity mitogen-activated protein kinase kinase 2 1 0 1 0 0 1
Nicotinic acetylcholine receptor CHRNA7 Neuronal acetylcholine receptor protein alpha-7 subunit 2 2 2 0 0 1
Protein Kinase FLT3 Tyrosine-protein kinase receptor FLT3 1606 664 465 1 43 364
Protein Kinase ACVRL1 Serine/threonine-protein kinase receptor R3 1 0 1 0 0 1
Oxidoreductase HSD17B3 Estradiol 17-beta-dehydrogenase 3 25 9 9 0 1 3
Oxidoreductase HSD17B2 Estradiol 17-beta-dehydrogenase 2 887 361 251 1 26 176
Nuclear hormone receptor subfamily 1 PPARG Peroxisome proliferator-activated receptor gamma 66 44 27 0 0 25
Unclassified protein SNCA Alpha-synuclein 565 323 171 0 20 127
Enzyme BRCA1 Breast cancer type 1 susceptibility protein 15 12 8 0 0 10
Ionotropic glutamate receptor GRIK1 Glutamate receptor ionotropic kainate 1 158 114 30 0 8 29
Metallo protease MMP12 Matrix metalloproteinase 12 689 303 202 1 18 176
Secreted protein THPO Thrombopoietin 769 329 223 0 20 209
Transcription factor STAT3 Signal transducer and activator of transcription 3 16 11 7 0 1 6
Peptide receptor (family A GPCR) OPRD1 Delta opioid receptor 112 49 25 0 8 29
Peptide receptor (family A GPCR) OPRK1 Kappa opioid receptor 10 4 2 0 0 5
Small molecule receptor (family A GPCR) P2RY2 Purinergic receptor P2Y2 1 1 0 0 0 0
Protein Kinase CSK Tyrosine-protein kinase CSK 1 0 1 0 0 1
SLC superfamily of solute carriers SLC19A1 Folate transporter 1 1 0 0 0 0 0
Small molecule receptor (family C GPCR) GRM5 Metabotropic glutamate receptor 5 3 2 1 0 0 0
Small molecule receptor (family A GPCR) HTR2B Serotonin 2b (5-HT2b) receptor 146 81 40 0 9 37
Protein Kinase PRKCI Protein kinase C iota 1 0 1 0 0 1
Transcription factor STAT1 Signal transducer and activator of transcription 1-alpha/beta 17 5 5 0 1 6
Ionotropic glutamate receptor GRIA1 Glutamate receptor ionotropic, AMPA 1 2 2 0 0 0 0
Ionotropic glutamate receptor GRIA2 Glutamate receptor ionotropic, AMPA 2 2 2 0 0 0 0
Enzyme AKR1C3 Aldo-keto-reductase family 1 member C3 568 295 169 1 17 146
Transferase PIK3CA PI3-kinase p110-alpha subunit 154 70 42 0 1 28
Transferase PIK3CB PI3-kinase p110-beta subunit 154 70 42 0 1 28
Protein Kinase MTOR Serine/threonine-protein kinase mTOR 76 44 17 0 5 19
Cysteine protease CASP3 Caspase-3 4 3 1 0 0 4
Protein Kinase MATK Tyrosine-protein kinase CTK 2 0 2 0 0 1
Protein Kinase TEC Tyrosine-protein kinase TEC 1 0 1 0 0 1
Protein Kinase TXK Tyrosine-protein kinase TXK 1 0 1 0 0 1
Protein Kinase ABL2 Tyrosine-protein kinase ABL2 1 0 1 0 0 1
Protein Kinase FRK Tyrosine-protein kinase FRK 4 1 3 0 0 1
Unclassified protein HTT Huntingtin 42 22 12 0 0 27
Lyase CA7 Carbonic anhydrase VII 2259 889 652 3 57 512
Peptide receptor (family B GPCR) GLP1R Glucagon-like peptide 1 receptor 1 1 1 0 0 1
Cysteine protease CTSK Cathepsin K 8 6 3 0 0 2
Protein Kinase GRK6 G protein-coupled receptor kinase 6 1 0 1 0 0 1
Other nuclear protein RAD52 DNA repair protein RAD52 homolog 101 43 32 0 5 21
Protein Kinase ZAP70 Tyrosine-protein kinase ZAP-70 1 0 1 0 0 1
Protein Kinase SYK Tyrosine-protein kinase SYK 2 0 2 0 0 1
Protein Kinase MAPK8 c-Jun N-terminal kinase 1 2 0 2 0 0 1
Protein Kinase MAPK9 c-Jun N-terminal kinase 2 1 0 1 0 0 0
Protein Kinase MAP2K4 Dual specificity mitogen-activated protein kinase kinase 4 163 94 44 1 8 17
Enzyme RECQL ATP-dependent DNA helicase Q1 1116 451 317 0 29 266
5HT3 receptor HTR3A Serotonin 3a (5-HT3a) receptor 43 27 6 0 6 8
Peptide receptor (family A GPCR) BDKRB1 Bradykinin B1 receptor 1 1 1 0 0 0
Protein Kinase MAP2K3 Dual specificity mitogen-activated protein kinase kinase 3 1 0 1 0 0 1
GABA-A receptor GABRA2 GABA receptor alpha-2 subunit 3 2 1 0 0 1
Peptide receptor (family B GPCR) GCGR Glucagon receptor 2 0 1 0 0 1
Small molecule receptor (family A GPCR) HTR5A Serotonin 5a (5-HT5a) receptor 103 46 28 0 7 26
Small molecule receptor (family A GPCR) P2RY1 Purinergic receptor P2Y1 1 1 0 0 0 0
Oxidoreductase XDH Xanthine dehydrogenase 167 60 47 0 3 42
Small molecule receptor (family A GPCR) MTNR1A Melatonin receptor 1A 11 11 1 0 1 0
Ionotropic glutamate receptor GRIA4 Glutamate receptor ionotropic, AMPA 4 142 111 25 0 8 22
Serine protease PREP Prolyl endopeptidase 2 1 0 0 0 0
Nuclear hormone receptor subfamily 2 RXRG Retinoid X receptor gamma 2 1 1 0 0 0
Protein Kinase CSNK1A1 Casein kinase I alpha 11 5 4 0 0 2
Protein Kinase CSNK1D Casein kinase I delta 1 0 1 0 0 0
Transferase PIK3CG PI3-kinase p110-gamma subunit 1 0 0 0 0 0
Oxidoreductase TDO2 Tryptophan 2,3-dioxygenase 13 7 2 0 0 3
Protein Kinase MAPKAPK2 MAP kinase-activated protein kinase 2 1 0 1 0 0 1
Small molecule receptor (family A GPCR) MTNR1B Melatonin receptor 1B 11 11 1 0 1 0
Protein Kinase CDK8 Cell division protein kinase 8 134 48 37 0 4 35
Protein Kinase CLK1 Dual specificty protein kinase CLK1 6 3 4 0 0 1
Protein Kinase CLK2 Dual specificity protein kinase CLK2 10 3 4 0 0 2
Protein Kinase CLK3 Dual specificity protein kinase CLK3 1 0 1 0 0 1
Protein Kinase GSK3A Glycogen synthase kinase-3 alpha 2 0 1 0 0 1
Protein Kinase GSK3B Glycogen synthase kinase-3 beta 6 3 3 0 0 1
Transferase HNMT Histamine N-methyltransferase 1 0 0 0 0 1
Transferase SULT1A1 Sulfotransferase 1A1 65 55 4 0 5 16
Small molecule receptor (family A GPCR) HTR6 Serotonin 6 (5-HT6) receptor 144 75 34 0 7 31
Metallo protease METAP2 Methionine aminopeptidase 2 5 1 1 0 0 1
Protein Kinase CDK7 Cyclin-dependent kinase 7 1 0 0 0 0 0
Protein Kinase CDK9 Cyclin-dependent kinase 9 1 0 0 0 0 0
Hydrolase RAB9A Ras-related protein Rab-9A 171 67 47 0 6 58
Nuclear hormone receptor subfamily 1 RORC Nuclear receptor ROR-gamma 839 306 229 0 22 202
Protein Kinase BLK Tyrosine-protein kinase BLK 2 0 2 0 0 1
P2X receptor P2RX1 P2X purinoceptor 1 1 1 0 0 0 0
Protein Kinase IRAK1 Interleukin-1 receptor-associated kinase 1 3 1 2 0 0 1
Peptide receptor (family A GPCR) CCR6 C-C chemokine receptor type 6 1 0 0 0 0 1
Protein Kinase RPS6KA3 Ribosomal protein S6 kinase alpha 3 4 1 4 0 0 1
Protein Kinase BMX Tyrosine-protein kinase BMX 1 0 1 0 0 1
Protein Kinase PRKX Serine/threonine-protein kinase PRKX 8 3 3 0 0 2
Protein Kinase NEK2 Serine/threonine-protein kinase NEK2 1 0 1 0 0 1
Protein Kinase NEK4 Serine/threonine-protein kinase Nek4 1 0 1 0 0 1
Oxidoreductase PGD 6-phosphogluconate dehydrogenase 198 82 60 0 9 39
Protein Kinase JAK3 Tyrosine-protein kinase JAK3 3 1 2 0 0 1
Protein Kinase MAP2K6 Dual specificity mitogen-activated protein kinase kinase 6 1 0 1 0 0 1
Protein Kinase PLK1 Serine/threonine-protein kinase PLK1 1 0 1 0 0 1
Protein Kinase DAPK1 Death-associated protein kinase 1 1 0 1 0 0 1
Transferase ACLY ATP-citrate synthase 1 1 0 0 0 0
Protein Kinase LIMK1 LIM domain kinase 1 13 6 2 0 0 3
Protein Kinase LIMK2 LIM domain kinase 2 1 0 1 0 0 1
Protein Kinase MAPK12 MAP kinase p38 gamma 1 0 1 0 0 1
Protein Kinase MAPK10 c-Jun N-terminal kinase 3 10 4 4 0 0 1
Enzyme BLM Bloom syndrome protein 541 264 157 1 18 111
Calcium channel auxiliary subunit alpha2delta family CACNA2D1 Voltage-gated calcium channel alpha2/delta subunit 1 2 2 0 0 1 0
Hydrolase ATP12A Potassium-transporting ATPase alpha chain 2 31 13 6 0 3 13
Protein Kinase EPHA5 Ephrin type-A receptor 5 1 0 1 0 0 1
Protein Kinase EPHB4 Ephrin type-B receptor 4 4 2 2 0 0 2
Protein Kinase EPHB1 Ephrin type-B receptor 1 1 0 1 0 0 1
Protein Kinase EPHA4 Ephrin type-A receptor 4 1 0 1 0 0 1
Peptide receptor (family A GPCR) F2RL1 Proteinase-activated receptor 2 1 1 0 0 0 0
Cysteine protease CASP7 Caspase-7 15 12 8 0 0 10
Cysteine protease CASP6 Caspase-6 396 170 107 0 13 86
Enzyme GFER FAD-linked sulfhydryl oxidase ALR 240 101 63 0 4 65
P2X receptor P2RX3 P2X purinoceptor 3 2 1 0 0 0 1
Histone deacetylase HDAC4 Histone deacetylase 4 1 0 0 0 0 0
Aspartic protease BACE1 Beta-secretase 1 76 27 24 0 6 16
Protein Kinase SIK1 Serine/threonine-protein kinase SIK1 1 0 1 0 0 1
Hydrolase EIF4A1 Eukaryotic initiation factor 4A-I 38 9 6 0 0 12
Nuclear hormone receptor subfamily 3 ESRRG Estrogen-related receptor gamma 1 1 0 0 0 0
Isomerase PPIA Cyclophilin A 4 4 2 0 0 2
Isomerase FKBP1A FK506-binding protein 1A 6 5 2 0 0 3
Isomerase FKBP1B FK506-binding protein 1B 4 4 2 0 0 2
Protein Kinase CSNK2A1 Casein kinase II alpha 1025 407 300 0 25 272
Secreted protein HBB Hemoglobin beta chain 27 21 11 0 1 12
Protein Kinase SRPK2 Serine/threonine-protein kinase SRPK2 1 0 1 0 0 1
Protein Kinase MAP3K9 Mitogen-activated protein kinase kinase kinase 9 1 0 1 0 0 1
Enzyme HSD11B2 11-beta-hydroxysteroid dehydrogenase 2 16 9 4 0 0 0
Transcription factor SMAD3 Mothers against decapentaplegic homolog 3 294 115 93 0 5 70
Protein Kinase CDK3 Cyclin-dependent kinase 3 1 0 1 0 0 1
Protein Kinase CDK6 Cyclin-dependent kinase 6 66 22 14 0 2 15
Protein Kinase CDK5 Cyclin-dependent kinase 5 2 0 0 0 0 0
Other nuclear protein MDM2 p53-binding protein Mdm-2 7 2 1 0 0 6
Unclassified protein PMP22 Peripheral myelin protein 22 73 43 16 0 5 18
Fatty acid binding protein family FABP5 Fatty acid binding protein epidermal 479 250 149 1 12 114
SLC superfamily of solute carriers SLC6A3 Dopamine transporter 75 63 6 0 5 16
Protein Kinase PRKCE Protein kinase C epsilon 13 7 8 0 1 7
Protein Kinase MAP2K1 Dual specificity mitogen-activated protein kinase kinase 1 54 21 16 0 2 13
Protein Kinase TEK Tyrosine-protein kinase TIE-2 305 123 100 0 5 72
Protein Kinase MAP3K10 Mitogen-activated protein kinase kinase kinase 10 8 3 3 0 0 2
Isomerase FKBP4 FK506 binding protein 4 4 4 2 0 0 2
Isomerase TOP2B DNA topoisomerase II beta 10 6 4 0 1 1
Protein methyltransferase KMT2A Histone-lysine N-methyltransferase MLL 90 50 33 0 5 34
Nuclear hormone receptor subfamily 1 PPARD Peroxisome proliferator-activated receptor delta 30 19 3 0 2 8
Transcription factor RELA Nuclear factor NF-kappa-B p65 subunit 708 261 207 0 17 171
Serine protease HGFAC Hepatocyte growth factor activator 1 1 0 0 0 1
Protein Kinase PRKCQ Protein kinase C theta 10 5 5 0 1 3
Lyase GLO1 Glyoxalase I 441 194 124 0 15 91
Protein Kinase ACVR1 Activin receptor type-1 7 3 2 0 0 1
Nicotinic acetylcholine receptor CHRNE Acetylcholine receptor protein epsilon chain 2 2 0 0 1 0
Protein Kinase MST1R Macrophage-stimulating protein receptor 1 0 1 0 0 1
Protein Kinase PTK2 Focal adhesion kinase 1 41 14 7 0 1 16
Protein Kinase PRKCZ Protein kinase C zeta 1 0 1 0 0 1
Protein Kinase PRKCD Protein kinase C delta 16 9 6 0 1 6
Protein Kinase BTK Tyrosine-protein kinase BTK 8 3 3 0 0 2
Oxidoreductase AOX1 Aldehyde oxidase 220 140 49 1 11 30
Protein Kinase TYRO3 Tyrosine-protein kinase receptor TYRO3 8 3 3 0 0 2
Transcription factor PAX8 Paired box protein Pax-8 99 33 26 0 1 24
Phosphodiesterase 4 PDE4B Phosphodiesterase 4B 7 6 4 0 0 0
Miscellaneous ion channel BCL2L1 Apoptosis regulator Bcl-X 4 4 2 0 0 1
Other cytosolic protein MCL1 Induced myeloid leukemia cell differentiation protein Mcl-1 27 10 9 0 2 6
Nuclear hormone receptor subfamily 1 PPARA Peroxisome proliferator-activated receptor alpha 497 258 152 1 12 118
Protein Kinase TNK2 Tyrosine kinase non-receptor protein 2 8 3 3 0 0 2
Cytochrome P450 family 24 CYP24A1 Cytochrome P450 24A1 1 0 0 0 0 0
Protein Phosphatase PPP3CA Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform 5 5 2 0 0 3
Protein Kinase DDR1 Epithelial discoidin domain-containing receptor 1 1 0 1 0 0 1
Phosphodiesterase 4 PDE4D Phosphodiesterase 4D 34 22 19 0 0 4
Enzyme ADCY1 Brain adenylate cyclase 1 1 0 0 0 0 0
Protein Kinase ITK Tyrosine-protein kinase ITK/TSK 1 0 1 0 0 1
Protein Kinase DMPK Myotonin-protein kinase 1 0 1 0 0 1
Transferase FUT7 Alpha-(1,3)-fucosyltransferase 7 605 265 182 0 18 134
Transcription factor SREBF2 Sterol regulatory element-binding protein 2 1 1 0 0 0 1
Potassium channels KCNH2 HERG 17 13 6 0 1 8
Protein Kinase MAP4K2 Mitogen-activated protein kinase kinase kinase kinase 2 1 0 1 0 0 0
Protein Kinase MAP3K12 Mitogen-activated protein kinase kinase kinase 12 1 0 1 0 0 1
Protein Kinase MERTK Proto-oncogene tyrosine-protein kinase MER 1 0 1 0 0 1
Ionotropic glutamate receptor GRIK2 Glutamate receptor ionotropic kainate 2 16 3 5 0 0 7
Ionotropic glutamate receptor GRIK3 Glutamate receptor ionotropic kainate 3 158 114 30 0 8 29
Protein Kinase STK4 Serine/threonine-protein kinase MST1 1 0 1 0 0 1
Hydrolase PLA2G7 LDL-associated phospholipase A2 3 3 2 0 1 0
Nuclear hormone receptor subfamily 1 NR1H3 LXR-alpha 7 1 4 0 0 1
Protein Kinase PAK1 Serine/threonine-protein kinase PAK 1 1 0 1 0 0 1
Protein Kinase MAP2K5 Dual specificity mitogen-activated protein kinase kinase 5 1 0 1 0 0 1
Protein Kinase PAK2 Serine/threonine-protein kinase PAK 2 1 0 1 0 0 1
Protein Kinase STK3 Serine/threonine-protein kinase MST2 9 3 4 0 0 2
Protein Kinase MAP3K1 Mitogen-activated protein kinase kinase kinase 1 1 0 1 0 0 1
Protein Kinase PRKG2 cGMP-dependent protein kinase 2 1 0 1 0 0 1
Small molecule receptor (family C GPCR) GRM1 Metabotropic glutamate receptor 1 145 113 26 0 8 22
Protein Kinase ATM Serine-protein kinase ATM 2 1 1 0 0 0
Protein Phosphatase PTPRS Receptor-type tyrosine-protein phosphatase S 30 17 13 0 0 5
Metallo protease ADAM9 ADAM9 1 0 0 0 0 0
Enzyme FKBP5 Peptidyl-prolyl cis-trans isomerase FKBP5 2 1 0 0 0 1
Protein Kinase ROCK1 Rho-associated protein kinase 1 1 0 1 0 0 1
Protein Kinase TNK1 Non-receptor tyrosine-protein kinase TNK1 1 0 1 0 0 1
Structural protein TUBB3 Tubulin beta-3 chain 37 20 11 0 4 13
Isomerase PIN1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 2 1 1 0 0 0
Protein Kinase ATR Serine-protein kinase ATR 2 1 1 0 0 0
Histone deacetylase HDAC1 Histone deacetylase 1 2 0 0 0 0 0
Protein Kinase CAMK2B CaM kinase II beta 1 0 1 0 0 1
Protein Kinase CAMK2G CaM kinase II gamma 1 0 1 0 0 1
Protein Kinase CAMK2D CaM kinase II delta 1 0 1 0 0 1
Protein Kinase DYRK1A Dual-specificity tyrosine-phosphorylation regulated kinase 1A 118 50 39 0 5 25
Small molecule receptor (family A GPCR) HTR4 Serotonin 4 (5-HT4) receptor 39 23 5 0 5 8
Protein Kinase PTK6 Tyrosine-protein kinase BRK 3 1 2 0 0 1
Transcription factor KLF5 Kruppel-like factor 5 4 3 1 0 0 3
Voltage-gated calcium channel CACNA1C Voltage-gated L-type calcium channel alpha-1C subunit 8 6 5 0 0 0
Protein Kinase PRKG1 cGMP-dependent protein kinase 1 beta 1 0 1 0 0 1
Protein Kinase CAMK1 CaM kinase I alpha 1 0 1 0 0 1
Protein Kinase IKBKE Inhibitor of nuclear factor kappa B kinase epsilon subunit 8 3 3 0 0 2
Protein Kinase PTK2B Protein tyrosine kinase 2 beta 1 0 1 0 0 1
Phosphodiesterase 3 PDE3A Phosphodiesterase 3A 9 7 2 0 0 5
Voltage-gated sodium channel SCN5A Sodium channel protein type V alpha subunit 8 5 2 0 0 2
Protein Kinase MELK Maternal embryonic leucine zipper kinase 9 3 4 0 0 2
Nuclear hormone receptor subfamily 1 NR1I3 Nuclear receptor subfamily 1 group I member 3 1 1 1 0 0 0
Enzyme KARS1 Lysyl-tRNA synthetase 104 30 34 0 3 24
Protein Kinase PDK1 Pyruvate dehydrogenase kinase isoform 1 1 0 1 0 0 1
Isomerase EBP 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase 5 5 3 0 0 0
Protein Kinase PRKD1 Protein kinase C mu 1 0 1 0 0 1
Protein Kinase STK38 Serine/threonine-protein kinase 38 1 0 1 0 0 1
Protein Kinase ERBB4 Receptor protein-tyrosine kinase erbB-4 3 1 2 0 0 1
Protein Kinase RPS6KA2 Ribosomal protein S6 kinase alpha 2 1 0 1 0 0 1
Protein Kinase EPHA7 Ephrin type-A receptor 7 1 0 1 0 0 1
Small molecule receptor (family A GPCR) P2RY14 Purinergic receptor P2Y14 1 1 0 0 0 0
Other nuclear protein SF3B3 Splicing factor 3B subunit 3 2 1 0 0 0 1
Protein Kinase RPS6KA1 Ribosomal protein S6 kinase alpha 1 1 0 1 0 0 1
Unclassified protein SHH Sonic hedgehog protein 11 7 4 0 0 2
Protein Kinase TESK1 Dual specificity testis-specific protein kinase 1 1 0 1 0 0 1
Unclassified protein ELAVL1 ELAV-like protein 1 36 15 2 0 0 7
Small molecule receptor (family A GPCR) LTB4R Leukotriene B4 receptor 1 2 2 1 0 1 0
Protein Kinase MYLK Myosin light chain kinase, smooth muscle 1 0 1 0 0 1
Unclassified protein TAB1 Mitogen-activated protein kinase kinase kinase 7-interacting protein 1 1 0 1 0 0 1
Protein Kinase MAPK11 MAP kinase p38 beta 1 0 1 0 0 0
Protein Kinase STK11 Serine/threonine-protein kinase 11 1 0 1 0 0 1
Protein Kinase GRK1 Rhodopsin kinase 1 0 1 0 0 1
Voltage-gated sodium channel SCN9A Sodium channel protein type IX alpha subunit 9 5 3 0 0 2
F-type and V-type ATPases ATP6AP1 Vacuolar ATP synthase subunit S1 1 0 0 0 0 1
Transcription factor NFE2L2 Nuclear factor erythroid 2-related factor 2 18 7 5 1 1 3
Protein Kinase NTRK3 NT-3 growth factor receptor 2 0 2 0 0 1
Ionotropic glutamate receptor GRIK5 Glutamate receptor ionotropic kainate 5 158 114 30 0 8 29
Protein Kinase PKN1 Protein kinase N1 1 0 1 0 0 1
Protein Kinase PKN2 Protein kinase N2 1 0 1 0 0 1
Protein Kinase MAPK14 MAP kinase p38 alpha 18 11 6 0 0 1
Protein Kinase CAMK4 CaM kinase IV 1 0 1 0 0 1
Protein Kinase MAP3K11 Mitogen-activated protein kinase kinase kinase 11 1 0 1 0 0 1
Protein Kinase NTRK2 Neurotrophic tyrosine kinase receptor type 2 2 0 2 0 0 1
Methyl-lysine/arginine binding protein SMN1 Survival motor neuron protein 328 157 91 0 9 101
Transcription factor HIF1A Hypoxia-inducible factor 1 alpha 936 390 264 1 22 244
Cytochrome P450 family 1 CYP1B1 Cytochrome P450 1B1 2147 861 584 2 48 513
Cytochrome P450 family 2 CYP2A13 Cytochrome P450 2A13 76 40 23 0 1 39
Lyase CA9 Carbonic anhydrase IX 1053 463 310 0 24 285
Protein Kinase PHKG1 Phosphorylase kinase gamma subunit 1 1 0 1 0 0 1
Protein Kinase DDR2 Discoidin domain-containing receptor 2 4 2 2 0 0 2
Cytochrome P450 family 51 CYP51A1 Cytochrome P450 51 1 1 1 0 0 0
Enzyme PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 15 4 4 0 0 3
Unclassified protein MPEG1 Macrophage-expressed gene 1 protein 19 14 7 0 1 0
Protein Kinase MYLK3 Myosin light chain kinase 1 0 1 0 0 1
SLC superfamily of solute carriers SLC22A6 Solute carrier family 22 member 6 294 115 93 0 5 70
Protein Kinase SBK1 Serine/threonine-protein kinase SBK1 1 0 1 0 0 1
Unclassified protein PDCD4 Programmed cell death protein 4 1 0 0 0 0 0
Protein Kinase MAP3K19 SPS1/STE20-related protein kinase YSK4 1 0 1 0 0 1
Small molecule receptor (family A GPCR) FFAR4 G-protein coupled receptor 120 549 288 166 1 17 139
Protein Kinase LRRK2 Leucine-rich repeat serine/threonine-protein kinase 2 8 3 3 0 0 2
Protein Kinase CDC42BPA Serine/threonine-protein kinase MRCK-A 1 0 1 0 0 1
Protein Kinase CDC42BPG Serine/threonine-protein kinase MRCK gamma 1 0 1 0 0 1
Protein Kinase NEK5 Serine/threonine-protein kinase Nek5 1 0 1 0 0 1
Protein Kinase ULK3 Serine/threonine-protein kinase ULK3 1 0 1 0 0 1
Peptide receptor (family A GPCR) NPSR1 Neuropeptide S receptor 1374 576 407 0 37 313
Enzyme DSTYK Dual serine/threonine and tyrosine protein kinase 1 0 1 0 0 1
SLC superfamily of solute carriers SLCO4C1 Solute carrier organic anion transporter family member 4C1 12 8 5 0 1 3
Protein Kinase MARK2 MAP/microtubule affinity-regulating kinase 2 1 0 1 0 0 1
Protein Kinase TAOK1 Serine/threonine-protein kinase TAO1 1 0 1 0 0 1
Protein Kinase TLK2 Serine/threonine-protein kinase tousled-like 2 1 0 1 0 0 1
Protein Kinase STK32C Serine/threonine-protein kinase 32C 1 0 1 0 0 1
Protein Kinase PIM3 Serine/threonine-protein kinase PIM3 2 0 2 0 0 1
SLC superfamily of solute carriers SLC47A2 Multidrug and toxin extrusion protein 2 4 1 1 0 0 0
Protein Kinase MYLK4 Myosin light chain kinase family member 4 1 0 1 0 0 1
Protein Kinase HIPK1 Homeodomain-interacting protein kinase 1 3 2 1 0 0 1
Protein Kinase CAMK1D CaM kinase I delta 8 3 3 0 0 2
Protein Kinase MAP4K3 Mitogen-activated protein kinase kinase kinase kinase 3 1 0 1 0 0 1
Protein Kinase MAPKAPK5 MAP kinase-activated protein kinase 5 1 0 1 0 0 1
Protein Kinase BRSK2 BR serine/threonine-protein kinase 2 1 0 1 0 0 1
Protein Kinase NIM1K Serine/threonine-protein kinase NIM1 1 0 1 0 0 1
Protein Kinase ULK2 Serine/threonine-protein kinase ULK2 1 0 1 0 0 1
Lyase CA13 Carbonic anhydrase XIII 4 1 0 0 0 0
Enzyme ABHD12 Monoacylglycerol lipase ABHD12 3 3 2 0 1 0
Protein Kinase MINK1 Misshapen-like kinase 1 2 0 2 0 0 1
Protein Kinase DCLK2 Serine/threonine-protein kinase DCLK2 1 0 1 0 0 1
Protein Kinase CAMKK1 CaM-kinase kinase alpha 1 0 1 0 0 1
Enzyme DAGLB Sn1-specific diacylglycerol lipase beta 3 3 2 0 1 0
Protein Kinase HIPK4 Homeodomain-interacting protein kinase 4 4 2 2 0 0 2
Transient receptor potential channel TRPV1 Vanilloid receptor 91 33 23 0 3 24
Protein Kinase MYO3A Myosin IIIA 1 0 1 0 0 1
Protein Kinase NEK11 Serine/threonine-protein kinase Nek11 1 0 1 0 0 1
Protein Kinase MAPK15 Mitogen-activated protein kinase 15 1 0 1 0 0 1
Protein Kinase NEK9 Serine/threonine-protein kinase NEK9 1 0 1 0 0 1
Protein Kinase BRSK1 BR serine/threonine-protein kinase 1 2 0 2 0 0 1
Small molecule receptor (family A GPCR) HCAR2 Hydroxycarboxylic acid receptor 2 277 179 69 0 12 61
Small molecule receptor (family A GPCR) GPBAR1 G-protein coupled bile acid receptor 1 4 2 2 0 0 2
Hydrolase GANC Neutral alpha-glucosidase C 1 0 0 0 0 0
Protein Kinase HASPIN Serine/threonine-protein kinase haspin 10 8 4 0 1 2
Protein Kinase GRK7 G protein-coupled receptor kinase 7 1 0 1 0 0 1
Histone deacetylase HDAC7 Histone deacetylase 7 1 0 0 0 0 0
Protein Kinase MYO3B Myosin-IIIB 1 0 1 0 0 1
Protein Kinase DYRK2 Dual-specificity tyrosine-phosphorylation regulated kinase 2 5 3 4 0 0 1
Nuclear hormone receptor subfamily 3 ESR2 Estrogen receptor beta 982 449 281 1 28 233
Histone deacetylase HDAC2 Histone deacetylase 2 9 4 1 0 0 1
Histone deacetylase HDAC10 Histone deacetylase 10 1 0 0 0 0 0
Protein Kinase SGK3 Serine/threonine-protein kinase Sgk3 1 0 1 0 0 1
Histone deacetylase HDAC11 Histone deacetylase 11 1 0 0 0 0 0
Histone deacetylase SIRT1 NAD-dependent deacetylase sirtuin 1 1 0 1 0 0 0
SLC superfamily of solute carriers SLC47A1 Multidrug and toxin extrusion protein 1 4 1 1 0 0 0
Small molecule receptor (family A GPCR) P2RY11 Purinergic receptor P2Y11 1 0 1 0 0 0
Protein Kinase AURKB Serine/threonine-protein kinase Aurora-B 1426 581 410 0 37 336
Protein Kinase PBK PDZ-binding kinase 1 0 1 0 0 1
Protein methyltransferase EHMT2 Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 1 1 1 0 0 0
Protein Kinase MARK4 MAP/microtubule affinity-regulating kinase 4 8 3 3 0 0 2
Protein Kinase CAMK1G CaM kinase I gamma 1 0 1 0 0 1
Protein Kinase TSSK2 Testis-specific serine/threonine-protein kinase 2 1 0 1 0 0 1
Protein Kinase NEK1 Serine/threonine-protein kinase Nek1 1 0 1 0 0 1
Protein Kinase PASK PAS domain-containing serine/threonine-protein kinase 1 0 1 0 0 1
Nuclear hormone receptor subfamily 1 NR1H4 Bile acid receptor FXR 1537 531 411 0 40 361
Small molecule receptor (family A GPCR) TAAR1 Trace amine-associated receptor 1 62 36 17 0 3 12
Protein Kinase CAMKK2 CaM-kinase kinase beta 8 3 3 0 0 2
Protein Kinase SRPK1 Serine/threonine-protein kinase SRPK1 1 0 1 0 0 1
Voltage-gated sodium channel SCN2A Sodium channel protein type II alpha subunit 9 5 3 0 0 2
Small molecule receptor (family A GPCR) GPER1 G-protein coupled estrogen receptor 1 8 6 4 0 0 0
P2X receptor P2RX4 P2X purinoceptor 4 1 1 0 0 0 0
Protein Kinase MAP3K5 Mitogen-activated protein kinase kinase kinase 5 1 0 1 0 0 1
Hydrolase MGLL Monoglyceride lipase 1 1 1 0 0 0
Oxidoreductase HSD17B10 Endoplasmic reticulum-associated amyloid beta-peptide-binding protein 1523 668 449 0 43 343
Membrane receptor SIGMAR1 Sigma opioid receptor 40 29 13 0 0 15
Protein Kinase MAP3K3 Mitogen-activated protein kinase kinase kinase 3 1 0 1 0 0 1
SLC superfamily of solute carriers SLC29A1 Equilibrative nucleoside transporter 1 3 2 0 0 0 1
Smoothened receptor (frizzled family GPCR) SMO Smoothened homolog 5 2 2 0 0 0
Serine protease CTRC Chymotrypsin C 1 1 1 0 1 0
Hydrolase FUCA2 Alpha-L-fucosidase 2 1 1 0 0 0 0
Protein Kinase MKNK1 MAP kinase-interacting serine/threonine-protein kinase MNK1 689 302 203 1 18 177
Hydrolase ABHD6 Monoacylglycerol lipase ABHD6 3 3 2 0 1 0
Protein Kinase CDK19 Cell division cycle 2-like protein kinase 6 3 2 1 0 0 1
Protein Kinase TSSK1B Testis-specific serine/threonine-protein kinase 1 1 0 1 0 0 1
Unclassified protein EBPL Emopamil-binding protein-like 3 3 2 0 0 0
Histone deacetylase HDAC8 Histone deacetylase 8 9 4 1 0 0 1
Protein Kinase STK33 Serine/threonine-protein kinase 33 1 0 1 0 0 1
Protein Kinase PRKD2 Serine/threonine-protein kinase D2 2 0 2 0 0 1
Cysteine protease SENP6 Sentrin-specific protease 6 5 3 0 0 0 3
Protein Kinase NUAK2 NUAK family SNF1-like kinase 2 1 0 1 0 0 1
Protein Kinase SIK2 Serine/threonine-protein kinase SIK2 10 4 4 0 0 2
Protein Kinase MYLK2 myosin light chain kinase 2 1 0 1 0 0 1
Protein Kinase SLK Serine/threonine-protein kinase 2 3 1 2 0 0 1
Transferase TNKS2 Tankyrase-2 46 25 16 1 2 7
Protein Kinase TAOK3 Serine/threonine-protein kinase TAO3 1 0 1 0 0 1
Protein Kinase HIPK2 Homeodomain-interacting protein kinase 2 5 2 3 0 0 2
Small molecule receptor (family A GPCR) HRH4 Histamine H4 receptor 19 9 8 0 1 7
Protein Kinase HIPK3 Homeodomain-interacting protein kinase 3 4 2 2 0 0 2
Protein Kinase PLK3 Serine/threonine-protein kinase PLK3 1 0 1 0 0 1
Protein Kinase CLK4 Dual specificity protein kinase CLK4 3 0 2 0 0 1
Protein Kinase MKNK2 MAP kinase signal-integrating kinase 2 1066 443 303 1 25 283
Peptide receptor (family A GPCR) RXFP1 Relaxin receptor 1 1 0 0 0 0 0
Protein Kinase SGK2 Serine/threonine-protein kinase Sgk2 9 3 4 0 0 2
Small molecule receptor (family A GPCR) GPR35 G-protein coupled receptor 35 294 115 93 0 5 70
SLC superfamily of solute carriers SLCO1B3 Solute carrier organic anion transporter family member 1B3 145 58 41 0 5 34
Enzyme NOX4 NADPH oxidase 4 1635 674 468 1 44 374
Protein Kinase PAK6 Serine/threonine-protein kinase PAK6 1 0 1 0 0 1
Protein Kinase SNRK SNF-related serine/threonine-protein kinase 1 0 1 0 0 1
Protein Kinase LATS2 Serine/threonine-protein kinase LATS2 1 0 1 0 0 1
Phosphodiesterase TDP1 Tyrosyl-DNA phosphodiesterase 1 1019 486 289 1 28 211
Protein Kinase IRAK4 Interleukin-1 receptor-associated kinase 4 2 0 2 0 0 1
Voltage-gated sodium channel SCN3A Sodium channel protein type III alpha subunit 9 5 3 0 0 2
Protein Kinase STK32B Serine/threonine-protein kinase 32B 1 0 1 0 0 1
SLC superfamily of solute carriers SLC5A4 Low affinity sodium-glucose cotransporter 61 20 13 0 2 13
Protein Kinase MAP3K20 Mixed lineage kinase 7 1 0 1 0 0 0
Protein Kinase PLK2 Serine/threonine-protein kinase PLK2 1 0 1 0 0 1
Metallo protease ERAP1 Endoplasmic reticulum aminopeptidase 1 4 2 2 0 0 0
Protein Kinase MARK1 Serine/threonine-protein kinase MARK1 1 0 1 0 0 1
Protein Kinase PIM2 Serine/threonine-protein kinase PIM2 2 0 2 0 0 1
Protein Kinase PAK5 Serine/threonine-protein kinase PAK7 1 0 1 0 0 1
Protein Kinase STK26 Serine/threonine-protein kinase MST4 1 0 1 0 0 1
Methyl-lysine/arginine binding protein DNMT3B DNA (cytosine-5)-methyltransferase 3B 2 2 0 0 0 0
Protein Kinase NLK Serine/threonine protein kinase NLK 1 0 1 0 0 1
Histone deacetylase HDAC6 Histone deacetylase 6 1 0 0 0 0 0
Protein Kinase RPS6KB2 Ribosomal protein S6 kinase 2 1 0 1 0 0 1
Small molecule receptor (family C GPCR) GABBR1 GABA-B receptor 1 3 3 3 0 0 3
Protein Kinase STK17A Serine/threonine-protein kinase 17A 2 0 2 0 0 1
Protein Kinase STK39 STE20/SPS1-related proline-alanine-rich protein kinase 1 0 1 0 0 1
Protein Kinase EPHA6 Ephrin type-A receptor 6 1 0 1 0 0 1
Protein Kinase TBK1 Serine/threonine-protein kinase TBK1 8 3 3 0 0 2
Voltage-gated sodium channel SCN11A Sodium channel protein type XI alpha subunit 2 1 1 0 0 1
Protein Kinase DAPK2 Death-associated protein kinase 2 1 0 1 0 0 1
Protein Kinase RPS6KA6 Ribosomal protein S6 kinase alpha 6 1 0 1 0 0 1
Protein Kinase TNIK TRAF2- and NCK-interacting kinase 1 0 1 0 0 1
Protein Kinase TLK1 Serine/threonine-protein kinase tousled-like 1 1 0 1 0 0 1
Histone deacetylase HDAC9 Histone deacetylase 9 1 0 0 0 0 0
Protein Kinase TAOK2 Serine/threonine-protein kinase TAO2 1 0 1 0 0 1
Lyase CA14 Carbonic anhydrase XIV 977 416 266 1 21 243
Protein Kinase ALK ALK tyrosine kinase receptor 41 14 7 0 1 16
Transferase POLI DNA polymerase iota 294 115 93 0 5 70
Serine protease CELA1 Elastase 1 1 0 0 0 0 0
ATP-binding cassette ABCG2 ATP-binding cassette sub-family G member 2 146 43 35 0 1 35
Plant homeodomain PHF8 Histone lysine demethylase PHF8 3 1 0 0 0 1
Protein Kinase CILK1 Serine/threonine-protein kinase ICK 1 0 1 0 0 1
Protein Kinase AURKC Serine/threonine-protein kinase Aurora-C 2 0 1 0 0 1
Voltage-gated sodium channel SCN8A Sodium channel protein type VIII alpha subunit 9 5 3 0 0 2
Histone deacetylase HDAC5 Histone deacetylase 5 1 0 0 0 0 0
Protein Kinase CAMK2A CaM kinase II alpha 8 3 3 0 0 2
Phosphodiesterase 10 PDE10A Phosphodiesterase 10A 9 7 2 0 0 5
Protein Kinase AKT3 Serine/threonine-protein kinase AKT3 2 1 1 0 0 1
Transferase POLH DNA polymerase eta 294 115 93 0 5 70
Unclassified protein PLAA Phospholipase A-2-activating protein 2 2 2 0 0 0
Lyase CA5B Carbonic anhydrase VB 76 28 15 0 2 22
Protein Kinase STK38L Serine/threonine-protein kinase 38-like 1 0 1 0 0 1
Other cytosolic protein NISCH Nischarin 2 1 1 0 0 1
Protein Kinase SIK3 Serine/threonine-protein kinase SIK3 1 0 1 0 0 1
Transferase GSTK1 Glutathione S-transferase kappa 1 7 6 2 0 0 0
Small molecule receptor (family A GPCR) GPR55 G-protein coupled receptor 55 1 1 0 0 0 1
Protein Kinase MAP3K2 Mitogen-activated protein kinase kinase kinase 2 1 0 1 0 0 1
Protein Kinase DYRK1B Dual specificity tyrosine-phosphorylation-regulated kinase 1B 13 6 6 0 0 2
Methyl-lysine/arginine binding protein L3MBTL1 Lethal(3)malignant brain tumor-like protein 1 493 211 136 0 16 107
Hydrolase DAGLA Sn1-specific diacylglycerol lipase alpha 3 3 2 0 1 0
Protein Kinase MAP4K5 Mitogen-activated protein kinase kinase kinase kinase 5 1 0 1 0 0 1
Small molecule receptor (family A GPCR) HRH3 Histamine H3 receptor 46 21 15 0 2 13
Protein Kinase CDC42BPB Serine/threonine-protein kinase MRCK beta 1 0 1 0 0 1
Transmembrane 1-electron transfer carriers NOX1 NADPH oxidase 1 2 2 1 0 1 0
Hydrolase LIPG Endothelial lipase 3 3 2 0 1 0
Protein Kinase STK24 Serine/threonine-protein kinase 24 1 0 1 0 0 1
SLC superfamily of solute carriers SLCO1B1 Solute carrier organic anion transporter family member 1B1 526 268 126 0 17 124
Histone acetyltransferase NCOA3 Nuclear receptor coactivator 3 10 6 4 0 1 1
Access Plants by Target Gene Ontology (Enriched by target proteins of the plant)

GO Type GO Category GO Term No. of Plants No. of Medicinal Plants No. of Food Plants No. of Human Edible Plants No. of Agricultural Plants No. of Garden Plants No. of Drug-producing Plants
BP GO:0051179;localization GO:0015908;fatty acid transport 333 182 61 115 1 11 85
BP GO:0008152;metabolic process GO:0019433;triglyceride catabolic process 318 169 52 111 1 8 79
BP GO:0051179;localization GO:0015909;long-chain fatty acid transport 288 143 42 97 1 8 74
BP GO:0008152;metabolic process GO:0046464;acylglycerol catabolic process 284 139 38 97 1 9 72
BP GO:0008152;metabolic process GO:0006641;triglyceride metabolic process 248 106 20 81 1 6 67
BP GO:0065007;biological regulation GO:0050727;regulation of inflammatory response 713 342 123 214 1 19 188
BP GO:0008152;metabolic process GO:0019369;arachidonic acid metabolic process 2303 956 208 657 2 60 558
BP GO:0008152;metabolic process GO:0019371;cyclooxygenase pathway 270 113 14 79 0 4 72
BP GO:0065007;biological regulation GO:0120162;positive regulation of cold-induced thermogenesis 745 385 108 241 0 22 183
BP GO:0065007;biological regulation GO:0009893;positive regulation of metabolic process 634 345 98 215 0 21 159
BP GO:0008152;metabolic process GO:0019372;lipoxygenase pathway 539 217 41 150 0 10 127
BP GO:0065007;biological regulation GO:0046320;regulation of fatty acid oxidation 229 103 33 73 1 3 61
BP GO:0008152;metabolic process GO:0006631;fatty acid metabolic process 816 319 63 239 0 18 205
BP GO:0065007;biological regulation GO:0019217;regulation of fatty acid metabolic process 245 112 37 75 1 4 64
BP GO:0008152;metabolic process GO:0001516;prostaglandin biosynthetic process 180 75 13 55 0 3 48
BP GO:0065007;biological regulation GO:0032691;negative regulation of interleukin-1 beta production 417 208 111 123 1 10 106
BP GO:0065007;biological regulation GO:0062012;regulation of small molecule metabolic process 505 184 22 150 0 11 119
BP GO:0008152;metabolic process GO:0042759;long-chain fatty acid biosynthetic process 2138 877 206 622 1 51 529
BP GO:0065007;biological regulation GO:0032692;negative regulation of interleukin-1 production 410 202 105 123 1 10 104
BP GO:0008152;metabolic process GO:0006693;prostaglandin metabolic process 194 99 44 56 0 4 43
BP GO:0065007;biological regulation GO:0046889;positive regulation of lipid biosynthetic process 180 78 19 60 1 3 50
BP GO:0008152;metabolic process GO:1901617;organic hydroxy compound biosynthetic process 1225 508 128 360 1 35 312
BP GO:0008152;metabolic process GO:0006690;icosanoid metabolic process 1400 570 102 395 1 32 330
BP GO:0009987;cellular process GO:0031669;cellular response to nutrient levels 156 59 11 51 1 3 41
BP GO:0009987;cellular process GO:0071277;cellular response to calcium ion 241 87 18 74 1 7 59
BP GO:0009987;cellular process GO:0036294;cellular response to decreased oxygen levels 329 160 22 101 1 14 96
BP GO:0008152;metabolic process GO:0006633;fatty acid biosynthetic process 1882 755 174 539 1 44 454
BP GO:0065007;biological regulation GO:0051240;positive regulation of multicellular organismal process 266 160 60 101 0 14 63
BP GO:0008152;metabolic process GO:0001676;long-chain fatty acid metabolic process 2322 951 209 659 2 57 568
BP GO:0065007;biological regulation GO:0032651;regulation of interleukin-1 beta production 349 167 92 99 0 8 90
BP GO:0065007;biological regulation GO:0031347;regulation of defense response 60 29 3 24 0 2 9
BP GO:0065007;biological regulation GO:0031348;negative regulation of defense response 249 102 16 76 0 4 66
BP GO:0065007;biological regulation GO:0019216;regulation of lipid metabolic process 86 27 3 21 0 1 18
BP GO:0065007;biological regulation GO:0031325;positive regulation of cellular metabolic process 430 208 83 136 1 10 114
BP GO:0050896;response to stimulus GO:0051592;response to calcium ion 152 56 10 47 0 4 41
BP GO:0051179;localization GO:0006869;lipid transport 281 125 31 85 0 3 68
BP GO:0050896;response to stimulus GO:0033993;response to lipid 502 251 120 149 0 17 119
BP GO:0065007;biological regulation GO:0032102;negative regulation of response to external stimulus 323 155 27 101 0 5 89
BP GO:0009987;cellular process GO:0071345;cellular response to cytokine stimulus 1157 526 108 349 1 31 289
BP GO:0065007;biological regulation GO:0032101;regulation of response to external stimulus 49 21 1 17 0 0 9
BP GO:0009987;cellular process GO:0071456;cellular response to hypoxia 584 261 24 176 1 17 159
BP GO:0009987;cellular process GO:0071248;cellular response to metal ion 340 214 119 103 0 11 82
BP GO:0008152;metabolic process GO:0006367;transcription initiation from RNA polymerase II promoter 574 237 63 175 1 15 116
BP GO:0065007;biological regulation GO:0032096;negative regulation of response to food 221 78 10 62 0 2 55
BP GO:0065007;biological regulation GO:0031620;regulation of fever generation 96 42 1 29 0 1 24
BP GO:0032501;multicellular organismal process GO:1990379;lipid transport across blood-brain barrier 207 73 9 61 0 2 52
BP GO:0065007;biological regulation GO:0031394;positive regulation of prostaglandin biosynthetic process 86 36 0 23 0 1 23
BP GO:0065007;biological regulation GO:0031652;positive regulation of heat generation 86 36 0 23 0 1 23
BP GO:0050896;response to stimulus GO:0034694;response to prostaglandin 188 71 15 60 0 5 51
BP GO:0065007;biological regulation GO:0002820;negative regulation of adaptive immune response 234 94 14 77 0 5 65
BP GO:0009987;cellular process GO:0009267;cellular response to starvation 121 54 12 33 1 3 33
BP GO:0065007;biological regulation GO:0010891;negative regulation of sequestering of triglyceride 228 88 5 67 0 2 59
BP GO:0065007;biological regulation GO:0070092;regulation of glucagon secretion 160 54 5 53 0 4 45
BP GO:0065007;biological regulation GO:0046137;negative regulation of vitamin metabolic process 575 268 108 162 1 16 156
BP GO:0065007;biological regulation GO:1903242;regulation of cardiac muscle hypertrophy in response to stress 574 254 26 167 2 15 163
BP GO:0065007;biological regulation GO:0031622;positive regulation of fever generation 85 35 0 22 0 1 23
BP GO:0008152;metabolic process GO:0006352;DNA-templated transcription, initiation 485 202 53 151 1 14 99
BP GO:0065007;biological regulation GO:0070374;positive regulation of ERK1 and ERK2 cascade 449 222 89 133 0 14 116
BP GO:0065007;biological regulation GO:0043950;positive regulation of cAMP-mediated signaling 131 44 4 44 0 3 36
BP GO:0065007;biological regulation GO:0071073;positive regulation of phospholipid biosynthetic process 741 296 50 221 0 24 186
BP GO:0008152;metabolic process GO:2001301;lipoxin biosynthetic process 834 346 80 257 0 18 205
BP GO:0065007;biological regulation GO:0010566;regulation of ketone biosynthetic process 129 42 3 43 0 3 35
BP GO:0032501;multicellular organismal process GO:0072539;T-helper 17 cell differentiation 227 71 3 70 0 4 56
BP GO:0065007;biological regulation GO:2001280;positive regulation of unsaturated fatty acid biosynthetic process 75 31 0 20 0 0 18
BP GO:0009987;cellular process GO:0050872;white fat cell differentiation 137 49 3 47 0 3 38
BP GO:0065007;biological regulation GO:0031392;regulation of prostaglandin biosynthetic process 74 30 0 19 0 0 17
BP GO:0009987;cellular process GO:0019221;cytokine-mediated signaling pathway 922 404 78 269 1 23 232
BP GO:0065007;biological regulation GO:0031328;positive regulation of cellular biosynthetic process 162 61 9 40 0 4 55
BP GO:0065007;biological regulation GO:0001818;negative regulation of cytokine production 246 91 7 84 0 6 56
BP GO:0065007;biological regulation GO:0032099;negative regulation of appetite 163 53 1 47 0 1 43
BP GO:0009987;cellular process GO:0050873;brown fat cell differentiation 124 38 2 39 0 3 34
BP GO:0008152;metabolic process GO:0042181;ketone biosynthetic process 388 152 19 114 0 9 104
BP GO:0065007;biological regulation GO:2001171;positive regulation of ATP biosynthetic process 160 51 1 45 0 1 42
BP GO:0065007;biological regulation GO:0032368;regulation of lipid transport 156 48 1 44 0 1 41
BP GO:0065007;biological regulation GO:0032000;positive regulation of fatty acid beta-oxidation 157 50 1 45 0 1 42
BP GO:0008152;metabolic process GO:0006636;unsaturated fatty acid biosynthetic process 352 149 39 116 0 7 94
BP GO:0008152;metabolic process GO:0051122;hepoxilin biosynthetic process 583 293 134 169 0 13 143
BP GO:0008152;metabolic process GO:0051121;hepoxilin metabolic process 582 292 134 169 0 13 143
BP GO:0008152;metabolic process GO:0042448;progesterone metabolic process 81 27 1 28 0 1 19
BP GO:0065007;biological regulation GO:0009914;hormone transport 115 35 2 35 0 3 31
BP GO:0065007;biological regulation GO:0035358;regulation of peroxisome proliferator activated receptor signaling pathway 94 36 1 32 0 1 25
BP GO:0065007;biological regulation GO:0009966;regulation of signal transduction 112 57 28 42 0 3 24
BP GO:0009987;cellular process GO:0071379;cellular response to prostaglandin stimulus 51 17 1 18 0 1 12
BP GO:0065007;biological regulation GO:0010887;negative regulation of cholesterol storage 429 160 18 135 0 7 98
BP GO:0065007;biological regulation GO:0042753;positive regulation of circadian rhythm 175 50 2 55 0 4 46
BP GO:0065007;biological regulation GO:0045820;negative regulation of glycolytic process 92 32 0 27 0 0 21
BP GO:0008152;metabolic process GO:0034310;primary alcohol catabolic process 119 55 20 36 0 2 37
BP GO:0065007;biological regulation GO:0060099;regulation of phagocytosis, engulfment 90 34 0 30 0 1 25
BP GO:0065007;biological regulation GO:1900543;negative regulation of purine nucleotide metabolic process 91 31 0 26 0 0 21
BP GO:0065007;biological regulation GO:0051896;regulation of protein kinase B signaling 1840 763 159 529 2 42 429
BP GO:0065007;biological regulation GO:0050728;negative regulation of inflammatory response 939 467 140 295 0 25 209
BP GO:0065007;biological regulation GO:0071636;positive regulation of transforming growth factor beta production 58 23 0 13 0 0 14
BP GO:0050896;response to stimulus GO:0031960;response to corticosteroid 36 12 0 13 0 0 6
BP GO:0050896;response to stimulus GO:0036314;response to sterol 133 38 2 39 0 4 34
BP GO:0065007;biological regulation GO:0010614;negative regulation of cardiac muscle hypertrophy 285 122 9 75 2 5 79
BP GO:0032502;developmental process GO:0060612;adipose tissue development 149 41 2 39 0 4 43
BP GO:0065007;biological regulation GO:1903037;regulation of leukocyte cell-cell adhesion 194 68 7 52 0 3 46
BP GO:0065007;biological regulation GO:0046321;positive regulation of fatty acid oxidation 83 27 0 23 0 0 21
BP GO:0042592;homeostatic process GO:0055091;phospholipid homeostasis 35 13 0 12 0 0 8
BP GO:0008152;metabolic process GO:0034440;lipid oxidation 325 141 31 101 0 6 77
BP GO:0009987;cellular process GO:0090399;replicative senescence 71 30 0 17 0 2 21
BP GO:0009987;cellular process GO:0043618;regulation of transcription from RNA polymerase II promoter in response to stress 240 91 5 70 1 7 65
BP GO:0008152;metabolic process GO:0006259;DNA metabolic process 677 287 69 198 0 19 155
BP GO:0008152;metabolic process GO:0006281;DNA repair 616 240 33 188 0 13 151
BP GO:0065007;biological regulation GO:0051000;positive regulation of nitric-oxide synthase activity 95 51 3 26 0 2 22
BP GO:0065007;biological regulation GO:0048522;positive regulation of cellular process 1438 598 88 421 1 38 359
BP GO:0009987;cellular process GO:0036003;positive regulation of transcription from RNA polymerase II promoter in response to stress 67 35 2 15 1 3 19
BP GO:0065007;biological regulation GO:0032770;positive regulation of monooxygenase activity 54 32 0 14 0 2 12
BP GO:0008152;metabolic process GO:0016310;phosphorylation 1019 412 71 308 0 24 241
BP GO:0065007;biological regulation GO:1901796;regulation of signal transduction by p53 class mediator 582 237 29 184 0 14 141
BP GO:0065007;biological regulation GO:1902895;positive regulation of pri-miRNA transcription by RNA polymerase II 210 96 11 71 1 5 59
BP GO:0065007;biological regulation GO:0045639;positive regulation of myeloid cell differentiation 312 120 6 86 0 6 86
BP GO:0065007;biological regulation GO:0050999;regulation of nitric-oxide synthase activity 62 31 3 11 0 1 16
BP GO:0009987;cellular process GO:0048863;stem cell differentiation 27 18 0 6 0 2 4
BP GO:0065007;biological regulation GO:0010628;positive regulation of gene expression 41 31 5 23 0 3 6
BP GO:0065007;biological regulation GO:1902893;regulation of pri-miRNA transcription by RNA polymerase II 288 130 26 91 1 5 82
BP GO:0009987;cellular process GO:0006796;phosphate-containing compound metabolic process 68 29 0 18 0 1 17
BP GO:0009987;cellular process GO:0048762;mesenchymal cell differentiation 19 11 0 2 0 1 3
BP GO:0065007;biological regulation GO:0042770;signal transduction in response to DNA damage 12 8 0 4 0 1 2
BP GO:0065007;biological regulation GO:0048523;negative regulation of cellular process 407 194 37 130 2 14 102
BP GO:0065007;biological regulation GO:0010507;negative regulation of autophagy 159 67 9 44 0 5 34
BP GO:0050896;response to stimulus GO:0000302;response to reactive oxygen species 467 282 160 135 1 21 114
BP GO:0009987;cellular process GO:0044773;mitotic DNA damage checkpoint signaling 79 46 3 29 0 2 25
BP GO:0065007;biological regulation GO:0031330;negative regulation of cellular catabolic process 29 18 0 7 0 2 6
BP GO:0065007;biological regulation GO:0051726;regulation of cell cycle 45 18 1 14 0 2 13
BP GO:0065007;biological regulation GO:0001938;positive regulation of endothelial cell proliferation 174 70 6 60 0 4 43
BP GO:0009987;cellular process GO:0034644;cellular response to UV 458 261 75 150 0 16 126
BP GO:0065007;biological regulation GO:0001936;regulation of endothelial cell proliferation 244 101 7 76 0 8 61
BP GO:0050896;response to stimulus GO:0006974;cellular response to DNA damage stimulus 668 264 52 200 0 15 154
BP GO:0065007;biological regulation GO:0010634;positive regulation of epithelial cell migration 342 143 16 100 0 6 99
BP GO:0065007;biological regulation GO:0042127;regulation of cell population proliferation 2208 933 187 623 2 60 542
BP GO:0065007;biological regulation GO:0010941;regulation of cell death 59 23 6 19 0 2 18
BP GO:0065007;biological regulation GO:0010604;positive regulation of macromolecule metabolic process 117 67 29 49 0 4 25
BP GO:0008152;metabolic process GO:0006260;DNA replication 363 123 3 80 0 7 79
BP GO:0032501;multicellular organismal process GO:0014831;gastro-intestinal system smooth muscle contraction 92 45 5 27 0 5 23
BP GO:0032502;developmental process GO:0048539;bone marrow development 345 146 15 97 0 8 89
BP GO:0065007;biological regulation GO:1903377;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway 312 104 8 75 0 4 80
BP GO:0009987;cellular process GO:0071236;cellular response to antibiotic 109 58 5 30 0 4 36
BP GO:0009987;cellular process GO:0061419;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia 306 102 9 76 1 5 77
BP GO:0065007;biological regulation GO:0010511;regulation of phosphatidylinositol biosynthetic process 118 68 23 29 0 8 32
BP GO:0065007;biological regulation GO:0050679;positive regulation of epithelial cell proliferation 584 221 24 160 0 10 151
BP GO:0009987;cellular process GO:0034599;cellular response to oxidative stress 931 482 197 281 1 30 234
BP GO:0065007;biological regulation GO:1902531;regulation of intracellular signal transduction 250 114 8 85 0 3 46
BP GO:0065007;biological regulation GO:0070243;regulation of thymocyte apoptotic process 73 42 4 18 0 3 24
BP GO:0065007;biological regulation GO:1902033;regulation of hematopoietic stem cell proliferation 276 98 4 62 0 6 77
BP GO:0065007;biological regulation GO:0046885;regulation of hormone biosynthetic process 256 86 7 60 0 4 66
BP GO:0032501;multicellular organismal process GO:0014897;striated muscle hypertrophy 58 26 0 18 0 3 17
BP GO:0009987;cellular process GO:0035855;megakaryocyte development 237 86 4 53 0 6 68
BP GO:0042592;homeostatic process GO:0032364;oxygen homeostasis 255 85 7 59 0 4 66
BP GO:0042592;homeostatic process GO:0033483;gas homeostasis 236 81 7 54 0 4 60
BP GO:0065007;biological regulation GO:0032909;regulation of transforming growth factor beta2 production 280 103 8 79 0 5 73
BP GO:0009987;cellular process GO:0032060;bleb assembly 30 18 0 6 0 1 12
BP GO:0065007;biological regulation GO:0032352;positive regulation of hormone metabolic process 251 89 11 58 0 3 66
BP GO:0065007;biological regulation GO:0045899;positive regulation of RNA polymerase II transcription preinitiation complex assembly 191 105 26 50 1 2 43
BP GO:0051179;localization GO:0015671;oxygen transport 12 8 0 4 0 0 6
BP GO:0065007;biological regulation GO:1903376;regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway 232 80 7 52 0 4 60
BP GO:0065007;biological regulation GO:2000112;regulation of cellular macromolecule biosynthetic process 136 59 10 35 1 3 22
BP GO:0065007;biological regulation GO:0006983;ER overload response 64 33 0 15 0 1 21
BP GO:0009987;cellular process GO:0043619;regulation of transcription from RNA polymerase II promoter in response to oxidative stress 183 65 6 41 0 3 51
BP GO:0065007;biological regulation GO:1903689;regulation of wound healing, spreading of epidermal cells 29 18 0 6 0 1 11
BP GO:0065007;biological regulation GO:1900119;positive regulation of execution phase of apoptosis 58 29 0 12 0 1 21
BP GO:0065007;biological regulation GO:0045839;negative regulation of mitotic nuclear division 7 4 0 1 0 0 2
BP GO:0065007;biological regulation GO:0070099;regulation of chemokine-mediated signaling pathway 183 65 6 41 0 3 51
BP GO:0032501;multicellular organismal process GO:0003300;cardiac muscle hypertrophy 18 14 0 4 0 1 4
BP GO:0008152;metabolic process GO:0000012;single strand break repair 173 85 2 48 1 4 41
BP GO:0009987;cellular process GO:0090400;stress-induced premature senescence 86 42 0 21 0 2 24
BP GO:0065007;biological regulation GO:0038202;TORC1 signaling 29 18 0 6 0 1 11
BP GO:0065007;biological regulation GO:0002761;regulation of myeloid leukocyte differentiation 29 18 0 6 0 1 11
BP GO:0065007;biological regulation GO:0006975;DNA damage induced protein phosphorylation 9 5 0 2 0 0 2
BP GO:0008152;metabolic process GO:0006468;protein phosphorylation 1766 714 142 503 1 47 422
BP GO:0008152;metabolic process GO:0018105;peptidyl-serine phosphorylation 642 272 30 194 1 15 162
BP GO:0009987;cellular process GO:0043276;anoikis 65 36 0 13 0 1 17
BP GO:0065007;biological regulation GO:0035563;positive regulation of chromatin binding 25 12 0 3 0 0 10
BP GO:0009987;cellular process GO:0098751;bone cell development 185 77 4 45 0 6 51
BP GO:0065007;biological regulation GO:0045654;positive regulation of megakaryocyte differentiation 154 64 4 35 0 5 40
BP GO:0065007;biological regulation GO:0051095;regulation of helicase activity 53 26 0 9 0 1 18
BP GO:0065007;biological regulation GO:0046602;regulation of mitotic centrosome separation 7 4 0 1 0 0 2
BP GO:0008152;metabolic process GO:0006265;DNA topological change 30 19 0 6 0 0 6
BP GO:0008152;metabolic process GO:0006302;double-strand break repair 369 137 10 106 1 8 83
BP GO:0008152;metabolic process GO:0018209;peptidyl-serine modification 623 258 26 183 1 15 159
BP GO:0065007;biological regulation GO:0045898;regulation of RNA polymerase II transcription preinitiation complex assembly 166 88 20 42 1 2 34
BP GO:0065007;biological regulation GO:0098664;G protein-coupled serotonin receptor signaling pathway 118 69 25 31 0 7 32
BP GO:0009987;cellular process GO:0060218;hematopoietic stem cell differentiation 52 26 0 9 0 1 17
BP GO:0050896;response to stimulus GO:0043201;response to leucine 27 17 0 5 0 0 9
BP GO:0065007;biological regulation GO:0051549;positive regulation of keratinocyte migration 47 34 2 10 0 0 13
BP GO:0009987;cellular process GO:0071233;cellular response to leucine 27 17 0 5 0 0 9
BP GO:0009987;cellular process GO:1990253;cellular response to leucine starvation 27 17 0 5 0 0 9
BP GO:0065007;biological regulation GO:0051974;negative regulation of telomerase activity 53 25 1 8 0 1 17
BP GO:0065007;biological regulation GO:0070234;positive regulation of T cell apoptotic process 48 22 0 6 0 1 15
BP GO:0065007;biological regulation GO:0045945;positive regulation of transcription by RNA polymerase III 38 19 0 5 0 0 14
BP GO:0065007;biological regulation GO:1901838;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I 26 16 0 4 0 0 9
BP GO:0065007;biological regulation GO:0030949;positive regulation of vascular endothelial growth factor receptor signaling pathway 132 49 6 29 0 2 35
BP GO:0009987;cellular process GO:0006978;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator 40 15 0 6 0 1 13
BP GO:0032502;developmental process GO:0032288;myelin assembly 22 13 0 4 0 0 8
BP GO:0009987;cellular process GO:0007167;enzyme linked receptor protein signaling pathway 1503 619 139 431 0 37 359
BP GO:0065007;biological regulation GO:0051347;positive regulation of transferase activity 1527 629 141 444 0 40 371
BP GO:0065007;biological regulation GO:0043549;regulation of kinase activity 1500 618 140 434 0 38 361
BP GO:0065007;biological regulation GO:0043069;negative regulation of programmed cell death 1778 753 185 512 0 48 430
BP GO:0065007;biological regulation GO:0033674;positive regulation of kinase activity 1519 625 140 436 0 39 363
BP GO:0065007;biological regulation GO:0043066;negative regulation of apoptotic process 1809 782 202 530 0 51 430
BP GO:0065007;biological regulation GO:0042981;regulation of apoptotic process 1809 743 170 516 1 47 436
BP GO:0008152;metabolic process GO:0046777;protein autophosphorylation 1818 728 143 515 1 46 438
BP GO:0065007;biological regulation GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway 1493 607 132 431 0 35 359
BP GO:0065007;biological regulation GO:0042327;positive regulation of phosphorylation 1699 687 147 482 0 42 408
BP GO:0051179;localization GO:0015701;bicarbonate transport 2264 919 158 659 3 59 549
BP GO:0009987;cellular process GO:0000165;MAPK cascade 1286 519 101 365 0 29 296
BP GO:0065007;biological regulation GO:0051897;positive regulation of protein kinase B signaling 1697 698 141 484 1 43 392
BP GO:0008152;metabolic process GO:0018108;peptidyl-tyrosine phosphorylation 1390 541 85 402 0 34 323
BP GO:0009987;cellular process GO:1903083;protein localization to condensed chromosome 1193 445 56 343 0 28 279
BP GO:0065007;biological regulation GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling 1393 534 64 404 0 32 331
BP GO:0009987;cellular process GO:0034501;protein localization to kinetochore 1165 422 45 330 0 28 268
BP GO:0065007;biological regulation GO:2001028;positive regulation of endothelial cell chemotaxis 1282 461 48 358 0 29 307
BP GO:0008152;metabolic process GO:0042554;superoxide anion generation 1189 433 43 335 0 29 273
BP GO:0008152;metabolic process GO:0038083;peptidyl-tyrosine autophosphorylation 1443 560 87 418 1 36 339
BP GO:0009987;cellular process GO:0071459;protein localization to chromosome, centromeric region 1104 388 36 311 0 27 257
BP GO:0051179;localization GO:0015711;organic anion transport 2250 902 159 649 3 58 554
BP GO:0032502;developmental process GO:0061436;establishment of skin barrier 1031 373 34 294 0 26 244
BP GO:0032502;developmental process GO:0033561;regulation of water loss via skin 1028 371 32 291 0 26 244
BP GO:0065007;biological regulation GO:0014066;regulation of phosphatidylinositol 3-kinase signaling 1425 563 108 408 0 33 337
BP GO:0065007;biological regulation GO:1902533;positive regulation of intracellular signal transduction 1752 726 174 498 1 48 412
BP GO:0065007;biological regulation GO:0070371;ERK1 and ERK2 cascade 1138 477 121 314 0 31 271
BP GO:0009987;cellular process GO:0097028;dendritic cell differentiation 947 339 25 265 0 25 222
BP GO:0009987;cellular process GO:1903131;mononuclear cell differentiation 938 333 24 262 0 25 220
BP GO:0008152;metabolic process GO:0008210;estrogen metabolic process 2221 936 198 626 1 59 542
BP GO:0009987;cellular process GO:0002244;hematopoietic progenitor cell differentiation 1097 419 51 316 1 31 263
BP GO:0009987;cellular process GO:0006801;superoxide metabolic process 873 300 19 241 0 23 212
BP GO:0065007;biological regulation GO:0043408;regulation of MAPK cascade 1441 604 164 408 0 41 345
BP GO:0032501;multicellular organismal process GO:0048754;branching morphogenesis of an epithelial tube 700 238 18 182 0 19 172
BP GO:0065007;biological regulation GO:0050921;positive regulation of chemotaxis 832 299 22 226 0 23 197
BP GO:0065007;biological regulation GO:0008284;positive regulation of cell population proliferation 1950 773 116 548 1 51 469
BP GO:0008152;metabolic process GO:0033559;unsaturated fatty acid metabolic process 1161 480 127 322 2 29 292
BP GO:0032502;developmental process GO:0048514;blood vessel morphogenesis 651 212 11 162 0 18 169
BP GO:0008152;metabolic process GO:0018212;peptidyl-tyrosine modification 998 356 45 265 0 26 247
BP GO:0008152;metabolic process GO:0019395;fatty acid oxidation 672 246 40 175 0 18 171
BP GO:0050896;response to stimulus GO:0014070;response to organic cyclic compound 1676 664 128 455 1 45 425
BP GO:0065007;biological regulation GO:2000142;regulation of DNA-templated transcription, initiation 363 151 12 110 1 9 93
BP GO:0065007;biological regulation GO:0060260;regulation of transcription initiation from RNA polymerase II promoter 324 134 11 98 1 9 79
BP GO:0065007;biological regulation GO:0048010;vascular endothelial growth factor receptor signaling pathway 775 275 18 188 0 15 180
BP GO:0065007;biological regulation GO:0043410;positive regulation of MAPK cascade 1297 565 164 377 1 37 314
BP GO:0032502;developmental process GO:0043588;skin development 441 158 13 109 0 13 103
BP GO:0008152;metabolic process GO:0031145;anaphase-promoting complex-dependent catabolic process 494 167 10 121 0 14 120
BP GO:0032501;multicellular organismal process GO:0030098;lymphocyte differentiation 422 150 6 103 0 12 89
BP GO:0065007;biological regulation GO:0010595;positive regulation of endothelial cell migration 901 322 19 251 0 18 235
BP GO:0009987;cellular process GO:0030097;hemopoiesis 1387 528 62 393 1 31 336
BP GO:0009987;cellular process GO:0030855;epithelial cell differentiation 652 218 13 173 0 16 148
BP GO:0065007;biological regulation GO:1904018;positive regulation of vasculature development 1097 407 30 303 0 27 289
BP GO:0065007;biological regulation GO:2000138;positive regulation of cell proliferation involved in heart morphogenesis 394 138 4 88 0 9 95
BP GO:0009987;cellular process GO:0038033;positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway 422 141 5 95 0 11 112
BP GO:0065007;biological regulation GO:0051901;positive regulation of mitochondrial depolarization 422 141 5 95 0 11 112
BP GO:0009987;cellular process GO:0071316;cellular response to nicotine 700 267 44 193 0 16 175
BP GO:0065007;biological regulation GO:1905097;regulation of guanyl-nucleotide exchange factor activity 358 120 3 81 0 9 85
BP GO:0009987;cellular process GO:0071305;cellular response to vitamin D 390 136 3 88 0 9 93
BP GO:0065007;biological regulation GO:0010957;negative regulation of vitamin D biosynthetic process 325 123 19 86 0 7 93
BP GO:0065007;biological regulation GO:2000628;regulation of miRNA metabolic process 662 257 44 187 0 15 161
BP GO:0008152;metabolic process GO:0000965;mitochondrial RNA 3'-end processing 437 165 8 107 0 12 102
BP GO:0008152;metabolic process GO:0070901;mitochondrial tRNA methylation 409 156 8 100 0 12 92
BP GO:0065007;biological regulation GO:0032823;regulation of natural killer cell differentiation 314 106 3 70 0 9 71
BP GO:0065007;biological regulation GO:0036324;vascular endothelial growth factor receptor-2 signaling pathway 335 112 4 76 0 10 80
BP GO:0008152;metabolic process GO:0051103;DNA ligation involved in DNA repair 370 132 4 85 0 10 82
BP GO:0008152;metabolic process GO:0008202;steroid metabolic process 2216 918 203 624 1 57 539
BP GO:0065007;biological regulation GO:0032466;negative regulation of cytokinesis 285 95 4 69 0 9 73
BP GO:0065007;biological regulation GO:0060556;regulation of vitamin D biosynthetic process 259 99 12 72 0 7 74
BP GO:0050896;response to stimulus GO:1990776;response to angiotensin 576 229 35 168 0 16 140
BP GO:0050896;response to stimulus GO:0035404;histone-serine phosphorylation 283 93 3 69 0 8 73
BP GO:0008152;metabolic process GO:0006549;isoleucine metabolic process 324 123 5 81 0 10 77
BP GO:0008152;metabolic process GO:2001300;lipoxin metabolic process 518 188 9 152 0 11 117
BP GO:0065007;biological regulation GO:1900125;regulation of hyaluronan biosynthetic process 246 93 12 67 0 7 72
BP GO:0008152;metabolic process GO:0042780;tRNA 3'-end processing 312 117 5 79 0 10 72
BP GO:0009987;cellular process GO:0071219;cellular response to molecule of bacterial origin 131 49 5 34 0 3 35
BP GO:0065007;biological regulation GO:0045766;positive regulation of angiogenesis 963 363 27 280 0 25 259
BP GO:0009987;cellular process GO:0071222;cellular response to lipopolysaccharide 123 44 4 33 0 3 31
BP GO:0032502;developmental process GO:0060429;epithelium development 402 132 8 105 0 12 87
BP GO:0009987;cellular process GO:0071310;cellular response to organic substance 1734 617 48 479 1 39 421
BP GO:0065007;biological regulation GO:2000669;negative regulation of dendritic cell apoptotic process 217 70 1 52 0 5 49
BP GO:0065007;biological regulation GO:0060558;regulation of calcidiol 1-monooxygenase activity 219 84 10 64 0 6 63
BP GO:0009987;cellular process GO:0090166;Golgi disassembly 215 67 1 51 0 5 48
BP GO:0065007;biological regulation GO:1904181;positive regulation of membrane depolarization 225 72 2 58 0 6 55
BP GO:0065007;biological regulation GO:2000630;positive regulation of miRNA metabolic process 496 195 31 147 0 14 118
BP GO:0065007;biological regulation GO:0045685;regulation of glial cell differentiation 187 59 1 45 0 5 43
BP GO:0065007;biological regulation GO:0048549;positive regulation of pinocytosis 181 55 1 44 0 4 42
BP GO:0009987;cellular process GO:0002320;lymphoid progenitor cell differentiation 261 91 5 56 0 5 59
BP GO:0008152;metabolic process GO:0097267;omega-hydroxylase P450 pathway 1980 819 166 561 2 48 479
BP GO:0008152;metabolic process GO:0019373;epoxygenase P450 pathway 1923 787 165 540 1 49 471
BP GO:0008152;metabolic process GO:0042572;retinol metabolic process 1942 801 162 551 1 46 472
BP GO:0008152;metabolic process GO:0034308;primary alcohol metabolic process 1906 773 156 539 1 45 462
BP GO:0065007;biological regulation GO:0001819;positive regulation of cytokine production 631 273 39 197 0 19 141
BP GO:0008152;metabolic process GO:0042420;dopamine catabolic process 222 104 7 71 0 4 56
BP GO:0008152;metabolic process GO:0016098;monoterpenoid metabolic process 1294 545 131 362 2 32 307
BP GO:0065007;biological regulation GO:1904251;regulation of bile acid metabolic process 878 333 40 260 0 20 201
BP GO:0008152;metabolic process GO:0042424;catecholamine catabolic process 198 90 6 62 0 3 52
BP GO:0008152;metabolic process GO:0006721;terpenoid metabolic process 1195 505 123 331 2 28 289
BP GO:0065007;biological regulation GO:0070857;regulation of bile acid biosynthetic process 813 299 32 237 0 16 184
BP GO:0008152;metabolic process GO:0001523;retinoid metabolic process 1964 791 166 555 1 51 484
BP GO:0065007;biological regulation GO:0050810;regulation of steroid biosynthetic process 747 282 40 215 0 16 172
BP GO:0008152;metabolic process GO:0042417;dopamine metabolic process 388 192 50 122 0 14 97
BP GO:0065007;biological regulation GO:0090181;regulation of cholesterol metabolic process 633 229 20 179 0 13 149
BP GO:0008152;metabolic process GO:0042738;exogenous drug catabolic process 804 350 96 220 1 20 202
BP GO:0008152;metabolic process GO:0042737;drug catabolic process 756 344 95 204 1 19 189
BP GO:0009987;cellular process GO:0071407;cellular response to organic cyclic compound 1813 747 148 522 2 45 414
BP GO:0065007;biological regulation GO:0010575;positive regulation of vascular endothelial growth factor production 828 306 34 225 2 16 220
BP GO:0065007;biological regulation GO:0010574;regulation of vascular endothelial growth factor production 815 297 31 219 2 15 217
BP GO:0008152;metabolic process GO:0016042;lipid catabolic process 658 245 32 183 1 10 145
BP GO:0065007;biological regulation GO:0031326;regulation of cellular biosynthetic process 524 194 17 151 0 11 127
BP GO:0065007;biological regulation GO:0045765;regulation of angiogenesis 284 109 9 78 0 9 82
BP GO:0065007;biological regulation GO:0046425;regulation of receptor signaling pathway via JAK-STAT 271 85 8 73 1 7 67
BP GO:0065007;biological regulation GO:0009967;positive regulation of signal transduction 287 101 6 81 0 5 83
BP GO:0065007;biological regulation GO:0030335;positive regulation of cell migration 682 274 32 208 0 12 172
BP GO:0065007;biological regulation GO:0010565;regulation of cellular ketone metabolic process 572 207 17 164 0 10 130
BP GO:0008152;metabolic process GO:0016125;sterol metabolic process 621 217 17 165 0 14 163
BP GO:0065007;biological regulation GO:0007162;negative regulation of cell adhesion 110 36 4 28 0 2 28
BP GO:0065007;biological regulation GO:0032677;regulation of interleukin-8 production 359 141 12 104 0 9 85
BP GO:0065007;biological regulation GO:0032680;regulation of tumor necrosis factor production 233 93 15 62 0 6 56
BP GO:0008152;metabolic process GO:0009820;alkaloid metabolic process 1141 467 110 310 1 22 275
BP GO:0065007;biological regulation GO:1905449;regulation of Fc-gamma receptor signaling pathway involved in phagocytosis 225 78 4 61 0 4 53
BP GO:0009987;cellular process GO:0031580;membrane raft distribution 218 76 3 60 0 4 53
BP GO:0008152;metabolic process GO:0006464;cellular protein modification process 564 232 19 184 0 9 140
BP GO:0008152;metabolic process GO:0032787;monocarboxylic acid metabolic process 1368 529 120 372 1 30 319
BP GO:0065007;biological regulation GO:0090205;positive regulation of cholesterol metabolic process 352 123 4 99 0 4 89
BP GO:0065007;biological regulation GO:0010901;regulation of very-low-density lipoprotein particle remodeling 418 146 5 124 0 9 100
BP GO:0008152;metabolic process GO:0050665;hydrogen peroxide biosynthetic process 79 33 2 25 0 0 16
BP GO:0042592;homeostatic process GO:0035356;cellular triglyceride homeostasis 432 145 5 124 0 9 109
BP GO:0008152;metabolic process GO:0002933;lipid hydroxylation 861 335 81 224 1 19 203
BP GO:0065007;biological regulation GO:0044070;regulation of anion transport 869 317 34 244 1 18 214
BP GO:0065007;biological regulation GO:1903979;negative regulation of microglial cell activation 196 67 2 49 0 3 52
BP GO:0065007;biological regulation GO:0001915;negative regulation of T cell mediated cytotoxicity 193 65 2 49 0 3 51
BP GO:0065007;biological regulation GO:0050926;regulation of positive chemotaxis 418 165 14 131 0 9 101
BP GO:0032501;multicellular organismal process GO:0001779;natural killer cell differentiation 285 116 8 92 0 7 58
BP GO:0008152;metabolic process GO:0034969;histone arginine methylation 262 90 3 83 0 6 61
BP GO:0065007;biological regulation GO:2000258;negative regulation of protein activation cascade 199 72 4 62 0 5 45
BP GO:0008152;metabolic process GO:1901361;organic cyclic compound catabolic process 739 289 63 202 1 13 164
BP GO:0065007;biological regulation GO:0033629;negative regulation of cell adhesion mediated by integrin 402 145 13 101 1 10 107
BP GO:0065007;biological regulation GO:0010988;regulation of low-density lipoprotein particle clearance 252 85 2 80 0 6 58
BP GO:0008152;metabolic process GO:0046466;membrane lipid catabolic process 376 131 11 91 1 8 103
BP GO:0065007;biological regulation GO:2000434;regulation of protein neddylation 123 43 6 26 0 2 33
BP GO:0051179;localization GO:0019896;axonal transport of mitochondrion 129 58 12 31 0 2 27
BP GO:0051179;localization GO:1903204;negative regulation of oxidative stress-induced neuron death 103 37 6 20 0 2 24
BP GO:0009987;cellular process GO:0071397;cellular response to cholesterol 168 57 2 51 0 4 40
BP GO:0065007;biological regulation GO:0060761;negative regulation of response to cytokine stimulus 108 36 2 26 0 3 25
BP GO:0065007;biological regulation GO:0060255;regulation of macromolecule metabolic process 14 3 0 5 0 0 3
BP GO:0008152;metabolic process GO:0002003;angiotensin maturation 161 52 2 49 0 4 40
BP GO:0065007;biological regulation GO:0002002;regulation of angiotensin levels in blood 159 50 2 48 0 4 40
BP GO:0065007;biological regulation GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress 320 108 11 73 1 7 81
BP GO:0065007;biological regulation GO:1904892;regulation of receptor signaling pathway via STAT 105 32 2 24 0 3 26
BP GO:0065007;biological regulation GO:0050854;regulation of antigen receptor-mediated signaling pathway 78 24 0 22 0 1 19
BP GO:0050896;response to stimulus GO:0010039;response to iron ion 283 124 38 86 0 10 71
BP GO:0008152;metabolic process GO:0006576;cellular biogenic amine metabolic process 75 30 1 18 0 0 19
BP GO:0065007;biological regulation GO:0045940;positive regulation of steroid metabolic process 129 41 0 44 0 2 32
BP GO:0009987;cellular process GO:0047497;mitochondrion transport along microtubule 94 45 10 25 0 2 16
BP GO:0065007;biological regulation GO:0010640;regulation of platelet-derived growth factor receptor signaling pathway 194 75 14 63 0 5 43
BP GO:0065007;biological regulation GO:0150079;negative regulation of neuroinflammatory response 67 18 0 17 0 1 16
BP GO:0065007;biological regulation GO:0051584;regulation of dopamine uptake involved in synaptic transmission 352 194 64 110 0 12 99
BP GO:0065007;biological regulation GO:0060158;phospholipase C-activating dopamine receptor signaling pathway 269 128 27 79 0 7 75
BP GO:0008152;metabolic process GO:0006584;catecholamine metabolic process 81 54 20 25 0 3 23
BP GO:0065007;biological regulation GO:0071880;adenylate cyclase-activating adrenergic receptor signaling pathway 175 105 36 57 0 7 51
BP GO:0009987;cellular process GO:0071875;adrenergic receptor signaling pathway 173 104 37 55 0 7 51
BP GO:0065007;biological regulation GO:0043269;regulation of ion transport 297 152 38 90 0 11 87
BP GO:0065007;biological regulation GO:0051940;regulation of catecholamine uptake involved in synaptic transmission 320 148 30 90 0 8 95
BP GO:0065007;biological regulation GO:0060134;prepulse inhibition 280 132 27 81 0 7 80
BP GO:0009987;cellular process GO:0007191;adenylate cyclase-activating dopamine receptor signaling pathway 240 113 21 74 0 3 69
BP GO:0065007;biological regulation GO:1903531;negative regulation of secretion by cell 88 62 23 20 0 4 21
BP GO:0051179;localization GO:1903963;arachidonate transport 71 45 15 19 0 3 20
BP GO:0051179;localization GO:0050482;arachidonic acid secretion 71 45 15 19 0 3 20
BP GO:0050896;response to stimulus GO:0034776;response to histamine 72 46 15 19 0 3 20
BP GO:0065007;biological regulation GO:1901386;negative regulation of voltage-gated calcium channel activity 76 50 20 20 0 6 20
BP GO:0051179;localization GO:0032309;icosanoid secretion 64 39 13 17 0 2 18
BP GO:0009987;cellular process GO:0007200;phospholipase C-activating G protein-coupled receptor signaling pathway 207 129 45 61 0 9 56
BP GO:0065007;biological regulation GO:0045761;regulation of adenylate cyclase activity 65 41 10 19 0 2 17
BP GO:0065007;biological regulation GO:1901385;regulation of voltage-gated calcium channel activity 59 35 10 17 0 2 16
BP GO:0042592;homeostatic process GO:0055074;calcium ion homeostasis 126 75 19 37 0 5 35
BP GO:0009987;cellular process GO:0071870;cellular response to catecholamine stimulus 295 176 101 96 0 7 72
BP GO:0065007;biological regulation GO:0050805;negative regulation of synaptic transmission 172 104 32 36 0 6 46
BP GO:0065007;biological regulation GO:0014059;regulation of dopamine secretion 63 40 8 19 0 2 15
BP GO:0065007;biological regulation GO:0051224;negative regulation of protein transport 52 30 6 14 0 2 15
BP GO:0065007;biological regulation GO:2001258;negative regulation of cation channel activity 77 53 21 20 0 6 19
BP GO:0065007;biological regulation GO:1901020;negative regulation of calcium ion transmembrane transporter activity 72 47 10 24 0 3 23
BP GO:0065007;biological regulation GO:0051482;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway 126 78 34 35 0 8 32
BP GO:0065007;biological regulation GO:0050433;regulation of catecholamine secretion 67 44 10 19 0 3 15
BP GO:0065007;biological regulation GO:0007189;adenylate cyclase-activating G protein-coupled receptor signaling pathway 268 148 41 85 0 9 77
BP GO:0065007;biological regulation GO:0043266;regulation of potassium ion transport 75 49 11 24 0 3 24
BP GO:0065007;biological regulation GO:0050708;regulation of protein secretion 359 168 25 100 0 10 107
BP GO:0009987;cellular process GO:0050808;synapse organization 258 126 30 83 0 4 81
BP GO:0065007;biological regulation GO:0050709;negative regulation of protein secretion 70 40 4 21 0 3 25
BP GO:0050896;response to stimulus GO:0010243;response to organonitrogen compound 56 43 7 20 0 3 17
BP GO:0065007;biological regulation GO:0051966;regulation of synaptic transmission, glutamatergic 178 137 128 40 0 8 33
BP GO:0050896;response to stimulus GO:0042220;response to cocaine 107 60 11 26 0 4 35
BP GO:0050896;response to stimulus GO:0043278;response to morphine 111 64 11 30 0 5 37
BP GO:0065007;biological regulation GO:0043270;positive regulation of ion transport 67 46 13 23 0 0 20
BP GO:0065007;biological regulation GO:0051481;negative regulation of cytosolic calcium ion concentration 81 56 15 25 0 5 20
BP GO:0050896;response to stimulus GO:0071869;response to catecholamine 233 102 7 72 0 1 69
BP GO:0065007;biological regulation GO:0007193;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway 172 106 29 52 0 8 53
BP GO:0050896;response to stimulus GO:0043279;response to alkaloid 96 70 20 24 0 6 25
BP GO:0009987;cellular process GO:0071868;cellular response to monoamine stimulus 213 90 4 66 0 1 64
BP GO:0065007;biological regulation GO:0001963;synaptic transmission, dopaminergic 185 117 81 48 0 7 41
BP GO:0065007;biological regulation GO:0060159;regulation of dopamine receptor signaling pathway 66 42 5 21 0 3 19
BP GO:0009987;cellular process GO:0007416;synapse assembly 106 51 2 27 0 1 37
BP GO:0065007;biological regulation GO:0051354;negative regulation of oxidoreductase activity 81 30 2 28 0 1 22
BP GO:0065007;biological regulation GO:0007194;negative regulation of adenylate cyclase activity 51 28 2 16 0 2 15
BP GO:0065007;biological regulation GO:0031280;negative regulation of cyclase activity 51 28 2 16 0 2 15
BP GO:0009987;cellular process GO:0034329;cell junction assembly 87 42 0 22 0 0 32
BP GO:0065007;biological regulation GO:0045776;negative regulation of blood pressure 54 30 2 17 0 3 15
BP GO:0065007;biological regulation GO:0007268;chemical synaptic transmission 276 190 128 67 0 13 61
BP GO:0065007;biological regulation GO:0006875;cellular metal ion homeostasis 116 65 14 33 0 5 36
BP GO:0065007;biological regulation GO:0051350;negative regulation of lyase activity 50 27 2 15 0 2 15
BP GO:0065007;biological regulation GO:0072503;cellular divalent inorganic cation homeostasis 106 56 10 30 0 4 30
BP GO:0042592;homeostatic process GO:0006874;cellular calcium ion homeostasis 70 47 11 19 0 3 19
BP GO:0065007;biological regulation GO:0008285;negative regulation of cell population proliferation 389 200 60 134 2 11 115
BP GO:0065007;biological regulation GO:0007204;positive regulation of cytosolic calcium ion concentration 104 64 33 25 0 8 29
BP GO:0032501;multicellular organismal process GO:0099565;chemical synaptic transmission, postsynaptic 26 19 1 10 0 0 9
BP GO:0065007;biological regulation GO:0030334;regulation of cell migration 926 384 43 277 1 25 241
BP GO:0065007;biological regulation GO:1904427;positive regulation of calcium ion transmembrane transport 319 155 55 106 0 9 72
BP GO:0065007;biological regulation GO:0010524;positive regulation of calcium ion transport into cytosol 268 125 40 87 0 6 66
BP GO:0065007;biological regulation GO:0051281;positive regulation of release of sequestered calcium ion into cytosol 269 132 40 92 0 6 70
BP GO:0065007;biological regulation GO:0060078;regulation of postsynaptic membrane potential 23 16 2 8 0 0 7
BP GO:0065007;biological regulation GO:0007190;activation of adenylate cyclase activity 180 98 13 68 0 4 46
BP GO:0065007;biological regulation GO:0032467;positive regulation of cytokinesis 99 44 4 28 0 3 24
BP GO:0065007;biological regulation GO:0051898;negative regulation of protein kinase B signaling 105 48 6 32 0 0 29
BP GO:0065007;biological regulation GO:0051781;positive regulation of cell division 126 67 12 32 0 6 32
BP GO:0009987;cellular process GO:0031623;receptor internalization 5 5 1 4 0 0 0
BP GO:0065007;biological regulation GO:0098916;anterograde trans-synaptic signaling 234 152 94 56 0 10 52
BP GO:0065007;biological regulation GO:0051279;regulation of release of sequestered calcium ion into cytosol 209 93 23 68 0 5 53
BP GO:0065007;biological regulation GO:2000377;regulation of reactive oxygen species metabolic process 554 271 89 167 1 15 149
BP GO:0009987;cellular process GO:0007187;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger 305 172 43 89 0 11 83
BP GO:0065007;biological regulation GO:1903532;positive regulation of secretion by cell 52 32 5 21 0 1 14
BP GO:0065007;biological regulation GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process 76 32 4 25 0 1 19
BP GO:0065007;biological regulation GO:0032465;regulation of cytokinesis 86 36 3 23 0 2 26
BP GO:0065007;biological regulation GO:0090068;positive regulation of cell cycle process 85 36 2 23 0 2 26
BP GO:0065007;biological regulation GO:2000146;negative regulation of cell motility 57 31 2 17 0 2 20
BP GO:0065007;biological regulation GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process 56 22 0 16 0 1 15
BP GO:0032502;developmental process GO:0007399;nervous system development 77 52 3 25 0 1 26
BP GO:0065007;biological regulation GO:0032415;regulation of sodium:proton antiporter activity 16 11 0 4 0 0 4
BP GO:0065007;biological regulation GO:1903421;regulation of synaptic vesicle recycling 138 64 18 41 0 2 33
BP GO:0008152;metabolic process GO:0120178;steroid hormone biosynthetic process 804 302 45 232 1 18 214
BP GO:0008152;metabolic process GO:0006703;estrogen biosynthetic process 932 366 68 275 1 24 254
BP GO:0009987;cellular process GO:0097062;dendritic spine maintenance 310 118 12 90 0 4 75
BP GO:0044419;biological process involved in interspecies interaction between organisms GO:0035635;entry of bacterium into host cell 270 96 8 81 0 3 68
BP GO:0065007;biological regulation GO:0022407;regulation of cell-cell adhesion 149 53 3 43 0 5 45
BP GO:0009987;cellular process GO:0030261;chromosome condensation 335 104 11 101 0 7 83
BP GO:0065007;biological regulation GO:0031401;positive regulation of protein modification process 236 92 12 69 0 2 62
BP GO:0065007;biological regulation GO:0001558;regulation of cell growth 267 110 8 66 1 4 65
BP GO:0065007;biological regulation GO:0051900;regulation of mitochondrial depolarization 437 149 14 117 0 9 118
BP GO:0065007;biological regulation GO:0051893;regulation of focal adhesion assembly 268 89 6 65 0 3 75
BP GO:0065007;biological regulation GO:0001934;positive regulation of protein phosphorylation 406 173 57 116 0 10 103
BP GO:0065007;biological regulation GO:0090342;regulation of cell aging 382 158 14 110 2 6 97
BP GO:0009987;cellular process GO:0043954;cellular component maintenance 244 85 7 66 0 2 60
BP GO:0044419;biological process involved in interspecies interaction between organisms GO:0044409;entry into host 227 75 5 61 0 2 61
BP GO:0008152;metabolic process GO:0006706;steroid catabolic process 1113 444 94 319 1 24 276
BP GO:0065007;biological regulation GO:0043243;positive regulation of protein-containing complex disassembly 223 71 5 57 0 2 58
BP GO:0008152;metabolic process GO:0006694;steroid biosynthetic process 754 299 43 223 0 16 203
BP GO:0065007;biological regulation GO:0001932;regulation of protein phosphorylation 141 49 10 38 0 2 39
BP GO:0065007;biological regulation GO:0051983;regulation of chromosome segregation 471 154 9 130 0 9 130
BP GO:0065007;biological regulation GO:0043244;regulation of protein-containing complex disassembly 192 59 4 46 0 2 53
BP GO:0065007;biological regulation GO:0045927;positive regulation of growth 224 72 7 59 0 2 57
BP GO:0065007;biological regulation GO:0051894;positive regulation of focal adhesion assembly 179 56 4 39 0 1 51
BP GO:0065007;biological regulation GO:2001234;negative regulation of apoptotic signaling pathway 412 162 33 123 0 10 95
BP GO:0009987;cellular process GO:0061515;myeloid cell development 135 62 6 31 0 2 42
BP GO:0065007;biological regulation GO:0051094;positive regulation of developmental process 238 81 5 51 1 4 78
BP GO:0008152;metabolic process GO:0008209;androgen metabolic process 564 249 59 170 0 18 131
BP GO:0008152;metabolic process GO:0042276;error-prone translesion synthesis 156 51 3 34 0 1 43
BP GO:0009987;cellular process GO:0030316;osteoclast differentiation 23 6 0 4 0 0 5
BP GO:0065007;biological regulation GO:0007179;transforming growth factor beta receptor signaling pathway 169 57 3 35 0 2 54
BP GO:0008152;metabolic process GO:0008207;C21-steroid hormone metabolic process 258 120 23 78 0 3 72
BP GO:0009987;cellular process GO:0036315;cellular response to sterol 520 175 12 145 0 10 120
BP GO:0065007;biological regulation GO:2000648;positive regulation of stem cell proliferation 172 71 6 45 0 5 42
BP GO:0065007;biological regulation GO:0050857;positive regulation of antigen receptor-mediated signaling pathway 248 89 7 72 0 9 62
BP GO:0065007;biological regulation GO:0019218;regulation of steroid metabolic process 428 150 11 121 0 9 107
BP GO:0051179;localization GO:0015721;bile acid and bile salt transport 121 63 11 45 0 4 34
BP GO:0008152;metabolic process GO:0006656;phosphatidylcholine biosynthetic process 586 204 13 157 0 14 164
BP GO:0065007;biological regulation GO:0033628;regulation of cell adhesion mediated by integrin 844 291 24 222 2 19 210
BP GO:0008152;metabolic process GO:1901362;organic cyclic compound biosynthetic process 551 196 13 148 0 13 153
BP GO:0009987;cellular process GO:0070301;cellular response to hydrogen peroxide 286 105 5 70 2 6 70
BP GO:0009987;cellular process GO:0043542;endothelial cell migration 814 298 23 219 2 17 194
BP GO:0051179;localization GO:0015850;organic hydroxy compound transport 96 53 11 35 0 2 23
BP GO:0009987;cellular process GO:0010631;epithelial cell migration 807 290 21 216 2 16 194
BP GO:0050896;response to stimulus GO:0042542;response to hydrogen peroxide 240 71 6 59 2 6 62
BP GO:0051179;localization GO:0015718;monocarboxylic acid transport 107 54 10 40 0 2 25
BP GO:0009987;cellular process GO:0071396;cellular response to lipid 732 288 66 208 1 18 157
BP GO:0065007;biological regulation GO:0032757;positive regulation of interleukin-8 production 175 60 3 45 0 4 45
BP GO:0009987;cellular process GO:0034614;cellular response to reactive oxygen species 799 398 149 236 1 29 181
BP GO:0008152;metabolic process GO:0016101;diterpenoid metabolic process 157 60 5 50 0 2 51
BP GO:0008152;metabolic process GO:1903508;positive regulation of nucleic acid-templated transcription 601 247 58 183 2 17 124
BP GO:0008152;metabolic process GO:0046470;phosphatidylcholine metabolic process 289 100 5 74 0 6 81
BP GO:0008152;metabolic process GO:0008610;lipid biosynthetic process 291 108 8 75 0 6 79
BP GO:0032501;multicellular organismal process GO:0042110;T cell activation 63 24 0 15 0 0 19
BP GO:0065007;biological regulation GO:1905818;regulation of chromosome separation 286 97 5 72 0 6 80
BP GO:0051179;localization GO:0015849;organic acid transport 100 50 5 32 0 2 28
BP GO:0008152;metabolic process GO:0006366;transcription by RNA polymerase II 324 139 31 98 1 7 70
BP GO:0009987;cellular process GO:1901701;cellular response to oxygen-containing compound 1096 539 187 321 1 35 253
BP GO:0009987;cellular process GO:0071417;cellular response to organonitrogen compound 340 126 13 108 0 8 71
BP GO:0065007;biological regulation GO:0050796;regulation of insulin secretion 157 70 5 54 0 3 42
BP GO:0050896;response to stimulus GO:0070391;response to lipoteichoic acid 229 74 3 69 0 4 54
BP GO:0050896;response to stimulus GO:0032494;response to peptidoglycan 220 70 3 68 0 4 54
BP GO:0009987;cellular process GO:0071223;cellular response to lipoteichoic acid 229 74 3 69 0 4 54
BP GO:0065007;biological regulation GO:0000122;negative regulation of transcription by RNA polymerase II 278 91 14 84 0 4 69
BP GO:0008152;metabolic process GO:0072521;purine-containing compound metabolic process 212 73 4 46 0 5 62
BP GO:0002376;immune system process GO:0070431;nucleotide-binding oligomerization domain containing 2 signaling pathway 196 60 3 62 0 4 49
BP GO:0009987;cellular process GO:1904385;cellular response to angiotensin 1093 462 92 330 1 25 289
BP GO:0008152;metabolic process GO:0006001;fructose catabolic process 73 26 1 20 0 4 18
BP GO:0008152;metabolic process GO:0061624;fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate 73 26 1 20 0 4 18
BP GO:0008152;metabolic process GO:0009448;gamma-aminobutyric acid metabolic process 73 26 1 20 0 4 18
BP GO:0065007;biological regulation GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation 326 129 9 87 1 10 67
BP GO:0065007;biological regulation GO:0002862;negative regulation of inflammatory response to antigenic stimulus 411 220 43 138 0 12 94
BP GO:0065007;biological regulation GO:0002861;regulation of inflammatory response to antigenic stimulus 406 216 42 134 0 12 92
BP GO:0008152;metabolic process GO:0046348;amino sugar catabolic process 69 24 0 19 0 4 18
BP GO:0008152;metabolic process GO:0019682;glyceraldehyde-3-phosphate metabolic process 69 24 0 19 0 4 18
BP GO:0008152;metabolic process GO:0008652;cellular amino acid biosynthetic process 69 24 0 19 0 4 18
BP GO:0009987;cellular process GO:0036089;cleavage furrow formation 145 51 2 35 0 4 45
BP GO:0032502;developmental process GO:0061042;vascular wound healing 96 37 2 24 0 4 30
BP GO:0032502;developmental process GO:0001886;endothelial cell morphogenesis 68 26 1 14 0 3 18
BP GO:0065007;biological regulation GO:0043433;negative regulation of DNA-binding transcription factor activity 191 71 5 44 0 5 45
BP GO:0065007;biological regulation GO:0002903;negative regulation of B cell apoptotic process 72 30 2 20 0 4 22
BP GO:0009987;cellular process GO:0038089;positive regulation of cell migration by vascular endothelial growth factor signaling pathway 68 27 2 20 0 4 21
BP GO:0065007;biological regulation GO:0010656;negative regulation of muscle cell apoptotic process 63 21 1 17 0 4 19
BP GO:0008152;metabolic process GO:0006775;fat-soluble vitamin metabolic process 366 136 19 92 1 5 83
BP GO:0065007;biological regulation GO:0030641;regulation of cellular pH 825 281 28 240 1 18 204
BP GO:0065007;biological regulation GO:0051453;regulation of intracellular pH 658 227 21 195 1 15 164
BP GO:0008152;metabolic process GO:0030258;lipid modification 1049 430 130 301 1 24 245
BP GO:0065007;biological regulation GO:0031323;regulation of cellular metabolic process 183 56 6 53 2 2 50
BP GO:0065007;biological regulation GO:2000379;positive regulation of reactive oxygen species metabolic process 211 105 33 70 1 8 63
BP GO:0065007;biological regulation GO:0042326;negative regulation of phosphorylation 68 24 0 22 0 0 20
BP GO:0051179;localization GO:0015670;carbon dioxide transport 493 181 13 135 1 9 131
BP GO:0008152;metabolic process GO:0046102;inosine metabolic process 86 28 2 27 0 0 26
BP GO:0008152;metabolic process GO:0046130;purine ribonucleoside catabolic process 84 27 0 27 0 0 26
BP GO:0009987;cellular process GO:0038166;angiotensin-activated signaling pathway 518 183 14 153 1 9 132
BP GO:0008152;metabolic process GO:0009169;purine ribonucleoside monophosphate catabolic process 81 25 0 25 0 0 24
BP GO:0008152;metabolic process GO:0042373;vitamin K metabolic process 80 25 0 25 0 0 24
BP GO:0008152;metabolic process GO:0046085;adenosine metabolic process 82 26 0 26 0 0 26
BP GO:0051179;localization GO:0019755;one-carbon compound transport 280 99 4 80 1 2 70
BP GO:0032502;developmental process GO:0046545;development of primary female sexual characteristics 236 90 4 64 0 6 64
BP GO:0065007;biological regulation GO:0045601;regulation of endothelial cell differentiation 50 15 0 15 0 0 15
BP GO:0065007;biological regulation GO:1900747;negative regulation of vascular endothelial growth factor signaling pathway 87 34 0 24 0 0 21
BP GO:0065007;biological regulation GO:0045596;negative regulation of cell differentiation 91 38 0 31 1 2 19
BP GO:0065007;biological regulation GO:1902548;negative regulation of cellular response to vascular endothelial growth factor stimulus 74 29 0 21 0 0 20
BP GO:0051179;localization GO:0015669;gas transport 233 82 5 66 1 2 56
BP GO:0065007;biological regulation GO:1902532;negative regulation of intracellular signal transduction 443 180 40 117 0 12 104
BP GO:0008152;metabolic process GO:0006195;purine nucleotide catabolic process 47 13 0 14 0 0 15
BP GO:0008152;metabolic process GO:0072523;purine-containing compound catabolic process 47 13 0 14 0 0 15
BP GO:0008152;metabolic process GO:0046033;AMP metabolic process 47 13 0 14 0 0 15
BP GO:0065007;biological regulation GO:1900373;positive regulation of purine nucleotide biosynthetic process 60 22 0 17 0 1 15
BP GO:0065007;biological regulation GO:0010745;negative regulation of macrophage derived foam cell differentiation 62 26 0 18 0 0 18
BP GO:0065007;biological regulation GO:0032370;positive regulation of lipid transport 140 54 2 33 0 4 37
BP GO:0065007;biological regulation GO:1903427;negative regulation of reactive oxygen species biosynthetic process 62 22 0 14 0 0 15
BP GO:0065007;biological regulation GO:0031998;regulation of fatty acid beta-oxidation 55 19 0 14 0 0 17
BP GO:0065007;biological regulation GO:2001212;regulation of vasculogenesis 99 29 2 28 0 3 26
BP GO:0065007;biological regulation GO:0034764;positive regulation of transmembrane transport 198 60 2 52 1 1 47
BP GO:0008152;metabolic process GO:0042574;retinal metabolic process 494 199 41 139 2 9 129
BP GO:0065007;biological regulation GO:1902894;negative regulation of pri-miRNA transcription by RNA polymerase II 179 65 5 59 0 3 46
BP GO:0065007;biological regulation GO:0010889;regulation of sequestering of triglyceride 48 21 0 17 0 0 15
BP GO:0009987;cellular process GO:0071492;cellular response to UV-A 452 271 104 143 0 20 121
BP GO:0050896;response to stimulus GO:0070141;response to UV-A 498 295 106 161 1 20 124
BP GO:0065007;biological regulation GO:1903670;regulation of sprouting angiogenesis 35 11 0 8 0 0 6
BP GO:0009987;cellular process GO:0014065;phosphatidylinositol 3-kinase signaling 182 86 9 50 0 3 35
BP GO:0065007;biological regulation GO:0032769;negative regulation of monooxygenase activity 441 234 105 134 0 11 120
BP GO:0008152;metabolic process GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process 142 62 5 39 0 0 27
BP GO:0050896;response to stimulus GO:1904645;response to amyloid-beta 556 309 108 172 0 20 159
BP GO:0065007;biological regulation GO:0022898;regulation of transmembrane transporter activity 466 228 76 137 0 15 113
BP GO:0009987;cellular process GO:0048017;inositol lipid-mediated signaling 136 57 1 38 0 0 27
BP GO:0065007;biological regulation GO:0009889;regulation of biosynthetic process 135 79 65 35 0 2 27
BP GO:0065007;biological regulation GO:1903671;negative regulation of sprouting angiogenesis 100 39 0 24 0 0 18
BP GO:0065007;biological regulation GO:0090336;positive regulation of brown fat cell differentiation 135 53 1 31 0 1 34
BP GO:0065007;biological regulation GO:0038084;vascular endothelial growth factor signaling pathway 117 42 1 32 0 1 28
BP GO:0009987;cellular process GO:0022411;cellular component disassembly 380 210 53 124 0 15 110
BP GO:0009987;cellular process GO:0022617;extracellular matrix disassembly 376 206 51 122 0 15 109
BP GO:0008152;metabolic process GO:0046222;aflatoxin metabolic process 409 179 40 108 1 5 99
BP GO:0008152;metabolic process GO:1901376;organic heteropentacyclic compound metabolic process 407 177 40 108 1 5 99
BP GO:0008152;metabolic process GO:0042359;vitamin D metabolic process 390 153 31 98 1 5 82
BP GO:0009987;cellular process GO:0043385;mycotoxin metabolic process 399 171 37 107 1 5 99
BP GO:0009987;cellular process GO:0051262;protein tetramerization 37 26 3 14 0 1 5
BP GO:0009987;cellular process GO:0048015;phosphatidylinositol-mediated signaling 116 58 1 33 0 1 22
BP GO:0002376;immune system process GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis 154 70 7 42 0 2 34
BP GO:0065007;biological regulation GO:0038094;Fc-gamma receptor signaling pathway 154 70 7 42 0 2 34
BP GO:0009987;cellular process GO:0002431;Fc receptor mediated stimulatory signaling pathway 153 70 6 43 0 2 34
BP GO:0065007;biological regulation GO:0090335;regulation of brown fat cell differentiation 90 31 0 21 0 1 25
BP GO:0065007;biological regulation GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis 107 30 0 28 0 1 34
BP GO:0009987;cellular process GO:0030198;extracellular matrix organization 636 309 74 190 0 17 177
BP GO:0065007;biological regulation GO:0150077;regulation of neuroinflammatory response 18 13 0 8 0 2 4
BP GO:0065007;biological regulation GO:2000811;negative regulation of anoikis 103 33 3 22 0 1 28
BP GO:0065007;biological regulation GO:2000209;regulation of anoikis 51 17 1 8 0 1 16
BP GO:0065007;biological regulation GO:0038095;Fc-epsilon receptor signaling pathway 296 127 27 85 0 7 63
BP GO:0065007;biological regulation GO:0038093;Fc receptor signaling pathway 296 127 27 85 0 7 63
BP GO:0009987;cellular process GO:0050851;antigen receptor-mediated signaling pathway 326 129 8 87 0 6 69
BP GO:0065007;biological regulation GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process 196 93 19 52 0 10 52
BP GO:0008152;metabolic process GO:0043651;linoleic acid metabolic process 291 160 103 79 0 8 71
BP GO:0065007;biological regulation GO:0038127;ERBB signaling pathway 53 26 2 10 0 2 19
BP GO:0008152;metabolic process GO:0006691;leukotriene metabolic process 137 58 12 44 0 5 29
BP GO:0009987;cellular process GO:0050852;T cell receptor signaling pathway 316 124 6 81 0 6 69
BP GO:0065007;biological regulation GO:0048013;ephrin receptor signaling pathway 262 133 16 86 0 7 74
BP GO:0065007;biological regulation GO:0120041;positive regulation of macrophage proliferation 115 71 25 31 0 4 25
BP GO:0065007;biological regulation GO:0120040;regulation of macrophage proliferation 88 56 15 25 0 2 24
BP GO:0009987;cellular process GO:0007411;axon guidance 69 29 2 11 0 2 20
BP GO:0065007;biological regulation GO:0010810;regulation of cell-substrate adhesion 2 2 0 1 0 0 0
BP GO:0050896;response to stimulus GO:1990858;cellular response to lectin 139 48 0 40 0 3 41
BP GO:0002376;immune system process GO:0002223;stimulatory C-type lectin receptor signaling pathway 139 48 0 40 0 3 41
BP GO:0065007;biological regulation GO:0031334;positive regulation of protein-containing complex assembly 69 41 19 17 0 2 19
BP GO:0065007;biological regulation GO:0007173;epidermal growth factor receptor signaling pathway 50 20 1 7 0 1 17
BP GO:0065007;biological regulation GO:0007198;adenylate cyclase-inhibiting serotonin receptor signaling pathway 97 51 18 25 0 6 25
BP GO:0009987;cellular process GO:0007188;adenylate cyclase-modulating G protein-coupled receptor signaling pathway 148 91 24 46 0 5 42
BP GO:0065007;biological regulation GO:0035624;receptor transactivation 88 55 28 30 0 3 22
BP GO:0065007;biological regulation GO:0014060;regulation of epinephrine secretion 73 46 17 26 0 3 21
BP GO:0065007;biological regulation GO:0051283;negative regulation of sequestering of calcium ion 82 55 21 19 0 7 19
BP GO:0065007;biological regulation GO:0033604;negative regulation of catecholamine secretion 70 44 15 26 0 3 20
BP GO:0065007;biological regulation GO:0014061;regulation of norepinephrine secretion 69 43 17 23 0 3 21
BP GO:0009987;cellular process GO:0051209;release of sequestered calcium ion into cytosol 79 52 19 18 0 7 19
BP GO:0032501;multicellular organismal process GO:0014821;phasic smooth muscle contraction 55 37 14 12 0 4 14
BP GO:0009987;cellular process GO:0097553;calcium ion transmembrane import into cytosol 72 47 17 14 0 5 17
BP GO:0065007;biological regulation GO:0050777;negative regulation of immune response 322 188 50 115 0 9 71
BP GO:0065007;biological regulation GO:1904707;positive regulation of vascular associated smooth muscle cell proliferation 331 170 32 98 0 12 93
BP GO:0065007;biological regulation GO:0032148;activation of protein kinase B activity 54 29 5 17 0 3 19
BP GO:0065007;biological regulation GO:1904705;regulation of vascular associated smooth muscle cell proliferation 211 109 11 66 0 9 61
BP GO:0065007;biological regulation GO:2000273;positive regulation of signaling receptor activity 53 30 8 19 0 2 17
BP GO:0065007;biological regulation GO:0042053;regulation of dopamine metabolic process 52 23 2 15 0 1 17
BP GO:0065007;biological regulation GO:0051254;positive regulation of RNA metabolic process 431 174 26 134 1 9 101
BP GO:0065007;biological regulation GO:0048661;positive regulation of smooth muscle cell proliferation 195 94 8 55 0 9 52
BP GO:0050896;response to stimulus GO:0070741;response to interleukin-6 288 111 11 89 0 7 72
BP GO:0065007;biological regulation GO:0034762;regulation of transmembrane transport 327 152 80 93 0 12 81
BP GO:0009987;cellular process GO:0097306;cellular response to alcohol 270 94 21 80 1 8 59
BP GO:0009987;cellular process GO:0007077;mitotic nuclear membrane disassembly 42 14 0 12 0 1 9
BP GO:0008152;metabolic process GO:0018107;peptidyl-threonine phosphorylation 235 89 10 70 0 4 66
BP GO:0009987;cellular process GO:0051081;nuclear membrane disassembly 39 13 0 12 0 1 9
BP GO:0008152;metabolic process GO:0018210;peptidyl-threonine modification 177 72 8 56 0 3 50
BP GO:0065007;biological regulation GO:0010885;regulation of cholesterol storage 195 72 8 62 0 4 44
BP GO:0065007;biological regulation GO:0062013;positive regulation of small molecule metabolic process 202 77 8 67 0 4 45
BP GO:0009987;cellular process GO:0071398;cellular response to fatty acid 170 64 6 55 0 5 44
BP GO:0065007;biological regulation GO:0002819;regulation of adaptive immune response 181 51 15 49 1 5 48
BP GO:0002376;immune system process GO:0045087;innate immune response 6 3 1 4 0 0 0
BP GO:0009987;cellular process GO:0051403;stress-activated MAPK cascade 84 37 23 17 0 1 19
BP GO:0065007;biological regulation GO:0038128;ERBB2 signaling pathway 63 27 4 18 0 1 18
BP GO:0065007;biological regulation GO:2000668;regulation of dendritic cell apoptotic process 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0002902;regulation of B cell apoptotic process 18 4 1 7 0 1 6
BP GO:0009987;cellular process GO:0071347;cellular response to interleukin-1 106 39 2 38 0 2 29
BP GO:0050896;response to stimulus GO:0071363;cellular response to growth factor stimulus 143 44 4 35 0 2 42
BP GO:0065007;biological regulation GO:0070498;interleukin-1-mediated signaling pathway 118 44 0 39 0 2 27
BP GO:0065007;biological regulation GO:0043405;regulation of MAP kinase activity 18 14 2 7 0 2 4
BP GO:0065007;biological regulation GO:0032872;regulation of stress-activated MAPK cascade 193 114 79 43 0 6 43
BP GO:0065007;biological regulation GO:0051270;regulation of cellular component movement 4 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0090330;regulation of platelet aggregation 31 10 0 14 0 2 12
BP GO:0009987;cellular process GO:0031663;lipopolysaccharide-mediated signaling pathway 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:2000145;regulation of cell motility 23 15 1 7 1 0 2
BP GO:0065007;biological regulation GO:0042509;regulation of tyrosine phosphorylation of STAT protein 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043406;positive regulation of MAP kinase activity 36 20 1 9 0 1 9
BP GO:0002376;immune system process GO:0070423;nucleotide-binding oligomerization domain containing signaling pathway 12 5 0 7 0 1 4
BP GO:0065007;biological regulation GO:0032481;positive regulation of type I interferon production 46 20 0 17 0 0 11
BP GO:0002376;immune system process GO:0034134;toll-like receptor 2 signaling pathway 2 1 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0032496;response to lipopolysaccharide 121 59 24 41 0 2 28
BP GO:0065007;biological regulation GO:1903039;positive regulation of leukocyte cell-cell adhesion 34 15 2 14 0 1 8
BP GO:0050896;response to stimulus GO:0070555;response to interleukin-1 457 214 90 138 0 7 124
BP GO:0065007;biological regulation GO:0045893;positive regulation of transcription, DNA-templated 327 139 28 107 2 9 57
BP GO:0050896;response to stimulus GO:0035924;cellular response to vascular endothelial growth factor stimulus 95 33 1 24 0 2 27
BP GO:0009987;cellular process GO:0032870;cellular response to hormone stimulus 88 36 7 26 0 3 29
BP GO:0065007;biological regulation GO:2000637;positive regulation of gene silencing by miRNA 25 18 1 14 0 1 4
BP GO:0065007;biological regulation GO:0051348;negative regulation of transferase activity 28 23 2 16 0 1 6
BP GO:0009987;cellular process GO:0034504;protein localization to nucleus 10 9 1 3 0 0 3
BP GO:0065007;biological regulation GO:1905050;positive regulation of metallopeptidase activity 4 4 0 1 0 0 2
BP GO:0050896;response to stimulus GO:1990416;cellular response to brain-derived neurotrophic factor stimulus 35 26 2 17 0 3 5
BP GO:0009987;cellular process GO:0048312;intracellular distribution of mitochondria 35 26 2 17 0 3 5
BP GO:0065007;biological regulation GO:1904428;negative regulation of tubulin deacetylation 34 25 1 17 0 2 5
BP GO:0032502;developmental process GO:0072079;nephron tubule formation 27 12 2 8 0 0 11
BP GO:0065007;biological regulation GO:1902474;positive regulation of protein localization to synapse 34 25 1 17 0 2 5
BP GO:0032502;developmental process GO:0072235;metanephric distal tubule development 27 12 2 8 0 0 11
BP GO:0032502;developmental process GO:0072207;metanephric epithelium development 27 12 2 8 0 0 11
BP GO:0032502;developmental process GO:0072282;metanephric nephron tubule morphogenesis 27 12 2 8 0 0 11
BP GO:0032502;developmental process GO:0072283;metanephric renal vesicle morphogenesis 27 12 2 8 0 0 11
BP GO:0009987;cellular process GO:0060019;radial glial cell differentiation 4 4 0 1 0 0 2
BP GO:0065007;biological regulation GO:1903748;negative regulation of establishment of protein localization to mitochondrion 32 23 1 16 0 2 5
BP GO:0009987;cellular process GO:0008088;axo-dendritic transport 83 50 19 30 0 2 17
BP GO:0065007;biological regulation GO:2000698;positive regulation of epithelial cell differentiation involved in kidney development 27 12 2 8 0 0 11
BP GO:0050896;response to stimulus GO:0034698;response to gonadotropin 27 12 2 8 0 0 11
BP GO:0009987;cellular process GO:0070841;inclusion body assembly 27 18 1 12 0 1 4
BP GO:0009987;cellular process GO:0072540;T-helper 17 cell lineage commitment 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0003337;mesenchymal to epithelial transition involved in metanephros morphogenesis 29 12 2 8 0 0 10
BP GO:0032502;developmental process GO:0048793;pronephros development 26 11 2 7 0 0 10
BP GO:0009987;cellular process GO:0072386;plus-end-directed organelle transport along microtubule 27 18 1 12 0 1 4
BP GO:0009987;cellular process GO:0035850;epithelial cell differentiation involved in kidney development 26 11 2 7 0 0 10
BP GO:0009987;cellular process GO:0048708;astrocyte differentiation 23 9 0 6 0 1 8
BP GO:0065007;biological regulation GO:0090043;regulation of tubulin deacetylation 25 16 1 11 0 1 3
BP GO:0050896;response to stimulus GO:0010288;response to lead ion 25 16 1 11 0 1 3
BP GO:0008152;metabolic process GO:0044270;cellular nitrogen compound catabolic process 131 76 11 40 0 2 34
BP GO:0008152;metabolic process GO:1905618;positive regulation of miRNA mediated inhibition of translation 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0071371;cellular response to gonadotropin stimulus 26 11 2 7 0 0 10
BP GO:0032502;developmental process GO:0072234;metanephric nephron tubule development 24 9 1 5 0 0 9
BP GO:0032502;developmental process GO:1905616;regulation of miRNA mediated inhibition of translation 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0046530;photoreceptor cell differentiation 3 3 0 0 0 0 1
BP GO:0065007;biological regulation GO:0010917;negative regulation of mitochondrial membrane potential 24 15 1 10 0 1 3
BP GO:0065007;biological regulation GO:0038114;interleukin-21-mediated signaling pathway 3 3 0 0 0 0 1
BP GO:0008152;metabolic process GO:0006475;internal protein amino acid acetylation 23 15 1 10 0 1 3
BP GO:0065007;biological regulation GO:1903747;regulation of establishment of protein localization to mitochondrion 23 15 1 10 0 1 3
BP GO:0032502;developmental process GO:0072073;kidney epithelium development 23 9 1 5 0 0 8
BP GO:0050896;response to stimulus GO:0098757;cellular response to interleukin-21 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0002295;T-helper cell lineage commitment 3 3 0 0 0 0 1
BP GO:0032502;developmental process GO:0030878;thyroid gland development 22 8 1 4 0 0 8
BP GO:0065007;biological regulation GO:0043067;regulation of programmed cell death 109 36 2 23 0 3 25
BP GO:0065007;biological regulation GO:0045837;negative regulation of membrane potential 23 15 1 10 0 1 3
BP GO:0050896;response to stimulus GO:0044321;response to leptin 3 3 0 0 0 0 1
BP GO:0065007;biological regulation GO:0038155;interleukin-23-mediated signaling pathway 5 4 1 1 0 0 1
BP GO:0065007;biological regulation GO:0038113;interleukin-9-mediated signaling pathway 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0071355;cellular response to interleukin-9 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0044320;cellular response to leptin stimulus 3 3 0 0 0 0 1
BP GO:0065007;biological regulation GO:0072182;regulation of nephron tubule epithelial cell differentiation 20 7 1 2 0 0 6
BP GO:0065007;biological regulation GO:1904950;negative regulation of establishment of protein localization 19 13 0 9 0 0 3
BP GO:0009987;cellular process GO:0072202;cell differentiation involved in metanephros development 20 7 1 2 0 0 6
BP GO:0065007;biological regulation GO:0033210;leptin-mediated signaling pathway 3 3 0 0 0 0 1
BP GO:0065007;biological regulation GO:1900452;regulation of long-term synaptic depression 19 13 0 9 0 0 3
BP GO:0009987;cellular process GO:0060231;mesenchymal to epithelial transition 20 7 1 2 0 0 6
BP GO:0008152;metabolic process GO:0006351;transcription, DNA-templated 45 17 1 9 0 2 14
BP GO:0065007;biological regulation GO:0099622;cardiac muscle cell membrane repolarization 4 3 0 1 0 0 1
BP GO:0065007;biological regulation GO:0070757;interleukin-35-mediated signaling pathway 3 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0060148;positive regulation of posttranscriptional gene silencing 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903800;positive regulation of production of miRNAs involved in gene silencing by miRNA 111 47 3 32 1 1 18
BP GO:0032502;developmental process GO:0001823;mesonephros development 18 6 1 2 0 0 5
BP GO:0009987;cellular process GO:1990440;positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress 34 11 0 3 0 0 11
BP GO:0065007;biological regulation GO:0042772;DNA damage response, signal transduction resulting in transcription 34 11 0 3 0 0 11
BP GO:0065007;biological regulation GO:0010506;regulation of autophagy 9 6 0 4 0 0 0
BP GO:0065007;biological regulation GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis 17 6 1 2 0 0 5
BP GO:0009987;cellular process GO:0007197;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway 36 29 7 11 0 1 14
BP GO:0065007;biological regulation GO:0007213;G protein-coupled acetylcholine receptor signaling pathway 30 24 6 10 0 1 11
BP GO:0009987;cellular process GO:0095500;acetylcholine receptor signaling pathway 27 21 6 8 0 1 9
BP GO:0065007;biological regulation GO:0001996;positive regulation of heart rate by epinephrine-norepinephrine 42 25 6 14 0 3 10
BP GO:0032501;multicellular organismal process GO:0019229;regulation of vasoconstriction 40 19 4 10 0 2 11
BP GO:0032501;multicellular organismal process GO:0045907;positive regulation of vasoconstriction 29 13 3 7 0 2 10
BP GO:0065007;biological regulation GO:0010460;positive regulation of heart rate 32 16 4 9 0 2 10
BP GO:0065007;biological regulation GO:0032147;activation of protein kinase activity 42 16 2 11 0 3 16
BP GO:0065007;biological regulation GO:0006940;regulation of smooth muscle contraction 19 13 2 5 0 1 9
BP GO:0042592;homeostatic process GO:0051480;regulation of cytosolic calcium ion concentration 60 34 6 16 0 3 16
BP GO:0065007;biological regulation GO:0045666;positive regulation of neuron differentiation 16 9 2 5 0 0 9
BP GO:0065007;biological regulation GO:0090276;regulation of peptide hormone secretion 99 60 9 37 1 3 27
BP GO:0065007;biological regulation GO:0045664;regulation of neuron differentiation 13 8 1 4 0 0 5
BP GO:0065007;biological regulation GO:0045760;positive regulation of action potential 18 13 3 7 0 0 6
BP GO:0065007;biological regulation GO:0045955;negative regulation of calcium ion-dependent exocytosis 15 12 1 7 0 1 9
BP GO:0065007;biological regulation GO:0060452;positive regulation of cardiac muscle contraction 11 8 3 4 0 0 4
BP GO:0032501;multicellular organismal process GO:0003056;regulation of vascular associated smooth muscle contraction 16 10 1 2 0 0 7
BP GO:0065007;biological regulation GO:0045989;positive regulation of striated muscle contraction 8 5 2 2 0 0 3
BP GO:0065007;biological regulation GO:0032230;positive regulation of synaptic transmission, GABAergic 8 5 2 2 0 0 3
BP GO:0065007;biological regulation GO:1903306;negative regulation of regulated secretory pathway 10 9 0 6 0 1 7
BP GO:0065007;biological regulation GO:0060251;regulation of glial cell proliferation 14 8 1 2 0 0 5
BP GO:0065007;biological regulation GO:0090037;positive regulation of protein kinase C signaling 6 4 0 1 0 0 3
BP GO:0065007;biological regulation GO:0055083;monovalent inorganic anion homeostasis 440 161 12 111 2 11 105
BP GO:0042592;homeostatic process GO:0055064;chloride ion homeostasis 453 170 12 118 2 11 108
BP GO:0009987;cellular process GO:1905145;cellular response to acetylcholine 16 10 1 4 0 0 7
BP GO:0065007;biological regulation GO:1903170;negative regulation of calcium ion transmembrane transport 13 12 1 7 0 0 9
BP GO:0009987;cellular process GO:0007205;protein kinase C-activating G protein-coupled receptor signaling pathway 22 16 1 4 0 0 6
BP GO:0065007;biological regulation GO:0045741;positive regulation of epidermal growth factor-activated receptor activity 7 6 0 4 0 0 6
BP GO:0065007;biological regulation GO:0090343;positive regulation of cell aging 208 98 5 61 2 3 54
BP GO:0032501;multicellular organismal process GO:0006939;smooth muscle contraction 4 3 0 0 0 0 2
BP GO:0065007;biological regulation GO:0090036;regulation of protein kinase C signaling 4 3 0 0 0 0 2
BP GO:0032501;multicellular organismal process GO:0050892;intestinal absorption 29 7 0 9 0 0 14
BP GO:0009987;cellular process GO:0070206;protein trimerization 4 2 1 0 0 0 2
BP GO:0065007;biological regulation GO:0032228;regulation of synaptic transmission, GABAergic 29 14 1 6 0 2 11
BP GO:0009987;cellular process GO:0070207;protein homotrimerization 4 2 1 0 0 0 2
BP GO:0065007;biological regulation GO:0051044;positive regulation of membrane protein ectodomain proteolysis 6 4 0 3 0 0 5
BP GO:0065007;biological regulation GO:0046676;negative regulation of insulin secretion 5 4 0 3 0 0 5
BP GO:0065007;biological regulation GO:0050995;negative regulation of lipid catabolic process 11 9 2 3 0 0 8
BP GO:0065007;biological regulation GO:0090278;negative regulation of peptide hormone secretion 8 7 0 4 0 0 7
BP GO:0065007;biological regulation GO:0051926;negative regulation of calcium ion transport 6 5 0 3 0 0 5
BP GO:0065007;biological regulation GO:0045823;positive regulation of heart contraction 4 3 0 0 0 0 2
BP GO:0065007;biological regulation GO:0032413;negative regulation of ion transmembrane transporter activity 8 7 0 3 0 0 4
BP GO:0009987;cellular process GO:0060402;calcium ion transport into cytosol 4 3 0 0 0 0 2
BP GO:0065007;biological regulation GO:0050994;regulation of lipid catabolic process 10 8 2 2 0 0 7
BP GO:0065007;biological regulation GO:0051043;regulation of membrane protein ectodomain proteolysis 5 3 0 2 0 0 4
BP GO:0065007;biological regulation GO:0045833;negative regulation of lipid metabolic process 9 7 2 2 0 0 7
BP GO:0065007;biological regulation GO:0045597;positive regulation of cell differentiation 16 8 9 5 0 0 7
BP GO:0065007;biological regulation GO:0043271;negative regulation of ion transport 33 18 2 8 0 2 9
BP GO:0065007;biological regulation GO:0007176;regulation of epidermal growth factor-activated receptor activity 4 3 0 2 0 0 4
BP GO:0009987;cellular process GO:0060401;cytosolic calcium ion transport 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0006937;regulation of muscle contraction 13 7 1 2 0 0 4
BP GO:0065007;biological regulation GO:0061178;regulation of insulin secretion involved in cellular response to glucose stimulus 23 13 0 11 0 1 9
BP GO:0065007;biological regulation GO:1903036;positive regulation of response to wounding 4 3 0 2 0 0 4
BP GO:0065007;biological regulation GO:1901019;regulation of calcium ion transmembrane transporter activity 7 6 0 3 0 0 5
BP GO:0065007;biological regulation GO:0017158;regulation of calcium ion-dependent exocytosis 4 3 0 2 0 0 4
BP GO:0065007;biological regulation GO:0007202;activation of phospholipase C activity 44 25 6 10 0 4 12
MF GO:0060089;molecular transducer activity GO:0004936;alpha-adrenergic receptor activity 2 1 0 0 0 0 1
MF GO:0060089;molecular transducer activity GO:0016907;G protein-coupled acetylcholine receptor activity 13 7 0 3 0 0 5
MF GO:0060089;molecular transducer activity GO:0099528;G protein-coupled neurotransmitter receptor activity 13 7 0 3 0 0 5
MF GO:0060089;molecular transducer activity GO:0008227;G protein-coupled amine receptor activity 20 12 0 4 0 0 5
MF GO:0060089;molecular transducer activity GO:0015464;acetylcholine receptor activity 14 8 0 3 0 0 5
MF GO:0060089;molecular transducer activity GO:0099589;serotonin receptor activity 20 12 0 4 0 0 5
MF GO:0060089;molecular transducer activity GO:0004993;G protein-coupled serotonin receptor activity 20 12 0 4 0 0 5
MF GO:0060089;molecular transducer activity GO:0004930;G protein-coupled receptor activity 16 13 1 4 0 0 2
MF GO:0005488;binding GO:0051379;epinephrine binding 1 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:0010468;regulation of gene expression 226 100 19 69 1 6 53
BP GO:0009987;cellular process GO:0002076;osteoblast development 361 143 10 87 0 9 97
BP GO:0065007;biological regulation GO:0010605;negative regulation of macromolecule metabolic process 247 112 33 73 0 8 70
BP GO:0008152;metabolic process GO:0006508;proteolysis 320 162 31 100 0 14 82
BP GO:0065007;biological regulation GO:0010822;positive regulation of mitochondrion organization 188 85 11 53 0 6 70
BP GO:0065007;biological regulation GO:0010972;negative regulation of G2/M transition of mitotic cell cycle 107 33 2 28 0 4 33
BP GO:0065007;biological regulation GO:0010629;negative regulation of gene expression 88 44 20 31 0 3 21
BP GO:0065007;biological regulation GO:2001237;negative regulation of extrinsic apoptotic signaling pathway 152 62 8 50 0 2 37
BP GO:0065007;biological regulation GO:0072091;regulation of stem cell proliferation 11 6 0 6 0 0 0
BP GO:0065007;biological regulation GO:0050927;positive regulation of positive chemotaxis 136 63 7 50 0 4 31
BP GO:0065007;biological regulation GO:1904355;positive regulation of telomere capping 160 88 31 62 1 8 30
BP GO:0065007;biological regulation GO:0090141;positive regulation of mitochondrial fission 68 25 5 17 0 3 21
BP GO:0009987;cellular process GO:0043062;extracellular structure organization 390 213 58 126 0 13 116
BP GO:0009987;cellular process GO:0045229;external encapsulating structure organization 386 209 57 123 0 13 115
BP GO:0065007;biological regulation GO:0035584;calcium-mediated signaling using intracellular calcium source 96 38 5 29 0 3 23
BP GO:0008152;metabolic process GO:0031293;membrane protein intracellular domain proteolysis 196 76 7 58 0 6 48
BP GO:0065007;biological regulation GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand 101 38 4 31 0 3 21
BP GO:0065007;biological regulation GO:1901099;negative regulation of signal transduction in absence of ligand 101 38 4 31 0 3 21
BP GO:0065007;biological regulation GO:1904353;regulation of telomere capping 100 67 21 45 1 8 16
BP GO:0065007;biological regulation GO:0090140;regulation of mitochondrial fission 79 36 5 25 0 3 22
BP GO:0065007;biological regulation GO:2001239;regulation of extrinsic apoptotic signaling pathway in absence of ligand 99 36 3 30 0 2 21
BP GO:0009987;cellular process GO:0071354;cellular response to interleukin-6 246 90 10 64 0 8 75
BP GO:0065007;biological regulation GO:0043393;regulation of protein binding 39 14 1 13 0 2 12
BP GO:0002376;immune system process GO:0002220;innate immune response activating cell surface receptor signaling pathway 136 46 0 39 0 3 41
BP GO:0065007;biological regulation GO:0030890;positive regulation of B cell proliferation 11 4 1 3 0 0 1
BP GO:0065007;biological regulation GO:2000147;positive regulation of cell motility 441 172 15 131 0 7 115
BP GO:0050896;response to stimulus GO:0071560;cellular response to transforming growth factor beta stimulus 111 39 3 23 0 1 36
BP GO:0065007;biological regulation GO:0150117;positive regulation of cell-substrate junction organization 131 48 4 29 0 1 39
BP GO:0065007;biological regulation GO:0010557;positive regulation of macromolecule biosynthetic process 118 48 5 31 0 1 36
BP GO:0065007;biological regulation GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway 84 29 3 16 0 1 29
BP GO:0065007;biological regulation GO:2000352;negative regulation of endothelial cell apoptotic process 105 40 4 25 0 2 28
BP GO:0065007;biological regulation GO:0045429;positive regulation of nitric oxide biosynthetic process 107 40 3 28 0 1 30
BP GO:0009987;cellular process GO:0097061;dendritic spine organization 107 43 4 27 0 1 28
BP GO:0065007;biological regulation GO:0031116;positive regulation of microtubule polymerization 106 42 3 29 0 1 29
BP GO:0065007;biological regulation GO:1904407;positive regulation of nitric oxide metabolic process 102 38 3 26 0 1 30
BP GO:0065007;biological regulation GO:0045937;positive regulation of phosphate metabolic process 221 125 91 68 0 7 41
BP GO:0008152;metabolic process GO:0006287;base-excision repair, gap-filling 222 84 7 57 0 4 49
BP GO:0065007;biological regulation GO:1904036;negative regulation of epithelial cell apoptotic process 108 45 5 38 1 3 29
BP GO:0009987;cellular process GO:0034622;cellular protein-containing complex assembly 48 19 3 11 0 0 15
BP GO:0065007;biological regulation GO:0045428;regulation of nitric oxide biosynthetic process 76 29 3 20 0 1 24
BP GO:0008152;metabolic process GO:0019985;translesion synthesis 52 19 3 10 0 0 15
BP GO:0008152;metabolic process GO:0000731;DNA synthesis involved in DNA repair 53 19 3 11 0 0 15
BP GO:0065007;biological regulation GO:0001954;positive regulation of cell-matrix adhesion 60 23 2 10 0 0 17
BP GO:0065007;biological regulation GO:2000351;regulation of endothelial cell apoptotic process 134 46 7 31 1 2 34
BP GO:0065007;biological regulation GO:0006282;regulation of DNA repair 122 43 4 38 0 1 27
BP GO:0008152;metabolic process GO:0006301;postreplication repair 32 12 2 5 0 0 7
BP GO:0008152;metabolic process GO:0006284;base-excision repair 135 54 5 32 0 3 23
BP GO:0032502;developmental process GO:0002040;sprouting angiogenesis 18 9 1 1 0 0 3
BP GO:0065007;biological regulation GO:2000117;negative regulation of cysteine-type endopeptidase activity 53 23 5 11 0 1 9
BP GO:0065007;biological regulation GO:1901890;positive regulation of cell junction assembly 11 7 0 1 0 0 2
BP GO:0009987;cellular process GO:1901653;cellular response to peptide 145 58 14 38 0 5 50
BP GO:0065007;biological regulation GO:0070372;regulation of ERK1 and ERK2 cascade 338 187 108 91 0 12 85
BP GO:0065007;biological regulation GO:2001243;negative regulation of intrinsic apoptotic signaling pathway 56 25 2 16 0 1 10
BP GO:0065007;biological regulation GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway 9 6 0 1 0 0 2
BP GO:0042592;homeostatic process GO:0033500;carbohydrate homeostasis 42 17 0 7 0 1 15
BP GO:0065007;biological regulation GO:0035023;regulation of Rho protein signal transduction 7 5 0 1 0 0 2
BP GO:0065007;biological regulation GO:0008286;insulin receptor signaling pathway 24 8 0 5 0 0 10
BP GO:0008152;metabolic process GO:0009251;glucan catabolic process 5 4 0 4 0 0 0
BP GO:0008152;metabolic process GO:0044247;cellular polysaccharide catabolic process 3 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0051782;negative regulation of cell division 240 95 10 69 1 4 43
BP GO:0032502;developmental process GO:0035162;embryonic hemopoiesis 43 14 2 14 0 2 15
BP GO:0065007;biological regulation GO:0002710;negative regulation of T cell mediated immunity 136 39 5 42 1 5 30
BP GO:0008152;metabolic process GO:0005980;glycogen catabolic process 3 3 0 3 0 0 0
BP GO:0009987;cellular process GO:0006268;DNA unwinding involved in DNA replication 162 64 3 53 1 4 34
BP GO:0009987;cellular process GO:0071312;cellular response to alkaloid 111 61 11 29 0 8 23
BP GO:0050896;response to stimulus GO:0070542;response to fatty acid 116 47 6 46 0 5 29
BP GO:0008152;metabolic process GO:0042438;melanin biosynthetic process 267 77 4 67 1 6 68
BP GO:0065007;biological regulation GO:0002840;regulation of T cell mediated immune response to tumor cell 190 48 4 45 1 4 50
BP GO:0032502;developmental process GO:0008406;gonad development 85 35 4 30 0 0 24
BP GO:0065007;biological regulation GO:0010971;positive regulation of G2/M transition of mitotic cell cycle 58 33 3 20 0 2 6
BP GO:0065007;biological regulation GO:1902751;positive regulation of cell cycle G2/M phase transition 50 26 3 19 0 2 5
BP GO:0065007;biological regulation GO:0032689;negative regulation of interferon-gamma production 164 55 2 48 0 6 36
BP GO:0032501;multicellular organismal process GO:0046651;lymphocyte proliferation 83 32 2 25 0 1 12
BP GO:0065007;biological regulation GO:0061097;regulation of protein tyrosine kinase activity 104 51 11 40 0 4 20
BP GO:0032501;multicellular organismal process GO:0030101;natural killer cell activation 24 9 1 10 0 1 3
BP GO:0065007;biological regulation GO:0030888;regulation of B cell proliferation 59 12 4 15 1 2 13
BP GO:0065007;biological regulation GO:1901992;positive regulation of mitotic cell cycle phase transition 23 13 0 8 0 0 3
BP GO:0050896;response to stimulus GO:0034097;response to cytokine 144 54 19 49 0 2 31
BP GO:0050896;response to stimulus GO:0009411;response to UV 170 55 2 48 0 3 42
BP GO:0009987;cellular process GO:0071375;cellular response to peptide hormone stimulus 256 118 22 73 0 5 68
BP GO:0050896;response to stimulus GO:1901652;response to peptide 310 161 27 99 0 11 91
BP GO:0065007;biological regulation GO:0045913;positive regulation of carbohydrate metabolic process 394 203 84 120 1 11 107
BP GO:0009987;cellular process GO:0035987;endodermal cell differentiation 264 120 16 80 0 10 77
BP GO:0032502;developmental process GO:0001706;endoderm formation 235 107 11 73 0 8 67
BP GO:0065007;biological regulation GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway 138 60 6 36 0 4 38
BP GO:0065007;biological regulation GO:1904904;regulation of endothelial cell-matrix adhesion via fibronectin 175 58 5 39 0 2 35
BP GO:0065007;biological regulation GO:1900122;positive regulation of receptor binding 86 35 5 22 0 4 25
BP GO:0009987;cellular process GO:0071472;cellular response to salt stress 53 17 1 12 0 0 11
BP GO:0009987;cellular process GO:0071474;cellular hyperosmotic response 33 9 1 6 0 0 6
BP GO:0008152;metabolic process GO:0009804;coumarin metabolic process 96 46 2 34 1 1 42
BP GO:0009987;cellular process GO:1904322;cellular response to forskolin 85 18 2 23 1 2 28
BP GO:0050896;response to stimulus GO:1904321;response to forskolin 86 19 3 23 1 3 28
BP GO:0008152;metabolic process GO:0046189;phenol-containing compound biosynthetic process 111 25 2 29 1 1 37
BP GO:0008152;metabolic process GO:0006570;tyrosine metabolic process 92 18 2 24 1 1 30
BP GO:0008152;metabolic process GO:0006809;nitric oxide biosynthetic process 212 82 8 55 1 5 49
BP GO:0008152;metabolic process GO:0046209;nitric oxide metabolic process 194 76 8 51 1 5 47
BP GO:0065007;biological regulation GO:0050670;regulation of lymphocyte proliferation 59 10 2 17 1 1 18
BP GO:0008152;metabolic process GO:0006643;membrane lipid metabolic process 161 54 3 38 1 2 44
BP GO:0065007;biological regulation GO:0019933;cAMP-mediated signaling 47 9 2 13 1 1 17
BP GO:0032502;developmental process GO:0043010;camera-type eye development 129 51 3 28 1 1 35
BP GO:0008152;metabolic process GO:0044242;cellular lipid catabolic process 124 53 5 30 1 3 33
BP GO:0065007;biological regulation GO:0050864;regulation of B cell activation 46 8 2 12 1 1 16
BP GO:0008152;metabolic process GO:0044271;cellular nitrogen compound biosynthetic process 120 48 4 29 1 3 30
BP GO:0009987;cellular process GO:0071320;cellular response to cAMP 44 7 2 12 1 1 15
BP GO:0065007;biological regulation GO:1904894;positive regulation of receptor signaling pathway via STAT 129 52 3 25 1 2 31
BP GO:0065007;biological regulation GO:0046427;positive regulation of receptor signaling pathway via JAK-STAT 120 46 3 24 1 2 29
BP GO:0065007;biological regulation GO:0019935;cyclic-nucleotide-mediated signaling 74 23 4 21 1 3 21
BP GO:0050896;response to stimulus GO:0051591;response to cAMP 42 6 2 11 1 1 14
BP GO:0009987;cellular process GO:1901655;cellular response to ketone 127 36 10 35 1 4 39
BP GO:0008152;metabolic process GO:0019752;carboxylic acid metabolic process 147 50 6 39 1 4 34
BP GO:0009987;cellular process GO:0101024;mitotic nuclear membrane organization 180 61 2 57 1 7 44
BP GO:0009987;cellular process GO:0007084;mitotic nuclear membrane reassembly 179 60 2 56 1 7 44
BP GO:0065007;biological regulation GO:0036498;IRE1-mediated unfolded protein response 54 9 0 12 1 1 20
BP GO:0009987;cellular process GO:0031468;nuclear membrane reassembly 176 57 2 55 1 7 44
MF GO:0003824;catalytic activity GO:0008395;steroid hydroxylase activity 173 55 2 41 1 4 36
MF GO:0003824;catalytic activity GO:0101020;estrogen 16-alpha-hydroxylase activity 216 66 3 53 1 5 49
MF GO:0003824;catalytic activity GO:0016836;hydro-lyase activity 206 79 5 59 2 3 45
MF GO:0003824;catalytic activity GO:0004089;carbonate dehydratase activity 201 78 4 57 2 3 43
BP GO:0003824;catalytic activity GO:1903506;regulation of nucleic acid-templated transcription 122 52 7 33 1 3 18
BP GO:0065007;biological regulation GO:0043401;steroid hormone mediated signaling pathway 341 164 41 87 1 6 66
BP GO:0065007;biological regulation GO:0045944;positive regulation of transcription by RNA polymerase II 215 100 22 65 2 6 42
BP GO:0065007;biological regulation GO:0051302;regulation of cell division 139 59 10 44 1 4 21
BP GO:0065007;biological regulation GO:1903798;regulation of production of miRNAs involved in gene silencing by miRNA 210 103 35 57 1 5 33
BP GO:0065007;biological regulation GO:0030520;intracellular estrogen receptor signaling pathway 299 129 34 71 1 6 59
BP GO:0009987;cellular process GO:0071392;cellular response to estradiol stimulus 127 60 13 34 1 3 15
BP GO:0009987;cellular process GO:0007095;mitotic G2 DNA damage checkpoint signaling 73 26 1 14 0 0 12
BP GO:0008152;metabolic process GO:0016579;protein deubiquitination 138 57 7 36 0 1 36
BP GO:0008152;metabolic process GO:0070646;protein modification by small protein removal 132 53 7 33 0 1 34
BP GO:0065007;biological regulation GO:0001961;positive regulation of cytokine-mediated signaling pathway 268 90 5 79 0 3 71
BP GO:0050896;response to stimulus GO:0006954;inflammatory response 222 113 13 80 1 6 57
BP GO:0065007;biological regulation GO:1903238;positive regulation of leukocyte tethering or rolling 101 38 3 30 0 2 23
BP GO:0008152;metabolic process GO:1901566;organonitrogen compound biosynthetic process 118 46 4 27 0 4 33
BP GO:0008152;metabolic process GO:0046474;glycerophospholipid biosynthetic process 187 76 2 46 0 4 47
BP GO:0008152;metabolic process GO:0006144;purine nucleobase metabolic process 138 55 4 33 0 5 37
BP GO:0065007;biological regulation GO:1903054;negative regulation of extracellular matrix organization 253 111 7 63 1 6 52
BP GO:0065007;biological regulation GO:0033632;regulation of cell-cell adhesion mediated by integrin 254 111 7 64 1 6 54
BP GO:0009987;cellular process GO:0030219;megakaryocyte differentiation 90 37 3 14 0 3 19
BP GO:0008152;metabolic process GO:0042136;neurotransmitter biosynthetic process 273 133 56 54 0 11 66
BP GO:0065007;biological regulation GO:0010715;regulation of extracellular matrix disassembly 141 68 2 34 1 3 28
BP GO:0009987;cellular process GO:0071243;cellular response to arsenic-containing substance 83 39 1 18 0 1 22
BP GO:0008152;metabolic process GO:0042982;amyloid precursor protein metabolic process 146 62 2 31 0 3 37
BP GO:0065007;biological regulation GO:0007271;synaptic transmission, cholinergic 120 57 1 28 0 2 31
BP GO:0065007;biological regulation GO:0046887;positive regulation of hormone secretion 97 49 15 23 0 2 25
BP GO:0032502;developmental process GO:0008585;female gonad development 72 30 0 13 0 2 21
BP GO:0009987;cellular process GO:0097696;receptor signaling pathway via STAT 59 28 0 8 0 1 16
BP GO:0065007;biological regulation GO:0090022;regulation of neutrophil chemotaxis 75 42 1 16 0 2 20
BP GO:0065007;biological regulation GO:1903051;negative regulation of proteolysis involved in cellular protein catabolic process 60 27 0 11 0 1 18
BP GO:0009987;cellular process GO:0007076;mitotic chromosome condensation 328 112 4 88 0 6 91
BP GO:0009987;cellular process GO:0097435;supramolecular fiber organization 57 24 2 11 0 1 14
BP GO:0065007;biological regulation GO:2000059;negative regulation of ubiquitin-dependent protein catabolic process 39 16 0 10 0 0 13
BP GO:0065007;biological regulation GO:0060054;positive regulation of epithelial cell proliferation involved in wound healing 81 34 4 18 0 2 15
BP GO:0009987;cellular process GO:0035313;wound healing, spreading of epidermal cells 81 34 4 18 0 2 15
BP GO:0008152;metabolic process GO:0050667;homocysteine metabolic process 51 19 4 9 0 2 6
MF GO:0003824;catalytic activity GO:0016712;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen 129 48 2 33 0 2 26
MF GO:0005488;binding GO:0020037;heme binding 109 36 3 27 0 2 22
MF GO:0005488;binding GO:0051879;Hsp90 protein binding 140 42 2 31 0 4 28
MF GO:0003824;catalytic activity GO:0101021;estrogen 2-hydroxylase activity 138 50 4 32 0 3 25
BP GO:0065007;biological regulation GO:0019228;neuronal action potential 8 6 0 3 0 0 1
BP GO:0065007;biological regulation GO:0086010;membrane depolarization during action potential 8 6 0 3 0 0 2
BP GO:0065007;biological regulation GO:0051899;membrane depolarization 7 5 0 3 0 0 1
BP GO:0065007;biological regulation GO:0001508;action potential 7 5 0 3 0 0 1
BP GO:0009987;cellular process GO:0035725;sodium ion transmembrane transport 55 26 19 12 0 2 18
BP GO:0051179;localization GO:0006814;sodium ion transport 70 28 20 13 0 2 17
BP GO:0051179;localization GO:0006812;cation transport 32 9 0 9 0 0 9
BP GO:0051179;localization GO:0098662;inorganic cation transmembrane transport 14 10 5 3 0 1 3
BP GO:0065007;biological regulation GO:0090218;positive regulation of lipid kinase activity 97 42 1 30 0 2 19
BP GO:0065007;biological regulation GO:1903580;positive regulation of ATP metabolic process 211 94 31 65 1 4 56
BP GO:0008152;metabolic process GO:0006310;DNA recombination 50 25 4 22 0 1 11
BP GO:0065007;biological regulation GO:0030195;negative regulation of blood coagulation 34 13 0 15 0 2 8
BP GO:0065007;biological regulation GO:1900015;regulation of cytokine production involved in inflammatory response 118 37 3 36 1 3 32
BP GO:0065007;biological regulation GO:0030518;intracellular steroid hormone receptor signaling pathway 175 86 16 58 1 6 31
BP GO:0009987;cellular process GO:0038003;G protein-coupled opioid receptor signaling pathway 42 19 1 10 0 3 17
BP GO:0009987;cellular process GO:0007218;neuropeptide signaling pathway 12 4 0 3 0 0 6
BP GO:0065007;biological regulation GO:0019934;cGMP-mediated signaling 42 24 2 13 0 3 12
BP GO:0032501;multicellular organismal process GO:0019233;sensory perception of pain 19 9 1 7 0 0 6
BP GO:0065007;biological regulation GO:0043268;positive regulation of potassium ion transport 9 8 1 5 0 1 6
BP GO:0065007;biological regulation GO:0010863;positive regulation of phospholipase C activity 139 73 13 37 1 6 23
BP GO:0032501;multicellular organismal process GO:0007600;sensory perception 17 10 0 8 0 0 7
BP GO:0065007;biological regulation GO:0071902;positive regulation of protein serine/threonine kinase activity 91 37 2 25 0 4 25
BP GO:0051179;localization GO:0006837;serotonin transport 15 9 5 4 0 2 5
BP GO:0051179;localization GO:0051610;serotonin uptake 14 8 4 4 0 2 4
BP GO:0065007;biological regulation GO:0044057;regulation of system process 19 15 1 5 0 1 4
BP GO:0065007;biological regulation GO:0060161;positive regulation of dopamine receptor signaling pathway 57 27 2 12 0 2 22
BP GO:0065007;biological regulation GO:0098915;membrane repolarization during ventricular cardiac muscle cell action potential 5 4 0 3 0 1 2
BP GO:0065007;biological regulation GO:0046621;negative regulation of organ growth 11 9 6 3 0 2 4
BP GO:0065007;biological regulation GO:0001817;regulation of cytokine production 5 5 0 3 0 1 3
BP GO:0065007;biological regulation GO:0046877;regulation of saliva secretion 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0044058;regulation of digestive system process 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0002031;G protein-coupled receptor internalization 9 6 1 4 0 1 3
BP GO:0065007;biological regulation GO:0048715;negative regulation of oligodendrocyte differentiation 9 6 1 4 0 1 3
BP GO:0065007;biological regulation GO:1903764;regulation of potassium ion export across plasma membrane 4 3 0 2 0 1 2
BP GO:0065007;biological regulation GO:0098810;neurotransmitter reuptake 10 6 1 3 0 1 3
BP GO:0065007;biological regulation GO:0099625;ventricular cardiac muscle cell membrane repolarization 3 3 0 2 0 1 1
BP GO:0051179;localization GO:0015844;monoamine transport 73 60 63 8 0 6 17
BP GO:0051179;localization GO:0046717;acid secretion 7 5 1 3 0 1 2
BP GO:0065007;biological regulation GO:0045686;negative regulation of glial cell differentiation 6 4 1 2 0 0 1
BP GO:0065007;biological regulation GO:0046620;regulation of organ growth 2 2 1 0 0 0 1
BP GO:0065007;biological regulation GO:0002029;desensitization of G protein-coupled receptor signaling pathway 21 7 0 4 0 2 6
BP GO:0032501;multicellular organismal process GO:0042310;vasoconstriction 8 8 0 2 0 0 1
BP GO:0065007;biological regulation GO:1901380;negative regulation of potassium ion transmembrane transport 2 2 0 1 0 0 0
BP GO:0009987;cellular process GO:0070528;protein kinase C signaling 8 8 0 2 0 0 1
BP GO:0032502;developmental process GO:0048854;brain morphogenesis 2 2 1 0 0 0 1
BP GO:0065007;biological regulation GO:0045744;negative regulation of G protein-coupled receptor signaling pathway 105 49 13 34 0 3 26
BP GO:0065007;biological regulation GO:1903902;positive regulation of viral life cycle 36 12 1 14 0 1 8
BP GO:0065007;biological regulation GO:0010564;regulation of cell cycle process 125 36 2 34 0 3 38
BP GO:0065007;biological regulation GO:0031113;regulation of microtubule polymerization 72 43 11 25 0 4 12
BP GO:0009987;cellular process GO:0043620;regulation of DNA-templated transcription in response to stress 150 44 2 50 0 4 40
BP GO:0050896;response to stimulus GO:1903350;response to dopamine 118 75 22 44 0 1 26
BP GO:0009987;cellular process GO:1903351;cellular response to dopamine 120 77 23 45 0 1 25
BP GO:0065007;biological regulation GO:0043122;regulation of I-kappaB kinase/NF-kappaB signaling 85 30 2 32 0 4 22
BP GO:0065007;biological regulation GO:1904994;regulation of leukocyte adhesion to vascular endothelial cell 190 58 2 61 0 6 46
BP GO:0050896;response to stimulus GO:0010224;response to UV-B 75 20 0 28 0 2 22
BP GO:0009987;cellular process GO:0071404;cellular response to low-density lipoprotein particle stimulus 116 41 0 43 0 2 29
BP GO:0051179;localization GO:0043252;sodium-independent organic anion transport 64 36 3 21 0 2 18
BP GO:0008152;metabolic process GO:0033619;membrane protein proteolysis 98 40 2 30 0 1 29
BP GO:0065007;biological regulation GO:0045892;negative regulation of transcription, DNA-templated 108 46 7 40 0 2 26
BP GO:0065007;biological regulation GO:0032479;regulation of type I interferon production 44 19 0 15 0 0 11
BP GO:0050896;response to stimulus GO:0140546;defense response to symbiont 115 35 2 30 0 3 31
BP GO:0044419;biological process involved in interspecies interaction between organisms GO:0051607;defense response to virus 110 34 2 29 0 3 30
BP GO:0008152;metabolic process GO:0016311;dephosphorylation 48 18 0 17 0 0 11
BP GO:0065007;biological regulation GO:0051092;positive regulation of NF-kappaB transcription factor activity 54 24 2 21 0 1 13
BP GO:0050896;response to stimulus GO:0033273;response to vitamin 102 32 1 33 0 2 29
BP GO:0050896;response to stimulus GO:0033280;response to vitamin D 102 32 1 33 0 2 29
BP GO:0065007;biological regulation GO:2000615;regulation of histone H3-K9 acetylation 15 10 3 6 0 0 10
BP GO:0065007;biological regulation GO:0051571;positive regulation of histone H3-K4 methylation 17 11 2 6 0 0 10
BP GO:0065007;biological regulation GO:0097193;intrinsic apoptotic signaling pathway 25 15 0 11 0 3 12
BP GO:0065007;biological regulation GO:0051569;regulation of histone H3-K4 methylation 14 9 0 5 0 0 9
BP GO:0065007;biological regulation GO:0031062;positive regulation of histone methylation 10 7 0 4 0 0 7
BP GO:0065007;biological regulation GO:0043153;entrainment of circadian clock by photoperiod 16 7 0 8 0 0 9
BP GO:0050896;response to stimulus GO:0009648;photoperiodism 16 7 0 8 0 0 9
BP GO:0065007;biological regulation GO:0035065;regulation of histone acetylation 19 15 2 11 0 0 14
BP GO:0065007;biological regulation GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage 17 10 1 7 0 1 6
BP GO:0009987;cellular process GO:0006915;apoptotic process 12 9 3 2 0 0 2
BP GO:0050896;response to stimulus GO:0010212;response to ionizing radiation 18 14 1 9 0 0 8
BP GO:0065007;biological regulation GO:0032088;negative regulation of NF-kappaB transcription factor activity 63 22 1 17 0 1 21
BP GO:0065007;biological regulation GO:0043068;positive regulation of programmed cell death 34 15 0 10 0 0 15
BP GO:0065007;biological regulation GO:0043065;positive regulation of apoptotic process 12 6 0 6 0 0 8
BP GO:0065007;biological regulation GO:2000617;positive regulation of histone H3-K9 acetylation 5 4 0 3 0 0 4
BP GO:0050896;response to stimulus GO:0071680;response to indole-3-methanol 5 4 0 3 0 0 4
BP GO:0009987;cellular process GO:0071681;cellular response to indole-3-methanol 5 4 0 3 0 0 4
BP GO:0009987;cellular process GO:2000618;regulation of histone H4-K16 acetylation 5 4 0 3 0 0 4
BP GO:0065007;biological regulation GO:0051573;negative regulation of histone H3-K9 methylation 32 13 0 11 0 1 9
BP GO:0032501;multicellular organismal process GO:0098596;imitative learning 29 12 0 9 0 0 16
BP GO:0032501;multicellular organismal process GO:0042297;vocal learning 29 12 0 9 0 0 16
BP GO:0009987;cellular process GO:0043933;protein-containing complex subunit organization 26 9 0 6 0 0 15
BP GO:0065007;biological regulation GO:0046600;negative regulation of centriole replication 5 4 0 3 0 0 4
BP GO:0065007;biological regulation GO:0090240;positive regulation of histone H4 acetylation 5 4 0 3 0 0 4
BP GO:0008152;metabolic process GO:0044648;histone H3-K4 dimethylation 10 7 1 4 0 0 6
BP GO:0008152;metabolic process GO:0097692;histone H3-K4 monomethylation 8 5 1 3 0 0 4
BP GO:0065007;biological regulation GO:1903599;positive regulation of autophagy of mitochondrion 27 11 0 8 0 0 14
BP GO:0065007;biological regulation GO:1903265;positive regulation of tumor necrosis factor-mediated signaling pathway 4 3 0 2 0 0 3
BP GO:0008152;metabolic process GO:0085020;protein K6-linked ubiquitination 4 3 0 2 0 0 3
BP GO:0065007;biological regulation GO:0030336;negative regulation of cell migration 38 22 0 12 0 0 14
BP GO:0065007;biological regulation GO:2000757;negative regulation of peptidyl-lysine acetylation 47 21 1 15 0 0 18
BP GO:0065007;biological regulation GO:0044030;regulation of DNA methylation 7 4 1 2 0 0 3
BP GO:0032501;multicellular organismal process GO:0030183;B cell differentiation 19 6 0 6 0 0 2
BP GO:0032501;multicellular organismal process GO:0042113;B cell activation 21 7 0 7 0 0 2
BP GO:0065007;biological regulation GO:0045860;positive regulation of protein kinase activity 34 12 2 6 0 0 9
BP GO:0065007;biological regulation GO:0051099;positive regulation of binding 61 33 4 18 0 1 20
BP GO:0009987;cellular process GO:0007215;glutamate receptor signaling pathway 143 112 127 26 0 8 22
BP GO:0065007;biological regulation GO:0050804;modulation of chemical synaptic transmission 143 112 127 26 0 8 22
BP GO:0065007;biological regulation GO:0007216;G protein-coupled glutamate receptor signaling pathway 141 110 124 26 0 7 21
BP GO:0065007;biological regulation GO:0035249;synaptic transmission, glutamatergic 135 105 119 24 0 6 21
BP GO:0065007;biological regulation GO:0099177;regulation of trans-synaptic signaling 131 103 115 24 0 5 20
BP GO:0065007;biological regulation GO:0033673;negative regulation of kinase activity 39 28 20 13 0 0 4
BP GO:0065007;biological regulation GO:0070302;regulation of stress-activated protein kinase signaling cascade 130 84 63 35 0 2 19
BP GO:0065007;biological regulation GO:0006469;negative regulation of protein kinase activity 22 15 13 7 0 0 3
BP GO:0065007;biological regulation GO:1905606;regulation of presynapse assembly 85 57 55 29 0 1 21
BP GO:0065007;biological regulation GO:0099174;regulation of presynapse organization 83 56 54 27 0 1 20
BP GO:0008152;metabolic process GO:0006692;prostanoid metabolic process 111 69 40 31 0 1 28
BP GO:0065007;biological regulation GO:0051173;positive regulation of nitrogen compound metabolic process 123 71 38 33 0 3 33
BP GO:0032501;multicellular organismal process GO:0001774;microglial cell activation 96 68 55 34 0 1 25
BP GO:0065007;biological regulation GO:0045859;regulation of protein kinase activity 16 12 10 6 0 0 2
BP GO:0065007;biological regulation GO:0010800;positive regulation of peptidyl-threonine phosphorylation 63 47 45 24 0 2 10
BP GO:0009987;cellular process GO:0071276;cellular response to cadmium ion 206 161 108 62 0 11 38
BP GO:0065007;biological regulation GO:0045931;positive regulation of mitotic cell cycle 18 7 3 11 0 1 4
BP GO:0065007;biological regulation GO:0031098;stress-activated protein kinase signaling cascade 124 62 37 31 0 4 33
BP GO:0050896;response to stimulus GO:0046686;response to cadmium ion 190 150 104 57 0 11 35
BP GO:0065007;biological regulation GO:0034248;regulation of cellular amide metabolic process 47 27 8 24 0 3 11
BP GO:0065007;biological regulation GO:2000310;regulation of NMDA receptor activity 23 14 18 4 0 0 3
BP GO:0032501;multicellular organismal process GO:0042116;macrophage activation 58 41 35 23 0 1 14
BP GO:0065007;biological regulation GO:0001933;negative regulation of protein phosphorylation 9 7 6 6 0 0 1
BP GO:0065007;biological regulation GO:0010799;regulation of peptidyl-threonine phosphorylation 39 27 29 14 0 2 7
BP GO:0065007;biological regulation GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling 60 32 21 16 0 2 8
BP GO:0065007;biological regulation GO:0032720;negative regulation of tumor necrosis factor production 15 12 7 9 0 2 0
BP GO:0065007;biological regulation GO:0051963;regulation of synapse assembly 33 21 23 13 0 0 7
BP GO:0065007;biological regulation GO:1903556;negative regulation of tumor necrosis factor superfamily cytokine production 15 12 7 9 0 2 0
BP GO:0065007;biological regulation GO:0032268;regulation of cellular protein metabolic process 65 30 17 18 0 2 13
BP GO:0065007;biological regulation GO:0070373;negative regulation of ERK1 and ERK2 cascade 7 6 5 4 0 0 0
BP GO:0065007;biological regulation GO:0031327;negative regulation of cellular biosynthetic process 52 18 12 16 1 1 13
BP GO:0065007;biological regulation GO:0001960;negative regulation of cytokine-mediated signaling pathway 7 5 5 4 0 0 0
BP GO:0065007;biological regulation GO:0099601;regulation of neurotransmitter receptor activity 16 8 12 3 0 0 2
BP GO:0008152;metabolic process GO:0000413;protein peptidyl-prolyl isomerization 5 5 1 2 0 0 3
BP GO:0008152;metabolic process GO:0018208;peptidyl-proline modification 5 5 1 2 0 0 3
BP GO:0008152;metabolic process GO:1990000;amyloid fibril formation 126 64 33 40 0 2 33
BP GO:0065007;biological regulation GO:0010523;negative regulation of calcium ion transport into cytosol 8 7 1 3 0 0 3
BP GO:0065007;biological regulation GO:0051280;negative regulation of release of sequestered calcium ion into cytosol 5 5 1 2 0 0 3
BP GO:0065007;biological regulation GO:0060315;negative regulation of ryanodine-sensitive calcium-release channel activity 5 5 1 2 0 0 3
BP GO:0008152;metabolic process GO:0006787;porphyrin-containing compound catabolic process 75 36 4 29 0 2 20
BP GO:0008152;metabolic process GO:0042167;heme catabolic process 75 36 4 29 0 2 20
BP GO:0065007;biological regulation GO:0035308;negative regulation of protein dephosphorylation 3 3 0 1 0 0 2
BP GO:0065007;biological regulation GO:0032515;negative regulation of phosphoprotein phosphatase activity 3 3 0 1 0 0 2
BP GO:0065007;biological regulation GO:0060314;regulation of ryanodine-sensitive calcium-release channel activity 4 4 0 1 0 0 2
BP GO:0009987;cellular process GO:0062197;cellular response to chemical stress 36 27 19 11 0 1 5
BP GO:0065007;biological regulation GO:1903900;regulation of viral life cycle 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0019722;calcium-mediated signaling 17 9 1 7 0 1 8
BP GO:0008152;metabolic process GO:0006699;bile acid biosynthetic process 5 4 0 1 0 0 1
BP GO:0065007;biological regulation GO:0010923;negative regulation of phosphatase activity 2 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0032273;positive regulation of protein polymerization 46 21 2 14 0 3 7
BP GO:0065007;biological regulation GO:1902905;positive regulation of supramolecular fiber organization 59 36 14 19 0 3 13
BP GO:0065007;biological regulation GO:0051972;regulation of telomerase activity 198 94 19 57 1 7 50
BP GO:0065007;biological regulation GO:0031331;positive regulation of cellular catabolic process 94 44 23 27 0 1 32
BP GO:0065007;biological regulation GO:0051769;regulation of nitric-oxide synthase biosynthetic process 67 29 21 16 0 2 18
BP GO:0065007;biological regulation GO:0090200;positive regulation of release of cytochrome c from mitochondria 29 24 6 10 0 2 8
BP GO:0009987;cellular process GO:0038171;cannabinoid signaling pathway 140 69 14 46 0 4 40
BP GO:0009987;cellular process GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest 37 15 1 14 0 1 12
BP GO:0009987;cellular process GO:0031571;mitotic G1 DNA damage checkpoint signaling 36 13 1 11 0 0 12
BP GO:0009987;cellular process GO:0071482;cellular response to light stimulus 36 15 0 11 0 1 10
BP GO:0009987;cellular process GO:0030330;DNA damage response, signal transduction by p53 class mediator 32 11 1 9 0 0 11
BP GO:0065007;biological regulation GO:1902749;regulation of cell cycle G2/M phase transition 54 15 1 11 0 0 21
BP GO:0065007;biological regulation GO:1901987;regulation of cell cycle phase transition 70 20 0 20 0 1 20
BP GO:0065007;biological regulation GO:1904996;positive regulation of leukocyte adhesion to vascular endothelial cell 134 39 2 40 0 5 31
BP GO:0065007;biological regulation GO:0051129;negative regulation of cellular component organization 79 27 1 20 0 1 27
BP GO:0008152;metabolic process GO:0006261;DNA-dependent DNA replication 95 39 3 28 0 2 18
BP GO:0008152;metabolic process GO:0010499;proteasomal ubiquitin-independent protein catabolic process 45 14 1 13 0 1 10
BP GO:0065007;biological regulation GO:0033238;regulation of cellular amine metabolic process 40 12 1 11 0 1 10
BP GO:0065007;biological regulation GO:0006521;regulation of cellular amino acid metabolic process 40 12 1 11 0 1 10
BP GO:0065007;biological regulation GO:1902750;negative regulation of cell cycle G2/M phase transition 40 12 1 11 0 1 10
BP GO:0009987;cellular process GO:0036388;pre-replicative complex assembly 39 11 1 11 0 1 10
BP GO:0008152;metabolic process GO:0000209;protein polyubiquitination 41 11 0 10 0 1 11
BP GO:0065007;biological regulation GO:1902036;regulation of hematopoietic stem cell differentiation 41 13 1 11 0 1 10
BP GO:0002376;immune system process GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent 39 11 1 11 0 1 10
BP GO:0009987;cellular process GO:0038061;NIK/NF-kappaB signaling 41 13 1 13 0 1 10
BP GO:0065007;biological regulation GO:1901532;regulation of hematopoietic progenitor cell differentiation 41 13 1 11 0 1 10
BP GO:0009987;cellular process GO:0061418;regulation of transcription from RNA polymerase II promoter in response to hypoxia 189 64 3 58 1 6 47
BP GO:0002376;immune system process GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I 39 11 1 11 0 1 10
BP GO:0009987;cellular process GO:0060071;Wnt signaling pathway, planar cell polarity pathway 39 11 1 11 0 1 10
BP GO:0065007;biological regulation GO:0090175;regulation of establishment of planar polarity 39 11 1 11 0 1 10
BP GO:0008152;metabolic process GO:0031146;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process 39 11 1 11 0 1 10
BP GO:0065007;biological regulation GO:2000736;regulation of stem cell differentiation 44 16 2 13 0 1 10
BP GO:0065007;biological regulation GO:1901991;negative regulation of mitotic cell cycle phase transition 40 10 0 10 0 1 10
BP GO:0065007;biological regulation GO:0033209;tumor necrosis factor-mediated signaling pathway 43 15 1 11 0 1 10
BP GO:0009987;cellular process GO:0051260;protein homooligomerization 49 19 1 15 0 2 12
BP GO:0065007;biological regulation GO:0061013;regulation of mRNA catabolic process 42 12 0 12 0 2 12
BP GO:0065007;biological regulation GO:0035567;non-canonical Wnt signaling pathway 38 10 0 10 0 1 10
BP GO:0065007;biological regulation GO:0090263;positive regulation of canonical Wnt signaling pathway 86 34 5 30 1 4 19
BP GO:0065007;biological regulation GO:0080090;regulation of primary metabolic process 55 17 1 14 0 1 13
BP GO:0008152;metabolic process GO:0016567;protein ubiquitination 50 12 0 13 1 2 12
BP GO:0009987;cellular process GO:0065004;protein-DNA complex assembly 38 10 0 10 0 1 10
BP GO:0065007;biological regulation GO:0043488;regulation of mRNA stability 39 11 0 11 0 2 10
BP GO:0065007;biological regulation GO:0010389;regulation of G2/M transition of mitotic cell cycle 47 16 1 13 0 1 10
BP GO:0065007;biological regulation GO:0030177;positive regulation of Wnt signaling pathway 173 61 10 52 1 6 42
BP GO:0065007;biological regulation GO:0051454;intracellular pH elevation 76 25 2 22 0 3 16
BP GO:0065007;biological regulation GO:0090090;negative regulation of canonical Wnt signaling pathway 38 10 0 10 0 1 10
BP GO:0009987;cellular process GO:0044806;G-quadruplex DNA unwinding 118 53 3 38 1 3 21
BP GO:0065007;biological regulation GO:0007346;regulation of mitotic cell cycle 57 21 1 18 0 1 14
BP GO:0008152;metabolic process GO:0061820;telomeric D-loop disassembly 110 47 2 35 1 3 19
BP GO:0008152;metabolic process GO:0048478;replication fork protection 113 49 2 37 1 3 20
BP GO:0008152;metabolic process GO:0090646;mitochondrial tRNA processing 83 45 3 21 0 4 17
BP GO:0065007;biological regulation GO:1901990;regulation of mitotic cell cycle phase transition 42 12 1 11 0 1 10
BP GO:0065007;biological regulation GO:0030178;negative regulation of Wnt signaling pathway 38 10 0 10 0 1 10
BP GO:0009987;cellular process GO:0071356;cellular response to tumor necrosis factor 43 14 1 12 0 1 10
BP GO:0008152;metabolic process GO:0042355;L-fucose catabolic process 61 19 1 18 0 2 16
BP GO:0008152;metabolic process GO:0042354;L-fucose metabolic process 61 19 1 18 0 2 16
BP GO:0008152;metabolic process GO:0019317;fucose catabolic process 61 19 1 18 0 2 16
BP GO:0065007;biological regulation GO:0060353;regulation of cell adhesion molecule production 68 22 2 19 0 2 20
BP GO:0008152;metabolic process GO:0070900;mitochondrial tRNA modification 63 32 2 18 0 3 14
BP GO:0065007;biological regulation GO:0002691;regulation of cellular extravasation 61 19 1 18 0 2 16
BP GO:0008152;metabolic process GO:0010498;proteasomal protein catabolic process 38 10 0 10 0 1 10
BP GO:0009987;cellular process GO:0072711;cellular response to hydroxyurea 109 46 2 34 1 3 19
BP GO:0065007;biological regulation GO:1903236;regulation of leukocyte tethering or rolling 59 18 1 17 0 2 16
BP GO:0008152;metabolic process GO:0090657;telomeric loop disassembly 106 43 2 33 1 3 19
BP GO:0065007;biological regulation GO:0002709;regulation of T cell mediated immunity 58 17 1 16 0 2 16
BP GO:0008152;metabolic process GO:0001325;formation of extrachromosomal circular DNA 103 42 1 32 1 3 19
BP GO:0008152;metabolic process GO:0090656;t-circle formation 102 41 1 32 1 3 19
BP GO:0008152;metabolic process GO:0090737;telomere maintenance via telomere trimming 102 41 1 32 1 3 19
BP GO:0050896;response to stimulus GO:0072710;response to hydroxyurea 102 41 1 31 1 3 19
BP GO:0008152;metabolic process GO:0033169;histone H3-K9 demethylation 62 19 1 17 0 2 16
BP GO:0065007;biological regulation GO:0090329;regulation of DNA-dependent DNA replication 119 49 1 34 1 3 25
BP GO:0065007;biological regulation GO:2000104;negative regulation of DNA-dependent DNA replication 117 49 1 34 1 3 25
BP GO:0065007;biological regulation GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator 40 11 1 10 0 1 10
BP GO:0008152;metabolic process GO:0006098;pentose-phosphate shunt 39 10 0 10 0 1 10
BP GO:0065007;biological regulation GO:1902165;regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator 40 11 1 10 0 1 10
BP GO:0050896;response to stimulus GO:0010165;response to X-ray 99 40 1 32 1 3 19
BP GO:0065007;biological regulation GO:0060828;regulation of canonical Wnt signaling pathway 57 18 0 17 1 2 14
BP GO:0009987;cellular process GO:0035457;cellular response to interferon-alpha 21 12 1 3 0 1 6
BP GO:0009987;cellular process GO:0000022;mitotic spindle elongation 39 15 2 11 0 2 13
BP GO:0051179;localization GO:0015874;norepinephrine transport 61 48 52 7 0 3 12
BP GO:0051179;localization GO:0090493;catecholamine uptake 55 42 46 6 0 3 12
BP GO:0051179;localization GO:0090494;dopamine uptake 128 89 74 23 0 5 27
BP GO:0065007;biological regulation GO:0006110;regulation of glycolytic process 136 44 9 38 1 2 38
BP GO:0032501;multicellular organismal process GO:0150104;transport across blood-brain barrier 41 8 0 7 0 1 12
BP GO:0065007;biological regulation GO:1903961;positive regulation of anion transmembrane transport 67 20 0 18 0 2 20
BP GO:0065007;biological regulation GO:2001225;regulation of chloride transport 69 22 1 20 0 2 20
BP GO:0065007;biological regulation GO:0010359;regulation of anion channel activity 66 19 0 17 0 2 20
BP GO:0032501;multicellular organismal process GO:1990962;xenobiotic transport across blood-brain barrier 73 21 1 23 0 2 24
BP GO:0065007;biological regulation GO:0003085;negative regulation of systemic arterial blood pressure 22 8 2 5 0 2 5
BP GO:0032501;multicellular organismal process GO:0042311;vasodilation 25 9 1 5 0 3 5
BP GO:0065007;biological regulation GO:0051053;negative regulation of DNA metabolic process 31 17 2 11 0 1 11
BP GO:0032501;multicellular organismal process GO:0003015;heart process 57 26 5 12 0 2 5
BP GO:0065007;biological regulation GO:0032411;positive regulation of transporter activity 2 0 1 0 0 0 0
BP GO:0008152;metabolic process GO:0080182;histone H3-K4 trimethylation 2 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:1900017;positive regulation of cytokine production involved in inflammatory response 28 18 1 8 0 0 3
BP GO:0065007;biological regulation GO:0071634;regulation of transforming growth factor beta production 72 34 1 21 0 3 21
BP GO:0008152;metabolic process GO:0006516;glycoprotein catabolic process 16 10 0 4 0 0 1
BP GO:0008152;metabolic process GO:0000729;DNA double-strand break processing 32 20 1 12 0 2 7
BP GO:0008152;metabolic process GO:0018027;peptidyl-lysine dimethylation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0043984;histone H4-K16 acetylation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1902176;negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway 42 22 1 13 1 1 6
BP GO:0009987;cellular process GO:1901699;cellular response to nitrogen compound 136 50 4 48 0 4 30
BP GO:0065007;biological regulation GO:1903320;regulation of protein modification by small protein conjugation or removal 44 21 1 9 0 0 12
MF GO:0003824;catalytic activity GO:0033764;steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 50 15 1 13 0 1 10
MF GO:0003824;catalytic activity GO:0030283;testosterone dehydrogenase [NAD(P)] activity 103 35 2 26 0 2 18
MF GO:0003824;catalytic activity GO:0004303;estradiol 17-beta-dehydrogenase activity 93 29 1 22 0 2 16
MF GO:0003824;catalytic activity GO:0001758;retinal dehydrogenase activity 11 7 0 6 0 0 1
MF GO:0003824;catalytic activity GO:0004032;alditol:NADP+ 1-oxidoreductase activity 6 4 0 3 0 0 0
MF GO:0003824;catalytic activity GO:0008106;alcohol dehydrogenase 6 4 0 3 0 0 0
MF GO:0003824;catalytic activity GO:0008391;arachidonic acid monooxygenase activity 58 22 0 14 0 1 11
MF GO:0003824;catalytic activity GO:0016620;oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor 7 6 0 4 0 0 1
MF GO:0005488;binding GO:0042803;protein homodimerization activity 42 13 0 8 0 0 9
MF GO:0005488;binding GO:0046914;transition metal ion binding 24 12 1 6 0 0 3
MF GO:0005488;binding GO:0062037;D-loop DNA binding 42 23 1 16 1 0 6
MF GO:0003824;catalytic activity GO:0047086;ketosteroid monooxygenase activity 3 3 0 2 0 0 0
MF GO:0005488;binding GO:0000403;Y-form DNA binding 36 23 1 16 1 0 4
MF GO:0003824;catalytic activity GO:0004064;arylesterase activity 25 20 1 8 0 0 2
MF GO:0140657;ATP-dependent activity GO:0009378;four-way junction helicase activity 50 27 1 18 1 0 6
MF GO:0003824;catalytic activity GO:0052689;carboxylic ester hydrolase activity 10 8 0 6 0 0 2
MF GO:0005488;binding GO:0003697;single-stranded DNA binding 29 15 1 9 1 0 3
MF GO:0005488;binding GO:0036041;long-chain fatty acid binding 15 11 1 5 0 0 2
MF GO:0005488;binding GO:0000405;bubble DNA binding 24 15 0 11 1 0 1
MF GO:0003824;catalytic activity GO:0010857;calcium-dependent protein kinase activity 56 21 1 14 0 1 11
MF GO:0003824;catalytic activity GO:0009931;calcium-dependent protein serine/threonine kinase activity 56 21 1 14 0 1 11
MF GO:0003824;catalytic activity GO:0047023;androsterone dehydrogenase activity 3 3 0 2 0 0 0
MF GO:0005488;binding GO:0032052;bile acid binding 10 7 1 6 0 0 1
MF GO:0060089;molecular transducer activity GO:0045125;bioactive lipid receptor activity 3 3 0 2 0 0 0
MF GO:0005488;binding GO:0032357;oxidized purine DNA binding 24 15 0 11 1 0 1
MF GO:0005488;binding GO:0051880;G-quadruplex DNA binding 23 14 0 10 1 0 1
MF GO:0003824;catalytic activity GO:0004033;aldo-keto reductase 4 3 0 3 0 0 0
MF GO:0003824;catalytic activity GO:0008239;dipeptidyl-peptidase activity 33 15 1 8 1 0 3
BP GO:0051179;localization GO:0006820;anion transport 44 22 3 11 0 1 13
BP GO:0051179;localization GO:0071702;organic substance transport 48 36 26 5 0 3 17
BP GO:0051179;localization GO:0051647;nucleus localization 20 12 0 3 0 0 8
BP GO:0009987;cellular process GO:0097067;cellular response to thyroid hormone stimulus 16 8 0 2 0 0 7
BP GO:0065007;biological regulation GO:0035561;regulation of chromatin binding 16 7 0 2 0 0 7
BP GO:0032502;developmental process GO:0061548;ganglion development 15 7 0 2 0 0 7
BP GO:0065007;biological regulation GO:0051547;regulation of keratinocyte migration 33 22 1 8 0 0 11
BP GO:0050896;response to stimulus GO:0097066;response to thyroid hormone 15 8 0 2 0 0 6
BP GO:0065007;biological regulation GO:1901836;regulation of transcription of nucleolar large rRNA by RNA polymerase I 18 11 0 2 0 0 6
BP GO:0065007;biological regulation GO:0008156;negative regulation of DNA replication 12 6 0 1 0 0 5
BP GO:0065007;biological regulation GO:0032516;positive regulation of phosphoprotein phosphatase activity 24 14 0 7 0 0 7
BP GO:0065007;biological regulation GO:0032793;positive regulation of CREB transcription factor activity 4 2 0 2 0 0 3
BP GO:0065007;biological regulation GO:0010922;positive regulation of phosphatase activity 14 8 0 1 0 0 6
BP GO:0065007;biological regulation GO:0006359;regulation of transcription by RNA polymerase III 13 7 0 1 0 0 8
BP GO:0065007;biological regulation GO:0045948;positive regulation of translational initiation 10 5 0 1 0 0 5
BP GO:0065007;biological regulation GO:0045943;positive regulation of transcription by RNA polymerase I 10 5 0 1 0 0 5
BP GO:0050896;response to stimulus GO:0031667;response to nutrient levels 10 5 0 1 0 0 5
BP GO:0065007;biological regulation GO:0008361;regulation of cell size 10 5 0 1 0 0 5
BP GO:0032502;developmental process GO:0007422;peripheral nervous system development 12 6 0 2 0 0 5
BP GO:0065007;biological regulation GO:0045834;positive regulation of lipid metabolic process 33 16 3 7 0 0 9
BP GO:0065007;biological regulation GO:0016242;negative regulation of macroautophagy 9 4 0 1 0 0 4
BP GO:0009987;cellular process GO:0031929;TOR signaling 9 4 0 1 0 0 4
BP GO:0008152;metabolic process GO:0009057;macromolecule catabolic process 7 3 0 1 0 0 3
BP GO:0009987;cellular process GO:0071229;cellular response to acid chemical 7 3 0 1 0 0 3
BP GO:0065007;biological regulation GO:0032535;regulation of cellular component size 7 3 0 1 0 0 3
BP GO:0050896;response to stimulus GO:0043200;response to amino acid 7 3 0 1 0 0 3
BP GO:0009987;cellular process GO:0080171;lytic vacuole organization 8 4 0 2 0 0 3
BP GO:0065007;biological regulation GO:0035307;positive regulation of protein dephosphorylation 9 5 0 2 0 0 4
BP GO:0009987;cellular process GO:0071230;cellular response to amino acid stimulus 7 3 0 1 0 0 3
BP GO:0065007;biological regulation GO:0046890;regulation of lipid biosynthetic process 8 4 0 2 0 0 3
MF GO:0005215;transporter activity GO:0015347;sodium-independent organic anion transmembrane transporter activity 17 9 0 3 0 0 4
MF GO:0005215;transporter activity GO:0022853;active ion transmembrane transporter activity 14 7 0 2 0 0 4
MF GO:0005215;transporter activity GO:0015291;secondary active transmembrane transporter activity 14 7 0 2 0 0 4
MF GO:0005215;transporter activity GO:0008514;organic anion transmembrane transporter activity 12 5 0 2 0 0 4
MF GO:0005488;binding GO:0000992;RNA polymerase III cis-regulatory region sequence-specific DNA binding 18 10 0 2 0 0 5
MF GO:0005488;binding GO:0001006;RNA polymerase III type 3 promoter sequence-specific DNA binding 18 10 0 2 0 0 5
MF GO:0060089;molecular transducer activity GO:0004985;G protein-coupled opioid receptor activity 5 3 0 2 0 0 3
MF GO:0005488;binding GO:0005525;GTP binding 9 5 0 1 0 0 4
MF GO:0005488;binding GO:0032561;guanyl ribonucleotide binding 9 5 0 1 0 0 4
MF GO:0005215;transporter activity GO:0008509;anion transmembrane transporter activity 9 4 0 1 0 0 4
MF GO:0005488;binding GO:0001223;transcription coactivator binding 41 15 0 8 0 0 13
MF GO:0005488;binding GO:0042923;neuropeptide binding 3 2 0 1 0 0 2
MF GO:0005488;binding GO:0035639;purine ribonucleoside triphosphate binding 9 3 1 2 0 0 4
CC GO:0110165;cellular anatomical entity GO:0045335;phagocytic vesicle 6 2 0 1 0 0 4
CC GO:0032991;protein-containing complex GO:0031931;TORC1 complex 8 3 0 1 0 0 5
CC GO:0110165;cellular anatomical entity GO:0030139;endocytic vesicle 7 1 0 2 0 0 5
CC GO:0032991;protein-containing complex GO:0031932;TORC2 complex 8 3 0 1 0 0 5
CC GO:0110165;cellular anatomical entity GO:0000323;lytic vacuole 7 2 0 1 0 0 4
BP GO:0065007;biological regulation GO:1900182;positive regulation of protein localization to nucleus 37 14 1 10 0 0 6
BP GO:0065007;biological regulation GO:0032210;regulation of telomere maintenance via telomerase 109 45 7 28 1 5 24
BP GO:0065007;biological regulation GO:0010544;negative regulation of platelet activation 60 21 0 19 0 2 14
BP GO:0008152;metabolic process GO:0071897;DNA biosynthetic process 33 8 1 7 0 0 7
BP GO:0065007;biological regulation GO:0010888;negative regulation of lipid storage 131 52 6 44 0 2 28
BP GO:0065007;biological regulation GO:0045923;positive regulation of fatty acid metabolic process 21 10 2 4 0 0 6
BP GO:0008152;metabolic process GO:1902652;secondary alcohol metabolic process 15 6 0 2 0 0 3
BP GO:0008152;metabolic process GO:0008203;cholesterol metabolic process 13 4 0 1 0 0 3
BP GO:0065007;biological regulation GO:0060967;negative regulation of gene silencing by RNA 44 18 0 8 0 0 12
BP GO:0065007;biological regulation GO:0060149;negative regulation of posttranscriptional gene silencing 44 18 0 8 0 0 12
BP GO:0065007;biological regulation GO:0060965;negative regulation of gene silencing by miRNA 134 59 2 38 1 2 24
BP GO:0009987;cellular process GO:0006929;substrate-dependent cell migration 52 17 0 13 0 1 12
BP GO:0032501;multicellular organismal process GO:0033077;T cell differentiation in thymus 52 17 0 13 0 1 12
BP GO:0065007;biological regulation GO:0045646;regulation of erythrocyte differentiation 21 8 0 10 0 0 7
BP GO:0065007;biological regulation GO:0007254;JNK cascade 3 2 0 3 0 0 0
BP GO:0065007;biological regulation GO:0070228;regulation of lymphocyte apoptotic process 8 3 0 2 0 0 1
BP GO:0065007;biological regulation GO:0070664;negative regulation of leukocyte proliferation 8 6 2 6 0 0 1
BP GO:0065007;biological regulation GO:0043300;regulation of leukocyte degranulation 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:1901224;positive regulation of NIK/NF-kappaB signaling 33 11 3 11 0 2 5
BP GO:0065007;biological regulation GO:0033006;regulation of mast cell activation involved in immune response 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0002886;regulation of myeloid leukocyte mediated immunity 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:2000108;positive regulation of leukocyte apoptotic process 38 22 2 11 0 0 8
BP GO:0065007;biological regulation GO:0030889;negative regulation of B cell proliferation 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:2001257;regulation of cation channel activity 26 18 16 7 0 0 6
BP GO:0065007;biological regulation GO:0033135;regulation of peptidyl-serine phosphorylation 37 24 24 11 0 1 5
BP GO:0008152;metabolic process GO:0009154;purine ribonucleotide catabolic process 17 5 1 8 0 0 5
BP GO:0065007;biological regulation GO:0043949;regulation of cAMP-mediated signaling 4 4 1 3 0 0 1
BP GO:0065007;biological regulation GO:0010942;positive regulation of cell death 45 29 12 14 0 1 13
BP GO:0009987;cellular process GO:0034330;cell junction organization 39 26 22 17 0 0 9
BP GO:0065007;biological regulation GO:0050806;positive regulation of synaptic transmission 6 5 3 4 0 0 2
BP GO:0065007;biological regulation GO:0032649;regulation of interferon-gamma production 60 18 1 15 0 2 13
BP GO:0009987;cellular process GO:0032392;DNA geometric change 91 36 2 26 0 3 20
BP GO:0008152;metabolic process GO:0070212;protein poly-ADP-ribosylation 28 16 4 11 1 2 4
BP GO:0008152;metabolic process GO:0070213;protein auto-ADP-ribosylation 25 13 4 9 1 2 4
BP GO:0009987;cellular process GO:0070198;protein localization to chromosome, telomeric region 24 11 3 8 1 2 3
BP GO:0065007;biological regulation GO:0032205;negative regulation of telomere maintenance 22 10 2 8 1 2 3
BP GO:0065007;biological regulation GO:1904356;regulation of telomere maintenance via telomere lengthening 22 10 2 8 1 2 3
BP GO:0065007;biological regulation GO:1904357;negative regulation of telomere maintenance via telomere lengthening 21 9 1 8 1 2 3
BP GO:0065007;biological regulation GO:0006471;protein ADP-ribosylation 21 9 1 8 1 2 3
BP GO:0065007;biological regulation GO:0032206;positive regulation of telomere maintenance 80 50 12 34 1 6 13
BP GO:0065007;biological regulation GO:0032212;positive regulation of telomere maintenance via telomerase 81 50 12 34 1 6 13
BP GO:0009987;cellular process GO:0034502;protein localization to chromosome 35 22 7 12 1 2 5
BP GO:0065007;biological regulation GO:1904358;positive regulation of telomere maintenance via telomere lengthening 62 42 11 26 1 5 6
BP GO:0065007;biological regulation GO:2000573;positive regulation of DNA biosynthetic process 40 21 6 14 1 3 5
BP GO:0008152;metabolic process GO:0046457;prostanoid biosynthetic process 135 53 4 38 0 1 31
BP GO:0050896;response to stimulus GO:0032355;response to estradiol 150 72 14 46 1 4 18
BP GO:0042592;homeostatic process GO:0001678;cellular glucose homeostasis 154 49 3 40 0 2 50
MF GO:0003824;catalytic activity GO:0004713;protein tyrosine kinase activity 66 19 1 17 0 3 13
MF GO:0003824;catalytic activity GO:0019199;transmembrane receptor protein kinase activity 66 19 1 17 0 3 13
MF GO:0003824;catalytic activity GO:0004714;transmembrane receptor protein tyrosine kinase activity 63 17 1 15 0 3 13
MF GO:0003824;catalytic activity GO:0005021;vascular endothelial growth factor-activated receptor activity 61 19 1 13 0 2 9
MF GO:0003824;catalytic activity GO:0035173;histone kinase activity 40 12 1 9 0 2 6
CC GO:0110165;cellular anatomical entity GO:0005876;spindle microtubule 4 1 1 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0043231;intracellular membrane-bounded organelle 26 7 1 5 0 0 4
CC GO:0110165;cellular anatomical entity GO:0005789;endoplasmic reticulum membrane 31 9 1 7 0 0 5
CC GO:0110165;cellular anatomical entity GO:0005694;chromosome 14 4 1 3 0 0 2
CC GO:0110165;cellular anatomical entity GO:0005874;microtubule 4 1 1 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0000793;condensed chromosome 4 1 1 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005819;spindle 4 1 1 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005887;integral component of plasma membrane 22 15 1 5 0 0 4
CC GO:0110165;cellular anatomical entity GO:0097443;sorting endosome 1 1 1 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0043232;intracellular non-membrane-bounded organelle 7 4 1 3 0 0 1
BP GO:0065007;biological regulation GO:0034765;regulation of ion transmembrane transport 11 6 1 2 0 0 2
BP GO:0065007;biological regulation GO:0032412;regulation of ion transmembrane transporter activity 11 6 1 2 0 0 2
MF GO:0003824;catalytic activity GO:0004435;phosphatidylinositol phospholipase C activity 11 6 0 2 0 0 3
MF GO:0003824;catalytic activity GO:0004629;phospholipase C activity 10 5 0 2 0 0 2
MF GO:0060089;molecular transducer activity GO:0001594;trace-amine receptor activity 9 4 0 2 0 0 1
MF GO:0005488;binding GO:0030544;Hsp70 protein binding 12 6 0 3 0 0 1
CC GO:0110165;cellular anatomical entity GO:0030425;dendrite 18 11 0 4 0 0 3
CC GO:0110165;cellular anatomical entity GO:0043005;neuron projection 19 11 0 4 0 0 3
BP GO:0065007;biological regulation GO:0031112;positive regulation of microtubule polymerization or depolymerization 9 7 0 6 0 0 1
BP GO:0009987;cellular process GO:1903008;organelle disassembly 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1903829;positive regulation of cellular protein localization 13 11 0 3 0 0 0
MF GO:0003824;catalytic activity GO:0004674;protein serine/threonine kinase activity 30 11 0 7 0 0 4
MF GO:0003824;catalytic activity GO:0004715;non-membrane spanning protein tyrosine kinase activity 3 2 0 2 0 0 1
BP GO:0009987;cellular process GO:0098708;glucose import across plasma membrane 74 18 6 15 0 1 21
BP GO:0009987;cellular process GO:0140271;hexose import across plasma membrane 73 18 5 15 0 1 21
BP GO:0009987;cellular process GO:0046323;glucose import 48 11 0 12 0 1 11
BP GO:0009987;cellular process GO:0015749;monosaccharide transmembrane transport 46 10 0 11 0 1 11
BP GO:0009987;cellular process GO:0098719;sodium ion import across plasma membrane 45 9 0 10 0 1 10
BP GO:0009987;cellular process GO:0008645;hexose transmembrane transport 43 8 0 9 0 0 10
BP GO:0009987;cellular process GO:0098659;inorganic cation import across plasma membrane 28 6 0 7 0 0 11
BP GO:0008152;metabolic process GO:0042416;dopamine biosynthetic process 132 60 18 39 0 2 33
BP GO:0065007;biological regulation GO:0035542;regulation of SNARE complex assembly 120 54 12 38 0 2 30
BP GO:0065007;biological regulation GO:0032410;negative regulation of transporter activity 117 53 11 36 0 2 30
BP GO:0065007;biological regulation GO:0010919;regulation of inositol phosphate biosynthetic process 94 39 8 29 0 2 23
BP GO:0065007;biological regulation GO:0031340;positive regulation of vesicle fusion 93 38 7 28 0 2 23
BP GO:0050896;response to stimulus GO:0071871;response to epinephrine 56 29 5 18 0 1 12
BP GO:0065007;biological regulation GO:1904714;regulation of chaperone-mediated autophagy 53 26 4 16 0 0 12
BP GO:0009987;cellular process GO:0071872;cellular response to epinephrine stimulus 53 28 4 17 0 0 12
BP GO:0065007;biological regulation GO:0045920;negative regulation of exocytosis 46 21 2 14 0 0 11
BP GO:0065007;biological regulation GO:0060732;positive regulation of inositol phosphate biosynthetic process 51 24 1 16 0 0 12
BP GO:0050896;response to stimulus GO:0032026;response to magnesium ion 44 20 1 13 0 0 11
BP GO:0009987;cellular process GO:0035493;SNARE complex assembly 37 14 0 10 0 0 10
BP GO:0065007;biological regulation GO:0001921;positive regulation of receptor recycling 35 12 0 10 0 0 10
BP GO:0065007;biological regulation GO:1902932;positive regulation of alcohol biosynthetic process 33 10 0 9 0 0 9
BP GO:0065007;biological regulation GO:0010894;negative regulation of steroid biosynthetic process 90 36 2 27 0 3 24
BP GO:0065007;biological regulation GO:0032375;negative regulation of cholesterol transport 95 39 2 29 0 3 25
BP GO:0065007;biological regulation GO:1905954;positive regulation of lipid localization 91 37 2 26 0 3 24
BP GO:0065007;biological regulation GO:0010517;regulation of phospholipase activity 33 9 0 10 0 0 9
BP GO:0065007;biological regulation GO:0010642;negative regulation of platelet-derived growth factor receptor signaling pathway 33 10 0 9 0 0 9
BP GO:0065007;biological regulation GO:0035067;negative regulation of histone acetylation 38 13 1 12 0 0 14
BP GO:0065007;biological regulation GO:0031115;negative regulation of microtubule polymerization 53 17 2 17 0 1 14
BP GO:0008152;metabolic process GO:0042423;catecholamine biosynthetic process 31 8 0 9 0 0 9
BP GO:0009987;cellular process GO:0015791;polyol transport 23 2 0 5 0 0 8
BP GO:0009987;cellular process GO:0010676;positive regulation of cellular carbohydrate metabolic process 31 8 0 10 0 0 9
BP GO:0065007;biological regulation GO:1902931;negative regulation of alcohol biosynthetic process 65 22 1 17 0 2 20
BP GO:0065007;biological regulation GO:0060191;regulation of lipase activity 26 3 0 6 0 0 8
BP GO:0051179;localization GO:0008643;carbohydrate transport 23 2 0 5 0 0 8
BP GO:0032501;multicellular organismal process GO:0003081;regulation of systemic arterial blood pressure by renin-angiotensin 1 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0072001;renal system development 1 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0001822;kidney development 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0035296;regulation of tube diameter 2 2 0 1 0 0 0
BP GO:0032501;multicellular organismal process GO:0003018;vascular process in circulatory system 2 2 0 1 0 0 0
BP GO:0032501;multicellular organismal process GO:0001990;regulation of systemic arterial blood pressure by hormone 2 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006289;nucleotide-excision repair 7 5 0 2 0 0 1
BP GO:0008152;metabolic process GO:0034645;cellular macromolecule biosynthetic process 4 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:1903522;regulation of blood circulation 6 6 0 2 0 0 2
BP GO:0032501;multicellular organismal process GO:0097746;blood vessel diameter maintenance 9 8 0 3 0 1 0
BP GO:0065007;biological regulation GO:0061098;positive regulation of protein tyrosine kinase activity 34 13 0 9 0 0 13
BP GO:0065007;biological regulation GO:0097659;nucleic acid-templated transcription 7 4 0 2 0 0 2
BP GO:0009987;cellular process GO:0071478;cellular response to radiation 16 14 1 9 0 1 4
BP GO:0009987;cellular process GO:0071479;cellular response to ionizing radiation 16 13 1 8 0 1 3
BP GO:0032501;multicellular organismal process GO:0008015;blood circulation 9 9 0 3 0 0 2
BP GO:0008152;metabolic process GO:0006303;double-strand break repair via nonhomologous end joining 6 2 0 2 0 0 3
BP GO:0008152;metabolic process GO:0009101;glycoprotein biosynthetic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0010467;gene expression 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0042749;regulation of circadian sleep/wake cycle 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032430;positive regulation of phospholipase A2 activity 2 2 0 2 0 0 0
BP GO:0008152;metabolic process GO:0006269;DNA replication, synthesis of RNA primer 4 2 0 1 0 0 1
BP GO:0008152;metabolic process GO:1902315;nuclear cell cycle DNA replication initiation 4 2 0 1 0 0 1
BP GO:0008152;metabolic process GO:1902975;mitotic DNA replication initiation 4 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:2000169;regulation of peptidyl-cysteine S-nitrosylation 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0033860;regulation of NAD(P)H oxidase activity 41 15 0 14 0 1 12
BP GO:0008152;metabolic process GO:0006486;protein glycosylation 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1901897;regulation of relaxation of cardiac muscle 8 7 0 4 0 0 0
BP GO:0065007;biological regulation GO:1901078;negative regulation of relaxation of muscle 8 7 0 4 0 0 0
BP GO:0065007;biological regulation GO:1903115;regulation of actin filament-based movement 11 10 0 6 0 0 0
BP GO:0065007;biological regulation GO:0043281;regulation of cysteine-type endopeptidase activity involved in apoptotic process 3 3 0 1 0 0 1
BP GO:0065007;biological regulation GO:0033138;positive regulation of peptidyl-serine phosphorylation 38 25 24 11 0 2 5
BP GO:0065007;biological regulation GO:0051091;positive regulation of DNA-binding transcription factor activity 60 36 17 21 0 3 15
BP GO:0065007;biological regulation GO:0010883;regulation of lipid storage 48 17 1 12 0 2 17
BP GO:0065007;biological regulation GO:0051130;positive regulation of cellular component organization 59 30 6 21 0 1 13
BP GO:0065007;biological regulation GO:0043254;regulation of protein-containing complex assembly 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032743;positive regulation of interleukin-2 production 6 5 0 4 0 0 0
BP GO:0065007;biological regulation GO:0086004;regulation of cardiac muscle cell contraction 5 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0055117;regulation of cardiac muscle contraction 6 5 0 2 0 0 0
BP GO:0065007;biological regulation GO:2001233;regulation of apoptotic signaling pathway 19 5 0 7 0 0 7
BP GO:0065007;biological regulation GO:0023056;positive regulation of signaling 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1901216;positive regulation of neuron death 39 15 1 10 0 1 5
BP GO:0065007;biological regulation GO:0032663;regulation of interleukin-2 production 3 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:0032729;positive regulation of interferon-gamma production 2 2 0 1 0 0 0
BP GO:0009987;cellular process GO:0072584;caveolin-mediated endocytosis 110 67 25 30 0 4 24
BP GO:0050896;response to stimulus GO:0034976;response to endoplasmic reticulum stress 14 12 2 5 0 1 3
BP GO:0065007;biological regulation GO:0052150;modulation by symbiont of host apoptotic process 42 35 10 17 0 1 5
BP GO:0044419;biological process involved in interspecies interaction between organisms GO:0033668;negative regulation by symbiont of host apoptotic process 36 30 9 13 0 1 5
BP GO:0044419;biological process involved in interspecies interaction between organisms GO:0052041;negative regulation by symbiont of host programmed cell death 35 29 8 13 0 1 4
BP GO:0009987;cellular process GO:0071383;cellular response to steroid hormone stimulus 64 29 4 18 0 1 21
BP GO:0065007;biological regulation GO:1901522;positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus 179 68 3 53 1 4 41
BP GO:0065007;biological regulation GO:0045821;positive regulation of glycolytic process 100 54 11 31 0 0 26
BP GO:0065007;biological regulation GO:1900544;positive regulation of purine nucleotide metabolic process 100 54 11 31 0 0 26
BP GO:0065007;biological regulation GO:0032642;regulation of chemokine production 44 16 1 15 0 0 14
BP GO:0065007;biological regulation GO:0032722;positive regulation of chemokine production 42 14 1 14 0 0 13
BP GO:0002376;immune system process GO:0034142;toll-like receptor 4 signaling pathway 61 17 0 24 0 2 15
MF GO:0005488;binding GO:0046982;protein heterodimerization activity 26 9 0 6 0 1 4
BP GO:0065007;biological regulation GO:0031648;protein destabilization 43 13 1 16 0 1 14
BP GO:0065007;biological regulation GO:0060548;negative regulation of cell death 38 11 0 13 0 1 11
BP GO:0008152;metabolic process GO:0042428;serotonin metabolic process 48 20 0 15 0 1 13
BP GO:0008152;metabolic process GO:0018958;phenol-containing compound metabolic process 48 20 0 15 0 1 13
BP GO:0065007;biological regulation GO:0070163;regulation of adiponectin secretion 72 30 15 24 0 3 20
BP GO:0009987;cellular process GO:0021795;cerebral cortex cell migration 54 26 0 17 0 1 14
BP GO:0009987;cellular process GO:0022029;telencephalon cell migration 54 26 0 17 0 1 14
BP GO:0008152;metabolic process GO:0018364;peptidyl-glutamine methylation 36 9 0 12 0 1 11
BP GO:0065007;biological regulation GO:0045762;positive regulation of adenylate cyclase activity 42 16 0 14 0 1 12
BP GO:0009987;cellular process GO:0044818;mitotic G2/M transition checkpoint 10 6 0 3 0 0 0
BP GO:0065007;biological regulation GO:0045807;positive regulation of endocytosis 35 11 1 8 0 2 6
BP GO:0065007;biological regulation GO:0001952;regulation of cell-matrix adhesion 7 3 0 2 0 0 1
BP GO:0065007;biological regulation GO:1900274;regulation of phospholipase C activity 58 31 1 22 1 1 10
BP GO:0065007;biological regulation GO:0032092;positive regulation of protein binding 30 15 3 8 0 1 7
BP GO:0065007;biological regulation GO:0060396;growth hormone receptor signaling pathway 7 3 0 1 0 0 1
BP GO:0032502;developmental process GO:0007498;mesoderm development 6 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0051128;regulation of cellular component organization 9 3 0 1 0 0 2
BP GO:0065007;biological regulation GO:0010518;positive regulation of phospholipase activity 26 16 1 10 0 1 5
BP GO:0065007;biological regulation GO:0045595;regulation of cell differentiation 9 1 0 2 0 0 1
BP GO:0065007;biological regulation GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process 6 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity 26 18 0 7 0 0 4
BP GO:0065007;biological regulation GO:0010975;regulation of neuron projection development 7 1 0 1 0 0 1
BP GO:0009987;cellular process GO:1904885;beta-catenin destruction complex assembly 10 5 0 2 0 0 1
BP GO:0032502;developmental process GO:0060993;kidney morphogenesis 6 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0010976;positive regulation of neuron projection development 6 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0010508;positive regulation of autophagy 8 4 0 3 0 0 1
BP GO:0065007;biological regulation GO:0046928;regulation of neurotransmitter secretion 5 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0043551;regulation of phosphatidylinositol 3-kinase activity 12 6 0 4 0 0 2
BP GO:0065007;biological regulation GO:0032886;regulation of microtubule-based process 12 6 0 3 0 0 2
BP GO:0065007;biological regulation GO:0050773;regulation of dendrite development 5 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0070233;negative regulation of T cell apoptotic process 6 2 0 0 0 0 1
BP GO:0065007;biological regulation GO:1904781;positive regulation of protein localization to centrosome 9 4 0 1 0 0 1
BP GO:0065007;biological regulation GO:0051493;regulation of cytoskeleton organization 47 19 0 9 0 2 15
BP GO:0008152;metabolic process GO:0036289;peptidyl-serine autophosphorylation 30 11 0 10 0 1 6
BP GO:0008152;metabolic process GO:0007260;tyrosine phosphorylation of STAT protein 7 3 0 1 0 0 1
BP GO:0009987;cellular process GO:0001837;epithelial to mesenchymal transition 5 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:1904779;regulation of protein localization to centrosome 8 3 0 0 0 0 1
BP GO:0032502;developmental process GO:0120039;plasma membrane bounded cell projection morphogenesis 5 1 0 0 0 0 1
BP GO:0009987;cellular process GO:0030099;myeloid cell differentiation 6 2 0 0 0 0 1
BP GO:0065007;biological regulation GO:0030155;regulation of cell adhesion 62 16 2 9 0 1 23
BP GO:0065007;biological regulation GO:0010665;regulation of cardiac muscle cell apoptotic process 5 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0070232;regulation of T cell apoptotic process 6 2 0 0 0 0 1
BP GO:0009987;cellular process GO:0071378;cellular response to growth hormone stimulus 7 3 0 1 0 0 1
BP GO:0065007;biological regulation GO:0009968;negative regulation of signal transduction 8 4 0 3 0 1 3
BP GO:0065007;biological regulation GO:1901983;regulation of protein acetylation 8 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0044843;cell cycle G1/S phase transition 5 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0060397;growth hormone receptor signaling pathway via JAK-STAT 6 2 0 0 0 0 1
BP GO:0065007;biological regulation GO:0060070;canonical Wnt signaling pathway 5 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0060333;interferon-gamma-mediated signaling pathway 6 2 0 0 0 0 1
BP GO:0065007;biological regulation GO:0010811;positive regulation of cell-substrate adhesion 5 2 0 1 0 0 1
BP GO:0009987;cellular process GO:0031175;neuron projection development 8 3 0 0 0 0 1
BP GO:0065007;biological regulation GO:0034250;positive regulation of cellular amide metabolic process 11 0 0 1 0 0 4
BP GO:0008152;metabolic process GO:0006704;glucocorticoid biosynthetic process 38 17 2 13 0 0 6
BP GO:0008152;metabolic process GO:0008211;glucocorticoid metabolic process 34 13 1 11 0 0 6
BP GO:0032501;multicellular organismal process GO:0042093;T-helper cell differentiation 70 19 0 26 0 2 20
BP GO:0065007;biological regulation GO:0050862;positive regulation of T cell receptor signaling pathway 83 23 0 26 0 2 21
BP GO:0065007;biological regulation GO:0051046;regulation of secretion 95 30 0 37 0 2 24
BP GO:0065007;biological regulation GO:0001911;negative regulation of leukocyte mediated cytotoxicity 35 10 0 12 0 1 9
BP GO:0008152;metabolic process GO:0051791;medium-chain fatty acid metabolic process 90 27 0 35 0 2 24
BP GO:0065007;biological regulation GO:1903978;regulation of microglial cell activation 35 10 0 12 0 1 9
BP GO:0065007;biological regulation GO:0010675;regulation of cellular carbohydrate metabolic process 61 13 0 21 0 2 19
BP GO:0065007;biological regulation GO:1903649;regulation of cytoplasmic transport 91 45 8 25 0 2 21
BP GO:0065007;biological regulation GO:0070665;positive regulation of leukocyte proliferation 55 28 4 9 0 1 17
BP GO:0065007;biological regulation GO:0010759;positive regulation of macrophage chemotaxis 52 25 2 9 0 1 17
BP GO:0065007;biological regulation GO:2000641;regulation of early endosome to late endosome transport 71 32 3 20 0 1 19
BP GO:0065007;biological regulation GO:1905523;positive regulation of macrophage migration 42 19 2 7 0 1 15
BP GO:0065007;biological regulation GO:0071622;regulation of granulocyte chemotaxis 41 18 2 6 0 1 15
BP GO:0065007;biological regulation GO:0010758;regulation of macrophage chemotaxis 41 19 2 8 0 1 17
BP GO:0065007;biological regulation GO:0071675;regulation of mononuclear cell migration 39 17 2 6 0 1 15
BP GO:0032502;developmental process GO:0007409;axonogenesis 64 24 3 12 0 2 20
BP GO:0065007;biological regulation GO:0010632;regulation of epithelial cell migration 31 9 0 4 0 1 14
BP GO:0065007;biological regulation GO:0002690;positive regulation of leukocyte chemotaxis 31 9 0 4 0 1 14
BP GO:0009987;cellular process GO:0007229;integrin-mediated signaling pathway 31 9 0 4 0 1 14
BP GO:0065007;biological regulation GO:0033043;regulation of organelle organization 38 16 1 7 0 2 15
BP GO:0065007;biological regulation GO:0010594;regulation of endothelial cell migration 33 10 0 5 0 1 15
BP GO:0065007;biological regulation GO:0060627;regulation of vesicle-mediated transport 41 17 1 10 0 2 15
BP GO:0065007;biological regulation GO:2001286;regulation of caveolin-mediated endocytosis 31 9 0 4 0 1 14
BP GO:0065007;biological regulation GO:0010743;regulation of macrophage derived foam cell differentiation 78 39 12 29 1 2 24
BP GO:0065007;biological regulation GO:1900034;regulation of cellular response to heat 19 16 1 8 0 1 1
BP GO:0065007;biological regulation GO:0080135;regulation of cellular response to stress 28 19 1 12 0 1 5
BP GO:0008152;metabolic process GO:0042363;fat-soluble vitamin catabolic process 51 28 2 12 0 0 12
BP GO:0008152;metabolic process GO:1901616;organic hydroxy compound catabolic process 50 27 2 12 0 0 12
BP GO:0032502;developmental process GO:0001655;urogenital system development 18 6 1 3 0 0 7
BP GO:0051179;localization GO:0006836;neurotransmitter transport 22 17 22 2 0 2 6
BP GO:0065007;biological regulation GO:0060261;positive regulation of transcription initiation from RNA polymerase II promoter 24 17 8 8 0 1 5
BP GO:0051179;localization GO:0071705;nitrogen compound transport 9 7 9 0 0 2 3
BP GO:0008152;metabolic process GO:0043436;oxoacid metabolic process 3 3 3 0 0 0 1
BP GO:0065007;biological regulation GO:0090199;regulation of release of cytochrome c from mitochondria 20 17 2 9 0 2 5
BP GO:0065007;biological regulation GO:2001242;regulation of intrinsic apoptotic signaling pathway 31 20 5 8 0 2 5
BP GO:0008152;metabolic process GO:0072524;pyridine-containing compound metabolic process 68 37 9 23 1 4 6
MF GO:0003824;catalytic activity GO:0004683;calmodulin-dependent protein kinase activity 33 13 1 8 0 1 4
MF GO:0005488;binding GO:0005524;ATP binding 7 1 1 1 0 0 2
MF GO:0005488;binding GO:0032559;adenyl ribonucleotide binding 7 1 1 1 0 0 2
MF GO:0003824;catalytic activity GO:0016174;NAD(P)H oxidase H2O2-forming activity 25 9 0 4 0 0 3
BP GO:0009987;cellular process GO:0014002;astrocyte development 20 6 0 6 0 1 7
BP GO:0009987;cellular process GO:0002068;glandular epithelial cell development 20 6 0 6 0 1 7
BP GO:0009987;cellular process GO:0003323;type B pancreatic cell development 20 6 0 6 0 1 7
BP GO:0009987;cellular process GO:0003309;type B pancreatic cell differentiation 20 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0090331;negative regulation of platelet aggregation 28 7 0 10 0 1 10
BP GO:0008152;metabolic process GO:0043247;telomere maintenance in response to DNA damage 45 17 0 14 0 1 12
BP GO:0065007;biological regulation GO:0034111;negative regulation of homotypic cell-cell adhesion 28 7 0 10 0 1 10
BP GO:0065007;biological regulation GO:2000773;negative regulation of cellular senescence 20 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0045655;regulation of monocyte differentiation 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0090344;negative regulation of cell aging 23 9 1 8 0 1 7
BP GO:0009987;cellular process GO:0042063;gliogenesis 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0010744;positive regulation of macrophage derived foam cell differentiation 32 15 1 9 0 2 9
BP GO:0065007;biological regulation GO:0010884;positive regulation of lipid storage 32 15 1 9 0 2 9
BP GO:0065007;biological regulation GO:0045638;negative regulation of myeloid cell differentiation 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0032374;regulation of cholesterol transport 31 14 2 9 0 2 9
BP GO:0009987;cellular process GO:0021782;glial cell development 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0048146;positive regulation of fibroblast proliferation 22 8 1 7 0 1 7
BP GO:0065007;biological regulation GO:0002762;negative regulation of myeloid leukocyte differentiation 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:2000772;regulation of cellular senescence 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:0045668;negative regulation of osteoblast differentiation 19 6 0 6 0 1 7
BP GO:0065007;biological regulation GO:1902807;negative regulation of cell cycle G1/S phase transition 19 5 0 6 0 1 7
BP GO:0065007;biological regulation GO:2000134;negative regulation of G1/S transition of mitotic cell cycle 19 5 0 6 0 1 7
BP GO:0065007;biological regulation GO:0031324;negative regulation of cellular metabolic process 20 6 1 7 0 0 8
BP GO:0008152;metabolic process GO:1901570;fatty acid derivative biosynthetic process 48 17 0 16 0 1 16
BP GO:0065007;biological regulation GO:0030194;positive regulation of blood coagulation 32 16 2 11 0 2 4
BP GO:0008152;metabolic process GO:0006700;C21-steroid hormone biosynthetic process 9 6 1 2 0 0 0
BP GO:0065007;biological regulation GO:0046626;regulation of insulin receptor signaling pathway 4 3 0 2 0 1 1
BP GO:0065007;biological regulation GO:1905599;positive regulation of low-density lipoprotein receptor activity 18 12 0 6 0 0 5
BP GO:0065007;biological regulation GO:1905563;negative regulation of vascular endothelial cell proliferation 18 12 0 6 0 0 5
BP GO:0065007;biological regulation GO:1905461;positive regulation of vascular associated smooth muscle cell apoptotic process 18 12 0 6 0 0 5
BP GO:0032501;multicellular organismal process GO:0030432;peristalsis 28 20 1 6 0 0 7
BP GO:0009987;cellular process GO:0090077;foam cell differentiation 18 12 0 6 0 0 5
BP GO:0065007;biological regulation GO:0060124;positive regulation of growth hormone secretion 15 12 1 4 0 0 4
BP GO:0009987;cellular process GO:1990535;neuron projection maintenance 32 9 2 12 0 1 8
BP GO:0009987;cellular process GO:0106027;neuron projection organization 29 6 1 9 0 1 6
BP GO:0050896;response to stimulus GO:0098586;cellular response to virus 20 4 0 2 0 0 10
BP GO:0009987;cellular process GO:0042149;cellular response to glucose starvation 18 3 0 1 0 0 10
BP GO:0065007;biological regulation GO:0032880;regulation of protein localization 21 5 0 3 0 0 10
BP GO:0042592;homeostatic process GO:0042632;cholesterol homeostasis 36 11 1 6 0 1 12
BP GO:0042592;homeostatic process GO:0055092;sterol homeostasis 36 11 1 6 0 1 12
BP GO:0050896;response to stimulus GO:0009750;response to fructose 17 2 0 1 0 0 9
BP GO:0009987;cellular process GO:0031670;cellular response to nutrient 17 2 0 1 0 0 9
BP GO:0008152;metabolic process GO:0046351;disaccharide biosynthetic process 20 3 0 2 0 0 9
BP GO:0009987;cellular process GO:0022618;ribonucleoprotein complex assembly 17 2 0 1 0 0 9
BP GO:0065007;biological regulation GO:2000345;regulation of hepatocyte proliferation 17 2 0 1 0 0 9
BP GO:0065007;biological regulation GO:1902949;positive regulation of tau-protein kinase activity 20 4 0 3 0 0 9
BP GO:0065007;biological regulation GO:0061043;regulation of vascular wound healing 29 6 0 5 0 0 10
BP GO:0065007;biological regulation GO:0045348;positive regulation of MHC class II biosynthetic process 19 4 0 2 0 0 9
BP GO:0008152;metabolic process GO:0097264;self proteolysis 17 2 0 1 0 0 9
BP GO:0065007;biological regulation GO:0045579;positive regulation of B cell differentiation 17 2 0 1 0 0 9
BP GO:0009987;cellular process GO:0036500;ATF6-mediated unfolded protein response 17 2 0 1 0 0 9
BP GO:0008152;metabolic process GO:0019852;L-ascorbic acid metabolic process 19 3 0 2 0 0 9
BP GO:0065007;biological regulation GO:1902947;regulation of tau-protein kinase activity 20 4 0 3 0 0 9
BP GO:0050896;response to stimulus GO:0070670;response to interleukin-4 18 3 0 1 0 0 9
BP GO:0065007;biological regulation GO:1900101;regulation of endoplasmic reticulum unfolded protein response 17 2 0 1 0 0 9
BP GO:0009987;cellular process GO:0071353;cellular response to interleukin-4 18 3 0 1 0 0 9
BP GO:0051179;localization GO:0044539;long-chain fatty acid import into cell 19 3 0 2 0 0 9
BP GO:0042592;homeostatic process GO:0055089;fatty acid homeostasis 17 2 0 1 0 0 9
BP GO:0008152;metabolic process GO:0046146;tetrahydrobiopterin metabolic process 21 4 0 2 0 0 9
BP GO:0065007;biological regulation GO:1900103;positive regulation of endoplasmic reticulum unfolded protein response 17 2 0 1 0 0 9
BP GO:0009987;cellular process GO:0006333;chromatin assembly or disassembly 33 10 0 3 0 0 11
BP GO:0065007;biological regulation GO:0009890;negative regulation of biosynthetic process 23 20 17 8 0 0 1
BP GO:0065007;biological regulation GO:0048147;negative regulation of fibroblast proliferation 11 9 6 3 0 1 2
BP GO:0065007;biological regulation GO:1903426;regulation of reactive oxygen species biosynthetic process 42 30 14 17 0 0 10
BP GO:0065007;biological regulation GO:0032091;negative regulation of protein binding 32 10 1 10 0 1 11
BP GO:0065007;biological regulation GO:0051100;negative regulation of binding 36 13 1 11 0 1 11
BP GO:0009987;cellular process GO:1902850;microtubule cytoskeleton organization involved in mitosis 27 9 1 10 0 1 11
BP GO:0009987;cellular process GO:0007052;mitotic spindle organization 26 8 1 9 0 1 11
BP GO:0009987;cellular process GO:0051256;mitotic spindle midzone assembly 31 9 1 10 0 2 12
BP GO:0065007;biological regulation GO:0070229;negative regulation of lymphocyte apoptotic process 24 6 1 8 0 1 10
BP GO:0065007;biological regulation GO:2001214;positive regulation of vasculogenesis 21 5 1 7 0 1 10
BP GO:0032502;developmental process GO:0003158;endothelium development 21 5 1 7 0 1 10
BP GO:0008152;metabolic process GO:0019941;modification-dependent protein catabolic process 16 3 1 5 0 1 7
BP GO:0065007;biological regulation GO:0051770;positive regulation of nitric-oxide synthase biosynthetic process 18 6 1 6 0 1 7
BP GO:0032502;developmental process GO:0060055;angiogenesis involved in wound healing 16 4 1 5 0 1 7
BP GO:0032502;developmental process GO:0016569;covalent chromatin modification 14 2 1 4 0 1 5
BP GO:0032501;multicellular organismal process GO:0001569;branching involved in blood vessel morphogenesis 14 3 1 5 0 1 6
BP GO:0009987;cellular process GO:0045446;endothelial cell differentiation 13 2 1 4 0 1 5
BP GO:0009987;cellular process GO:0002042;cell migration involved in sprouting angiogenesis 11 0 0 4 0 0 4
BP GO:0065007;biological regulation GO:0043536;positive regulation of blood vessel endothelial cell migration 121 42 4 37 0 4 44
BP GO:0065007;biological regulation GO:0043535;regulation of blood vessel endothelial cell migration 102 35 4 31 0 3 34
BP GO:0065007;biological regulation GO:0006275;regulation of DNA replication 81 38 3 25 1 3 9
BP GO:0065007;biological regulation GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity 62 33 2 22 1 2 4
BP GO:0065007;biological regulation GO:1900020;positive regulation of protein kinase C activity 60 32 2 21 1 2 4
BP GO:0065007;biological regulation GO:1900019;regulation of protein kinase C activity 60 32 2 21 1 2 4
BP GO:0065007;biological regulation GO:0010749;regulation of nitric oxide mediated signal transduction 60 32 2 21 1 2 4
BP GO:0065007;biological regulation GO:1905208;negative regulation of cardiocyte differentiation 56 29 2 18 1 1 4
BP GO:0065007;biological regulation GO:0006355;regulation of transcription, DNA-templated 59 28 2 20 1 3 4
BP GO:0065007;biological regulation GO:2000035;regulation of stem cell division 55 26 2 18 1 1 4
BP GO:0065007;biological regulation GO:1903799;negative regulation of production of miRNAs involved in gene silencing by miRNA 101 47 2 32 1 2 15
BP GO:0065007;biological regulation GO:2000737;negative regulation of stem cell differentiation 44 20 0 16 1 1 4
BP GO:0008152;metabolic process GO:0046394;carboxylic acid biosynthetic process 56 30 0 20 1 2 9
BP GO:0065007;biological regulation GO:0050729;positive regulation of inflammatory response 27 18 18 10 0 0 6
BP GO:0065007;biological regulation GO:0031349;positive regulation of defense response 24 15 16 7 0 0 5
BP GO:0065007;biological regulation GO:0032103;positive regulation of response to external stimulus 8 7 5 5 0 0 2
BP GO:0051179;localization GO:0033365;protein localization to organelle 7 6 3 4 0 0 2
BP GO:0009987;cellular process GO:0016198;axon choice point recognition 69 32 17 22 0 1 17
BP GO:0065007;biological regulation GO:1905598;negative regulation of low-density lipoprotein receptor activity 11 9 7 6 0 0 1
BP GO:0065007;biological regulation GO:0070303;negative regulation of stress-activated protein kinase signaling cascade 10 7 4 5 0 0 1
BP GO:0065007;biological regulation GO:0002674;negative regulation of acute inflammatory response 8 5 2 5 0 0 1
BP GO:0009987;cellular process GO:0045055;regulated exocytosis 3 3 2 3 0 0 1
BP GO:0065007;biological regulation GO:1900272;negative regulation of long-term synaptic potentiation 6 6 4 4 0 0 1
BP GO:0065007;biological regulation GO:0035235;ionotropic glutamate receptor signaling pathway 2 2 0 1 0 0 1
BP GO:0009987;cellular process GO:0016322;neuron remodeling 2 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0048169;regulation of long-term neuronal synaptic plasticity 9 5 2 3 0 0 3
BP GO:0065007;biological regulation GO:0071637;regulation of monocyte chemotactic protein-1 production 4 3 0 3 0 0 1
BP GO:0065007;biological regulation GO:0043508;negative regulation of JUN kinase activity 4 3 0 3 0 0 1
BP GO:0008152;metabolic process GO:0009166;nucleotide catabolic process 14 3 0 6 0 0 4
BP GO:0065007;biological regulation GO:0030857;negative regulation of epithelial cell differentiation 42 15 1 10 0 1 13
BP GO:0065007;biological regulation GO:1900746;regulation of vascular endothelial growth factor signaling pathway 29 8 0 10 0 0 9
BP GO:0065007;biological regulation GO:1900745;positive regulation of p38MAPK cascade 13 2 0 5 0 0 4
BP GO:0008152;metabolic process GO:0006163;purine nucleotide metabolic process 13 2 0 5 0 0 4
BP GO:0008152;metabolic process GO:0046415;urate metabolic process 13 2 1 6 0 0 3
BP GO:0051179;localization GO:0070633;transepithelial transport 16 3 1 6 0 0 3
BP GO:0051179;localization GO:0043691;reverse cholesterol transport 57 19 0 24 0 1 14
BP GO:0050896;response to stimulus GO:0070723;response to cholesterol 55 17 0 22 0 1 14
BP GO:0051179;localization GO:0042908;xenobiotic transport 17 3 1 6 0 0 3
BP GO:0032501;multicellular organismal process GO:0043312;neutrophil degranulation 44 30 13 15 0 1 8
BP GO:0032501;multicellular organismal process GO:0002283;neutrophil activation involved in immune response 43 30 13 15 0 1 8
BP GO:0002376;immune system process GO:0002446;neutrophil mediated immunity 41 29 13 14 0 1 8
BP GO:0009987;cellular process GO:0030263;apoptotic chromosome condensation 61 30 0 13 0 1 10
BP GO:0009987;cellular process GO:0051276;chromosome organization 23 12 0 5 0 0 3
BP GO:0009987;cellular process GO:0044772;mitotic cell cycle phase transition 8 5 1 3 0 0 0
BP GO:0065007;biological regulation GO:0043304;regulation of mast cell degranulation 1 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0060341;regulation of cellular localization 4 3 0 2 0 0 0
BP GO:0009987;cellular process GO:0000086;G2/M transition of mitotic cell cycle 12 8 1 4 0 0 0
BP GO:0009987;cellular process GO:0044839;cell cycle G2/M phase transition 12 8 1 4 0 0 0
BP GO:0009987;cellular process GO:2000249;regulation of actin cytoskeleton reorganization 4 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0060193;positive regulation of lipase activity 1 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0034110;regulation of homotypic cell-cell adhesion 9 7 0 8 0 1 2
BP GO:0065007;biological regulation GO:0051495;positive regulation of cytoskeleton organization 4 2 0 3 0 0 1
BP GO:0009987;cellular process GO:0000082;G1/S transition of mitotic cell cycle 2 0 0 1 0 0 0
BP GO:0009987;cellular process GO:0030218;erythrocyte differentiation 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1901215;negative regulation of neuron death 2 1 1 2 0 0 0
BP GO:0065007;biological regulation GO:1905562;regulation of vascular endothelial cell proliferation 3 1 0 2 0 0 1
BP GO:0065007;biological regulation GO:0010727;negative regulation of hydrogen peroxide metabolic process 12 6 0 2 0 0 0
BP GO:0065007;biological regulation GO:0010310;regulation of hydrogen peroxide metabolic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903209;positive regulation of oxidative stress-induced cell death 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071732;cellular response to nitric oxide 2 1 0 0 0 0 0
BP GO:0009987;cellular process GO:1902170;cellular response to reactive nitrogen species 2 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0048311;mitochondrion distribution 15 10 0 8 0 0 2
BP GO:0009987;cellular process GO:0044819;mitotic G1/S transition checkpoint signaling 17 8 0 2 0 0 2
BP GO:0042592;homeostatic process GO:0030007;cellular potassium ion homeostasis 3 2 0 1 0 0 3
BP GO:0009987;cellular process GO:0036376;sodium ion export across plasma membrane 3 2 0 1 0 0 3
BP GO:0042592;homeostatic process GO:0006883;cellular sodium ion homeostasis 3 2 0 1 0 0 3
BP GO:0042592;homeostatic process GO:0030004;cellular monovalent inorganic cation homeostasis 3 2 0 1 0 0 3
BP GO:0042592;homeostatic process GO:0055075;potassium ion homeostasis 4 3 0 1 0 0 4
BP GO:0042592;homeostatic process GO:0055078;sodium ion homeostasis 3 2 0 1 0 0 3
BP GO:0051179;localization GO:0070839;metal ion export 3 2 0 1 0 0 3
BP GO:0008152;metabolic process GO:0008206;bile acid metabolic process 6 4 0 2 0 0 5
BP GO:0009987;cellular process GO:1902600;proton transmembrane transport 3 2 0 1 0 0 3
BP GO:0009987;cellular process GO:1990573;potassium ion import across plasma membrane 3 2 0 1 0 0 3
BP GO:0009987;cellular process GO:0051170;import into nucleus 3 3 0 1 0 0 3
BP GO:0065007;biological regulation GO:0044089;positive regulation of cellular component biogenesis 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0106070;regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway 12 10 0 10 0 1 4
BP GO:0065007;biological regulation GO:0035405;histone-threonine phosphorylation 13 11 0 11 0 1 5
BP GO:0008152;metabolic process GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1900120;regulation of receptor binding 17 16 2 3 0 1 5
BP GO:0009987;cellular process GO:0007264;small GTPase mediated signal transduction 30 12 0 9 0 1 6
BP GO:0009987;cellular process GO:0070200;establishment of protein localization to telomere 29 11 0 10 0 1 5
BP GO:0065007;biological regulation GO:0034392;negative regulation of smooth muscle cell apoptotic process 29 11 1 10 0 1 5
BP GO:0008152;metabolic process GO:0010792;DNA double-strand break processing involved in repair via single-strand annealing 29 11 1 10 0 1 5
BP GO:0008152;metabolic process GO:0045002;double-strand break repair via single-strand annealing 28 10 0 9 0 1 5
BP GO:0008152;metabolic process GO:0010216;maintenance of DNA methylation 20 8 0 8 0 1 5
BP GO:0065007;biological regulation GO:1905459;regulation of vascular associated smooth muscle cell apoptotic process 26 13 0 12 0 1 7
BP GO:0065007;biological regulation GO:1905064;negative regulation of vascular associated smooth muscle cell differentiation 20 8 0 8 0 1 5
BP GO:0065007;biological regulation GO:1904749;regulation of protein localization to nucleolus 21 9 0 9 0 1 5
BP GO:0065007;biological regulation GO:0007265;Ras protein signal transduction 20 9 0 7 0 1 4
BP GO:0008152;metabolic process GO:0034205;amyloid-beta formation 23 10 0 7 0 1 4
BP GO:0065007;biological regulation GO:0090311;regulation of protein deacetylation 21 8 0 7 0 1 4
BP GO:0065007;biological regulation GO:0042634;regulation of hair cycle 19 8 0 7 0 1 4
BP GO:0008152;metabolic process GO:0030422;production of siRNA involved in RNA interference 19 8 0 7 0 1 4
BP GO:0065007;biological regulation GO:0090309;positive regulation of DNA methylation-dependent heterochromatin assembly 18 7 0 6 0 1 4
BP GO:0032502;developmental process GO:0060348;bone development 10 4 0 3 0 1 1
BP GO:0065007;biological regulation GO:0050730;regulation of peptidyl-tyrosine phosphorylation 33 19 8 8 0 3 5
BP GO:0008152;metabolic process GO:0009299;mRNA transcription 13 5 0 1 0 0 2
BP GO:0050896;response to stimulus GO:0042060;wound healing 40 12 0 13 1 1 10
BP GO:0065007;biological regulation GO:0030111;regulation of Wnt signaling pathway 3 2 2 0 0 0 1
BP GO:0065007;biological regulation GO:0051247;positive regulation of protein metabolic process 1 1 0 0 0 0 1
BP GO:0042592;homeostatic process GO:0042593;glucose homeostasis 43 18 2 14 0 2 17
BP GO:0065007;biological regulation GO:1903573;negative regulation of response to endoplasmic reticulum stress 11 5 0 3 0 0 5
BP GO:0065007;biological regulation GO:0009895;negative regulation of catabolic process 30 23 18 11 0 1 4
BP GO:0051179;localization GO:0030301;cholesterol transport 9 3 0 2 0 0 2
BP GO:0009987;cellular process GO:0090150;establishment of protein localization to membrane 6 0 0 0 0 0 2
MF GO:0005488;binding GO:0003677;DNA binding 64 29 1 17 1 0 11
MF GO:0005488;binding GO:0017025;TBP-class protein binding 15 3 0 2 0 0 5
MF GO:0005488;binding GO:0003690;double-stranded DNA binding 38 20 0 13 1 0 6
MF GO:0005488;binding GO:0140296;general transcription initiation factor binding 8 1 0 1 0 0 2
MF GO:0005488;binding GO:0001221;transcription coregulator binding 17 5 0 4 0 0 4
MF GO:0005488;binding GO:0043565;sequence-specific DNA binding 10 2 0 2 0 0 2
MF GO:0005488;binding GO:0051117;ATPase binding 34 16 0 11 1 0 5
MF GO:0005488;binding GO:0001091;RNA polymerase II general transcription initiation factor binding 43 18 0 12 1 0 7
BP GO:0009987;cellular process GO:0032200;telomere organization 10 8 2 4 0 0 0
BP GO:0008152;metabolic process GO:0000723;telomere maintenance 8 6 2 3 0 0 0
BP GO:0065007;biological regulation GO:0060123;regulation of growth hormone secretion 12 9 1 3 0 0 3
BP GO:0065007;biological regulation GO:0045600;positive regulation of fat cell differentiation 11 3 0 2 0 0 5
BP GO:0009987;cellular process GO:0001885;endothelial cell development 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0090049;regulation of cell migration involved in sprouting angiogenesis 32 9 0 7 0 0 10
BP GO:0008152;metabolic process GO:0044267;cellular protein metabolic process 15 6 0 2 0 0 3
BP GO:0065007;biological regulation GO:0045652;regulation of megakaryocyte differentiation 15 4 0 5 0 1 7
BP GO:0065007;biological regulation GO:0051241;negative regulation of multicellular organismal process 9 6 0 4 0 1 0
BP GO:0008152;metabolic process GO:0006069;ethanol oxidation 29 22 0 12 0 1 4
BP GO:0008152;metabolic process GO:0006067;ethanol metabolic process 18 15 1 7 0 1 4
BP GO:0065007;biological regulation GO:0032740;positive regulation of interleukin-17 production 25 11 0 11 0 1 8
BP GO:0065007;biological regulation GO:0010875;positive regulation of cholesterol efflux 26 12 0 11 0 1 9
BP GO:0042592;homeostatic process GO:0070328;triglyceride homeostasis 17 9 0 8 0 1 5
BP GO:0065007;biological regulation GO:0010874;regulation of cholesterol efflux 7 5 0 2 0 0 1
BP GO:0065007;biological regulation GO:0032660;regulation of interleukin-17 production 13 7 0 5 0 0 4
BP GO:0065007;biological regulation GO:0032376;positive regulation of cholesterol transport 7 5 0 2 0 0 1
BP GO:0008152;metabolic process GO:1902653;secondary alcohol biosynthetic process 4 3 0 1 0 0 1
BP GO:0008152;metabolic process GO:0006695;cholesterol biosynthetic process 3 3 0 1 0 0 0
BP GO:0008152;metabolic process GO:0016126;sterol biosynthetic process 3 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0120163;negative regulation of cold-induced thermogenesis 2 2 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0006968;cellular defense response 18 9 0 5 0 0 6
MF GO:0005488;binding GO:0050660;flavin adenine dinucleotide binding 15 5 0 1 0 0 4
MF GO:0005488;binding GO:0051537;2 iron, 2 sulfur cluster binding 22 9 0 6 1 0 4
MF GO:0003824;catalytic activity GO:0008392;arachidonic acid epoxygenase activity 18 7 0 4 0 1 5
BP GO:0065007;biological regulation GO:0032768;regulation of monooxygenase activity 21 14 3 8 0 1 2
BP GO:0008152;metabolic process GO:1901565;organonitrogen compound catabolic process 19 12 1 4 0 0 8
MF GO:0005488;binding GO:0000978;RNA polymerase II cis-regulatory region sequence-specific DNA binding 16 9 0 5 1 0 2
MF GO:0005488;binding GO:0000987;cis-regulatory region sequence-specific DNA binding 9 5 0 3 0 0 2
BP GO:0065007;biological regulation GO:2001236;regulation of extrinsic apoptotic signaling pathway 40 16 1 10 0 1 11
BP GO:0065007;biological regulation GO:0043409;negative regulation of MAPK cascade 4 4 1 2 0 0 0
BP GO:0065007;biological regulation GO:0033034;positive regulation of myeloid cell apoptotic process 65 35 9 16 0 1 15
BP GO:0065007;biological regulation GO:1903076;regulation of protein localization to plasma membrane 8 5 1 4 0 2 1
BP GO:0050896;response to stimulus GO:0043627;response to estrogen 9 7 2 4 0 1 1
BP GO:0065007;biological regulation GO:0033143;regulation of intracellular steroid hormone receptor signaling pathway 7 5 2 2 0 1 1
BP GO:0065007;biological regulation GO:1904377;positive regulation of protein localization to cell periphery 3 3 0 3 0 1 1
BP GO:0065007;biological regulation GO:1903078;positive regulation of protein localization to plasma membrane 3 3 0 3 0 1 1
BP GO:0065007;biological regulation GO:0042058;regulation of epidermal growth factor receptor signaling pathway 4 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:0050714;positive regulation of protein secretion 10 9 7 7 0 1 0
BP GO:0065007;biological regulation GO:1905477;positive regulation of protein localization to membrane 7 7 1 4 0 1 1
BP GO:0065007;biological regulation GO:0051590;positive regulation of neurotransmitter transport 4 2 0 2 0 0 0
BP GO:0009987;cellular process GO:0071394;cellular response to testosterone stimulus 19 9 1 5 0 1 6
BP GO:0065007;biological regulation GO:0032960;regulation of inositol trisphosphate biosynthetic process 5 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:0045113;regulation of integrin biosynthetic process 19 9 0 6 0 0 6
BP GO:0050896;response to stimulus GO:0033574;response to testosterone 16 6 0 3 0 0 6
BP GO:0065007;biological regulation GO:0001956;positive regulation of neurotransmitter secretion 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0006357;regulation of transcription by RNA polymerase II 34 19 2 13 0 2 5
BP GO:0065007;biological regulation GO:1905065;positive regulation of vascular associated smooth muscle cell differentiation 4 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0042325;regulation of phosphorylation 13 7 1 4 0 0 3
BP GO:0065007;biological regulation GO:0045987;positive regulation of smooth muscle contraction 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0045785;positive regulation of cell adhesion 11 8 1 9 0 0 2
BP GO:0032502;developmental process GO:0072012;glomerulus vasculature development 1 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0060347;heart trabecula formation 2 2 0 1 0 0 1
BP GO:0009987;cellular process GO:0060216;definitive hemopoiesis 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1904035;regulation of epithelial cell apoptotic process 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0043031;negative regulation of macrophage activation 30 8 0 10 0 1 8
BP GO:0032502;developmental process GO:0061008;hepaticobiliary system development 45 24 0 14 0 1 18
BP GO:0032502;developmental process GO:0001889;liver development 54 23 1 16 0 1 18
BP GO:0008152;metabolic process GO:0046854;phosphatidylinositol phosphate biosynthetic process 65 28 0 15 0 0 12
BP GO:0008152;metabolic process GO:2001022;positive regulation of response to DNA damage stimulus 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0043517;positive regulation of DNA damage response, signal transduction by p53 class mediator 2 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0071480;cellular response to gamma radiation 4 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:1901798;positive regulation of signal transduction by p53 class mediator 2 1 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0010332;response to gamma radiation 3 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0043516;regulation of DNA damage response, signal transduction by p53 class mediator 5 2 1 1 0 0 1
BP GO:0009987;cellular process GO:0000077;DNA damage checkpoint signaling 2 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0031297;replication fork processing 4 3 0 1 0 0 0
BP GO:0009987;cellular process GO:0031570;DNA integrity checkpoint signaling 2 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0045005;DNA-dependent DNA replication maintenance of fidelity 3 2 0 1 0 0 0
BP GO:0009987;cellular process GO:0071481;cellular response to X-ray 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1904354;negative regulation of telomere capping 2 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0000425;pexophagy 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:2001267;regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway 12 12 1 3 0 0 2
BP GO:0009987;cellular process GO:0030225;macrophage differentiation 6 6 0 2 0 0 2
BP GO:0008152;metabolic process GO:0099116;tRNA 5'-end processing 13 12 0 4 0 0 2
BP GO:0065007;biological regulation GO:1903358;regulation of Golgi organization 34 19 2 14 0 0 5
BP GO:0032501;multicellular organismal process GO:0021513;spinal cord dorsal/ventral patterning 1 1 1 0 0 0 0
BP GO:0065007;biological regulation GO:0033089;positive regulation of T cell differentiation in thymus 5 2 1 1 0 0 1
BP GO:0032502;developmental process GO:0021983;pituitary gland development 1 1 1 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0009954;proximal/distal pattern formation 1 1 1 0 0 0 0
BP GO:0032502;developmental process GO:0021510;spinal cord development 1 1 1 0 0 0 0
BP GO:0032502;developmental process GO:0021952;central nervous system projection neuron axonogenesis 1 1 1 0 0 0 0
BP GO:0065007;biological regulation GO:0033081;regulation of T cell differentiation in thymus 1 1 1 0 0 0 0
BP GO:0032502;developmental process GO:0042475;odontogenesis of dentin-containing tooth 5 3 1 2 0 0 0
BP GO:0065007;biological regulation GO:0045740;positive regulation of DNA replication 21 14 1 8 1 1 3
BP GO:0032502;developmental process GO:0048566;embryonic digestive tract development 3 2 1 0 0 0 2
BP GO:0032502;developmental process GO:0030879;mammary gland development 1 1 1 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0009953;dorsal/ventral pattern formation 1 1 1 0 0 0 0
BP GO:0032502;developmental process GO:0035270;endocrine system development 3 2 1 0 0 0 0
BP GO:0065007;biological regulation GO:0051248;negative regulation of protein metabolic process 7 1 2 1 0 0 1
BP GO:0065007;biological regulation GO:0045649;regulation of macrophage differentiation 5 4 0 4 0 0 2
BP GO:0065007;biological regulation GO:0042176;regulation of protein catabolic process 3 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0046627;negative regulation of insulin receptor signaling pathway 4 3 0 3 0 1 3
BP GO:0065007;biological regulation GO:1900077;negative regulation of cellular response to insulin stimulus 4 3 0 3 0 1 3
BP GO:0009987;cellular process GO:0032869;cellular response to insulin stimulus 16 3 0 3 0 0 7
BP GO:0065007;biological regulation GO:1901185;negative regulation of ERBB signaling pathway 15 2 0 2 0 0 7
BP GO:0065007;biological regulation GO:0042059;negative regulation of epidermal growth factor receptor signaling pathway 15 2 0 2 0 0 7
BP GO:0065007;biological regulation GO:1903792;negative regulation of anion transport 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051956;negative regulation of amino acid transport 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071420;cellular response to histamine 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051253;negative regulation of RNA metabolic process 41 19 1 13 0 1 9
BP GO:0065007;biological regulation GO:0048016;inositol phosphate-mediated signaling 2 2 0 0 0 0 1
BP GO:0009987;cellular process GO:0071241;cellular response to inorganic substance 21 13 0 7 0 2 5
BP GO:0009987;cellular process GO:0071168;protein localization to chromatin 15 11 1 6 0 1 3
BP GO:0065007;biological regulation GO:0033146;regulation of intracellular estrogen receptor signaling pathway 2 2 1 0 0 0 1
BP GO:0065007;biological regulation GO:0000018;regulation of DNA recombination 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0099643;signal release from synapse 2 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0007269;neurotransmitter secretion 2 1 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0050890;cognition 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0043097;pyrimidine nucleoside salvage 19 15 3 9 0 1 2
BP GO:0008152;metabolic process GO:0008655;pyrimidine-containing compound salvage 19 15 3 9 0 1 2
BP GO:0008152;metabolic process GO:0043174;nucleoside salvage 19 15 3 9 0 1 2
BP GO:0008152;metabolic process GO:0006206;pyrimidine nucleobase metabolic process 6 6 0 3 0 0 0
BP GO:0008152;metabolic process GO:0046134;pyrimidine nucleoside biosynthetic process 18 14 2 9 0 1 1
BP GO:0008152;metabolic process GO:0034654;nucleobase-containing compound biosynthetic process 5 4 0 1 0 0 0
BP GO:0065007;biological regulation GO:0062014;negative regulation of small molecule metabolic process 5 4 0 1 0 0 0
BP GO:0065007;biological regulation GO:0045936;negative regulation of phosphate metabolic process 15 13 2 8 0 0 5
MF GO:0003824;catalytic activity GO:0004126;cytidine deaminase activity 5 5 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0016814;hydrolase activity, acting on carbon-nitrogen 4 4 0 1 0 0 0
MF GO:0098772;molecular function regulator activity GO:0045499;chemorepellent activity 5 3 1 2 0 0 0
MF GO:0005488;binding GO:0008270;zinc ion binding 6 5 1 2 0 0 1
BP GO:0065007;biological regulation GO:2000026;regulation of multicellular organismal development 7 5 0 1 0 0 1
BP GO:0008152;metabolic process GO:0006705;mineralocorticoid biosynthetic process 3 2 1 0 0 0 0
BP GO:0008152;metabolic process GO:0046184;aldehyde biosynthetic process 3 2 1 0 0 0 0
BP GO:0008152;metabolic process GO:0046488;phosphatidylinositol metabolic process 40 20 0 8 0 0 7
BP GO:0008152;metabolic process GO:0006661;phosphatidylinositol biosynthetic process 38 19 0 7 0 0 7
BP GO:0008152;metabolic process GO:1901662;quinone catabolic process 41 21 0 10 0 0 7
BP GO:0009987;cellular process GO:0030835;negative regulation of actin filament depolymerization 41 21 0 9 0 0 7
BP GO:0065007;biological regulation GO:0003376;sphingosine-1-phosphate receptor signaling pathway 40 20 0 8 0 0 7
BP GO:0009987;cellular process GO:0070252;actin-mediated cell contraction 36 18 0 7 0 0 6
BP GO:0065007;biological regulation GO:0110053;regulation of actin filament organization 36 18 0 7 0 0 6
BP GO:0009987;cellular process GO:0030834;regulation of actin filament depolymerization 25 14 0 5 0 0 5
BP GO:0032501;multicellular organismal process GO:0055119;relaxation of cardiac muscle 24 13 0 5 0 0 5
BP GO:0032501;multicellular organismal process GO:0090075;relaxation of muscle 22 11 0 4 0 0 5
BP GO:0008152;metabolic process GO:0034356;NAD biosynthesis via nicotinamide riboside salvage pathway 26 14 0 5 0 0 8
BP GO:0065007;biological regulation GO:0002675;positive regulation of acute inflammatory response 25 13 0 5 0 0 8
BP GO:0050896;response to stimulus GO:0035994;response to muscle stretch 20 9 0 4 0 0 5
MF GO:0003824;catalytic activity GO:0004222;metalloendopeptidase activity 3 2 0 1 0 1 0
MF GO:0003824;catalytic activity GO:0008237;metallopeptidase activity 3 2 0 1 0 1 0
MF GO:0003824;catalytic activity GO:0004175;endopeptidase activity 9 4 0 3 0 1 2
MF GO:0003824;catalytic activity GO:0004252;serine-type endopeptidase activity 5 3 0 4 0 0 1
BP GO:0065007;biological regulation GO:1901214;regulation of neuron death 14 12 0 6 0 0 1
BP GO:0050896;response to stimulus GO:0010038;response to metal ion 21 17 6 14 0 1 1
BP GO:0065007;biological regulation GO:0010728;regulation of hydrogen peroxide biosynthetic process 10 5 0 2 0 0 0
BP GO:0065007;biological regulation GO:1903997;positive regulation of non-membrane spanning protein tyrosine kinase activity 15 10 1 5 0 0 1
BP GO:0065007;biological regulation GO:1900449;regulation of glutamate receptor signaling pathway 10 5 0 2 0 0 0
BP GO:0065007;biological regulation GO:1903995;regulation of non-membrane spanning protein tyrosine kinase activity 14 9 1 4 0 0 1
BP GO:0065007;biological regulation GO:1902950;regulation of dendritic spine maintenance 9 4 0 1 0 0 0
BP GO:0065007;biological regulation GO:0045921;positive regulation of exocytosis 12 4 1 4 0 0 5
BP GO:0065007;biological regulation GO:0017157;regulation of exocytosis 6 2 1 4 0 0 4
BP GO:0009987;cellular process GO:0072683;T cell extravasation 2 2 0 2 0 1 0
BP GO:0065007;biological regulation GO:1902004;positive regulation of amyloid-beta formation 34 9 0 14 0 1 10
BP GO:0065007;biological regulation GO:1902993;positive regulation of amyloid precursor protein catabolic process 34 9 0 14 0 1 10
BP GO:0065007;biological regulation GO:1901223;negative regulation of NIK/NF-kappaB signaling 17 5 0 8 0 1 7
BP GO:0008152;metabolic process GO:0006473;protein acetylation 3 3 0 3 0 0 1
BP GO:0009987;cellular process GO:0065003;protein-containing complex assembly 9 8 0 4 0 0 3
BP GO:0009987;cellular process GO:0006898;receptor-mediated endocytosis 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:2000535;regulation of entry of bacterium into host cell 6 2 0 1 0 0 3
BP GO:0032501;multicellular organismal process GO:0036230;granulocyte activation 7 3 0 1 0 0 3
BP GO:0065007;biological regulation GO:0050930;induction of positive chemotaxis 4 2 0 0 0 0 2
BP GO:0009987;cellular process GO:0036499;PERK-mediated unfolded protein response 4 2 0 0 0 0 2
BP GO:0008152;metabolic process GO:0042558;pteridine-containing compound metabolic process 3 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010558;negative regulation of macromolecule biosynthetic process 10 6 1 2 0 0 2
BP GO:0009987;cellular process GO:0032366;intracellular sterol transport 11 5 1 3 0 0 2
BP GO:0032502;developmental process GO:0021955;central nervous system neuron axonogenesis 2 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0032774;RNA biosynthetic process 4 3 0 2 0 0 1
BP GO:0065007;biological regulation GO:1903828;negative regulation of cellular protein localization 5 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0070507;regulation of microtubule cytoskeleton organization 5 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0030516;regulation of axon extension 6 5 0 2 0 0 0
BP GO:0065007;biological regulation GO:0043666;regulation of phosphoprotein phosphatase activity 14 9 1 2 0 0 4
BP GO:0065007;biological regulation GO:0010821;regulation of mitochondrion organization 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0051093;negative regulation of developmental process 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0031400;negative regulation of protein modification process 5 4 0 2 0 0 1
BP GO:0065007;biological regulation GO:0010760;negative regulation of macrophage chemotaxis 4 4 2 2 0 1 0
BP GO:0065007;biological regulation GO:1901984;negative regulation of protein acetylation 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0022603;regulation of anatomical structure morphogenesis 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0045719;negative regulation of glycogen biosynthetic process 5 3 0 1 0 0 0
BP GO:0009987;cellular process GO:0120036;plasma membrane bounded cell projection organization 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0070874;negative regulation of glycogen metabolic process 5 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:2000465;regulation of glycogen 5 3 0 1 0 0 0
BP GO:0009987;cellular process GO:0048666;neuron development 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:1905522;negative regulation of macrophage migration 3 3 2 1 0 1 0
BP GO:0065007;biological regulation GO:0061387;regulation of extent of cell growth 4 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0010739;positive regulation of protein kinase A signaling 2 2 1 1 0 0 0
BP GO:0065007;biological regulation GO:2000074;regulation of type B pancreatic cell development 5 3 0 1 0 0 0
BP GO:0051179;localization GO:0015695;organic cation transport 2 1 0 1 0 0 0
BP GO:0051179;localization GO:0015872;dopamine transport 6 2 1 1 0 0 2
BP GO:0051179;localization GO:1901998;toxin transport 4 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0031282;regulation of guanylate cyclase activity 8 6 1 5 0 1 1
BP GO:0065007;biological regulation GO:1900180;regulation of protein localization to nucleus 3 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032930;positive regulation of superoxide anion generation 18 15 4 10 0 1 2
BP GO:0065007;biological regulation GO:0032928;regulation of superoxide anion generation 17 14 3 10 0 1 2
BP GO:0065007;biological regulation GO:0030307;positive regulation of cell growth 11 5 1 4 0 0 0
BP GO:0065007;biological regulation GO:1900739;regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway 3 3 1 2 0 0 0
BP GO:0009987;cellular process GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway 3 3 1 2 0 0 0
BP GO:0009987;cellular process GO:1901030;positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway 3 3 1 2 0 0 0
BP GO:0065007;biological regulation GO:0071900;regulation of protein serine/threonine kinase activity 6 5 0 3 0 1 0
BP GO:0008152;metabolic process GO:0046456;icosanoid biosynthetic process 41 27 0 18 1 3 6
MF GO:0060089;molecular transducer activity GO:0004952;dopamine neurotransmitter receptor activity 16 6 0 3 0 0 3
BP GO:0032502;developmental process GO:0048732;gland development 17 10 0 5 0 1 8
BP GO:0009987;cellular process GO:0071805;potassium ion transmembrane transport 2 1 0 0 0 0 2
BP GO:0009987;cellular process GO:0098930;axonal transport 6 3 0 5 0 0 0
BP GO:0009987;cellular process GO:0021954;central nervous system neuron development 11 8 0 7 0 0 1
BP GO:0009987;cellular process GO:0034063;stress granule assembly 5 3 0 4 0 0 1
BP GO:0065007;biological regulation GO:0045773;positive regulation of axon extension 5 3 0 4 0 0 1
BP GO:0050896;response to stimulus GO:1990090;cellular response to nerve growth factor stimulus 5 3 0 4 0 0 1
BP GO:0008152;metabolic process GO:0043603;cellular amide metabolic process 4 1 0 0 0 1 2
BP GO:0008152;metabolic process GO:0009312;oligosaccharide biosynthetic process 15 5 1 4 0 1 5
BP GO:0008152;metabolic process GO:0016051;carbohydrate biosynthetic process 15 5 1 4 0 1 5
BP GO:0008152;metabolic process GO:0070076;histone lysine demethylation 9 4 1 2 0 1 2
BP GO:0008152;metabolic process GO:0000096;sulfur amino acid metabolic process 9 8 0 2 0 0 1
BP GO:0065007;biological regulation GO:0030947;regulation of vascular endothelial growth factor receptor signaling pathway 14 12 0 4 0 0 2
BP GO:0009987;cellular process GO:0044319;wound healing, spreading of cells 9 8 0 2 0 0 1
BP GO:0065007;biological regulation GO:0045648;positive regulation of erythrocyte differentiation 28 16 0 9 0 1 7
BP GO:0065007;biological regulation GO:0001953;negative regulation of cell-matrix adhesion 5 5 0 1 0 0 0
BP GO:0009987;cellular process GO:0071318;cellular response to ATP 5 5 1 1 0 0 1
BP GO:0050896;response to stimulus GO:0033198;response to ATP 4 4 1 0 0 0 1
BP GO:0008152;metabolic process GO:0052651;monoacylglycerol catabolic process 4 4 1 3 0 1 0
BP GO:0008152;metabolic process GO:0046462;monoacylglycerol metabolic process 3 3 1 2 0 1 0
BP GO:0008152;metabolic process GO:0046475;glycerophospholipid catabolic process 3 3 1 2 0 1 0
BP GO:0008152;metabolic process GO:0046461;neutral lipid catabolic process 4 4 1 3 0 1 0
MF GO:0003824;catalytic activity GO:0004709;MAP kinase kinase kinase activity 16 7 0 6 1 0 2
MF GO:0003824;catalytic activity GO:0004029;aldehyde dehydrogenase 7 5 0 3 0 0 2
MF GO:0003824;catalytic activity GO:0004708;MAP kinase kinase activity 16 6 0 3 0 0 3
MF GO:0003824;catalytic activity GO:0004030;aldehyde dehydrogenase [NAD(P)+] activity 6 4 0 2 0 0 2
MF GO:0140657;ATP-dependent activity GO:0043138;3'-5' DNA helicase activity 17 9 0 5 0 0 2
MF GO:0005488;binding GO:0000400;four-way junction DNA binding 10 6 0 4 0 0 1
MF GO:0003824;catalytic activity GO:0004523;RNA-DNA hybrid ribonuclease activity 13 5 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0004528;phosphodiesterase I activity 13 5 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0004035;alkaline phosphatase activity 6 3 1 2 0 0 1
MF GO:0003824;catalytic activity GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 6 3 1 2 0 0 1
MF GO:0003824;catalytic activity GO:0016803;ether hydrolase activity 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0003691;double-stranded telomeric DNA binding 12 5 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0008296;3'-5'-exodeoxyribonuclease activity 12 5 0 1 0 0 2
BP GO:0009987;cellular process GO:0031579;membrane raft organization 10 5 1 3 0 0 2
BP GO:0065007;biological regulation GO:0090189;regulation of branching involved in ureteric bud morphogenesis 9 4 1 2 0 0 1
BP GO:0009987;cellular process GO:0032367;intracellular cholesterol transport 10 5 1 3 0 0 2
BP GO:0009987;cellular process GO:0071384;cellular response to corticosteroid stimulus 19 13 2 7 0 0 3
BP GO:0009987;cellular process GO:0071385;cellular response to glucocorticoid stimulus 11 7 1 4 0 0 2
BP GO:0032501;multicellular organismal process GO:0001658;branching involved in ureteric bud morphogenesis 10 4 1 2 0 0 2
BP GO:0032502;developmental process GO:0060675;ureteric bud morphogenesis 10 4 1 2 0 0 2
BP GO:0051179;localization GO:0015918;sterol transport 9 4 1 2 0 0 2
BP GO:0032502;developmental process GO:0042471;ear morphogenesis 8 3 1 1 0 0 1
BP GO:0065007;biological regulation GO:1905332;positive regulation of morphogenesis of an epithelium 7 2 1 1 0 0 1
MF GO:0060089;molecular transducer activity GO:0004896;cytokine receptor activity 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0070102;interleukin-6-mediated signaling pathway 17 6 0 4 0 1 6
BP GO:0009987;cellular process GO:0071260;cellular response to mechanical stimulus 4 2 1 1 0 1 0
BP GO:0065007;biological regulation GO:0038066;p38MAPK cascade 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031279;regulation of cyclase activity 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010831;positive regulation of myotube differentiation 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:1901741;positive regulation of myoblast fusion 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:1901739;regulation of myoblast fusion 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903201;regulation of oxidative stress-induced cell death 9 4 1 1 0 0 0
BP GO:0065007;biological regulation GO:0035331;negative regulation of hippo signaling 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031281;positive regulation of cyclase activity 12 6 0 2 0 1 0
BP GO:0065007;biological regulation GO:0051249;regulation of lymphocyte activation 7 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:0034116;positive regulation of heterotypic cell-cell adhesion 6 2 0 0 0 0 0
BP GO:0065007;biological regulation GO:1900744;regulation of p38MAPK cascade 7 2 0 2 0 0 2
BP GO:0065007;biological regulation GO:0001937;negative regulation of endothelial cell proliferation 7 1 0 2 0 0 1
BP GO:0032501;multicellular organismal process GO:0003140;determination of left/right asymmetry in lateral mesoderm 5 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:2000027;regulation of animal organ morphogenesis 3 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0048745;smooth muscle tissue development 3 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0061053;somite development 3 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0060537;muscle tissue development 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0045880;positive regulation of smoothened signaling pathway 4 2 0 1 0 0 1
BP GO:0009987;cellular process GO:0007224;smoothened signaling pathway 3 1 0 1 0 0 0
BP GO:0032501;multicellular organismal process GO:0007368;determination of left/right symmetry 3 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0001947;heart looping 3 1 0 1 0 0 0
BP GO:0032501;multicellular organismal process GO:0061371;determination of heart left/right asymmetry 3 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0003143;embryonic heart tube morphogenesis 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0008589;regulation of smoothened signaling pathway 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0051152;positive regulation of smooth muscle cell differentiation 5 1 0 1 0 0 1
BP GO:0002376;immune system process GO:0045059;positive thymic T cell selection 4 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1900175;regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry 4 1 0 1 0 0 1
BP GO:0032502;developmental process GO:0072359;circulatory system development 4 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0033084;regulation of immature T cell proliferation in thymus 4 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0007405;neuroblast proliferation 4 1 0 1 0 0 1
BP GO:0050896;response to stimulus GO:0060242;contact inhibition 3 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0072205;metanephric collecting duct development 4 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0046637;regulation of alpha-beta T cell differentiation 4 1 0 1 0 0 1
BP GO:0032502;developmental process GO:0072044;collecting duct development 3 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0071679;commissural neuron axon guidance 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0051151;negative regulation of smooth muscle cell differentiation 3 1 0 1 0 0 0
BP GO:0009987;cellular process GO:1904646;cellular response to amyloid-beta 12 11 7 5 0 1 1
BP GO:0065007;biological regulation GO:0048385;regulation of retinoic acid receptor signaling pathway 5 3 0 2 0 0 0
BP GO:0032501;multicellular organismal process GO:0070293;renal absorption 9 5 0 4 0 0 4
BP GO:0008152;metabolic process GO:0006646;phosphatidylethanolamine biosynthetic process 7 5 0 3 0 0 1
BP GO:0065007;biological regulation GO:2001169;regulation of ATP biosynthetic process 4 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:2000353;positive regulation of endothelial cell apoptotic process 5 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0002705;positive regulation of leukocyte mediated immunity 2 1 0 1 0 0 0
BP GO:0032501;multicellular organismal process GO:0002327;immature B cell differentiation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0002730;regulation of dendritic cell cytokine production 2 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0036018;cellular response to erythropoietin 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0001692;histamine metabolic process 4 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:1905063;regulation of vascular associated smooth muscle cell differentiation 1 0 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0002279;mast cell activation involved in immune response 1 0 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0043303;mast cell degranulation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0002732;positive regulation of dendritic cell cytokine production 1 0 0 0 0 0 0
BP GO:0051179;localization GO:0015697;quaternary ammonium group transport 3 0 0 0 0 0 0
BP GO:0002376;immune system process GO:0002448;mast cell mediated immunity 1 0 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0050910;detection of mechanical stimulus involved in sensory perception of sound 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0090136;epithelial cell-cell adhesion 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0001504;neurotransmitter uptake 3 0 0 0 0 0 1
BP GO:0032502;developmental process GO:0030318;melanocyte differentiation 1 0 0 0 0 0 0
BP GO:0032502;developmental process GO:0055123;digestive system development 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:2000767;positive regulation of cytoplasmic translation 8 6 0 2 0 0 0
BP GO:0065007;biological regulation GO:1903672;positive regulation of sprouting angiogenesis 6 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:2000765;regulation of cytoplasmic translation 6 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0031057;negative regulation of histone modification 6 2 0 3 0 0 4
BP GO:0065007;biological regulation GO:0001919;regulation of receptor recycling 2 0 0 1 0 0 0
BP GO:0009987;cellular process GO:0071280;cellular response to copper ion 2 0 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0048545;response to steroid hormone 11 5 1 3 0 1 5
BP GO:0065007;biological regulation GO:1901222;regulation of NIK/NF-kappaB signaling 6 4 2 2 0 1 0
BP GO:0065007;biological regulation GO:2000369;regulation of clathrin-dependent endocytosis 19 8 0 4 0 0 5
BP GO:0065007;biological regulation GO:0035020;regulation of Rac protein signal transduction 17 6 0 4 0 0 5
BP GO:0032502;developmental process GO:0001944;vasculature development 19 7 0 4 0 0 6
BP GO:0009987;cellular process GO:0048864;stem cell development 8 5 0 5 0 0 0
BP GO:0065007;biological regulation GO:0032703;negative regulation of interleukin-2 production 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0061099;negative regulation of protein tyrosine kinase activity 2 1 0 2 0 0 0
BP GO:0050896;response to stimulus GO:0002526;acute inflammatory response 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0002637;regulation of immunoglobulin production 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0001914;regulation of T cell mediated cytotoxicity 1 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation 2 1 0 2 0 0 1
BP GO:0032501;multicellular organismal process GO:0042100;B cell proliferation 9 2 0 3 0 0 1
BP GO:0065007;biological regulation GO:0051973;positive regulation of telomerase activity 38 29 7 17 0 3 5
BP GO:0065007;biological regulation GO:0051924;regulation of calcium ion transport 11 4 2 3 0 0 1
BP GO:0065007;biological regulation GO:0042177;negative regulation of protein catabolic process 4 2 1 0 0 0 0
BP GO:0065007;biological regulation GO:0045787;positive regulation of cell cycle 10 8 1 5 0 1 1
BP GO:0008152;metabolic process GO:0019441;tryptophan catabolic process to kynurenine 4 4 0 1 0 0 1
BP GO:0065007;biological regulation GO:0070230;positive regulation of lymphocyte apoptotic process 3 3 0 0 0 0 0
BP GO:0008152;metabolic process GO:0070189;kynurenine metabolic process 3 3 0 1 0 0 1
BP GO:0065007;biological regulation GO:0051932;synaptic transmission, GABAergic 3 2 1 1 0 0 1
BP GO:0009987;cellular process GO:1902476;chloride transmembrane transport 3 2 1 1 0 0 1
BP GO:0009987;cellular process GO:0098661;inorganic anion transmembrane transport 3 2 1 1 0 0 1
BP GO:0051179;localization GO:0006821;chloride transport 3 2 1 1 0 0 1
BP GO:0009987;cellular process GO:1904862;inhibitory synapse assembly 3 2 1 1 0 0 1
BP GO:0051179;localization GO:0006816;calcium ion transport 1 1 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0006936;muscle contraction 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0035865;cellular response to potassium ion 2 2 1 0 0 0 0
BP GO:0050896;response to stimulus GO:0035864;response to potassium ion 2 2 1 0 0 0 0
BP GO:0009987;cellular process GO:0071468;cellular response to acidic pH 6 6 0 2 0 0 1
BP GO:0065007;biological regulation GO:2000344;positive regulation of acrosome reaction 2 2 1 0 0 0 0
BP GO:0051179;localization GO:0098660;inorganic ion transmembrane transport 2 2 1 0 0 0 0
BP GO:0065007;biological regulation GO:0045956;positive regulation of calcium ion-dependent exocytosis 2 2 1 0 0 0 0
BP GO:0065007;biological regulation GO:0060046;regulation of acrosome reaction 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0098703;calcium ion import across plasma membrane 4 4 0 1 0 0 1
BP GO:0050896;response to stimulus GO:0010447;response to acidic pH 4 4 0 1 0 0 1
BP GO:0051179;localization GO:1902656;calcium ion import into cytosol 4 4 0 1 0 0 1
BP GO:0009987;cellular process GO:0007520;myoblast fusion 2 2 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903307;positive regulation of regulated secretory pathway 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071467;cellular response to pH 3 3 0 0 0 0 1
BP GO:0009987;cellular process GO:0014902;myotube differentiation 2 2 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006527;arginine catabolic process 7 5 1 4 0 1 1
BP GO:0008152;metabolic process GO:0006525;arginine metabolic process 6 5 0 4 0 1 1
BP GO:0065007;biological regulation GO:1901184;regulation of ERBB signaling pathway 22 15 0 10 1 1 2
BP GO:0065007;biological regulation GO:0045737;positive regulation of cyclin-dependent protein serine/threonine kinase activity 20 13 0 8 1 1 2
BP GO:0065007;biological regulation GO:2000036;regulation of stem cell population maintenance 16 11 0 7 0 1 2
BP GO:0065007;biological regulation GO:1904031;positive regulation of cyclin-dependent protein kinase activity 13 9 0 6 0 1 2
BP GO:0065007;biological regulation GO:1900087;positive regulation of G1/S transition of mitotic cell cycle 12 8 0 6 0 1 2
BP GO:0050896;response to stimulus GO:0071364;cellular response to epidermal growth factor stimulus 2 1 0 2 0 1 0
BP GO:0065007;biological regulation GO:0045746;negative regulation of Notch signaling pathway 2 1 0 2 0 1 0
BP GO:0050896;response to stimulus GO:0051384;response to glucocorticoid 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0048671;negative regulation of collateral sprouting 16 10 1 6 0 0 2
BP GO:0065007;biological regulation GO:0032687;negative regulation of interferon-alpha production 16 10 1 6 0 0 2
BP GO:0065007;biological regulation GO:0030308;negative regulation of cell growth 16 10 1 6 0 0 2
BP GO:0065007;biological regulation GO:0048681;negative regulation of axon regeneration 14 8 0 5 0 0 1
BP GO:0065007;biological regulation GO:0061000;negative regulation of dendritic spine development 14 8 0 5 0 0 1
BP GO:0065007;biological regulation GO:0048670;regulation of collateral sprouting 14 8 0 5 0 0 1
BP GO:0065007;biological regulation GO:0070571;negative regulation of neuron projection regeneration 14 8 0 5 0 0 1
BP GO:0008152;metabolic process GO:0006470;protein dephosphorylation 10 5 0 3 0 0 0
BP GO:0065007;biological regulation GO:0032688;negative regulation of interferon-beta production 13 7 0 4 0 0 0
BP GO:0065007;biological regulation GO:2000058;regulation of ubiquitin-dependent protein catabolic process 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0022008;neurogenesis 2 2 0 1 0 0 0
BP GO:0051179;localization GO:0099111;microtubule-based transport 2 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:2000479;regulation of cAMP-dependent protein kinase activity 3 3 0 2 0 1 1
BP GO:0008152;metabolic process GO:0006266;DNA ligation 22 13 0 4 0 0 5
BP GO:0065007;biological regulation GO:2001251;negative regulation of chromosome organization 22 13 0 4 0 0 5
BP GO:0065007;biological regulation GO:0060045;positive regulation of cardiac muscle cell proliferation 14 9 0 3 0 0 5
BP GO:0009987;cellular process GO:0000712;resolution of meiotic recombination intermediates 17 11 0 2 0 0 3
BP GO:0065007;biological regulation GO:0055023;positive regulation of cardiac muscle tissue growth 14 9 0 3 0 0 5
BP GO:0065007;biological regulation GO:0045091;regulation of single stranded viral RNA replication via double stranded DNA intermediate 18 11 0 2 0 0 5
BP GO:0009987;cellular process GO:0071103;DNA conformation change 19 12 0 3 0 0 4
BP GO:0065007;biological regulation GO:0051783;regulation of nuclear division 11 6 0 1 0 0 3
BP GO:0065007;biological regulation GO:0060043;regulation of cardiac muscle cell proliferation 11 6 0 1 0 0 4
BP GO:0008152;metabolic process GO:0006297;nucleotide-excision repair, DNA gap filling 7 4 0 1 0 0 2
BP GO:0009987;cellular process GO:0030262;apoptotic nuclear changes 8 4 0 1 0 0 2
BP GO:0065007;biological regulation GO:0045070;positive regulation of viral genome replication 7 3 1 1 0 0 1
BP GO:0009987;cellular process GO:0000819;sister chromatid segregation 5 1 0 0 0 0 1
MF GO:0009987;cellular process GO:0031493;nucleosomal histone binding 13 5 0 2 0 0 3
MF GO:0003824;catalytic activity GO:0003906;DNA-(apurinic or apyrimidinic site) endonuclease activity 11 4 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0016895;exodeoxyribonuclease activity, producing 5'-phosphomonoesters 7 3 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0097200;cysteine-type endopeptidase activity involved in execution phase of apoptosis 8 4 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0004536;deoxyribonuclease activity 7 3 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0097153;cysteine-type endopeptidase activity involved in apoptotic process 8 4 0 2 0 0 2
MF GO:0005488;binding GO:0008301;DNA binding, bending 10 6 0 1 0 0 1
BP GO:0065007;biological regulation GO:0007088;regulation of mitotic nuclear division 2 1 0 0 0 0 1
BP GO:0008152;metabolic process GO:0006000;fructose metabolic process 12 4 1 1 0 0 3
BP GO:0065007;biological regulation GO:2000278;regulation of DNA biosynthetic process 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0048585;negative regulation of response to stimulus 6 1 0 0 0 0 1
MF GO:0003824;catalytic activity GO:0035005;1-phosphatidylinositol-4-phosphate 3-kinase activity 7 2 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0016303;1-phosphatidylinositol-3-kinase activity 7 2 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0035004;phosphatidylinositol 3-kinase activity 7 2 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0016307;phosphatidylinositol phosphate kinase activity 7 2 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0052742;phosphatidylinositol kinase activity 7 2 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0034061;DNA polymerase activity 11 5 1 3 0 0 2
MF GO:0005215;transporter activity GO:0015267;channel activity 9 3 1 2 0 0 2
MF GO:0005488;binding GO:0005506;iron ion binding 8 3 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0016773;phosphotransferase activity, alcohol group as acceptor 7 2 0 1 0 0 1
MF GO:0140657;ATP-dependent activity GO:0090554;phosphatidylcholine floppase activity 9 4 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0017083;4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity 11 3 1 2 0 0 1
MF GO:0003824;catalytic activity GO:0003964;RNA-directed DNA polymerase activity 9 4 0 2 0 0 2
MF GO:0140657;ATP-dependent activity GO:0090555;phosphatidylethanolamine flippase activity 9 4 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0009008;DNA-methyltransferase activity 9 4 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0003720;telomerase activity 9 4 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0016972;thiol oxidase activity 11 4 0 3 0 0 4
MF GO:0005488;binding GO:0051400;BH domain binding 11 4 0 2 0 0 2
MF GO:0005488;binding GO:0051434;BH3 domain binding 10 3 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0016301;kinase activity 9 2 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0046920;alpha-(1->3)-fucosyltransferase activity 11 3 1 2 0 0 1
MF GO:0005488;binding GO:0002020;protease binding 8 2 0 2 0 0 1
MF GO:0003824;catalytic activity GO:0008401;retinoic acid 4-hydroxylase activity 7 2 0 1 0 0 1
MF GO:0005488;binding GO:0031404;chloride ion binding 6 1 0 0 0 0 1
MF GO:0140657;ATP-dependent activity GO:0008559;ABC-type xenobiotic transporter activity 9 3 0 1 0 0 2
MF GO:0005215;transporter activity GO:0005217;intracellular ligand-gated ion channel activity 8 3 0 1 0 0 2
MF GO:0005488;binding GO:0070513;death domain binding 10 3 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0008417;fucosyltransferase activity 11 3 1 2 0 0 1
MF GO:0140657;ATP-dependent activity GO:0140333;glycerophospholipid flippase activity 8 3 0 1 0 0 2
MF GO:0003824;catalytic activity GO:0032454;histone demethylase activity 11 3 1 2 0 0 1
CC GO:0110165;cellular anatomical entity GO:0031965;nuclear membrane 7 2 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005634;nucleus 16 4 1 4 0 0 3
BP GO:0065007;biological regulation GO:0010720;positive regulation of cell development 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0050769;positive regulation of neurogenesis 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0010754;negative regulation of cGMP-mediated signaling 5 3 0 2 0 0 3
BP GO:0050896;response to stimulus GO:0070305;response to cGMP 5 3 0 2 0 0 3
BP GO:0009987;cellular process GO:0071321;cellular response to cGMP 5 3 0 2 0 0 3
BP GO:0065007;biological regulation GO:0010752;regulation of cGMP-mediated signaling 5 3 0 2 0 0 3
BP GO:0008152;metabolic process GO:0016926;protein desumoylation 3 1 0 0 0 0 2
BP GO:0032501;multicellular organismal process GO:0008306;associative learning 9 6 0 2 0 0 2
BP GO:0065007;biological regulation GO:0043951;negative regulation of cAMP-mediated signaling 9 7 0 4 0 0 3
BP GO:0065007;biological regulation GO:0002052;positive regulation of neuroblast proliferation 5 2 0 1 0 0 2
BP GO:0065007;biological regulation GO:0080134;regulation of response to stress 5 2 0 1 0 0 0
BP GO:0051179;localization GO:0035627;ceramide transport 3 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0051289;protein homotetramerization 10 8 0 4 0 2 1
BP GO:0065007;biological regulation GO:0002684;positive regulation of immune system process 5 4 1 0 0 0 3
BP GO:0009987;cellular process GO:0034605;cellular response to heat 3 3 0 2 0 0 1
MF GO:0005215;transporter activity GO:0005230;extracellular ligand-gated ion channel activity 2 2 0 1 0 0 1
MF GO:0005215;transporter activity GO:0015278;calcium-release channel activity 2 2 0 1 0 0 1
MF GO:0005215;transporter activity GO:0099604;ligand-gated calcium channel activity 2 2 0 1 0 0 1
MF GO:0005215;transporter activity GO:0005231;excitatory extracellular ligand-gated ion channel activity 2 2 0 1 0 0 1
MF GO:0005215;transporter activity GO:0015276;ligand-gated ion channel activity 5 4 0 2 0 0 1
MF GO:0005215;transporter activity GO:0015085;calcium ion transmembrane transporter activity 1 1 0 0 0 0 1
MF GO:0005488;binding GO:0001540;amyloid-beta binding 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0008324;cation transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0060089;molecular transducer activity GO:0008528;G protein-coupled peptide receptor activity 2 2 0 1 0 0 0
MF GO:0005488;binding GO:0042826;histone deacetylase binding 4 2 0 1 0 0 1
MF GO:0005215;transporter activity GO:0015220;choline transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0061459;L-arginine transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0035174;histone serine kinase activity 6 4 0 1 0 0 1
MF GO:0005215;transporter activity GO:0015214;pyrimidine nucleoside transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0015181;arginine transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0005337;nucleoside transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0008504;monoamine transmembrane transporter activity 2 2 1 0 0 0 1
MF GO:0003824;catalytic activity GO:0070001;aspartic-type peptidase activity 3 2 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0004190;aspartic-type endopeptidase activity 3 2 0 0 0 0 0
MF GO:0005215;transporter activity GO:0015101;organic cation transmembrane transporter activity 1 1 0 0 0 0 0
MF GO:0060089;molecular transducer activity GO:0098960;postsynaptic neurotransmitter receptor activity 5 4 0 0 0 0 1
MF GO:0060089;molecular transducer activity GO:0099529;neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential 5 4 0 2 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005798;Golgi-associated vesicle 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005802;trans-Golgi network 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0000228;nuclear chromosome 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0032588;trans-Golgi network membrane 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005641;nuclear envelope lumen 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0055037;recycling endosome 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031666;positive regulation of lipopolysaccharide-mediated signaling pathway 8 7 0 7 0 0 2
BP GO:0065007;biological regulation GO:0034350;regulation of glial cell apoptotic process 12 10 0 10 0 1 4
BP GO:0009987;cellular process GO:0002934;desmosome organization 8 7 0 7 0 0 2
BP GO:0065007;biological regulation GO:0034351;negative regulation of glial cell apoptotic process 12 10 0 10 0 1 4
BP GO:0065007;biological regulation GO:0016525;negative regulation of angiogenesis 9 3 0 2 0 0 1
BP GO:0065007;biological regulation GO:0106014;regulation of inflammatory response to wounding 18 8 1 8 0 1 1
BP GO:0009987;cellular process GO:0002232;leukocyte chemotaxis involved in inflammatory response 17 7 1 7 0 1 1
BP GO:0009987;cellular process GO:0071351;cellular response to interleukin-18 15 6 0 6 0 0 1
BP GO:0065007;biological regulation GO:0035655;interleukin-18-mediated signaling pathway 15 6 0 6 0 0 1
BP GO:0065007;biological regulation GO:1903034;regulation of response to wounding 12 4 0 4 0 0 1
BP GO:0065007;biological regulation GO:1900407;regulation of cellular response to oxidative stress 10 3 0 3 0 0 1
BP GO:0009987;cellular process GO:0006325;chromatin organization 5 2 0 1 0 0 1
BP GO:0008152;metabolic process GO:1902969;mitotic DNA replication 2 0 0 0 0 0 1
BP GO:0008152;metabolic process GO:0070914;UV-damage excision repair 2 0 0 0 0 0 1
BP GO:0008152;metabolic process GO:0022616;DNA strand elongation 3 0 0 0 0 0 1
BP GO:0008152;metabolic process GO:0006271;DNA strand elongation involved in DNA replication 2 0 0 0 0 0 1
MF GO:0003824;catalytic activity GO:0003887;DNA-directed DNA polymerase activity 4 2 0 0 0 0 1
MF GO:0003824;catalytic activity GO:0016175;superoxide-generating NAD(P)H oxidase activity 6 2 0 1 0 0 1
BP GO:0009987;cellular process GO:0086003;cardiac muscle cell contraction 6 4 0 3 0 0 1
BP GO:0065007;biological regulation GO:0086001;cardiac muscle cell action potential 6 4 0 3 0 0 1
BP GO:0065007;biological regulation GO:0086002;cardiac muscle cell action potential involved in contraction 6 4 0 3 0 0 1
BP GO:0009987;cellular process GO:0042552;myelination 7 5 0 3 0 0 1
BP GO:0065007;biological regulation GO:0086043;bundle of His cell action potential 6 4 0 3 0 0 1
BP GO:0050896;response to stimulus GO:0014894;response to denervation involved in regulation of muscle adaptation 7 4 0 3 0 0 1
BP GO:0009987;cellular process GO:0086018;SA node cell to atrial cardiac muscle cell signaling 6 4 0 3 0 0 1
BP GO:0065007;biological regulation GO:0086045;membrane depolarization during AV node cell action potential 8 6 0 5 0 0 1
BP GO:0065007;biological regulation GO:0086046;membrane depolarization during SA node cell action potential 6 4 0 3 0 0 1
BP GO:0065007;biological regulation GO:0060373;regulation of ventricular cardiac muscle cell membrane depolarization 6 4 0 3 0 0 1
BP GO:0065007;biological regulation GO:2000272;negative regulation of signaling receptor activity 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:2000279;negative regulation of DNA biosynthetic process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0048145;regulation of fibroblast proliferation 8 5 3 2 0 1 0
BP GO:0009987;cellular process GO:0009913;epidermal cell differentiation 3 0 1 1 0 0 0
BP GO:0065007;biological regulation GO:0009892;negative regulation of metabolic process 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0030521;androgen receptor signaling pathway 4 2 0 0 0 0 2
BP GO:0050896;response to stimulus GO:0140467;integrated stress response signaling 3 2 0 0 0 0 2
BP GO:0009987;cellular process GO:0071391;cellular response to estrogen stimulus 4 2 0 0 0 0 2
BP GO:0032501;multicellular organismal process GO:0042119;neutrophil activation 3 2 0 1 0 0 3
BP GO:0065007;biological regulation GO:0090023;positive regulation of neutrophil chemotaxis 2 1 0 0 0 0 2
BP GO:0065007;biological regulation GO:0052372;modulation by symbiont of entry into host 2 1 0 0 0 0 2
BP GO:0065007;biological regulation GO:1904375;regulation of protein localization to cell periphery 2 1 0 0 0 0 2
BP GO:0008152;metabolic process GO:0009435;NAD biosynthetic process 3 2 0 0 0 0 2
BP GO:0065007;biological regulation GO:1902624;positive regulation of neutrophil migration 2 1 0 0 0 0 2
BP GO:0065007;biological regulation GO:0071624;positive regulation of granulocyte chemotaxis 2 1 0 0 0 0 2
BP GO:0065007;biological regulation GO:0045598;regulation of fat cell differentiation 3 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0051050;positive regulation of transport 5 5 1 3 0 0 3
MF GO:0003824;catalytic activity GO:0016616;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor 4 2 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0003857;3-hydroxyacyl-CoA dehydrogenase activity 5 3 0 2 0 0 0
MF GO:0005488;binding GO:0035256;G protein-coupled glutamate receptor binding 3 1 0 0 0 0 0
MF GO:0098772;molecular function regulator activity GO:0016004;phospholipase activator activity 4 1 0 1 0 0 1
MF GO:0098772;molecular function regulator activity GO:0060229;lipase activator activity 4 1 0 1 0 0 1
MF GO:0005488;binding GO:0043274;phospholipase binding 4 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0010742;macrophage derived foam cell differentiation 6 5 0 4 0 0 2
BP GO:0009987;cellular process GO:0035357;peroxisome proliferator activated receptor signaling pathway 7 5 0 4 0 0 2
BP GO:0065007;biological regulation GO:0060331;negative regulation of response to interferon-gamma 7 5 0 4 0 0 2
BP GO:0065007;biological regulation GO:0060336;negative regulation of interferon-gamma-mediated signaling pathway 7 5 0 4 0 0 2
BP GO:0065007;biological regulation GO:0034393;positive regulation of smooth muscle cell apoptotic process 6 5 0 4 0 0 2
BP GO:0009987;cellular process GO:0042953;lipoprotein transport 7 6 0 5 0 0 2
BP GO:0009987;cellular process GO:0048384;retinoic acid receptor signaling pathway 8 6 0 5 0 0 2
BP GO:0051179;localization GO:0044872;lipoprotein localization 7 6 0 5 0 0 2
BP GO:0009987;cellular process GO:0030224;monocyte differentiation 6 5 0 4 0 0 2
BP GO:0032502;developmental process GO:0001890;placenta development 5 5 0 4 0 0 2
MF GO:0060089;molecular transducer activity GO:0008066;glutamate receptor activity 5 4 1 3 0 0 0
MF GO:0060089;molecular transducer activity GO:0004970;ionotropic glutamate receptor activity 5 4 1 3 0 0 0
MF GO:0005215;transporter activity GO:0015277;kainate selective glutamate receptor activity 5 4 1 3 0 0 0
MF GO:0005215;transporter activity GO:0022834;ligand-gated channel activity 4 3 0 2 0 0 0
MF GO:0060089;molecular transducer activity GO:0022824;transmitter-gated ion channel activity 4 3 0 2 0 0 0
MF GO:0060089;molecular transducer activity GO:0001640;adenylate cyclase inhibiting G protein-coupled glutamate receptor activity 4 3 0 2 0 0 0
MF GO:0060089;molecular transducer activity GO:0098988;G protein-coupled glutamate receptor activity 4 3 0 2 0 0 0
MF GO:0005215;transporter activity GO:0099094;ligand-gated cation channel activity 4 3 0 2 0 0 0
MF GO:0005215;transporter activity GO:0005216;ion channel activity 4 3 0 2 0 0 0
MF GO:0060089;molecular transducer activity GO:1904315;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential 4 3 0 2 0 0 0
MF GO:0005488;binding GO:0000217;DNA secondary structure binding 2 1 1 1 0 0 0
MF GO:0005215;transporter activity GO:0005272;sodium channel activity 5 4 0 3 0 0 0
MF GO:0005488;binding GO:0003680;minor groove of adenine-thymine-rich DNA binding 2 2 0 1 0 0 0
MF GO:0005215;transporter activity GO:0005267;potassium channel activity 4 3 0 2 0 0 0
MF GO:0005488;binding GO:0051721;protein phosphatase 2A binding 1 1 0 1 0 0 0
MF GO:0005488;binding GO:1902936;phosphatidylinositol bisphosphate binding 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0008172;S-methyltransferase activity 1 1 0 1 0 0 0
MF GO:0005488;binding GO:0019902;phosphatase binding 2 1 0 2 0 0 1
MF GO:0005488;binding GO:0045322;unmethylated CpG binding 1 1 0 1 0 0 0
MF GO:0005488;binding GO:0019903;protein phosphatase binding 2 1 0 2 0 0 1
MF GO:0060089;molecular transducer activity GO:0045028;G protein-coupled purinergic nucleotide receptor activity 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0008353;RNA polymerase II CTD heptapeptide repeat kinase activity 4 3 0 3 0 0 1
MF GO:0005488;binding GO:0034452;dynactin binding 2 2 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0004707;MAP kinase activity 3 2 0 2 0 0 1
MF GO:0060089;molecular transducer activity GO:0001614;purinergic nucleotide receptor activity 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0042800;histone methyltransferase activity 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0016655;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor 2 2 0 1 0 0 0
MF GO:0005488;binding GO:0023026;MHC class II protein complex binding 3 2 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0016702;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen 1 1 0 1 0 0 0
MF GO:0060089;molecular transducer activity GO:0004890;GABA-A receptor activity 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0004745;NAD-retinol dehydrogenase activity 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:1904813;ficolin-1-rich granule lumen 1 1 0 1 0 0 0
CC GO:0032991;protein-containing complex GO:0008328;ionotropic glutamate receptor complex 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0101002;ficolin-1-rich granule 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:1901606;alpha-amino acid catabolic process 3 2 0 2 0 1 0
BP GO:0065007;biological regulation GO:0045670;regulation of osteoclast differentiation 5 2 0 0 0 0 1
BP GO:0008152;metabolic process GO:0006270;DNA replication initiation 5 2 0 0 0 0 1
BP GO:0009987;cellular process GO:0007040;lysosome organization 6 3 0 1 0 0 1
BP GO:0065007;biological regulation GO:0090303;positive regulation of wound healing 7 4 0 1 0 1 4
BP GO:0065007;biological regulation GO:0010718;positive regulation of epithelial to mesenchymal transition 4 2 0 0 0 0 1
BP GO:0065007;biological regulation GO:0045724;positive regulation of cilium assembly 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1903146;regulation of autophagy of mitochondrion 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0002673;regulation of acute inflammatory response 3 3 0 2 0 0 1
BP GO:0065007;biological regulation GO:1901021;positive regulation of calcium ion transmembrane transporter activity 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0047496;vesicle transport along microtubule 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0000132;establishment of mitotic spindle orientation 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0010921;regulation of phosphatase activity 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0050848;regulation of calcium-mediated signaling 5 3 0 3 0 0 3
BP GO:0009987;cellular process GO:0040001;establishment of mitotic spindle localization 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0051294;establishment of spindle orientation 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0072384;organelle transport along microtubule 3 3 0 3 0 0 2
BP GO:0065007;biological regulation GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway 3 3 0 2 0 0 2
BP GO:0009987;cellular process GO:0099518;vesicle cytoskeletal trafficking 1 1 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0008236;serine-type peptidase activity 3 2 0 3 0 0 0
MF GO:0005488;binding GO:0000976;transcription cis-regulatory region binding 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0051205;protein insertion into membrane 1 0 1 0 0 0 0
BP GO:0009987;cellular process GO:0014033;neural crest cell differentiation 7 7 0 2 0 0 1
BP GO:0065007;biological regulation GO:0031644;regulation of nervous system process 10 9 1 2 0 0 1
BP GO:0009987;cellular process GO:0035690;cellular response to drug 7 7 0 2 0 0 0
BP GO:0008152;metabolic process GO:0046337;phosphatidylethanolamine metabolic process 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0050853;B cell receptor signaling pathway 8 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand 10 3 1 2 0 0 1
BP GO:0065007;biological regulation GO:0050856;regulation of T cell receptor signaling pathway 6 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:2001244;positive regulation of intrinsic apoptotic signaling pathway 8 4 0 2 0 0 0
BP GO:0032501;multicellular organismal process GO:0030217;T cell differentiation 6 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0050871;positive regulation of B cell activation 7 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:2001235;positive regulation of apoptotic signaling pathway 7 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:0097191;extrinsic apoptotic signaling pathway 6 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0050671;positive regulation of lymphocyte proliferation 7 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0050870;positive regulation of T cell activation 6 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:1903223;positive regulation of oxidative stress-induced neuron death 6 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:1904063;negative regulation of cation transmembrane transport 4 4 0 1 0 0 0
BP GO:0008152;metabolic process GO:0009083;branched-chain amino acid catabolic process 9 8 0 2 0 0 0
BP GO:0008152;metabolic process GO:0009081;branched-chain amino acid metabolic process 9 8 0 2 0 0 0
BP GO:0065007;biological regulation GO:1901186;positive regulation of ERBB signaling pathway 4 4 0 1 0 0 0
BP GO:0009987;cellular process GO:0042743;hydrogen peroxide metabolic process 9 8 0 2 0 0 0
BP GO:0032502;developmental process GO:0060562;epithelial tube morphogenesis 1 1 0 0 0 0 0
BP GO:0032502;developmental process GO:0048568;embryonic organ development 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0007093;mitotic cell cycle checkpoint signaling 3 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0060307;regulation of ventricular cardiac muscle cell membrane repolarization 3 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0086005;ventricular cardiac muscle cell action potential 3 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0099623;regulation of cardiac muscle cell membrane repolarization 3 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:1904062;regulation of cation transmembrane transport 3 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0061041;regulation of wound healing 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0007266;Rho protein signal transduction 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0045862;positive regulation of proteolysis 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0051055;negative regulation of lipid biosynthetic process 3 1 0 1 0 0 3
BP GO:0065007;biological regulation GO:2000378;negative regulation of reactive oxygen species metabolic process 3 1 0 1 0 0 3
BP GO:0065007;biological regulation GO:0032874;positive regulation of stress-activated MAPK cascade 1 0 1 0 0 0 0
BP GO:0050896;response to stimulus GO:0036296;response to increased oxygen levels 1 0 0 0 0 0 1
MF GO:0003824;catalytic activity GO:0008234;cysteine-type peptidase activity 1 1 0 1 0 0 1
MF GO:0005488;binding GO:0031625;ubiquitin protein ligase binding 2 1 0 2 0 0 2
MF GO:0003824;catalytic activity GO:0004197;cysteine-type endopeptidase activity 1 1 0 1 0 0 1
MF GO:0005488;binding GO:0044389;ubiquitin-like protein ligase binding 2 1 0 2 0 0 2
BP GO:0065007;biological regulation GO:0032006;regulation of TOR signaling 6 6 0 2 0 0 0
BP GO:0065007;biological regulation GO:1902904;negative regulation of supramolecular fiber organization 3 3 1 3 0 0 0
BP GO:0051179;localization GO:0015864;pyrimidine nucleoside transport 2 1 0 0 0 0 1
BP GO:0051179;localization GO:0015858;nucleoside transport 2 1 0 0 0 0 1
BP GO:0051179;localization GO:0015862;uridine transport 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0051349;positive regulation of lyase activity 4 3 0 2 0 1 0
BP GO:0008152;metabolic process GO:0009065;glutamine family amino acid catabolic process 4 3 0 2 0 1 0
BP GO:0065007;biological regulation GO:0007263;nitric oxide mediated signal transduction 4 3 0 2 0 1 0
BP GO:0050896;response to stimulus GO:0002237;response to molecule of bacterial origin 5 4 0 2 0 0 0
BP GO:0009987;cellular process GO:0019932;second-messenger-mediated signaling 3 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0009063;cellular amino acid catabolic process 5 4 0 3 0 1 0
BP GO:0032501;multicellular organismal process GO:0003100;regulation of systemic arterial blood pressure by endothelin 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0098735;positive regulation of the force of heart contraction 2 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0018119;peptidyl-cysteine S-nitrosylation 3 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0110150;negative regulation of biomineralization 2 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0018198;peptidyl-cysteine modification 3 2 0 1 0 0 0
BP GO:0009987;cellular process GO:0019430;removal of superoxide radicals 2 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071451;cellular response to superoxide 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:1902514;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:1902307;positive regulation of sodium ion transmembrane transport 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010765;positive regulation of sodium ion transport 4 3 0 2 0 0 0
BP GO:0032501;multicellular organismal process GO:0048872;homeostasis of number of cells 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043267;negative regulation of potassium ion transport 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0050866;negative regulation of cell activation 3 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0048011;neurotrophin TRK receptor signaling pathway 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045618;positive regulation of keratinocyte differentiation 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006309;apoptotic DNA fragmentation 1 1 0 0 0 0 0
BP GO:0032502;developmental process GO:0003184;pulmonary valve morphogenesis 1 1 0 0 0 0 0
BP GO:0032502;developmental process GO:0072132;mesenchyme morphogenesis 1 1 0 0 0 0 0
BP GO:0032502;developmental process GO:0003177;pulmonary valve development 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0034311;diol metabolic process 1 1 0 0 0 0 0
BP GO:0032502;developmental process GO:0003203;endocardial cushion morphogenesis 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:2000758;positive regulation of peptidyl-lysine acetylation 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045606;positive regulation of epidermal cell differentiation 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0038179;neurotrophin signaling pathway 1 1 0 0 0 0 0
BP GO:0032502;developmental process GO:0003197;endocardial cushion development 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0070168;negative regulation of biomineral tissue development 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010543;regulation of platelet activation 3 3 0 2 0 1 1
BP GO:0065007;biological regulation GO:1903169;regulation of calcium ion transmembrane transport 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0035066;positive regulation of histone acetylation 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0000737;DNA catabolic process, endonucleolytic 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043484;regulation of RNA splicing 3 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0035617;stress granule disassembly 2 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0032988;ribonucleoprotein complex disassembly 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0106057;negative regulation of calcineurin-mediated signaling 5 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0070885;negative regulation of calcineurin-NFAT signaling cascade 5 3 0 1 0 0 0
BP GO:0009987;cellular process GO:0030575;nuclear body organization 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0090312;positive regulation of protein deacetylation 2 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0042987;amyloid precursor protein catabolic process 2 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator 4 1 1 0 0 0 1
BP GO:0065007;biological regulation GO:0045725;positive regulation of glycogen biosynthetic process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0070875;positive regulation of glycogen metabolic process 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0007064;mitotic sister chromatid cohesion 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0050435;amyloid-beta metabolic process 2 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1901797;negative regulation of signal transduction by p53 class mediator 4 1 1 0 0 0 1
BP GO:0065007;biological regulation GO:1901989;positive regulation of cell cycle phase transition 2 1 0 0 0 0 1
BP GO:0009987;cellular process GO:0042771;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0033044;regulation of chromosome organization 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:1902903;regulation of supramolecular fiber organization 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0005979;regulation of glycogen biosynthetic process 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0031109;microtubule polymerization or depolymerization 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0032272;negative regulation of protein polymerization 5 3 1 3 0 0 1
BP GO:0065007;biological regulation GO:0070884;regulation of calcineurin-NFAT signaling cascade 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031110;regulation of microtubule polymerization or depolymerization 3 2 0 2 0 0 1
BP GO:0009987;cellular process GO:0046785;microtubule polymerization 3 2 0 2 0 0 1
BP GO:0008152;metabolic process GO:0007004;telomere maintenance via telomerase 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006278;RNA-dependent DNA biosynthetic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0010833;telomere maintenance via telomere lengthening 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0051131;chaperone-mediated protein complex assembly 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0048675;axon extension 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:1990138;neuron projection extension 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1901889;negative regulation of cell junction assembly 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031111;negative regulation of microtubule polymerization or depolymerization 3 2 1 2 0 0 0
BP GO:0009987;cellular process GO:0034198;cellular response to amino acid starvation 1 1 0 1 0 0 0
BP GO:0050896;response to stimulus GO:1990928;response to amino acid starvation 1 1 0 1 0 0 0
BP GO:0032501;multicellular organismal process GO:0034374;low-density lipoprotein particle remodeling 3 3 0 2 0 0 1
BP GO:0008152;metabolic process GO:0042744;hydrogen peroxide catabolic process 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032269;negative regulation of cellular protein metabolic process 2 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:0048712;negative regulation of astrocyte differentiation 1 0 0 0 0 0 1
MF GO:0005488;binding GO:0035035;histone acetyltransferase binding 2 2 0 1 0 0 0
MF GO:0005488;binding GO:0042162;telomeric DNA binding 2 1 1 2 0 0 0
BP GO:0008152;metabolic process GO:0006003;fructose 2,6-bisphosphate metabolic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0070935;3'-UTR-mediated mRNA stabilization 2 2 0 0 0 0 0
BP GO:0065007;biological regulation GO:1902373;negative regulation of mRNA catabolic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043489;RNA stabilization 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0048255;mRNA stabilization 1 1 0 0 0 0 0
BP GO:0050896;response to stimulus GO:0032868;response to insulin 2 1 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0062149;detection of stimulus involved in sensory perception of pain 5 3 0 3 0 0 0
BP GO:0065007;biological regulation GO:0014819;regulation of skeletal muscle contraction 5 3 0 3 0 0 0
BP GO:0065007;biological regulation GO:0060371;regulation of atrial cardiac muscle cell membrane depolarization 5 3 0 3 0 0 0
BP GO:0065007;biological regulation GO:0060372;regulation of atrial cardiac muscle cell membrane repolarization 5 3 0 3 0 0 0
BP GO:0065007;biological regulation GO:0086015;SA node cell action potential 5 3 0 3 0 0 0
BP GO:0065007;biological regulation GO:0086016;AV node cell action potential 6 4 0 4 0 0 0
BP GO:0009987;cellular process GO:0086067;AV node cell to bundle of His cell communication 5 3 0 3 0 0 0
BP GO:0009987;cellular process GO:0086026;atrial cardiac muscle cell to AV node cell signaling 4 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:1902882;regulation of response to oxidative stress 2 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0086014;atrial cardiac muscle cell action potential 3 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:1905897;regulation of response to endoplasmic reticulum stress 2 0 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0050974;detection of mechanical stimulus involved in sensory perception 3 2 0 2 0 0 0
BP GO:0008152;metabolic process GO:0018130;heterocycle biosynthetic process 2 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0086012;membrane depolarization during cardiac muscle cell action potential 2 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0036336;dendritic cell migration 2 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0003254;regulation of membrane depolarization 2 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0019370;leukotriene biosynthetic process 3 1 0 2 0 1 0
BP GO:0032502;developmental process GO:0003231;cardiac ventricle development 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1903035;negative regulation of response to wounding 4 2 0 1 0 0 0
BP GO:0009987;cellular process GO:0051402;neuron apoptotic process 6 4 2 3 0 1 0
BP GO:0009987;cellular process GO:0071470;cellular response to osmotic stress 2 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0003161;cardiac conduction system development 2 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0090398;cellular senescence 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1902305;regulation of sodium ion transmembrane transport 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0061045;negative regulation of wound healing 1 0 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0060048;cardiac muscle contraction 3 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0030501;positive regulation of bone mineralization 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0002028;regulation of sodium ion transport 2 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0042476;odontogenesis 3 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0086091;regulation of heart rate by cardiac conduction 2 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0048546;digestive tract morphogenesis 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:2000510;positive regulation of dendritic cell chemotaxis 1 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:2000508;regulation of dendritic cell chemotaxis 1 0 0 0 0 0 1
BP GO:0002376;immune system process GO:0045190;isotype switching 1 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:2000401;regulation of lymphocyte migration 1 0 0 0 0 0 1
BP GO:0009987;cellular process GO:0045444;fat cell differentiation 1 1 0 0 0 0 0
BP GO:0042592;homeostatic process GO:0055088;lipid homeostasis 4 3 0 1 0 0 2
BP GO:0009987;cellular process GO:0032508;DNA duplex unwinding 3 3 1 2 0 0 0
BP GO:0065007;biological regulation GO:0032682;negative regulation of chemokine production 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:1901687;glutathione derivative biosynthetic process 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:1901685;glutathione derivative metabolic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0046329;negative regulation of JNK cascade 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043506;regulation of JUN kinase activity 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032873;negative regulation of stress-activated MAPK cascade 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006749;glutathione metabolic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043407;negative regulation of MAP kinase activity 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0061564;axon development 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0000725;recombinational repair 3 3 0 1 0 0 0
BP GO:0008152;metabolic process GO:0000724;double-strand break repair via homologous recombination 3 3 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032760;positive regulation of tumor necrosis factor production 6 5 1 4 0 1 0
BP GO:0065007;biological regulation GO:1903557;positive regulation of tumor necrosis factor superfamily cytokine production 6 5 1 4 0 1 0
MF GO:0003824;catalytic activity GO:0004558;alpha-1,4-glucosidase activity 1 0 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0090599;alpha-glucosidase activity 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0016323;basolateral plasma membrane 3 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0034163;regulation of toll-like receptor 9 signaling pathway 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0048679;regulation of axon regeneration 3 2 0 1 0 0 0
BP GO:0009987;cellular process GO:0099560;synaptic membrane adhesion 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0060998;regulation of dendritic spine development 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032647;regulation of interferon-alpha production 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0050771;negative regulation of axonogenesis 2 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0035335;peptidyl-tyrosine dephosphorylation 2 2 0 1 0 0 1
BP GO:0008152;metabolic process GO:0070933;histone H4 deacetylation 3 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0070932;histone H3 deacetylation 3 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0006338;chromatin remodeling 4 2 1 1 0 0 0
BP GO:0008152;metabolic process GO:0016575;histone deacetylation 2 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0072330;monocarboxylic acid biosynthetic process 7 5 0 4 0 1 0
BP GO:0008152;metabolic process GO:0070827;chromatin maintenance 2 1 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0043116;negative regulation of vascular permeability 3 2 0 2 0 0 2
BP GO:0032501;multicellular organismal process GO:0043117;positive regulation of vascular permeability 3 2 0 2 0 0 2
BP GO:0065007;biological regulation GO:0051968;positive regulation of synaptic transmission, glutamatergic 5 4 0 3 0 0 2
BP GO:0065007;biological regulation GO:1901841;regulation of high voltage-gated calcium channel activity 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0046827;positive regulation of protein export from nucleus 4 3 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032780;negative regulation of ATPase activity 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:1900117;regulation of execution phase of apoptosis 1 1 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0050664;oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor 2 1 0 1 0 0 0
MF GO:0005488;binding GO:0043024;ribosomal small subunit binding 3 2 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005730;nucleolus 5 3 0 2 0 0 0
CC GO:0110165;cellular anatomical entity GO:0031981;nuclear lumen 5 3 0 2 0 0 0
BP GO:0065007;biological regulation GO:0031452;negative regulation of heterochromatin assembly 2 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0071557;histone H3-K27 demethylation 2 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0070544;histone H3-K36 demethylation 2 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0006356;regulation of transcription by RNA polymerase I 2 0 0 0 0 0 0
BP GO:0051179;localization GO:0033344;cholesterol efflux 2 1 0 0 0 0 1
BP GO:0032502;developmental process GO:0042472;inner ear morphogenesis 2 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0061718;glucose catabolic process to pyruvate 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0061621;canonical glycolysis 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0061620;glycolytic process through glucose-6-phosphate 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006096;glycolytic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032436;positive regulation of proteasomal ubiquitin-dependent protein catabolic process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0043087;regulation of GTPase activity 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0008277;regulation of G protein-coupled receptor signaling pathway 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060079;excitatory postsynaptic potential 5 3 0 1 0 0 1
BP GO:0065007;biological regulation GO:2000300;regulation of synaptic vesicle exocytosis 4 2 0 0 0 0 0
BP GO:0065007;biological regulation GO:0007549;dosage compensation 3 2 0 1 0 0 2
BP GO:0065007;biological regulation GO:0010826;negative regulation of centrosome duplication 3 2 0 1 0 0 2
BP GO:0065007;biological regulation GO:0033147;negative regulation of intracellular estrogen receptor signaling pathway 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045717;negative regulation of fatty acid biosynthetic process 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051570;regulation of histone H3-K9 methylation 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0009894;regulation of catabolic process 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0060398;regulation of growth hormone receptor signaling pathway 2 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0042976;activation of Janus kinase activity 2 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0036155;acylglycerol acyl-chain remodeling 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:2001269;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:1902253;regulation of intrinsic apoptotic signaling pathway by p53 class mediator 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0080164;regulation of nitric oxide metabolic process 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0051931;regulation of sensory perception 2 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0045346;regulation of MHC class II biosynthetic process 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0060306;regulation of membrane repolarization 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0034204;lipid translocation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032414;positive regulation of ion transmembrane transporter activity 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0045332;phospholipid translocation 1 0 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0007614;short-term memory 1 1 0 1 0 0 1
BP GO:0050896;response to stimulus GO:1905144;response to acetylcholine 2 2 0 2 0 0 2
BP GO:0032502;developmental process GO:0140058;neuron projection arborization 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0140059;dendrite arborization 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0099173;postsynapse organization 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0046218;indolalkylamine catabolic process 2 2 0 1 0 0 1
BP GO:0008152;metabolic process GO:0006569;tryptophan catabolic process 1 1 0 1 0 0 1
BP GO:0008152;metabolic process GO:0006568;tryptophan metabolic process 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1902991;regulation of amyloid precursor protein catabolic process 2 2 0 1 0 0 2
BP GO:0065007;biological regulation GO:1900273;positive regulation of long-term synaptic potentiation 1 1 0 1 0 0 1
BP GO:0008152;metabolic process GO:0006084;acetyl-CoA metabolic process 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0032077;positive regulation of deoxyribonuclease activity 4 3 0 3 0 1 2
BP GO:0050896;response to stimulus GO:0033194;response to hydroperoxide 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0032071;regulation of endodeoxyribonuclease activity 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0016572;histone phosphorylation 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:2000304;positive regulation of ceramide biosynthetic process 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0090154;positive regulation of sphingolipid biosynthetic process 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:2000303;regulation of ceramide biosynthetic process 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0050996;positive regulation of lipid catabolic process 2 2 0 2 0 0 2
BP GO:0009987;cellular process GO:0030837;negative regulation of actin filament polymerization 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0120033;negative regulation of plasma membrane bounded cell projection assembly 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0042307;positive regulation of protein import into nucleus 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0035306;positive regulation of dephosphorylation 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1904591;positive regulation of protein import 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0051494;negative regulation of cytoskeleton organization 1 1 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0004697;protein kinase C activity 2 1 0 2 0 0 2
MF GO:0140110;transcription regulator activity GO:0001228;DNA-binding transcription activator activity, RNA polymerase II-specific 2 2 0 1 0 0 1
MF GO:0005488;binding GO:0051287;NAD binding 1 1 0 1 0 0 1
MF GO:0005488;binding GO:0001046;core promoter sequence-specific DNA binding 1 1 0 1 0 0 1
MF GO:0005488;binding GO:0019900;kinase binding 2 1 0 2 0 0 2
MF GO:0005488;binding GO:0019901;protein kinase binding 2 1 0 2 0 0 2
MF GO:0005488;binding GO:0000977;RNA polymerase II transcription regulatory region sequence-specific DNA binding 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0045621;positive regulation of lymphocyte differentiation 2 2 0 0 0 0 1
BP GO:0009987;cellular process GO:0071331;cellular response to hexose stimulus 1 1 0 0 0 0 1
BP GO:0009987;cellular process GO:0071333;cellular response to glucose stimulus 1 1 0 0 0 0 1
BP GO:0008152;metabolic process GO:0042573;retinoic acid metabolic process 5 5 1 2 0 0 2
BP GO:0065007;biological regulation GO:0010823;negative regulation of mitochondrion organization 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0021953;central nervous system neuron differentiation 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032271;regulation of protein polymerization 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0034660;ncRNA metabolic process 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0051881;regulation of mitochondrial membrane potential 6 5 0 3 0 0 1
BP GO:0065007;biological regulation GO:2001020;regulation of response to DNA damage stimulus 3 2 0 2 0 1 0
BP GO:0065007;biological regulation GO:0050772;positive regulation of axonogenesis 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1903827;regulation of cellular protein localization 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0032754;positive regulation of interleukin-5 production 5 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0045822;negative regulation of heart contraction 4 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:1901844;regulation of cell communication by electrical coupling involved in cardiac conduction 4 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0032674;regulation of interleukin-5 production 4 4 0 2 0 0 0
BP GO:0065007;biological regulation GO:0051252;regulation of RNA metabolic process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010677;negative regulation of cellular carbohydrate metabolic process 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0090307;mitotic spindle assembly 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006511;ubiquitin-dependent protein catabolic process 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0016570;histone modification 3 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0055022;negative regulation of cardiac muscle tissue growth 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903524;positive regulation of blood circulation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0046325;negative regulation of glucose import 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0033689;negative regulation of osteoblast proliferation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:2000113;negative regulation of cellular macromolecule biosynthetic process 2 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0030182;neuron differentiation 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0048489;synaptic vesicle transport 2 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0048313;Golgi inheritance 2 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010829;negative regulation of glucose transmembrane transport 3 2 0 2 0 0 1
BP GO:0009987;cellular process GO:0048699;generation of neurons 2 0 0 0 0 0 0
BP GO:0051179;localization GO:0097479;synaptic vesicle localization 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045721;negative regulation of gluconeogenesis 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0048168;regulation of neuronal synaptic plasticity 3 2 2 2 0 0 0
BP GO:0065007;biological regulation GO:0002689;negative regulation of leukocyte chemotaxis 1 1 1 0 0 0 0
BP GO:0065007;biological regulation GO:0002694;regulation of leukocyte activation 3 2 1 0 0 0 0
BP GO:0065007;biological regulation GO:1902254;negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator 3 1 1 0 0 0 1
BP GO:0065007;biological regulation GO:0010738;regulation of protein kinase A signaling 1 1 1 0 0 0 0
BP GO:0065007;biological regulation GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage 1 1 1 0 0 0 0
BP GO:0065007;biological regulation GO:0043030;regulation of macrophage activation 1 1 1 0 0 0 0
BP GO:0065007;biological regulation GO:2001021;negative regulation of response to DNA damage stimulus 2 1 1 0 0 0 1
BP GO:0065007;biological regulation GO:0035722;interleukin-12-mediated signaling pathway 5 2 2 0 0 0 0
BP GO:0009987;cellular process GO:0071349;cellular response to interleukin-12 5 2 2 0 0 0 0
BP GO:0009987;cellular process GO:1903206;negative regulation of hydrogen peroxide-induced cell death 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:1902175;regulation of oxidative stress-induced intrinsic apoptotic signaling pathway 2 1 1 1 0 0 0
BP GO:0032502;developmental process GO:0001656;metanephros development 2 0 0 0 0 0 1
BP GO:0032502;developmental process GO:0006073;cellular glucan metabolic process 4 2 0 0 0 0 0
BP GO:0009987;cellular process GO:1901028;regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway 3 2 0 0 0 0 0
BP GO:0065007;biological regulation GO:1900181;negative regulation of protein localization to nucleus 3 2 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006112;energy reserve metabolic process 3 2 0 0 0 0 0
BP GO:0009987;cellular process GO:0007171;activation of transmembrane receptor protein tyrosine kinase activity 2 2 1 1 0 0 1
BP GO:0065007;biological regulation GO:0048172;regulation of short-term neuronal synaptic plasticity 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0010647;positive regulation of cell communication 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0030216;keratinocyte differentiation 2 0 1 1 0 0 0
MF GO:0005488;binding GO:0033293;monocarboxylic acid binding 3 1 1 1 0 0 0
BP GO:0008152;metabolic process GO:0006068;ethanol catabolic process 1 1 1 0 0 0 1
BP GO:0008152;metabolic process GO:0009308;amine metabolic process 1 1 1 0 0 0 1
BP GO:0009987;cellular process GO:0051923;sulfation 1 1 1 0 0 0 1
BP GO:0008152;metabolic process GO:0034035;purine ribonucleoside bisphosphate metabolic process 1 1 1 0 0 0 1
BP GO:0008152;metabolic process GO:0006783;heme biosynthetic process 1 1 1 0 0 0 1
BP GO:0008152;metabolic process GO:0006779;porphyrin-containing compound biosynthetic process 1 1 1 0 0 0 1
BP GO:0008152;metabolic process GO:0050427;3'-phosphoadenosine 5'-phosphosulfate metabolic process 1 1 1 0 0 0 1
BP GO:0051179;localization GO:0042886;amide transport 1 1 1 0 0 0 1
BP GO:0051179;localization GO:0072348;sulfur compound transport 1 1 1 0 0 0 1
BP GO:0051179;localization GO:0051180;vitamin transport 1 1 1 0 0 0 1
BP GO:0065007;biological regulation GO:0048640;negative regulation of developmental growth 2 2 1 0 0 0 1
MF GO:0005215;transporter activity GO:0015378;sodium:chloride symporter activity 1 1 1 0 0 0 1
BP GO:0009987;cellular process GO:0001755;neural crest cell migration 4 4 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032008;positive regulation of TOR signaling 5 5 0 1 0 0 0
BP GO:0009987;cellular process GO:0014032;neural crest cell development 4 4 0 0 0 0 0
BP GO:0009987;cellular process GO:0001667;ameboidal-type cell migration 4 4 0 0 0 0 0
BP GO:0032502;developmental process GO:0003007;heart morphogenesis 5 5 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903530;regulation of secretion by cell 4 4 0 0 0 0 0
BP GO:0065007;biological regulation GO:0030100;regulation of endocytosis 1 1 1 1 0 0 0
BP GO:0065007;biological regulation GO:2000644;regulation of receptor catabolic process 1 1 1 1 0 0 0
BP GO:0065007;biological regulation GO:1903898;negative regulation of PERK-mediated unfolded protein response 1 1 1 1 0 0 0
BP GO:0065007;biological regulation GO:1903896;positive regulation of IRE1-mediated unfolded protein response 1 1 1 1 0 0 0
BP GO:0065007;biological regulation GO:2000646;positive regulation of receptor catabolic process 1 1 1 1 0 0 0
BP GO:0065007;biological regulation GO:0070106;interleukin-27-mediated signaling pathway 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071350;cellular response to interleukin-15 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0035723;interleukin-15-mediated signaling pathway 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0098761;cellular response to interleukin-7 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0038111;interleukin-7-mediated signaling pathway 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0007259;receptor signaling pathway via JAK-STAT 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071352;cellular response to interleukin-2 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0038110;interleukin-2-mediated signaling pathway 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060330;regulation of response to interferon-gamma 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060334;regulation of interferon-gamma-mediated signaling pathway 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032653;regulation of interleukin-10 production 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032731;positive regulation of interleukin-1 beta production 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032732;positive regulation of interleukin-1 production 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071357;cellular response to type I interferon 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060337;type I interferon signaling pathway 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0001959;regulation of cytokine-mediated signaling pathway 2 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0042129;regulation of T cell proliferation 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0071346;cellular response to interferon-gamma 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045625;regulation of T-helper 1 cell differentiation 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0034112;positive regulation of homotypic cell-cell adhesion 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010561;negative regulation of glycoprotein biosynthetic process 1 1 0 0 0 0 0
BP GO:0042592;homeostatic process GO:0048878;chemical homeostasis 2 1 0 1 0 0 1
BP GO:0051179;localization GO:0015893;drug transport 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1903793;positive regulation of anion transport 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0009891;positive regulation of biosynthetic process 2 1 0 0 0 0 1
BP GO:0008152;metabolic process GO:0043112;receptor metabolic process 2 2 0 1 0 0 0
BP GO:0032502;developmental process GO:0048565;digestive tract development 1 0 0 1 0 0 1
BP GO:0065007;biological regulation GO:0070098;chemokine-mediated signaling pathway 2 1 0 2 0 0 1
BP GO:0065007;biological regulation GO:0048548;regulation of pinocytosis 2 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0007183;SMAD protein complex assembly 1 1 0 0 0 0 1
BP GO:0040007;growth GO:0043403;skeletal muscle tissue regeneration 1 1 0 0 0 0 1
BP GO:0009987;cellular process GO:0033173;calcineurin-NFAT signaling cascade 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0097720;calcineurin-mediated signaling 1 1 0 0 0 0 1
BP GO:0008152;metabolic process GO:0070262;peptidyl-serine dephosphorylation 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0032925;regulation of activin receptor signaling pathway 1 1 0 0 0 0 1
BP GO:0032502;developmental process GO:0061384;heart trabecula morphogenesis 1 1 0 0 0 0 1
BP GO:0032502;developmental process GO:0003229;ventricular cardiac muscle tissue development 1 1 0 0 0 0 1
MF GO:0005488;binding GO:0042805;actinin binding 3 2 1 2 0 0 0
BP GO:0065007;biological regulation GO:1903749;positive regulation of establishment of protein localization to mitochondrion 2 2 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006639;acylglycerol metabolic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0046434;organophosphate catabolic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0042219;cellular modified amino acid catabolic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006644;phospholipid metabolic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006650;glycerophospholipid metabolic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0046503;glycerolipid catabolic process 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0009395;phospholipid catabolic process 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0008593;regulation of Notch signaling pathway 2 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0007005;mitochondrion organization 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045637;regulation of myeloid cell differentiation 3 3 0 3 0 1 1
BP GO:0009987;cellular process GO:0051259;protein complex oligomerization 2 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0045926;negative regulation of growth 5 4 1 2 0 0 2
MF GO:0003824;catalytic activity GO:0004725;protein tyrosine phosphatase activity 5 3 0 3 0 0 1
BP GO:0065007;biological regulation GO:0010649;regulation of cell communication by electrical coupling 3 3 0 1 0 0 0
BP GO:0008152;metabolic process GO:0046058;cAMP metabolic process 3 3 0 1 0 0 0
MF GO:0005215;transporter activity GO:0015143;urate transmembrane transporter activity 1 0 0 0 0 0 0
MF GO:0005215;transporter activity GO:0032217;riboflavin transmembrane transporter activity 1 0 0 0 0 0 0
MF GO:0005215;transporter activity GO:0022832;voltage-gated channel activity 1 0 0 0 0 0 0
MF GO:0005215;transporter activity GO:0005244;voltage-gated ion channel activity 1 0 0 0 0 0 0
MF GO:0005215;transporter activity GO:0008028;monocarboxylic acid transmembrane transporter activity 1 0 0 0 0 0 0
MF GO:0005488;binding GO:0001222;transcription corepressor binding 1 0 0 0 0 0 0
MF GO:0005215;transporter activity GO:0005251;delayed rectifier potassium channel activity 1 0 0 0 0 0 0
MF GO:0005488;binding GO:0030331;estrogen receptor binding 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0098591;external side of apical plasma membrane 2 1 0 0 0 0 0
BP GO:0051179;localization GO:0015732;prostaglandin transport 1 1 0 1 0 0 0
BP GO:0044419;biological process involved in interspecies interaction between organisms GO:0051712;positive regulation of killing of cells of other organism 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0001910;regulation of leukocyte mediated cytotoxicity 1 1 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0034612;response to tumor necrosis factor 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010608;posttranscriptional regulation of gene expression 1 1 1 1 0 0 0
BP GO:0009987;cellular process GO:0030199;collagen fibril organization 1 0 1 0 0 0 0
BP GO:0008152;metabolic process GO:0018401;peptidyl-proline hydroxylation to 4-hydroxy-L-proline 1 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:0046598;positive regulation of viral entry into host cell 1 0 1 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0034378;chylomicron assembly 1 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:0075294;positive regulation by symbiont of entry into host 1 0 1 0 0 0 0
BP GO:0008152;metabolic process GO:0019511;peptidyl-proline hydroxylation 1 0 1 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0034379;very-low-density lipoprotein particle assembly 1 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:1900026;positive regulation of substrate adhesion-dependent cell spreading 1 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:0046596;regulation of viral entry into host cell 1 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:0010770;positive regulation of cell morphogenesis involved in differentiation 1 0 1 0 0 0 0
BP GO:0065007;biological regulation GO:1900024;regulation of substrate adhesion-dependent cell spreading 1 0 1 0 0 0 0
BP GO:0002376;immune system process GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II 1 0 0 0 0 0 0
BP GO:0002376;immune system process GO:0002495;antigen processing and presentation of peptide antigen via MHC class II 1 0 0 0 0 0 0
BP GO:0002376;immune system process GO:0002478;antigen processing and presentation of exogenous peptide antigen 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0033631;cell-cell adhesion mediated by integrin 1 0 0 0 0 0 0
BP GO:0050896;response to stimulus GO:0010042;response to manganese ion 1 0 0 0 0 0 0
BP GO:0016032;viral process GO:0019065;receptor-mediated endocytosis of virus by host cell 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0019064;fusion of virus membrane with host plasma membrane 1 0 0 0 0 0 0
BP GO:0016032;viral process GO:0039663;membrane fusion involved in viral entry into host cell 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0042157;lipoprotein metabolic process 1 0 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0042117;monocyte activation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0042159;lipoprotein catabolic process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0070201;regulation of establishment of protein localization 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060143;positive regulation of syncytium formation by plasma membrane fusion 2 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0016540;protein autoprocessing 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0033630;positive regulation of cell adhesion mediated by integrin 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006509;membrane protein ectodomain proteolysis 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045604;regulation of epidermal cell differentiation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045616;regulation of keratinocyte differentiation 1 0 0 0 0 0 0
MF GO:0005488;binding GO:0005080;protein kinase C binding 2 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0043202;lysosomal lumen 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0042583;chromaffin granule 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0036021;endolysosome lumen 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005775;vacuolar lumen 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0071682;endocytic vesicle lumen 2 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0031233;intrinsic component of external side of plasma membrane 3 2 0 2 0 0 0
CC GO:0110165;cellular anatomical entity GO:0036019;endolysosome 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0031904;endosome lumen 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0062023;collagen-containing extracellular matrix 1 0 0 0 0 0 0
MF GO:0005488;binding GO:0005507;copper ion binding 2 2 0 1 0 0 0
MF GO:0005488;binding GO:0001067;transcription regulatory region nucleic acid binding 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0030424;axon 2 1 0 2 0 0 1
BP GO:0050896;response to stimulus GO:0001580;detection of chemical stimulus involved in sensory perception of bitter taste 2 1 0 0 0 0 0
BP GO:0032501;multicellular organismal process GO:0050913;sensory perception of bitter taste 2 1 0 0 0 0 0
BP GO:0050896;response to stimulus GO:0050912;detection of chemical stimulus involved in sensory perception of taste 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0070527;platelet aggregation 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0034109;homotypic cell-cell adhesion 1 1 0 0 0 0 0
MF GO:0098772;molecular function regulator activity GO:0019855;calcium channel inhibitor activity 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0097718;disordered domain specific binding 2 1 0 1 0 0 1
MF GO:0098772;molecular function regulator activity GO:0005246;calcium channel regulator activity 1 1 0 0 0 0 0
MF GO:0098772;molecular function regulator activity GO:0008200;ion channel inhibitor activity 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0061629;RNA polymerase II-specific DNA-binding transcription factor binding 1 1 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0033192;calmodulin-dependent protein phosphatase activity 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0031721;hemoglobin alpha binding 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0008508;bile acid:sodium symporter activity 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0097100;supercoiled DNA binding 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0035184;histone threonine kinase activity 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1905475;regulation of protein localization to membrane 1 0 0 0 0 0 1
MF GO:0003824;catalytic activity GO:0019788;NEDD8 transferase activity 1 0 0 0 0 0 1
CC GO:0003824;catalytic activity GO:1905103;integral component of lysosomal membrane 1 0 0 0 0 0 1
CC GO:0003824;catalytic activity GO:0031166;integral component of vacuolar membrane 1 0 0 0 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005640;nuclear outer membrane 1 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:0031333;negative regulation of protein-containing complex assembly 1 1 0 0 0 0 0
BP GO:0050896;response to stimulus GO:0046688;response to copper ion 1 0 0 0 0 0 0
BP GO:0050896;response to stimulus GO:0072507;divalent inorganic cation homeostasis 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0140238;presynaptic endocytosis 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0099504;synaptic vesicle cycle 1 0 0 0 0 0 0
BP GO:0051179;localization GO:0036465;synaptic vesicle recycling 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051049;regulation of transport 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0048488;synaptic vesicle endocytosis 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0016079;synaptic vesicle exocytosis 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0019319;hexose biosynthetic process 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0055065;metal ion homeostasis 1 0 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0004712;protein serine/threonine/tyrosine kinase activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0000287;magnesium ion binding 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0050321;tau-protein kinase activity 2 1 0 1 0 0 1
MF GO:0005488;binding GO:0046872;metal ion binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0048156;tau protein binding 2 1 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0005005;transmembrane-ephrin receptor activity 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0005003;ephrin receptor activity 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0004711;ribosomal protein S6 kinase activity 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0005004;GPI-linked ephrin receptor activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0001784;phosphotyrosine residue binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0045309;protein phosphorylated amino acid binding 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0005007;fibroblast growth factor-activated receptor activity 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0004690;cyclic nucleotide-dependent protein kinase activity 1 0 0 1 0 0 1
MF GO:0098772;molecular function regulator activity GO:0030295;protein kinase activator activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0042169;SH2 domain binding 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0004691;cAMP-dependent protein kinase activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0070851;growth factor receptor binding 1 0 0 1 0 0 1
MF GO:0060089;molecular transducer activity GO:0038064;collagen receptor activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0043121;neurotrophin binding 1 0 0 1 0 0 1
MF GO:0098772;molecular function regulator activity GO:0043539;protein serine/threonine kinase activator activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0046875;ephrin receptor binding 2 1 0 1 0 0 1
MF GO:0005488;binding GO:0017134;fibroblast growth factor binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0005131;growth hormone receptor binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0030145;manganese ion binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0005161;platelet-derived growth factor receptor binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0034236;protein kinase A catalytic subunit binding 1 0 0 1 0 0 1
MF GO:0098772;molecular function regulator activity GO:0017080;sodium channel regulator activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0034987;immunoglobulin receptor binding 1 0 0 1 0 0 1
MF GO:0140657;ATP-dependent activity GO:0008554;P-type sodium transporter activity 1 0 0 1 0 0 1
MF GO:0140657;ATP-dependent activity GO:0005391;P-type sodium:potassium-exchanging transporter activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0051427;hormone receptor binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0051020;GTPase binding 1 0 0 1 0 0 1
MF GO:0140657;ATP-dependent activity GO:0008556;P-type potassium transmembrane transporter activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0045296;cadherin binding 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0097472;cyclin-dependent protein kinase activity 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0004693;cyclin-dependent protein serine/threonine kinase activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0043015;gamma-tubulin binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0031267;small GTPase binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0003785;actin monomer binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0005154;epidermal growth factor receptor binding 1 0 0 1 0 0 1
MF GO:0098772;molecular function regulator activity GO:0015459;potassium channel regulator activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0008140;cAMP response element binding protein binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0051019;mitogen-activated protein kinase binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:1990459;transferrin receptor binding 1 0 0 1 0 0 1
MF GO:0060090;molecular adaptor activity GO:0005078;MAP-kinase scaffold activity 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0031435;mitogen-activated protein kinase kinase kinase binding 1 0 0 1 0 0 1
MF GO:0005488;binding GO:0048407;platelet-derived growth factor binding 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005856;cytoskeleton 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0045121;membrane raft 1 0 0 1 0 0 1
CC GO:0032991;protein-containing complex GO:1902911;protein kinase complex 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0015629;actin cytoskeleton 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005925;focal adhesion 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0030055;cell-substrate junction 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0015630;microtubule cytoskeleton 1 0 0 1 0 0 1
CC GO:0110165;cellular anatomical entity GO:0005901;caveola 1 0 0 1 0 0 1
BP GO:0065007;biological regulation GO:0032369;negative regulation of lipid transport 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0048550;negative regulation of pinocytosis 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0032373;positive regulation of sterol transport 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060457;negative regulation of digestive system process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051006;positive regulation of lipoprotein lipase activity 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1905953;negative regulation of lipid localization 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0061365;positive regulation of triglyceride lipase activity 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0034145;positive regulation of toll-like receptor 4 signaling pathway 1 0 0 0 0 0 0
MF GO:0005488;binding GO:0050661;NADP binding 1 0 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0052650;NADP-retinol dehydrogenase activity 1 0 0 1 0 0 0
MF GO:0005488;binding GO:0008142;oxysterol binding 1 0 0 1 0 0 0
BP GO:0008152;metabolic process GO:0019439;aromatic compound catabolic process 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0045780;positive regulation of bone resorption 6 5 0 5 0 0 1
BP GO:0065007;biological regulation GO:0045651;positive regulation of macrophage differentiation 6 5 0 5 0 0 1
BP GO:0065007;biological regulation GO:1900222;negative regulation of amyloid-beta clearance 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006702;androgen biosynthetic process 1 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0035115;embryonic forelimb morphogenesis 1 1 0 1 0 0 0
BP GO:0032502;developmental process GO:0035136;forelimb morphogenesis 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0098911;regulation of ventricular cardiac muscle cell action potential 1 1 0 1 0 0 0
BP GO:0050896;response to stimulus GO:0032526;response to retinoic acid 5 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:0010906;regulation of glucose metabolic process 2 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:0050861;positive regulation of B cell receptor signaling pathway 4 4 0 4 0 1 2
BP GO:0009987;cellular process GO:0030833;regulation of actin filament polymerization 3 2 0 2 0 1 1
BP GO:0065007;biological regulation GO:0010827;regulation of glucose transmembrane transport 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0050855;regulation of B cell receptor signaling pathway 2 2 0 2 0 1 1
BP GO:0009987;cellular process GO:0030838;positive regulation of actin filament polymerization 1 1 0 1 0 0 1
BP GO:0009987;cellular process GO:0060326;cell chemotaxis 2 2 0 2 0 1 1
BP GO:0065007;biological regulation GO:0060252;positive regulation of glial cell proliferation 2 2 0 2 0 1 1
BP GO:0065007;biological regulation GO:0017015;regulation of transforming growth factor beta receptor signaling pathway 2 1 0 2 0 0 1
BP GO:0008152;metabolic process GO:0018394;peptidyl-lysine acetylation 1 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0002053;positive regulation of mesenchymal cell proliferation 2 0 0 1 0 0 0
BP GO:0032502;developmental process GO:0072075;metanephric mesenchyme development 2 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0048008;platelet-derived growth factor receptor signaling pathway 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:2000251;positive regulation of actin cytoskeleton reorganization 2 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0070816;phosphorylation of RNA polymerase II C-terminal domain 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0030851;granulocyte differentiation 2 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006368;transcription elongation from RNA polymerase II promoter 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006354;DNA-templated transcription, elongation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0042795;snRNA transcription by RNA polymerase II 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:2000045;regulation of G1/S transition of mitotic cell cycle 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0009301;snRNA transcription 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0002573;myeloid leukocyte differentiation 4 2 0 1 0 0 1
BP GO:0065007;biological regulation GO:2001166;regulation of histone H2B ubiquitination 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0033184;positive regulation of histone ubiquitination 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0033129;positive regulation of histone phosphorylation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0050821;protein stabilization 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1902416;positive regulation of mRNA binding 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010763;positive regulation of fibroblast migration 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:1900364;negative regulation of mRNA polyadenylation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031441;negative regulation of mRNA 3'-end processing 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1902306;negative regulation of sodium ion transmembrane transport 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:2000650;negative regulation of sodium ion transmembrane transporter activity 3 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:0033127;regulation of histone phosphorylation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0034763;negative regulation of transmembrane transport 2 2 0 2 0 0 1
BP GO:0065007;biological regulation GO:1903706;regulation of hemopoiesis 2 2 0 2 0 0 1
BP GO:0051179;localization GO:0046903;secretion 2 2 1 1 0 1 1
BP GO:0065007;biological regulation GO:0051047;positive regulation of secretion 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1904706;negative regulation of vascular associated smooth muscle cell proliferation 2 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:0014742;positive regulation of muscle hypertrophy 3 2 0 3 0 0 2
BP GO:0065007;biological regulation GO:0010613;positive regulation of cardiac muscle hypertrophy 2 1 0 2 0 0 2
BP GO:0032501;multicellular organismal process GO:0060047;heart contraction 2 1 0 2 0 0 0
BP GO:0032501;multicellular organismal process GO:0006941;striated muscle contraction 2 1 0 2 0 0 0
BP GO:0065007;biological regulation GO:0048524;positive regulation of viral process 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0002183;cytoplasmic translational initiation 1 1 0 1 0 0 0
MF GO:0005488;binding GO:0000339;RNA cap binding 1 1 0 1 0 0 0
MF GO:0045182;translation regulator activity GO:0003743;translation initiation factor activity 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0097013;phagocytic vesicle lumen 2 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005766;primary lysosome 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0004520;endodeoxyribonuclease activity 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0007249;I-kappaB kinase/NF-kappaB signaling 1 1 0 1 0 0 0
BP GO:0065007;biological regulation GO:1902915;negative regulation of protein polyubiquitination 1 1 0 1 0 0 0
BP GO:0002376;immune system process GO:0019885;antigen processing and presentation of endogenous peptide antigen via MHC class I 1 1 0 1 0 0 0
BP GO:0002376;immune system process GO:0002483;antigen processing and presentation of endogenous peptide antigen 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0032452;histone demethylase activity 1 0 1 1 0 0 0
BP GO:0050896;response to stimulus GO:0009416;response to light stimulus 3 1 0 0 0 0 1
MF GO:0005488;binding GO:0000049;tRNA binding 1 1 0 0 0 0 0
MF GO:0005488;binding GO:0015631;tubulin binding 1 1 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0004090;carbonyl reductase 1 1 0 0 0 0 0
MF GO:0005215;transporter activity GO:0008525;phosphatidylcholine transporter activity 1 1 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0016779;nucleotidyltransferase activity 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0097386;glial cell projection 1 1 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0097418;neurofibrillary tangle 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0046068;cGMP metabolic process 1 0 0 1 0 0 1
BP GO:0065007;biological regulation GO:0010611;regulation of cardiac muscle hypertrophy 1 0 0 1 0 0 1
MF GO:0003824;catalytic activity GO:0047555;3',5'-cyclic-GMP phosphodiesterase activity 2 1 0 2 0 0 1
BP GO:0065007;biological regulation GO:0046605;regulation of centrosome cycle 2 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051785;positive regulation of nuclear division 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045840;positive regulation of mitotic nuclear division 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045663;positive regulation of myoblast differentiation 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0033137;negative regulation of peptidyl-serine phosphorylation 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010880;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0061028;establishment of endothelial barrier 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0070647;protein modification by small protein conjugation or removal 1 0 0 0 0 0 1
BP GO:0065007;biological regulation GO:0030517;negative regulation of axon extension 1 1 0 0 0 0 0
BP GO:0065007;biological regulation GO:0034122;negative regulation of toll-like receptor signaling pathway 1 1 0 0 0 0 0
BP GO:0009987;cellular process GO:0035590;purinergic nucleotide receptor signaling pathway 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0045667;regulation of osteoblast differentiation 1 1 0 1 0 0 1
MF GO:0005488;binding GO:1990837;sequence-specific double-stranded DNA binding 1 0 0 1 0 0 0
BP GO:0065007;biological regulation GO:0051930;regulation of sensory perception of pain 1 1 0 1 0 0 0
BP GO:0008152;metabolic process GO:0006164;purine nucleotide biosynthetic process 1 1 0 1 0 0 1
BP GO:0008152;metabolic process GO:0043101;purine-containing compound salvage 1 1 0 1 0 0 1
BP GO:0032502;developmental process GO:0048738;cardiac muscle tissue development 1 1 0 1 0 0 0
MF GO:0005215;transporter activity GO:0005248;voltage-gated sodium channel activity 1 1 0 1 0 0 0
MF GO:0005488;binding GO:0030553;cGMP binding 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0004114;3',5'-cyclic-nucleotide phosphodiesterase activity 1 1 0 1 0 0 0
MF GO:0005488;binding GO:0030551;cyclic nucleotide binding 1 1 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0004112;cyclic-nucleotide phosphodiesterase activity 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005741;mitochondrial outer membrane 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0031968;organelle outer membrane 1 1 0 1 0 0 0
BP GO:0009987;cellular process GO:0035881;amacrine cell differentiation 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0046549;retinal cone cell development 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0042670;retinal cone cell differentiation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0045630;positive regulation of T-helper 2 cell differentiation 1 0 0 0 0 0 0
BP GO:0032502;developmental process GO:0035116;embryonic hindlimb morphogenesis 1 0 0 0 0 0 0
BP GO:0032502;developmental process GO:0035137;hindlimb morphogenesis 1 0 0 0 0 0 0
MF GO:0003824;catalytic activity GO:0019198;transmembrane receptor protein phosphatase activity 3 2 0 1 0 0 0
MF GO:0003824;catalytic activity GO:0005001;transmembrane receptor protein tyrosine phosphatase activity 3 2 0 1 0 0 0
MF GO:0005488;binding GO:0030506;ankyrin binding 3 2 0 1 0 0 0
BP GO:0065007;biological regulation GO:0007274;neuromuscular synaptic transmission 1 1 0 1 0 0 1
BP GO:0065007;biological regulation GO:1905209;positive regulation of cardiocyte differentiation 2 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0002695;negative regulation of leukocyte activation 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0071763;nuclear membrane organization 1 0 0 0 0 0 0
CC GO:0110165;cellular anatomical entity GO:0005811;lipid droplet 1 1 0 1 0 0 0
CC GO:0110165;cellular anatomical entity GO:0032059;bleb 3 2 0 2 0 0 0
BP GO:0065007;biological regulation GO:0043388;positive regulation of DNA binding 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0051101;regulation of DNA binding 1 1 0 0 0 0 1
BP GO:0065007;biological regulation GO:0043392;negative regulation of DNA binding 1 0 0 0 0 0 1
BP GO:0009987;cellular process GO:0070199;establishment of protein localization to chromosome 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031061;negative regulation of histone methylation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031453;positive regulation of heterochromatin assembly 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0090308;regulation of DNA methylation-dependent heterochromatin assembly 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006312;mitotic recombination 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010959;regulation of metal ion transport 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0016246;RNA interference 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0001836;release of cytochrome c from mitochondria 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0046902;regulation of mitochondrial membrane permeability 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006305;DNA alkylation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0044728;DNA methylation or demethylation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0070918;production of small RNA involved in gene silencing by RNA 1 0 0 0 0 0 0
BP GO:0042592;homeostatic process GO:0032469;endoplasmic reticulum calcium ion homeostasis 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0046824;positive regulation of nucleocytoplasmic transport 1 1 0 1 0 1 0
BP GO:0065007;biological regulation GO:0090316;positive regulation of intracellular protein transport 1 1 0 1 0 1 0
BP GO:0008152;metabolic process GO:0006107;oxaloacetate metabolic process 1 1 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006476;protein deacetylation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0035601;protein deacylation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010830;regulation of myotube differentiation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0034983;peptidyl-lysine deacetylation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:1903507;negative regulation of nucleic acid-templated transcription 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0010832;negative regulation of myotube differentiation 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051154;negative regulation of striated muscle cell differentiation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0018205;peptidyl-lysine modification 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0051153;regulation of striated muscle cell differentiation 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0008216;spermidine metabolic process 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0040029;regulation of gene expression, epigenetic 1 0 0 0 0 0 0
BP GO:0008152;metabolic process GO:0006595;polyamine metabolic process 1 0 0 0 0 0 0
BP GO:0032502;developmental process GO:0042733;embryonic digit morphogenesis 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0060765;regulation of androgen receptor signaling pathway 1 0 0 0 0 0 0
BP GO:0032502;developmental process GO:0030326;embryonic limb morphogenesis 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0043044;ATP-dependent chromatin remodeling 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0030162;regulation of proteolysis 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:1903322;positive regulation of protein modification by small protein conjugation or removal 1 0 0 0 0 0 0
BP GO:0032502;developmental process GO:0008544;epidermis development 1 0 0 0 0 0 0
BP GO:0065007;biological regulation GO:0031396;regulation of protein ubiquitination 1 0 0 0 0 0 0
BP GO:0009987;cellular process GO:0070842;aggresome assembly 1 0 0 0 0 0 0
Access Plants by Target KEGG Pathway (Enriched by target proteins of the plant)

KEGG Pathway Category Top Level KEGG Pathway Category Second Level KEGG Pathway Name No. of Plants No. of Medicinal Plants No. of Food Plants No. of Human Edible Plants No. of Agricultural Plants No. of Garden Plants No. of Drug-producing Plants
Organismal Systems Endocrine system PPAR signaling pathway 513 293 126 162 1 17 128
Metabolism Lipid metabolism Arachidonic acid metabolism 930 449 165 285 1 28 226
Organismal Systems Endocrine system Ovarian steroidogenesis 2298 924 193 639 2 59 571
Organismal Systems Endocrine system Regulation of lipolysis in adipocytes 485 273 59 172 0 16 125
Organismal Systems Nervous system Serotonergic synapse 1058 525 189 318 0 29 249
Metabolism Amino acid metabolism Tryptophan metabolism 1951 806 174 559 1 47 477
Human Diseases Cancer: overview Central carbon metabolism in cancer 1862 785 181 528 1 49 431
Human Diseases Cancer: overview Proteoglycans in cancer 1805 780 179 507 0 48 433
Metabolism Xenobiotics biodegradation and metabolism Drug metabolism 1101 509 169 311 2 22 258
Environmental Information Processing Signal transduction MAPK signaling pathway 2012 830 186 569 1 50 473
Metabolism Lipid metabolism Steroid hormone biosynthesis 2089 855 199 599 2 51 504
Cellular Processes Cellular community - eukaryotes Adherens junction 1558 649 158 447 0 41 374
Human Diseases Cancer: specific types Melanoma 1514 647 157 432 0 39 358
Human Diseases Cancer: overview Pathways in cancer 1943 836 199 546 1 55 460
Metabolism Xenobiotics biodegradation and metabolism Metabolism of xenobiotics by cytochrome P450 2017 847 204 573 1 48 485
Human Diseases Cancer: overview Transcriptional misregulation in cancer 1668 706 164 477 1 44 409
Environmental Information Processing Signal transduction PI3K-Akt signaling pathway 1665 704 163 480 1 43 398
Metabolism Amino acid metabolism Phenylalanine metabolism 225 95 8 67 0 4 58
Metabolism Amino acid metabolism Histidine metabolism 182 78 6 53 0 4 51
Environmental Information Processing Signal transduction Ras signaling pathway 1688 709 168 492 0 43 404
Human Diseases Cancer: overview Chemical carcinogenesis 2362 981 225 676 3 57 574
Metabolism Lipid metabolism Linoleic acid metabolism 1052 469 168 302 1 24 247
Organismal Systems Endocrine system Thyroid hormone signaling pathway 470 254 87 145 1 18 114
Genetic Information Processing Replication and repair Base excision repair 647 276 82 192 0 16 146
Metabolism Amino acid metabolism Tyrosine metabolism 400 168 62 105 1 11 93
Cellular Processes Cell growth and death Apoptosis 963 481 177 288 1 31 235
Human Diseases Cancer: overview MicroRNAs in cancer 1649 713 178 467 1 49 394
Metabolism Amino acid metabolism Glycine, serine and threonine metabolism 130 55 4 41 0 3 36
Human Diseases Cancer: specific types Hepatocellular carcinoma 979 463 146 280 0 27 240
Human Diseases Substance dependence Cocaine addiction 822 388 112 234 0 16 211
Metabolism Amino acid metabolism Arginine and proline metabolism 132 55 4 41 0 4 34
Cellular Processes Cellular community - eukaryotes Focal adhesion 1495 618 134 426 0 37 356
Human Diseases Cancer: overview Viral carcinogenesis 1114 537 159 330 0 26 281
Environmental Information Processing Signal transduction Rap1 signaling pathway 1465 613 135 420 0 35 348
Human Diseases Cancer: specific types Acute myeloid leukemia 1669 715 184 471 1 44 381
Human Diseases Cardiovascular disease Lipid and atherosclerosis 1249 593 183 365 2 34 299
Cellular Processes Transport and catabolism Mitophagy 797 324 52 243 1 18 215
Metabolism Metabolism of cofactors and vitamins Retinol metabolism 1696 700 183 468 2 42 402
Human Diseases Substance dependence Amphetamine addiction 216 126 60 65 0 6 60
Human Diseases Cancer: specific types Renal cell carcinoma 609 307 110 173 0 11 155
Human Diseases Cancer: specific types Non-small cell lung cancer 670 336 117 190 0 14 163
Cellular Processes Cell growth and death p53 signaling pathway 122 67 14 41 0 5 33
Human Diseases Cancer: specific types Glioma 675 338 114 192 0 16 166
Human Diseases Neurodegenerative disease Parkinson disease 219 139 47 72 0 7 55
Metabolism Biosynthesis of other secondary metabolites Caffeine metabolism 1440 537 85 386 1 29 370
Human Diseases Cancer: specific types Prostate cancer 1326 627 199 381 1 33 320
Human Diseases Endocrine and metabolic disease AGE-RAGE signaling pathway in diabetic complications 1931 819 201 546 1 53 459
Organismal Systems Endocrine system Progesterone-mediated oocyte maturation 1063 480 132 290 0 31 240
Organismal Systems Aging Longevity regulating pathway 857 384 76 249 1 16 219
Environmental Information Processing Signal transduction HIF-1 signaling pathway 1749 733 190 490 1 37 432
Environmental Information Processing Signal transduction Sphingolipid signaling pathway 718 365 102 223 1 18 171
Cellular Processes Cell growth and death Cell cycle 130 62 9 44 0 4 30
Cellular Processes Cell growth and death Oocyte meiosis 622 281 89 166 0 17 145
Environmental Information Processing Signaling molecules and interaction Neuroactive ligand-receptor interaction 487 317 156 152 0 18 115
Organismal Systems Nervous system Dopaminergic synapse 222 113 40 71 0 7 57
Cellular Processes Transport and catabolism Autophagy 338 181 55 105 0 8 87
Metabolism Energy metabolism Nitrogen metabolism 2357 962 180 686 3 63 565
Organismal Systems Endocrine system Insulin signaling pathway 413 200 54 130 1 9 94
Human Diseases Substance dependence Alcoholism 148 93 32 48 0 2 38
Organismal Systems Excretory system Proximal tubule bicarbonate reclamation 931 394 92 280 1 22 233
Organismal Systems Endocrine system Relaxin signaling pathway 1005 503 157 311 1 27 235
Human Diseases Cancer: specific types Bladder cancer 825 427 141 258 0 28 215
Human Diseases Cancer: overview PD-L1 expression and PD-1 checkpoint pathway in cancer 1318 584 167 376 1 27 327
Organismal Systems Immune system IL-17 signaling pathway 614 351 139 187 0 22 156
Organismal Systems Immune system Th17 cell differentiation 1036 455 151 293 1 27 252
Environmental Information Processing Signal transduction cAMP signaling pathway 834 480 187 259 0 18 196
Organismal Systems Endocrine system Prolactin signaling pathway 1072 506 178 302 1 23 246
Human Diseases Cardiovascular disease Fluid shear stress and atherosclerosis 1136 534 171 323 1 28 284
Human Diseases Neurodegenerative disease Alzheimer disease 1131 559 185 337 0 29 267
Organismal Systems Immune system T cell receptor signaling pathway 611 273 82 165 0 12 137
Environmental Information Processing Signal transduction TNF signaling pathway 664 354 139 185 0 16 148
Human Diseases Cardiovascular disease Diabetic cardiomyopathy 689 350 100 218 0 19 174
Human Diseases Neurodegenerative disease Pathways of neurodegeneration 844 440 190 238 0 25 205
Human Diseases Infectious disease: viral Coronavirus disease 346 202 72 106 0 8 76
Organismal Systems Endocrine system Estrogen signaling pathway 994 494 172 274 1 29 229
Human Diseases Immune disease Inflammatory bowel disease 628 236 37 186 0 15 149
Organismal Systems Endocrine system Adipocytokine signaling pathway 345 172 58 105 1 7 70
Human Diseases Infectious disease: viral Hepatitis C 624 323 130 182 1 18 144
Human Diseases Infectious disease: viral Hepatitis B 817 411 135 238 1 28 194
Human Diseases Cancer: specific types Chronic myeloid leukemia 763 362 126 217 1 19 187
Human Diseases Cancer: specific types Pancreatic cancer 929 450 146 270 1 22 223
Human Diseases Infectious disease: bacterial Pertussis 332 181 81 98 0 6 84
Human Diseases Infectious disease: parasitic Leishmaniasis 353 190 82 103 0 8 82
Organismal Systems Immune system B cell receptor signaling pathway 472 229 83 131 0 7 105
Organismal Systems Digestive system Bile secretion 734 340 142 203 0 20 148
Organismal Systems Immune system Th1 and Th2 cell differentiation 282 144 56 77 0 6 63
Human Diseases Infectious disease: viral Kaposi sarcoma-associated herpesvirus infection 616 319 105 165 1 16 151
Human Diseases Infectious disease: bacterial Pathogenic Escherichia coli infection 203 99 30 55 0 6 51
Human Diseases Infectious disease: parasitic Chagas disease 434 220 84 119 0 7 91
Organismal Systems Immune system Toll-like receptor signaling pathway 465 231 86 129 0 8 99
Organismal Systems Immune system C-type lectin receptor signaling pathway 522 249 80 143 0 9 122
Environmental Information Processing Signal transduction NF-kappa B signaling pathway 505 202 37 148 0 11 134
Human Diseases Endocrine and metabolic disease Insulin resistance 500 221 48 148 1 10 113
Human Diseases Infectious disease: viral Human T-cell leukemia virus 1 infection 711 348 125 199 0 12 175
Human Diseases Infectious disease: parasitic Toxoplasmosis 434 210 74 125 0 9 104
Organismal Systems Nervous system Neurotrophin signaling pathway 556 277 88 162 1 13 123
Organismal Systems Development and regeneration Osteoclast differentiation 411 192 57 119 0 4 83
Human Diseases Infectious disease: bacterial Salmonella infection 361 165 45 104 0 9 84
Human Diseases Infectious disease: bacterial Yersinia infection 450 222 80 131 0 7 92
Human Diseases Endocrine and metabolic disease Type II diabetes mellitus 235 118 32 71 0 4 49
Human Diseases Infectious disease: viral Measles 766 319 60 221 1 14 188
Human Diseases Endocrine and metabolic disease Non-alcoholic fatty liver disease 318 147 28 100 1 4 74
Cellular Processes Cell growth and death Cellular senescence 791 374 126 224 1 20 194
Human Diseases Infectious disease: bacterial Legionellosis 342 145 35 109 0 7 89
Human Diseases Infectious disease: viral Influenza A 327 151 35 98 0 6 81
Organismal Systems Immune system Cytosolic DNA-sensing pathway 170 84 20 49 0 3 35
Organismal Systems Endocrine system GnRH secretion 265 153 63 86 0 5 55
Human Diseases Infectious disease: bacterial Tuberculosis 203 102 35 58 0 4 46
Organismal Systems Immune system NOD-like receptor signaling pathway 194 95 30 55 0 4 48
Human Diseases Infectious disease: viral Human papillomavirus infection 259 138 33 82 0 5 51
Human Diseases Infectious disease: bacterial Epithelial cell signaling in Helicobacter pylori infection 956 431 115 289 1 21 226
Organismal Systems Immune system RIG-I-like receptor signaling pathway 175 85 15 56 0 3 37
Organismal Systems Immune system Neutrophil extracellular trap formation 275 139 34 83 0 6 60
Organismal Systems Immune system Chemokine signaling pathway 253 121 28 75 0 4 63
Organismal Systems Endocrine system Thyroid hormone synthesis 67 46 6 31 0 3 29
Cellular Processes Transport and catabolism Endocytosis 320 120 18 96 0 5 84
Environmental Information Processing Signal transduction FoxO signaling pathway 593 274 115 161 0 11 131
Human Diseases Cancer: specific types Gastric cancer 634 295 77 193 0 16 144
Genetic Information Processing Replication and repair Fanconi anemia pathway 288 108 17 88 0 5 68
Environmental Information Processing Signal transduction VEGF signaling pathway 611 290 95 179 0 11 146
Environmental Information Processing Signal transduction Calcium signaling pathway 613 308 92 180 0 14 149
Human Diseases Infectious disease: bacterial Bacterial invasion of epithelial cells 336 128 13 86 0 3 87
Environmental Information Processing Signal transduction ErbB signaling pathway 455 222 60 123 1 10 92
Human Diseases Cancer: specific types Colorectal cancer 433 218 65 121 0 10 89
Cellular Processes Cellular community - eukaryotes Gap junction 725 377 157 216 0 20 173
Organismal Systems Endocrine system GnRH signaling pathway 381 207 80 108 1 11 82
Environmental Information Processing Signal transduction AMPK signaling pathway 241 100 6 64 0 1 56
Cellular Processes Cellular community - eukaryotes Signaling pathways regulating pluripotency of stem cells 285 134 32 71 0 3 65
Human Diseases Cancer: specific types Breast cancer 723 377 131 202 1 20 155
Environmental Information Processing Signal transduction Phospholipase D signaling pathway 314 178 115 76 0 8 56
Environmental Information Processing Signal transduction mTOR signaling pathway 248 111 16 62 0 3 65
Organismal Systems Endocrine system Oxytocin signaling pathway 138 61 10 35 0 3 46
Organismal Systems Immune system Hematopoietic cell lineage 248 83 7 62 0 7 65
Organismal Systems Immune system Leukocyte transendothelial migration 303 145 20 85 0 9 77
Organismal Systems Immune system Fc epsilon RI signaling pathway 216 111 27 59 0 3 34
Human Diseases Cancer: specific types Small cell lung cancer 534 238 49 143 1 14 123
Organismal Systems Sensory system Inflammatory mediator regulation of TRP channels 246 134 36 65 0 9 50
Organismal Systems Excretory system Aldosterone-regulated sodium reabsorption 220 107 23 61 0 3 47
Organismal Systems Digestive system Carbohydrate digestion and absorption 139 59 2 38 0 0 28
Human Diseases Infectious disease: viral Human cytomegalovirus infection 547 264 73 159 0 12 137
Human Diseases Cancer: specific types Endometrial cancer 251 154 63 75 0 5 45
Metabolism Carbohydrate metabolism Inositol phosphate metabolism 96 39 0 24 0 0 18
Organismal Systems Immune system Fc gamma R-mediated phagocytosis 199 87 11 61 0 4 43
Environmental Information Processing Signal transduction Phosphatidylinositol signaling system 95 40 0 26 0 1 20
Human Diseases Cancer: overview Choline metabolism in cancer 233 129 41 65 0 7 43
Human Diseases Infectious disease: parasitic Amoebiasis 320 140 9 89 0 5 79
Organismal Systems Nervous system Cholinergic synapse 343 163 38 99 0 8 68
Organismal Systems Endocrine system Growth hormone synthesis, secretion and action 167 75 9 45 0 3 37
Organismal Systems Immune system Platelet activation 195 83 13 46 0 2 48
Organismal Systems Immune system Natural killer cell mediated cytotoxicity 91 48 3 26 0 1 16
Human Diseases Neurodegenerative disease Spinocerebellar ataxia 172 67 1 45 0 2 37
Environmental Information Processing Signal transduction JAK-STAT signaling pathway 361 157 36 95 1 7 72
Organismal Systems Development and regeneration Axon guidance 173 77 5 45 0 1 40
Human Diseases Infectious disease: viral Epstein-Barr virus infection 284 122 12 77 0 3 58
Human Diseases Infectious disease: viral Human immunodeficiency virus 1 infection 486 230 62 144 0 10 108
Cellular Processes Cell motility Regulation of actin cytoskeleton 120 62 10 30 0 2 35
Organismal Systems Nervous system Long-term depression 268 180 131 75 0 10 67
Organismal Systems Nervous system Long-term potentiation 82 61 58 24 0 2 14
Human Diseases Endocrine and metabolic disease Cushing syndrome 44 33 16 16 0 1 4
Organismal Systems Endocrine system Melanogenesis 39 29 9 22 0 3 8
Human Diseases Infectious disease: bacterial Shigellosis 428 208 70 113 0 9 107
Human Diseases Cancer: specific types Thyroid cancer 136 95 42 41 0 4 40
Organismal Systems Circulatory system Vascular smooth muscle contraction 43 24 3 15 0 4 15
Human Diseases Neurodegenerative disease Prion disease 78 39 6 24 0 0 13
Cellular Processes Cell growth and death Ferroptosis 90 68 28 37 1 4 34
Genetic Information Processing Translation RNA transport 46 18 0 8 0 1 20
Metabolism Metabolism of cofactors and vitamins Folate biosynthesis 502 211 55 154 0 11 142
Organismal Systems Digestive system Gastric acid secretion 46 19 1 14 0 1 15
Metabolism Carbohydrate metabolism Galactose metabolism 165 71 11 59 0 4 58
Metabolism Carbohydrate metabolism Fructose and mannose metabolism 161 68 10 57 0 4 58
Metabolism Carbohydrate metabolism Pentose and glucuronate interconversions 165 71 11 59 0 4 58
Metabolism Lipid metabolism Glycerolipid metabolism 149 60 6 51 0 4 49
Human Diseases Immune disease Rheumatoid arthritis 4 4 1 2 0 0 1
Environmental Information Processing Signal transduction cGMP-PKG signaling pathway 154 95 38 49 0 6 38
Organismal Systems Nervous system Synaptic vesicle cycle 63 53 60 5 0 4 16
Metabolism Amino acid metabolism Valine, leucine and isoleucine degradation 106 72 41 28 0 3 16
Organismal Systems Sensory system Taste transduction 66 46 22 13 0 5 12
Organismal Systems Digestive system Salivary secretion 39 22 5 14 0 3 13
Organismal Systems Circulatory system Adrenergic signaling in cardiomyocytes 52 25 7 12 0 4 10
Organismal Systems Endocrine system Renin secretion 23 9 2 5 0 2 5
Human Diseases Substance dependence Morphine addiction 64 37 3 28 0 3 24
Metabolism Metabolism of cofactors and vitamins Thiamine metabolism 140 43 1 36 0 2 47
Organismal Systems Excretory system Collecting duct acid secretion 136 39 1 30 1 2 43
Organismal Systems Immune system Complement and coagulation cascades 90 32 2 31 0 3 21
Genetic Information Processing Replication and repair Homologous recombination 43 20 2 21 0 1 10
Human Diseases Neurodegenerative disease Huntington disease 11 7 4 2 0 0 3
Human Diseases Neurodegenerative disease Amyotrophic lateral sclerosis 49 17 2 12 0 1 13
Metabolism Metabolism of cofactors and vitamins Vitamin B6 metabolism 152 84 47 38 1 3 22
Human Diseases Infectious disease: parasitic Malaria 27 16 3 13 0 1 12
Genetic Information Processing Folding, sorting and degradation Protein processing in endoplasmic reticulum 32 5 0 3 0 0 15
Cellular Processes Cell growth and death Necroptosis 36 10 1 6 0 0 10
Organismal Systems Nervous system Glutamatergic synapse 151 119 127 31 0 9 25
Organismal Systems Nervous system Retrograde endocannabinoid signaling 121 89 86 25 0 4 15
Organismal Systems Digestive system Cholesterol metabolism 5 5 1 3 0 0 2
Metabolism Metabolism of other amino acids Glutathione metabolism 7 6 7 4 0 1 0
Organismal Systems Endocrine system Parathyroid hormone synthesis, secretion and action 42 30 12 20 0 1 4
Human Diseases Infectious disease: viral Herpes simplex virus 1 infection 44 18 0 15 0 1 11
Organismal Systems Endocrine system Insulin secretion 11 10 2 7 0 1 7
Brite Hierarchies Protein families: genetic information processing Proteasome 49 18 2 15 0 1 11
Organismal Systems Environmental adaptation Circadian rhythm 69 25 0 20 0 1 21
Human Diseases Immune disease Primary immunodeficiency 60 21 0 15 0 0 14
Organismal Systems Environmental adaptation Circadian entrainment 50 38 29 14 0 3 7
Metabolism Amino acid metabolism Arginine biosynthesis 6 4 1 3 0 1 1
Environmental Information Processing Signal transduction Apelin signaling pathway 10 6 1 5 0 2 2
Environmental Information Processing Signal transduction Wnt signaling pathway 41 18 2 12 0 1 13
Environmental Information Processing Signal transduction Hedgehog signaling pathway 9 2 0 2 0 0 1
Organismal Systems Endocrine system Aldosterone synthesis and secretion 14 7 0 8 0 1 6
Environmental Information Processing Membrane transport ABC transporters 13 2 0 6 0 0 4
Human Diseases Cancer: specific types Basal cell carcinoma 6 4 1 3 0 0 1
Metabolism Nucleotide metabolism Pyrimidine metabolism 12 8 3 6 0 1 1
Human Diseases Infectious disease: parasitic African trypanosomiasis 8 7 1 6 0 1 3
Metabolism Nucleotide metabolism Purine metabolism 9 7 1 5 0 0 3
Environmental Information Processing Signal transduction TGF-beta signaling pathway 6 6 3 5 0 0 0
Organismal Systems Excretory system Endocrine and other factor-regulated calcium reabsorption 9 7 0 6 0 1 4
Organismal Systems Nervous system GABAergic synapse 9 6 1 6 0 1 5
Organismal Systems Digestive system Pancreatic secretion 9 8 0 6 0 1 5
Organismal Systems Endocrine system Renin-angiotensin system 2 2 0 1 0 0 0
Human Diseases Cardiovascular disease Hypertrophic cardiomyopathy 4 4 0 3 0 0 0
Human Diseases Cardiovascular disease Dilated cardiomyopathy 4 4 0 3 0 0 0
Metabolism Metabolism of cofactors and vitamins Nicotinate and nicotinamide metabolism 1 0 0 0 0 0 0
Human Diseases Cardiovascular disease Arrhythmogenic right ventricular cardiomyopathy 2 2 0 2 0 0 0
Human Diseases Substance dependence Nicotine addiction 6 5 1 2 0 0 1
Cellular Processes Transport and catabolism Lysosome 3 2 1 1 0 0 0
Organismal Systems Immune system Antigen processing and presentation 1 1 0 1 0 0 0
Human Diseases Infectious disease: bacterial Vibrio cholerae infection 2 2 0 2 0 0 1
Organismal Systems Endocrine system Glucagon signaling pathway 4 0 0 3 0 0 1
Environmental Information Processing Signal transduction Notch signaling pathway 1 0 0 0 0 0 0
Metabolism Carbohydrate metabolism Pyruvate metabolism 5 4 1 2 0 1 0
Cellular Processes Cellular community - eukaryotes Tight junction 1 0 0 0 0 0 0
Metabolism Carbohydrate metabolism Starch and sucrose metabolism 4 3 1 2 0 0 0
Genetic Information Processing Transcription Basal transcription factors 1 0 0 0 0 0 0
Genetic Information Processing Replication and repair Nucleotide excision repair 1 0 0 0 0 0 0
Metabolism Metabolism of cofactors and vitamins One carbon pool by folate 1 0 0 0 0 0 0
Organismal Systems Endocrine system Cortisol synthesis and secretion 1 1 0 1 0 0 0
Organismal Systems Environmental adaptation Thermogenesis 2 1 0 2 0 0 0
Metabolism Metabolism of cofactors and vitamins Ubiquinone and other terpenoid-quinone biosynthesis 1 1 0 0 0 0 0
Metabolism Carbohydrate metabolism Ascorbate and aldarate metabolism 1 1 1 0 0 0 0
Metabolism Carbohydrate metabolism Glycolysis / Gluconeogenesis 1 1 0 0 0 0 0
Access Plants by Associated Human Diseases

Disease Category Disease # Plants # Medicinal Plants # Food Plants # Human Edible Plants # Agricultural Plants # Garden Plants # Drug-producing Plants
13 Diseases of the digestive system Pulpitis 168 93 20 65 0 13 45
11 Diseases of the circulatory system Superficial thrombophlebitis, unspecified 1 1 0 0 0 0 1
14 Diseases of the skin Pressure ulceration 2 2 1 0 0 0 0
02 Neoplasms Lung cancer 3617 1441 251 966 2 82 881
02 Neoplasms Non-small cell lung cancer 2131 912 223 593 1 55 517
07 Sleep-wake disorders Insomnia 2428 1009 191 663 1 56 597
05 Endocrine, nutritional or metabolic diseases Hyperprolactinaemia 4 3 3 0 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Schizophrenia 2733 1191 242 764 2 60 661
06 Mental, behavioural or neurodevelopmental disorders Schizophrenia or other primary psychotic disorders, unspecified 346 209 185 88 0 12 75
01 Certain infectious or parasitic diseases Unspecified viral infection of unspecified site 2003 850 220 577 2 50 433
13 Diseases of the digestive system Noninfectious erosive or ulcerative disorders of oral mucosa 235 159 169 50 0 10 47
05 Endocrine, nutritional or metabolic diseases Metabolic disorder 2808 1115 240 769 3 62 676
05 Endocrine, nutritional or metabolic diseases Impaired glucose tolerance 435 242 55 137 0 15 133
11 Diseases of the circulatory system Blood Pressure 8 6 6 3 0 2 0
21 Symptoms, signs or clinical findings, not elsewhere classified Tachycardia, unspecified 1 1 1 0 0 1 0
05 Endocrine, nutritional or metabolic diseases Obesity 1963 879 227 559 1 41 502
01 Certain infectious or parasitic diseases Chronic hepatitis C 1482 643 188 431 0 40 339
21 Symptoms, signs or clinical findings, not elsewhere classified Dysphagia 61 41 5 26 0 2 14
14 Diseases of the skin Hidradenitis suppurativa 20 9 4 7 0 0 9
13 Diseases of the digestive system Haemorrhoids 27 14 5 8 0 0 6
21 Symptoms, signs or clinical findings, not elsewhere classified Systemic inflammatory response syndrome of noninfectious origin 5 4 4 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Overweight, obesity or specific nutrient excesses, unspecified 7 4 5 2 0 0 2
22 Injury, poisoning or certain other consequences of external causes Unspecified focal traumatic brain injury 1 1 0 0 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Dementia 2674 1106 216 727 1 61 647
08 Diseases of the nervous system Migraine 1223 556 138 318 1 33 272
13 Diseases of the digestive system Non-alcoholic fatty liver disease 1569 786 211 480 1 39 389
02 Neoplasms Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site 1 1 0 1 0 0 1
22 Injury, poisoning or certain other consequences of external causes Harmful effects of unspecified substance 3 2 0 1 0 0 3
13 Diseases of the digestive system Hepatic failure without mention whether acute or chronic 1 1 0 1 0 0 1
X Extension Codes Poisonous mushroom 1 1 0 1 0 0 1
13 Diseases of the digestive system Periodontal disease 321 179 144 81 0 13 76
11 Diseases of the circulatory system Acute ischaemic heart disease, unspecified 385 236 186 111 0 16 82
02 Neoplasms Breast cancer 4391 1718 264 1146 3 91 1061
08 Diseases of the nervous system Multiple sclerosis 3984 1491 251 1066 2 86 985
13 Diseases of the digestive system Crohn disease 3004 1205 246 817 1 68 762
13 Diseases of the digestive system Ulcerative colitis 834 446 125 244 0 26 215
08 Diseases of the nervous system Parkinsonism 3813 1591 257 1022 2 84 907
13 Diseases of the digestive system Indeterminate colitis 2645 1085 221 724 2 60 664
06 Mental, behavioural or neurodevelopmental disorders Agoraphobia 1 1 1 0 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Generalised anxiety disorder 94 48 30 20 0 3 29
06 Mental, behavioural or neurodevelopmental disorders Panic disorder 4 3 2 0 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Social anxiety disorder 165 97 40 46 0 12 42
16 Diseases of the genitourinary system Endometriosis 2412 972 198 675 1 54 557
16 Diseases of the genitourinary system Female pelvic pain 1277 593 181 359 2 30 299
15 Diseases of the musculoskeletal system or connective tissue Rheumatoid arthritis 3874 1536 257 1033 3 89 931
16 Diseases of the genitourinary system Interstitial cystitis 3 3 2 1 0 0 1
05 Endocrine, nutritional or metabolic diseases Acquired adrenocortical insufficiency 28 15 5 8 0 0 6
08 Diseases of the nervous system Ischaemic/haemorrhagic stroke 2659 1067 230 734 0 64 657
15 Diseases of the musculoskeletal system or connective tissue Osteoarthritis of knee 134 65 21 35 0 11 42
15 Diseases of the musculoskeletal system or connective tissue Osteoarthritis of hip 3 3 2 1 0 0 2
V Supplementary section for functioning assessment Other specified mental functions 11 11 8 2 0 2 1
V Supplementary section for functioning assessment Handling stress and other psychological demands 2 2 1 1 0 0 0
02 Neoplasms Prostate cancer 3789 1514 253 1019 2 83 932
11 Diseases of the circulatory system Primary Raynaud disease 11 8 5 4 0 2 3
08 Diseases of the nervous system Alzheimer disease 4044 1647 260 1064 2 90 982
09 Diseases of the visual system Glaucoma 3709 1523 238 999 3 79 912
08 Diseases of the nervous system Other specified cerebrovascular disease 1 1 1 0 0 1 0
06 Mental, behavioural or neurodevelopmental disorders Mild Cognitive Impairment 4 4 4 0 0 1 1
12 Diseases of the respiratory system Asthma 3877 1452 251 1027 2 78 941
10 Diseases of the ear or mastoid process Hearing Loss;Sensorineural 1 1 1 0 0 1 0
21 Symptoms, signs or clinical findings, not elsewhere classified Tinnitus 5 5 3 0 0 1 1
10 Diseases of the ear or mastoid process Vestibular neuritis 2 2 1 1 0 1 1
V Supplementary section for functioning assessment Memory functions 3 3 2 1 0 1 0
14 Diseases of the skin Vitiligo 1 1 1 0 0 1 0
05 Endocrine, nutritional or metabolic diseases Type 2 diabetes mellitus 4467 1681 261 1185 3 94 1104
09 Diseases of the visual system Diseases of the visual system, unspecified 113 57 17 40 0 7 27
21 Symptoms, signs or clinical findings, not elsewhere classified Age-associated cognitive decline 287 133 26 73 0 6 61
21 Symptoms, signs or clinical findings, not elsewhere classified Fatigue 242 188 185 65 0 12 41
09 Diseases of the visual system Age-related macular degeneration 1 1 1 0 0 0 0
09 Diseases of the visual system Cataract 2050 883 224 576 1 51 499
11 Diseases of the circulatory system Diseases of arteries or arterioles, unspecified 1 1 1 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Diabetes mellitus, type unspecified 3298 1321 249 910 3 71 808
11 Diseases of the circulatory system Pulmonary hypertension 2721 1178 237 763 2 57 682
11 Diseases of the circulatory system Essential hypertension, unspecified 2 2 2 0 0 1 0
16 Diseases of the genitourinary system Chronic kidney disease, stage unspecified 376 218 171 86 0 9 72
02 Neoplasms Squamous cell carcinoma 228 121 25 77 0 6 50
21 Symptoms, signs or clinical findings, not elsewhere classified Polyuria 86 70 21 30 0 2 34
07 Sleep-wake disorders Sleep-wake disorders 3 3 1 1 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Anxiety 1042 536 185 282 0 30 223
18 Pregnancy, childbirth or the puerperium Preterm labour or delivery 1 1 0 0 0 0 0
20 Developmental anomalies Functionally univentricular heart 1 1 1 0 0 1 0
05 Endocrine, nutritional or metabolic diseases Dyslipidemia 719 374 194 213 1 17 173
11 Diseases of the circulatory system Stable angina 1 1 0 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Erythema 1 1 0 1 0 0 0
14 Diseases of the skin Other specified skin disorders provoked by external factors 1 1 0 1 0 0 0
12 Diseases of the respiratory system Pneumonia 301 223 179 91 0 11 64
08 Diseases of the nervous system Intracerebral haemorrhage 1568 665 160 459 1 41 356
12 Diseases of the respiratory system Lung infections, unspecified 2 2 0 1 0 0 0
13 Diseases of the digestive system Chemotherapy/radiotherapy-induced mucositis 1 1 0 0 0 0 0
01 Certain infectious or parasitic diseases COVID-19 2066 876 223 585 0 50 486
06 Mental, behavioural or neurodevelopmental disorders Generalized Anxiety Disorder 5 3 2 1 0 1 3
13 Diseases of the digestive system Helicobacter infection 4 2 2 1 0 0 1
02 Neoplasms Thyroid cancer 2114 928 208 608 1 53 517
X Extension Codes Flare or flash 184 146 143 45 0 9 31
11 Diseases of the circulatory system Atherosclerotic chronic arterial occlusive disease 2 2 2 0 0 1 0
02 Neoplasms Malignant mixed epithelial mesenchymal tumour of ovary 63 38 11 20 0 4 18
02 Neoplasms Fallopian tube cancer 1925 834 214 544 1 53 466
02 Neoplasms Malignant neoplasms of peritoneum, unspecified 1 1 1 0 0 0 0
12 Diseases of the respiratory system Cystic fibrosis 1727 749 192 514 1 49 396
21 Symptoms, signs or clinical findings, not elsewhere classified Menopausal symptom or complaint 1 1 1 0 0 0 0
02 Neoplasms Solid tumour/cancer 5041 1984 272 1275 3 101 1219
05 Endocrine, nutritional or metabolic diseases Endocrine, nutritional or metabolic diseases 3 2 3 2 0 0 0
08 Diseases of the nervous system Diseases of the nervous system 29 23 9 14 0 1 2
16 Diseases of the genitourinary system Dysmenorrhoea 101 57 17 27 0 5 25
01 Certain infectious or parasitic diseases Malaria 1279 629 198 375 1 32 313
16 Diseases of the genitourinary system Chronic kidney disease, stage 5 3 3 1 2 0 0 1
14 Diseases of the skin Psoriasis 3949 1568 246 1083 3 89 956
21 Symptoms, signs or clinical findings, not elsewhere classified Pain in joint 3 3 2 0 0 0 1
05 Endocrine, nutritional or metabolic diseases Iron deficiency 3 3 3 1 0 0 0
02 Neoplasms Cervical intraepithelial neoplasia 57 33 8 18 0 6 18
X Extension Codes Cutaneous T-cell lymphoma, NOS 301 199 180 74 0 14 59
22 Injury, poisoning or certain other consequences of external causes Injury of muscle, fascia or tendon of triceps 3 3 3 0 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Bipolar disorder 656 357 180 187 0 25 158
16 Diseases of the genitourinary system Chronic kidney disease 2799 1149 236 778 1 64 691
15 Diseases of the musculoskeletal system or connective tissue Osteoarthritis 1843 807 211 535 0 48 436
21 Symptoms, signs or clinical findings, not elsewhere classified Proteinuria 17 12 2 8 0 1 3
02 Neoplasms Colorectal cancer 3316 1375 243 906 2 73 820
02 Neoplasms Other specified malignant neoplasms of colon 460 286 182 134 0 15 101
24 Factors influencing health status or contact with health services Stress, not elsewhere classified 3 2 1 0 0 0 1
08 Diseases of the nervous system Dravet syndrome 12 9 4 2 0 1 7
08 Diseases of the nervous system Epilepsy/seizure 544 334 197 161 0 19 136
08 Diseases of the nervous system Focal Seizures 1 1 1 0 0 0 0
08 Diseases of the nervous system Lennox-Gastaut syndrome 2 2 2 0 0 0 1
20 Developmental anomalies Tuberous sclerosis 1 1 1 0 0 0 0
22 Injury, poisoning or certain other consequences of external causes Hematoma;Subdural;Chronic 1 1 1 0 0 0 0
04 Diseases of the immune system Lupus erythematosus 1789 740 191 502 1 44 459
04 Diseases of the immune system Other specified systemic lupus erythematosus 1 1 1 0 0 0 0
12 Diseases of the respiratory system Vasomotor/allergic rhinitis 1573 709 156 442 1 34 385
15 Diseases of the musculoskeletal system or connective tissue Myalgia 3 3 2 1 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Depression 1418 697 197 403 1 34 328
02 Neoplasms Unspecified malignant neoplasms of unspecified sites 2220 984 226 639 1 57 543
06 Mental, behavioural or neurodevelopmental disorders Attention deficit hyperactivity disorder 1429 651 210 402 0 35 364
13 Diseases of the digestive system Irritable bowel syndrome 2672 1058 220 726 1 69 672
X Extension Codes Psychostimulants, ADHD and nootropic agents 1 1 1 0 0 1 0
02 Neoplasms Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified 1 1 1 0 0 1 0
02 Neoplasms Malignant neoplasms of kidney, except renal pelvis 225 123 22 82 0 11 55
02 Neoplasms Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified 1 1 1 0 0 1 0
05 Endocrine, nutritional or metabolic diseases Other specified disorders of carbohydrate absorption or transport 226 135 135 48 0 10 54
05 Endocrine, nutritional or metabolic diseases Hypercholesterolaemia 529 301 192 152 0 17 116
21 Symptoms, signs or clinical findings, not elsewhere classified Elevated blood glucose level 6 3 3 1 0 0 2
05 Endocrine, nutritional or metabolic diseases Hyperlipoproteinaemia, unspecified 3 1 1 2 0 0 2
21 Symptoms, signs or clinical findings, not elsewhere classified Anorexia 222 174 176 58 0 12 42
21 Symptoms, signs or clinical findings, not elsewhere classified Malignant cachexia 1 1 1 0 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Unknown and unspecified causes of morbidity 1 1 1 0 0 0 1
02 Neoplasms Malignant neoplasm of pancreas 909 494 195 298 1 27 227
21 Symptoms, signs or clinical findings, not elsewhere classified Nausea 10 8 5 1 0 0 2
21 Symptoms, signs or clinical findings, not elsewhere classified Pain, unspecified 3853 1578 257 1005 1 86 933
21 Symptoms, signs or clinical findings, not elsewhere classified Sleep disturbance, not elsewhere classified 1 1 1 0 0 0 1
24 Factors influencing health status or contact with health services Limited function or disability of body organ or system 1 1 1 0 0 0 1
08 Diseases of the nervous system Spastic cerebral palsy 17 7 4 6 0 0 8
08 Diseases of the nervous system Essential tremor or related tremors 171 98 48 50 0 9 41
06 Mental, behavioural or neurodevelopmental disorders Autism spectrum disorder 2034 853 227 575 3 49 455
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic primary musculoskeletal pain 1 1 1 0 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic pain 2427 1029 219 665 2 60 573
21 Symptoms, signs or clinical findings, not elsewhere classified Spinal pain, unspecified 1 1 1 0 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Restlessness 4 3 2 1 0 0 2
01 Certain infectious or parasitic diseases Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified 733 382 202 208 0 27 177
08 Diseases of the nervous system Neuropathic pain 56 31 12 14 0 3 21
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic peripheral neuropathic pain 1 1 1 0 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Obsessive-compulsive disorder 331 205 185 88 0 14 77
08 Diseases of the nervous system Tourette syndrome 30 23 16 7 0 1 7
15 Diseases of the musculoskeletal system or connective tissue Psoriatic arthritis 92 31 1 30 0 2 18
03 Diseases of the blood or blood-forming organs Sickle-cell disorder 1256 554 208 359 0 37 306
08 Diseases of the nervous system Other specified atypical parkinsonism 1 1 1 0 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Low back pain 154 94 30 48 0 5 49
13 Diseases of the digestive system Other specified periodontal disease 2 1 1 0 0 0 1
14 Diseases of the skin Pruritus 83 44 9 24 0 4 27
21 Symptoms, signs or clinical findings, not elsewhere classified Constipation 244 127 29 80 0 14 64
06 Mental, behavioural or neurodevelopmental disorders Stress-related physiological response affecting disorders or diseases classified elsewhere 1 0 1 1 0 0 0
03 Diseases of the blood or blood-forming organs Anemia 434 265 189 116 0 18 91
03 Diseases of the blood or blood-forming organs Diseases of the blood or blood-forming organs, unspecified 43 29 10 16 0 1 6
05 Endocrine, nutritional or metabolic diseases Hypertriglyceridaemia 25 23 13 11 0 2 4
16 Diseases of the genitourinary system Menopause 244 186 180 65 0 12 44
02 Neoplasms Neoplasms 1407 654 201 402 1 34 349
16 Diseases of the genitourinary system Hyperplasia of prostate 1 0 1 0 0 0 0
12 Diseases of the respiratory system Acute sinusitis 1 1 0 0 0 0 0
02 Neoplasms Myelodysplastic syndrome 2716 1107 240 754 3 68 654
01 Certain infectious or parasitic diseases Bacterial infection of unspecified site 67 28 7 13 0 2 16
12 Diseases of the respiratory system Upper respiratory tract disorder 420 267 182 115 0 13 80
10 Diseases of the ear or mastoid process Otitis media 762 336 95 208 0 22 176
05 Endocrine, nutritional or metabolic diseases Intermediate hyperglycaemia, unspecified 378 250 151 120 0 12 78
13 Diseases of the digestive system Necrosis of pulp 1 1 1 0 0 0 0
12 Diseases of the respiratory system Chronic obstructive pulmonary disease, unspecified 1 1 0 0 0 0 0
22 Injury, poisoning or certain other consequences of external causes Other specified effects of air pressure or water pressure 19 18 9 9 0 3 4
24 Factors influencing health status or contact with health services Chemotherapy session for neoplasm 1 1 1 0 0 0 0
04 Diseases of the immune system Neutropaenia 1 1 1 0 0 0 0
01 Certain infectious or parasitic diseases Acute viral hepatitis 180 134 139 43 0 7 36
06 Mental, behavioural or neurodevelopmental disorders Substance abuse 2783 1151 244 758 0 64 696
06 Mental, behavioural or neurodevelopmental disorders Alcohol dependence 128 72 21 37 0 4 36
X Extension Codes Postmenopausal osteoporosis 21 14 13 3 0 0 5
05 Endocrine, nutritional or metabolic diseases Hyperaldosteronism 6 3 3 1 0 1 1
15 Diseases of the musculoskeletal system or connective tissue Inflammatory spondyloarthritis 343 152 27 87 0 8 82
16 Diseases of the genitourinary system Autosomal dominant polycystic kidney disease 59 31 8 22 0 0 14
13 Diseases of the digestive system Diseases of liver, unspecified 1 1 1 0 0 0 0
08 Diseases of the nervous system Postviral fatigue syndrome 4 4 1 2 0 0 2
21 Symptoms, signs or clinical findings, not elsewhere classified Fibromyalgia 1 1 1 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Insulin-resistance syndromes 199 92 19 58 0 1 41
06 Mental, behavioural or neurodevelopmental disorders Schizoaffective disorder 460 276 148 126 0 17 115
08 Diseases of the nervous system Drug-induced dystonia 1 1 1 0 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Disorders specifically associated with stress 1 1 1 0 0 0 0
02 Neoplasms Malignant neoplasms of breast, unspecified 1 1 1 0 0 0 0
02 Neoplasms Malignant neoplasms of colon 623 354 188 181 1 18 116
15 Diseases of the musculoskeletal system or connective tissue Knee osteoarthritis 361 156 33 91 0 11 89
13 Diseases of the digestive system Irritable bowel syndrome, constipation predominant 2 2 1 1 0 0 0
15 Diseases of the musculoskeletal system or connective tissue Primary gout 3 2 2 2 0 0 0
04 Diseases of the immune system Autoimmune disease 848 308 46 231 0 22 205
02 Neoplasms Osteosarcoma 1835 752 163 520 1 47 436
05 Endocrine, nutritional or metabolic diseases Type 1 diabetes mellitus 2 1 1 0 0 0 1
05 Endocrine, nutritional or metabolic diseases Polycystic ovary syndrome 1923 820 217 535 1 44 460
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic primary visceral pain 1 0 0 0 0 0 0
16 Diseases of the genitourinary system Chronic prostatitis 4 1 0 2 0 0 0
11 Diseases of the circulatory system Other specified chronic ischaemic heart disease 1 0 0 0 0 0 0
07 Sleep-wake disorders Chronic insomnia 95 69 26 21 0 8 29
08 Diseases of the nervous system Neurodegenerative disorder 187 100 28 50 0 7 40
11 Diseases of the circulatory system Cardiovascular disease 3555 1339 243 953 1 72 885
21 Symptoms, signs or clinical findings, not elsewhere classified Ageing associated decline in intrinsic capacity 1443 617 143 429 0 36 329
05 Endocrine, nutritional or metabolic diseases Inborn errors of lipid metabolism 4 3 3 2 0 0 1
V Supplementary section for functioning assessment Other specified functions of the cardiovascular, haematological, immunological and respiratory systems 2 1 0 0 0 0 1
08 Diseases of the nervous system Neuropathy, ataxia, and retinitis pigmentosa 273 183 159 65 0 9 61
21 Symptoms, signs or clinical findings, not elsewhere classified Other and unspecified abdominal pain 1 1 0 1 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Dementia, unknown or unspecified cause 1 0 0 0 0 0 0
14 Diseases of the skin Lichen planus 1376 577 136 407 0 37 310
16 Diseases of the genitourinary system Cystitis 4 3 1 1 0 0 1
18 Pregnancy, childbirth or the puerperium Long labour 1 1 0 1 0 0 0
18 Pregnancy, childbirth or the puerperium Maternal care related to false labour, unspecified 1 1 0 1 0 0 0
14 Diseases of the skin Xerosis cutis or asteatosis 1 1 0 1 0 0 1
03 Diseases of the blood or blood-forming organs Iron deficiency anaemia 290 204 186 77 0 12 57
08 Diseases of the nervous system Neuropathy 2853 1162 227 779 1 65 685
V Supplementary section for functioning assessment Basic learning 1 1 0 1 0 0 0
17 Conditions related to sexual health Sexual dysfunctions 1 1 0 1 0 0 0
17 Conditions related to sexual health Hypoactive sexual desire dysfunction 126 66 22 35 0 9 30
X Extension Codes Unspecified Adult Solid Tumor;Protocol Specific 1 1 1 0 0 1 0
05 Endocrine, nutritional or metabolic diseases Hyperlipidemia 685 358 192 207 1 17 170
11 Diseases of the circulatory system Atherosclerosis of aorta 1 1 1 0 0 1 0
X Extension Codes C-REACTIVE PROTEIN 1 1 1 0 0 1 0
04 Diseases of the immune system Systemic lupus erythematosus 3617 1463 257 966 3 78 891
02 Neoplasms Malignant neoplasms of prostate 1 1 1 0 0 1 0
02 Neoplasms Malignant neoplasms of rectosigmoid junction, unspecified 1 1 1 0 0 1 0
13 Diseases of the digestive system Ischaemia reperfusion injury of liver 23 18 10 7 0 3 3
13 Diseases of the digestive system Dentofacial parafunctional disorders 2 2 2 1 0 0 0
12 Diseases of the respiratory system Acute nasopharyngitis 1 1 1 0 0 1 0
01 Certain infectious or parasitic diseases Influenza, virus not identified 1 1 1 0 0 1 0
12 Diseases of the respiratory system Acute upper respiratory infection, site unspecified 1 1 1 0 0 1 0
14 Diseases of the skin Acne vulgaris 1376 660 213 414 2 35 311
13 Diseases of the digestive system Dental caries 227 134 135 48 0 10 50
07 Sleep-wake disorders Obstructive sleep apnoea 178 92 21 64 0 13 48
16 Diseases of the genitourinary system Menopausal disorder 1264 563 145 358 1 32 289
11 Diseases of the circulatory system Chronic arterial occlusive disease, unspecified 444 230 146 112 0 13 108
11 Diseases of the circulatory system Heart failure 2991 1239 242 835 2 69 725
21 Symptoms, signs or clinical findings, not elsewhere classified Diarrhoea 18 9 3 5 0 0 6
05 Endocrine, nutritional or metabolic diseases Nontoxic single thyroid nodule 19 17 8 8 0 1 8
X Extension Codes Lymphocytic leukaemia, NOS 1 0 0 1 0 0 0
05 Endocrine, nutritional or metabolic diseases Other specified disorders of fluid, electrolyte or acid-base balance 2 1 1 0 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Urinary incontinence, unspecified 1 0 1 0 0 0 1
X Extension Codes Psyllium hydrophilic mucilloid 1 0 1 0 0 0 1
12 Diseases of the respiratory system Chronic rhinosinusitis 3028 1270 211 833 2 75 745
01 Certain infectious or parasitic diseases Coronavirus infection, unspecified site 1 0 0 0 0 0 0
03 Diseases of the blood or blood-forming organs Thalassaemia 105 62 28 25 0 4 33
21 Symptoms, signs or clinical findings, not elsewhere classified Vomiting 10 9 4 1 0 1 3
21 Symptoms, signs or clinical findings, not elsewhere classified Nausea/vomiting 1079 545 204 311 1 28 261
12 Diseases of the respiratory system Acute respiratory distress syndrome 1245 610 205 356 0 31 286
22 Injury, poisoning or certain other consequences of external causes Motion Sickness 1 1 1 0 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Post-traumatic stress disorder 440 280 186 122 0 18 103
06 Mental, behavioural or neurodevelopmental disorders Depressive disorders, unspecified 424 273 190 123 0 16 92
02 Neoplasms Malignant neoplasms of stomach 1343 675 203 422 1 37 333
02 Neoplasms Advanced/metastatic breast cancer 1 1 1 0 0 0 0
13 Diseases of the digestive system Other specified gingival diseases 1 1 1 0 0 0 1
X Extension Codes Human immunodeficiency virus type 1 340 214 183 90 0 16 80
14 Diseases of the skin Vesicular dermatitis of hands and feet 2 1 1 0 0 0 2
15 Diseases of the musculoskeletal system or connective tissue Other specified disorders of muscles 88 49 14 30 0 2 19
16 Diseases of the genitourinary system Urinary tract infection 705 350 186 209 0 19 159
01 Certain infectious or parasitic diseases Leishmaniasis 3972 1605 255 1058 3 88 947
21 Symptoms, signs or clinical findings, not elsewhere classified Acute pain 117 83 72 15 0 7 30
08 Diseases of the nervous system Diabetic polyneuropathy 689 386 190 226 0 24 162
16 Diseases of the genitourinary system Certain specified disorders of breast 1 0 0 0 0 0 0
02 Neoplasms Neoplasms of unknown behaviour of breast 439 287 180 122 1 17 103
02 Neoplasms Neoplasms of unknown behaviour of unspecified site 1 0 0 0 0 0 0
26 Supplementary Chapter Traditional Medicine Conditions - Module I Common cold disorder(TM1) 172 117 30 63 0 8 49
21 Symptoms, signs or clinical findings, not elsewhere classified Cough 485 321 93 144 0 26 127
V Supplementary section for functioning assessment Sensation of pain 1 1 0 0 0 0 0
02 Neoplasms Leukaemia, unspecified 1 1 1 0 0 0 0
09 Diseases of the visual system Optic neuritis 5 4 1 3 0 0 2
13 Diseases of the digestive system Gingival diseases 163 85 25 47 0 5 39
07 Sleep-wake disorders Sleep-wake disorder 182 119 36 56 0 11 57
24 Factors influencing health status or contact with health services Drug or substance interactions without injury or harm 4 4 2 1 0 1 0
08 Diseases of the nervous system Cerebral ischaemic stroke due to intracranial large artery atherosclerosis 1 1 0 1 0 0 0
08 Diseases of the nervous system Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery 1 1 0 1 0 0 0
08 Diseases of the nervous system Transient ischaemic attack 8 7 0 5 0 0 0
05 Endocrine, nutritional or metabolic diseases Vitamin A deficiency 180 138 152 38 0 6 38
23 External causes of morbidity or mortality Dialysis associated with injury or harm in therapeutic use 1 1 1 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Symptoms and signs involving cognition, unspecified 278 188 143 80 0 14 73
02 Neoplasms Malignant neoplasm metastasis in female reproductive system 37 21 6 11 0 4 13
11 Diseases of the circulatory system Diseases of the circulatory system, unspecified 23 13 1 9 0 0 3
05 Endocrine, nutritional or metabolic diseases Primary hypercholesterolaemia 1 0 1 1 0 0 0
11 Diseases of the circulatory system Chronic ischaemic heart disease, unspecified 2 1 1 1 0 0 0
13 Diseases of the digestive system Malabsorption or intolerance of specific nutrients 1 1 1 1 0 0 0
X Extension Codes Antivirals for treatment of hepatitis C infections 1 1 1 0 0 0 0
02 Neoplasms Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx 1 0 1 1 0 0 0
X Extension Codes Verrucous carcinoma, NOS 36 19 6 11 0 4 13
02 Neoplasms Malignant neoplasms of other or unspecified parts of tongue 1 0 1 1 0 0 0
01 Certain infectious or parasitic diseases Bacterial infection 3132 1276 232 863 3 76 749
13 Diseases of the digestive system Short bowel syndrome 1 1 1 0 0 0 0
12 Diseases of the respiratory system Acute upper respiratory infection 270 136 34 67 0 11 83
15 Diseases of the musculoskeletal system or connective tissue Osteoporosis 518 247 83 150 1 19 101
11 Diseases of the circulatory system Coronary Artery Disease 1 1 1 0 0 0 0
11 Diseases of the circulatory system Cardiac arrhythmia, unspecified 1 1 0 1 0 0 1
11 Diseases of the circulatory system Other specified diseases of the circulatory system 1 1 0 1 0 0 1
11 Diseases of the circulatory system Congestive heart failure 470 271 169 123 0 15 118
20 Developmental anomalies Other specified syndromic genetic deafness 1 1 0 1 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Other specified clinical findings in specimens from the urinary system 2 2 0 1 0 0 1
16 Diseases of the genitourinary system Glomerular diseases, unspecified 1 1 0 0 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Mild neurocognitive disorder 2650 1139 213 724 1 63 633
03 Diseases of the blood or blood-forming organs Inherited coagulation factor deficiency 342 152 27 87 0 8 83
05 Endocrine, nutritional or metabolic diseases Overweight 2 1 2 0 0 0 1
13 Diseases of the digestive system Functional dyspepsia 1 1 0 1 0 0 0
13 Diseases of the digestive system Postprandial Distress Syndrome 1 1 0 1 0 0 0
14 Diseases of the skin Dermatoses due to ionizing radiation, unspecified 26 19 5 13 0 1 3
16 Diseases of the genitourinary system Female genital tract noninflammatory disorder 662 312 112 176 1 16 115
02 Neoplasms Skin cancer 589 271 67 168 1 16 115
09 Diseases of the visual system Hypertension Stage 1 1 1 1 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Hypo-kalaemia 54 45 17 21 0 1 20
05 Endocrine, nutritional or metabolic diseases Unspecified undernutrition 364 233 179 102 0 11 89
11 Diseases of the circulatory system Heart disease 1 1 0 1 0 1 0
09 Diseases of the visual system Visual discomfort 1 1 1 0 0 0 0
13 Diseases of the digestive system Other specified non-alcoholic fatty liver disease 488 237 65 164 0 16 130
16 Diseases of the genitourinary system Neuromuscular dysfunction of bladder, not elsewhere classified 3 1 1 1 0 0 0
16 Diseases of the genitourinary system Urinary tract infection, site and agent not specified 1 0 1 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Pyuria 1 0 1 0 0 0 0
01 Certain infectious or parasitic diseases Gastroenteritis or colitis without specification of origin 23 15 5 6 0 1 6
V Supplementary section for functioning assessment Other specified genitourinary and reproductive functions 1 1 1 0 0 0 0
19 Certain conditions originating in the perinatal period Preterm newborn 1 1 1 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Testicular hypofunction 1 1 1 0 0 0 0
02 Neoplasms Adenocarcinoma 554 315 186 155 0 17 127
11 Diseases of the circulatory system Angina pectoris 3025 1137 191 833 1 64 726
05 Endocrine, nutritional or metabolic diseases Hyper-lipoproteinaemia 2927 1189 232 800 2 63 724
14 Diseases of the skin Seborrhoeic dermatitis 3012 1202 206 831 3 75 720
02 Neoplasms Metastatic lymph node neoplasm 1844 778 163 514 1 48 433
02 Neoplasms Renal cell carcinoma 2964 1223 213 809 2 73 727
02 Neoplasms Endometrial cancer 2047 894 180 582 1 56 505
07 Sleep-wake disorders Narcolepsy 281 161 85 69 0 14 73
02 Neoplasms Testicular cancer 1596 677 159 469 1 43 367
13 Diseases of the digestive system Oesophageal/gastroduodenal disorder 2004 825 157 548 0 48 495
13 Diseases of the digestive system Thrombosis 3000 1138 195 821 1 67 734
02 Neoplasms Cervical cancer 1918 847 220 551 1 54 473
02 Neoplasms Acute myeloid leukaemia 3665 1460 255 977 2 90 887
05 Endocrine, nutritional or metabolic diseases Acute diabete complication 3492 1408 245 951 3 75 853
14 Diseases of the skin Atopic eczema 3426 1363 245 944 3 79 835
02 Neoplasms Ovarian cancer 2591 1094 236 708 1 65 624
02 Neoplasms Pleural mesothelioma 423 259 182 103 0 16 94
02 Neoplasms Malignant mesenchymal neoplasm 1649 707 160 477 1 44 379
02 Neoplasms Biliary tract cancer 1523 646 142 452 0 39 370
02 Neoplasms Brain cancer 3052 1266 225 829 2 74 730
02 Neoplasms Malignant haematopoietic neoplasm 3261 1329 224 876 3 84 792
05 Endocrine, nutritional or metabolic diseases Inborn purine/pyrimidine/nucleotide metabolism error 1868 767 162 533 1 46 444
08 Diseases of the nervous system Tic disorder 701 321 80 206 0 14 174
08 Diseases of the nervous system Myasthenia gravis 2134 870 157 581 0 48 521
03 Diseases of the blood or blood-forming organs Coagulation defect 1718 613 89 462 0 40 437
08 Diseases of the nervous system Muscular dystrophy 2251 915 213 621 2 50 546
21 Symptoms, signs or clinical findings, not elsewhere classified Tonus and reflex abnormality 447 289 149 127 0 19 106
02 Neoplasms Liver cancer 2741 1131 203 745 3 65 659
22 Injury, poisoning or certain other consequences of external causes Transplant rejection 2122 900 176 585 1 56 505
02 Neoplasms Multiple myeloma 2724 1136 235 754 2 70 655
08 Diseases of the nervous system Myotonic disorder 759 325 81 219 1 20 191
20 Developmental anomalies Phakomatoses/hamartoneoplastic syndrome 1673 687 153 478 1 44 381
02 Neoplasms Spinal cord/cranial nerve neoplasm 1561 659 157 457 1 41 355
13 Diseases of the digestive system Oesophagitis 2149 839 188 598 0 50 507
02 Neoplasms Metastatic biliary tract neoplasms 1561 659 157 457 1 41 355
02 Neoplasms Peritoneal cancer 2165 911 188 599 1 59 526
01 Certain infectious or parasitic diseases Anogenital warts 523 219 80 145 0 16 112
02 Neoplasms Diffuse large B-cell lymphoma 2262 907 181 625 1 53 531
02 Neoplasms Head and neck cancer 2314 995 220 638 2 61 552
08 Diseases of the nervous system Autonomic nervous system disorder 1260 569 200 374 0 34 283
02 Neoplasms Melanoma 2626 1086 240 727 3 69 614
13 Diseases of the digestive system Acute/subacute hepatic failure 1710 712 191 486 1 43 443
06 Mental, behavioural or neurodevelopmental disorders Psychotic disorder 1106 530 168 318 0 25 268
05 Endocrine, nutritional or metabolic diseases Inborn lipid metabolism error 1352 605 205 406 1 32 348
02 Neoplasms Mature B-cell lymphoma 2092 861 174 590 1 52 486
05 Endocrine, nutritional or metabolic diseases Hypo-thyroidism 839 497 164 265 1 27 189
09 Diseases of the visual system Retinopathy 1948 830 213 561 0 47 466
01 Certain infectious or parasitic diseases Pediculosis 1990 821 156 542 0 47 491
08 Diseases of the nervous system Cerebral ischaemic stroke 2030 772 213 541 0 43 501
02 Neoplasms Bladder cancer 1782 785 168 511 1 50 413
12 Diseases of the respiratory system Idiopathic interstitial pneumonitis 2131 909 202 614 1 58 498
11 Diseases of the circulatory system Coronary atherosclerosis 672 392 192 204 0 19 146
17 Conditions related to sexual health Sexual dysfunction 390 214 48 118 0 15 102
03 Diseases of the blood or blood-forming organs Thrombocytopenia 3103 1151 240 835 1 71 762
15 Diseases of the musculoskeletal system or connective tissue Inflammatory arthropathy 1760 733 167 507 2 47 389
11 Diseases of the circulatory system Chronic arterial occlusive disease 3359 1355 247 904 3 81 812
02 Neoplasms Myeloproliferative neoplasm 2265 912 177 632 1 57 521
X Extension Codes Gastrointestinal stromal tumour 1692 690 146 477 0 44 422
02 Neoplasms Mature T-cell lymphoma 3697 1469 247 967 2 85 918
11 Diseases of the circulatory system Deep vein thrombosis 300 138 28 99 0 10 66
08 Diseases of the nervous system General pain disorder 1642 760 220 484 1 36 409
02 Neoplasms Stomach cancer 2435 1044 209 676 2 67 590
02 Neoplasms Malignant digestive organ neoplasm 1610 653 144 455 0 41 399
02 Neoplasms Mastocytosis 1715 705 153 494 1 47 392
15 Diseases of the musculoskeletal system or connective tissue Reactive arthropathy 341 151 27 87 0 8 82
09 Diseases of the visual system Corneal disease 256 169 88 58 0 13 75
08 Diseases of the nervous system Genetic prion disease 521 209 49 154 0 14 116
15 Diseases of the musculoskeletal system or connective tissue Low bone mass disorder 2073 849 181 578 2 49 480
05 Endocrine, nutritional or metabolic diseases Inborn metabolism deficiency 980 418 77 267 1 21 245
01 Certain infectious or parasitic diseases Parasitic infection 670 324 170 183 0 18 153
02 Neoplasms Mature B-cell leukaemia 2035 884 188 587 2 55 479
11 Diseases of the circulatory system Myocardial infarction 3486 1330 242 944 3 73 825
02 Neoplasms Pleomorphic sarcoma 1768 738 156 496 0 44 439
01 Certain infectious or parasitic diseases Skin and skin-structure infection 1731 719 191 489 1 45 448
02 Neoplasms Pancreatic cancer 3075 1312 242 836 2 75 718
01 Certain infectious or parasitic diseases Influenza 2161 915 218 612 1 51 496
01 Certain infectious or parasitic diseases Postoperative inflammation 2563 1039 207 688 1 60 599
06 Mental, behavioural or neurodevelopmental disorders Mood disorder 909 480 182 267 0 24 220
05 Endocrine, nutritional or metabolic diseases Pituitary gland disorder 2136 914 196 610 1 55 491
01 Certain infectious or parasitic diseases Hepatitis virus infection 2116 904 193 604 1 52 489
24 Factors influencing health status or contact with health services Transplanted organ/tissue 1993 798 164 555 1 48 459
01 Certain infectious or parasitic diseases HIV-infected patients with tuberculosis 975 458 199 271 0 24 233
22 Injury, poisoning or certain other consequences of external causes Unspecific substance harmful effect 2013 837 158 546 0 47 504
22 Injury, poisoning or certain other consequences of external causes Unspecific body region injury 1818 799 215 531 1 47 415
20 Developmental anomalies Skeletal anomaly 664 312 112 178 1 16 117
01 Certain infectious or parasitic diseases Filariasis 1414 597 137 411 0 38 317
02 Neoplasms Liposarcoma 1622 713 163 473 1 47 379
18 Pregnancy, childbirth or the puerperium Abortion 694 314 79 204 0 13 170
02 Neoplasms Ocular cancer 706 311 92 211 0 20 156
05 Endocrine, nutritional or metabolic diseases Nutritional deficiency 1934 739 172 512 0 40 477
02 Neoplasms Nasopharyngeal cancer 2214 912 184 606 1 56 506
02 Neoplasms Chronic myelomonocytic leukaemia 1852 779 165 536 1 50 421
16 Diseases of the genitourinary system Bleeding disorder 2065 762 108 577 0 49 510
11 Diseases of the circulatory system Essential hypertension 1929 797 197 535 1 48 467
12 Diseases of the respiratory system Chronic obstructive pulmonary disease 1962 866 180 572 0 47 469
02 Neoplasms BCR-ABL1-negative chronic myeloid leukaemia 2417 969 188 664 1 57 576
05 Endocrine, nutritional or metabolic diseases Adrenomedullary hyperfunction 1035 459 140 285 1 27 262
01 Certain infectious or parasitic diseases Human immunodeficiency virus disease 1700 701 153 488 1 45 384
02 Neoplasms Esophageal cancer 1873 845 218 539 1 58 445
02 Neoplasms Urethral cancer 1627 696 160 478 1 43 375
11 Diseases of the circulatory system Coronary vasospastic disease 116 52 5 25 0 8 29
20 Developmental anomalies Fragile X chromosome 990 454 165 283 1 28 240
02 Neoplasms Metastatic liver/bile duct neoplasm 1608 707 160 469 1 47 373
10 Diseases of the ear or mastoid process Otitis externa 569 257 121 150 0 17 128
05 Endocrine, nutritional or metabolic diseases Cushing syndrome 2246 895 199 629 1 52 514
06 Mental, behavioural or neurodevelopmental disorders Anorexia nervosa 155 63 10 51 0 3 46
09 Diseases of the visual system Eyelid inflammatory disorder 167 97 48 45 1 8 16
11 Diseases of the circulatory system Coronary thrombosis 1717 612 89 462 0 40 437
14 Diseases of the skin Acquired hypermelanosis 895 355 109 253 1 26 185
05 Endocrine, nutritional or metabolic diseases Peroxisomal disease 1356 483 59 352 0 29 332
06 Mental, behavioural or neurodevelopmental disorders Cocaine use disorder 990 478 180 272 0 22 238
20 Developmental anomalies Multiple structural anomalies syndrome 1504 620 142 432 0 38 362
08 Diseases of the nervous system Ischemia 1780 761 159 518 1 45 417
08 Diseases of the nervous system Cerebral ischaemia 725 328 63 202 0 23 173
01 Certain infectious or parasitic diseases Fungal infection 2635 1039 221 722 1 69 664
08 Diseases of the nervous system Muscular atrophy 569 265 50 159 0 19 160
08 Diseases of the nervous system Motor neuron disease 1608 659 148 468 0 40 383
05 Endocrine, nutritional or metabolic diseases Vitamin deficiency 359 197 106 92 1 11 65
02 Neoplasms Digestive organ benign neoplasm 1589 641 144 449 0 40 392
01 Certain infectious or parasitic diseases Coronavirus infection 2164 875 176 599 2 53 518
05 Endocrine, nutritional or metabolic diseases Synthesis disorder 1356 483 59 352 0 29 332
02 Neoplasms Metastatic tumour 704 325 112 183 1 17 132
05 Endocrine, nutritional or metabolic diseases Thyrotoxicosis 1629 675 149 470 0 41 397
08 Diseases of the nervous system Choreiform disorder 2307 992 207 650 2 55 561
14 Diseases of the skin Skin postprocedural disorder 1561 659 157 457 1 41 355
05 Endocrine, nutritional or metabolic diseases Ovarian dysfunction 1696 734 166 496 1 49 391
01 Certain infectious or parasitic diseases Parasitic worm infestation 1990 821 156 542 0 47 491
15 Diseases of the musculoskeletal system or connective tissue Gout 2124 892 190 613 1 49 508
02 Neoplasms Bone/articular cartilage neoplasm 1673 687 153 478 1 44 381
16 Diseases of the genitourinary system Prostate hyperplasia 1247 570 148 365 1 37 312
09 Diseases of the visual system Degenerative high myopia 176 104 49 46 1 8 23
02 Neoplasms Ureteral cancer 891 360 112 252 1 27 188
16 Diseases of the genitourinary system Male infertility 913 450 196 260 1 22 170
14 Diseases of the skin Epidermal dysplasias 1495 612 140 430 0 38 361
01 Certain infectious or parasitic diseases Sepsis 1325 619 214 393 1 40 315
06 Mental, behavioural or neurodevelopmental disorders Psychoactive substances use disorder 188 108 33 42 0 8 54
20 Developmental anomalies Intellectual development disorder 270 158 39 77 0 11 74
02 Neoplasms Leiomyosarcoma 1516 628 144 438 0 38 365
04 Diseases of the immune system Vasculitis 300 139 21 83 0 6 64
02 Neoplasms Follicular lymphoma 1789 759 198 515 0 43 416
11 Diseases of the circulatory system Diabetic foot ulcer 1762 757 163 521 1 44 406
11 Diseases of the circulatory system Ischemic heart disease 1592 688 211 460 0 40 378
01 Certain infectious or parasitic diseases Gonococcal infection 416 185 74 118 0 14 90
02 Neoplasms Hypopharyngeal cancer 1603 682 157 469 1 43 369
05 Endocrine, nutritional or metabolic diseases Lysosomal disease 296 115 23 95 0 5 71
16 Diseases of the genitourinary system Menstrual cycle bleeding disorder 687 326 112 184 1 16 123
02 Neoplasms Synovial sarcoma 1489 611 140 429 0 38 360
16 Diseases of the genitourinary system Kidney failure 1594 698 161 467 1 47 370
09 Diseases of the visual system Hyperaemia 171 90 27 48 0 7 42
01 Certain infectious or parasitic diseases Herpes simplex infection 767 411 190 223 0 18 190
08 Diseases of the nervous system Central and peripheral nervous disease 65 43 11 17 0 4 23
21 Symptoms, signs or clinical findings, not elsewhere classified Cardiac arrest 405 242 191 104 0 17 97
11 Diseases of the circulatory system Cardiac arrhythmia 293 154 24 98 0 8 70
11 Diseases of the circulatory system Arteries/arterioles disorder 568 363 178 157 0 21 114
09 Diseases of the visual system Extraocular muscle disorder 1485 610 140 429 0 38 359
13 Diseases of the digestive system Duodenal ulcer 1722 699 147 482 1 42 408
02 Neoplasms Metastatic malignant neoplasm 1486 611 140 430 0 38 359
21 Symptoms, signs or clinical findings, not elsewhere classified Somnolence 96 56 12 30 0 3 31
05 Endocrine, nutritional or metabolic diseases Mineral deficiency 1861 761 161 531 1 46 439
02 Neoplasms Breast in situ carcinoma 956 457 198 256 1 23 200
05 Endocrine, nutritional or metabolic diseases Amyloidosis 992 468 183 289 0 29 253
18 Pregnancy, childbirth or the puerperium Postpartum haemorrhage 396 264 179 116 0 14 93
15 Diseases of the musculoskeletal system or connective tissue Soft tissue disorder 302 218 184 83 0 15 64
22 Injury, poisoning or certain other consequences of external causes Spine/trunk injury 185 102 71 38 0 6 46
16 Diseases of the genitourinary system Female infertility 671 317 113 180 1 16 118
02 Neoplasms Metastatic digestive system neoplasm 1517 629 143 437 0 38 365
16 Diseases of the genitourinary system Functional bladder disorder 265 132 27 65 0 12 77
13 Diseases of the digestive system Liver disease 1577 677 191 465 0 40 373
08 Diseases of the nervous system Acquired prion disease 661 311 112 175 1 16 115
06 Mental, behavioural or neurodevelopmental disorders Dissociative neurological symptom disorder 397 241 141 99 0 16 86
01 Certain infectious or parasitic diseases Common warts 416 185 74 118 0 14 90
11 Diseases of the circulatory system Orthostatic hypotension 701 392 167 194 0 17 175
07 Sleep-wake disorders Restless legs syndrome 190 103 32 52 0 7 48
05 Endocrine, nutritional or metabolic diseases Carcinoid syndrome 1558 662 147 452 0 42 355
14 Diseases of the skin Skin tag/polyp 773 369 76 229 1 14 168
21 Symptoms, signs or clinical findings, not elsewhere classified Skin sensation disturbance 182 128 127 32 0 10 34
04 Diseases of the immune system Allergic/hypersensitivity disorder 1145 522 186 326 0 27 288
08 Diseases of the nervous system Encephalopathy 1885 767 161 535 1 46 449
11 Diseases of the circulatory system Hypotension 421 222 46 135 0 18 105
23 External causes of morbidity or mortality Ophthalmic devices/implants/grafts injury 595 237 38 165 0 16 128
05 Endocrine, nutritional or metabolic diseases Alpha-1-antitrypsin deficiency 143 111 127 25 0 8 22
20 Developmental anomalies Sex development malformative disorder 104 62 15 38 0 6 33
14 Diseases of the skin Acquired hypomelanotic disorder 1499 641 149 437 2 34 322
14 Diseases of the skin Skin disease 179 105 49 49 1 8 19
03 Diseases of the blood or blood-forming organs Thrombocytosis 175 81 14 51 0 5 43
02 Neoplasms Colon cancer 1794 741 167 524 1 47 409
18 Pregnancy, childbirth or the puerperium Preterm labour/delivery 56 32 6 18 0 4 15
11 Diseases of the circulatory system Cardiomyopathy 981 433 76 293 0 22 257
06 Mental, behavioural or neurodevelopmental disorders Mental/behavioural/neurodevelopmental disorder 280 170 137 65 1 13 65
16 Diseases of the genitourinary system Urinary system disease 344 154 27 88 0 8 84
08 Diseases of the nervous system Hydrocephalus 157 89 17 38 0 9 36
11 Diseases of the circulatory system Supraventricular tachyarrhythmia 434 204 34 142 0 11 105
14 Diseases of the skin Alopecia 89 57 13 33 0 2 26
13 Diseases of the digestive system Peptic ulcer 85 62 15 28 0 4 34
06 Mental, behavioural or neurodevelopmental disorders Bulimia nervosa 179 103 26 54 0 10 44
02 Neoplasms Kaposi sarcoma 517 235 76 151 0 19 115
08 Diseases of the nervous system Ataxic disorder 276 129 26 73 1 7 63
13 Diseases of the digestive system Hepatic fibrosis/cirrhosis 793 421 179 238 0 25 200
21 Symptoms, signs or clinical findings, not elsewhere classified Abnormal micturition 87 57 12 23 0 3 26
05 Endocrine, nutritional or metabolic diseases Adrenocortical insufficiency 56 34 5 20 0 1 15
06 Mental, behavioural or neurodevelopmental disorders Opioid use disorder 385 207 30 121 0 15 113
01 Certain infectious or parasitic diseases Syphilis 416 185 74 118 0 14 90
16 Diseases of the genitourinary system Vaginitis 661 311 112 175 1 16 115
12 Diseases of the respiratory system Respiratory system disease 525 251 87 151 0 18 134
06 Mental, behavioural or neurodevelopmental disorders Cannabis use disorder 491 231 70 156 0 17 132
02 Neoplasms Lip/oral cavity/pharynx neoplasm 1608 707 160 469 1 47 373
09 Diseases of the visual system Visual system disease 119 49 13 33 0 5 29
05 Endocrine, nutritional or metabolic diseases Inborn carbohydrate metabolism error 25 13 5 10 0 0 11
23 External causes of morbidity or mortality Intentional self-harm 60 35 6 20 0 4 20
06 Mental, behavioural or neurodevelopmental disorders Primary psychotic disorder manifestation 518 232 61 145 1 12 95
12 Diseases of the respiratory system Lymphangioleiomyomatosis 269 143 26 72 0 9 55
13 Diseases of the digestive system Pancreatitis 71 47 10 22 0 2 25
06 Mental, behavioural or neurodevelopmental disorders Nicotine use disorder 689 398 203 214 0 20 182
21 Symptoms, signs or clinical findings, not elsewhere classified Faecal incontinence 173 92 27 49 0 7 43
08 Diseases of the nervous system Neurobehavioral disorder 160 118 71 39 0 7 50
06 Mental, behavioural or neurodevelopmental disorders Unspecific substance use disorder 279 157 25 97 0 7 68
02 Neoplasms Adrenal cancer 717 334 118 187 1 17 132
21 Symptoms, signs or clinical findings, not elsewhere classified Breathing abnormality 205 106 31 59 0 8 53
04 Diseases of the immune system Sjogren syndrome 110 78 9 38 0 1 47
02 Neoplasms Ewing sarcoma 747 297 52 226 0 19 193
20 Developmental anomalies Eye anterior segment structural developmental anomaly 275 135 26 76 0 6 64
21 Symptoms, signs or clinical findings, not elsewhere classified Spinal pain 620 280 54 149 0 18 147
02 Neoplasms Mycosis fungoides 393 226 175 92 1 14 102
14 Diseases of the skin Dystrophic epidermolysis bullosa 423 256 166 127 0 15 105
11 Diseases of the circulatory system Hypertensive crisis 46 24 5 13 0 2 9
16 Diseases of the genitourinary system Dyspareunia 664 313 112 177 1 16 115
02 Neoplasms Endocrine gland neoplasm 171 90 27 48 0 7 42
21 Symptoms, signs or clinical findings, not elsewhere classified Bowel habit change 128 61 6 31 0 9 30
08 Diseases of the nervous system Radiculopathy 11 7 1 4 0 0 4
15 Diseases of the musculoskeletal system or connective tissue Juvenile idiopathic arthritis 134 72 25 38 0 11 34
21 Symptoms, signs or clinical findings, not elsewhere classified Non-specific cutaneous vascular sympton 104 57 8 27 0 2 28
03 Diseases of the blood or blood-forming organs Christmas disease 153 53 6 49 0 5 37
02 Neoplasms Uterine fibroid 346 227 176 99 0 15 69
21 Symptoms, signs or clinical findings, not elsewhere classified Joint pain 341 151 27 87 0 8 82
05 Endocrine, nutritional or metabolic diseases Inborn porphyrin/heme metabolism error 181 99 29 53 0 7 44
08 Diseases of the nervous system Epileptic encephalopathy 83 62 10 25 0 2 34
02 Neoplasms Desmoid tumour 420 253 165 126 0 15 104
02 Neoplasms Mammary tumour 49 28 6 16 0 1 14
21 Symptoms, signs or clinical findings, not elsewhere classified Cognition symptoms/signs/clinical sympton 34 27 6 10 0 1 16
13 Diseases of the digestive system Stomach disease 80 68 71 8 0 5 16
11 Diseases of the circulatory system Circulatory system disease 29 12 3 9 0 2 7
05 Endocrine, nutritional or metabolic diseases Type-1/2 diabete 355 132 30 107 0 6 85
13 Diseases of the digestive system Gastroduodenal motor/secretory disorder 225 115 33 56 0 10 64
15 Diseases of the musculoskeletal system or connective tissue Muscle disorder 94 60 14 30 0 2 32
14 Diseases of the skin Contact dermatitis 167 97 48 45 1 8 16
13 Diseases of the digestive system Gastro-oesophageal reflux disease 1370 574 141 402 0 40 316
05 Endocrine, nutritional or metabolic diseases Adrenogenital disorder 186 103 72 38 0 7 46
14 Diseases of the skin Prurigo 34 13 1 6 0 2 12
14 Diseases of the skin Sebaceous gland disorder 52 41 8 12 0 1 23
02 Neoplasms Anal cancer 15 9 0 4 0 1 4
21 Symptoms, signs or clinical findings, not elsewhere classified Gangrene 171 90 27 48 0 7 42
02 Neoplasms Metastatic meninges neoplasm 6 3 0 3 0 0 2
04 Diseases of the immune system Adaptive immunity immunodeficiency 273 157 80 70 0 11 75
11 Diseases of the circulatory system Ventricular tachyarrhythmia 44 22 4 11 0 3 14
02 Neoplasms Malignant intestine neoplasm 111 46 6 30 0 6 28
06 Mental, behavioural or neurodevelopmental disorders Binge eating disorder 137 98 78 21 0 9 37
04 Diseases of the immune system Systemic sclerosis 2312 992 203 668 1 58 555
11 Diseases of the circulatory system Aneurysm/dissection 66 34 11 19 0 3 16
14 Diseases of the skin Cutaneous lupus erythematosus 188 86 14 63 0 3 54
13 Diseases of the digestive system Liver vascular disorder 20 12 2 12 0 1 12
01 Certain infectious or parasitic diseases Itching 171 90 27 48 0 7 42
20 Developmental anomalies CNS anomalies syndrome 4 4 2 0 0 1 0
13 Diseases of the digestive system Digestive system disease 250 137 34 69 0 9 70
21 Symptoms, signs or clinical findings, not elsewhere classified Urinary system clinical sympton 20 9 3 6 1 1 3
22 Injury, poisoning or certain other consequences of external causes Intrathoracic organs injury 20 12 2 7 0 0 2
04 Diseases of the immune system Immune system disease 70 49 5 24 0 2 26
12 Diseases of the respiratory system Nasopharyngitis 166 102 27 70 0 10 35
17 Conditions related to sexual health Ejaculatory dysfunction 203 127 80 44 0 13 50
20 Developmental anomalies Skin/mucosal anomaly 125 65 22 34 0 9 30
13 Diseases of the digestive system Dental disease 27 20 7 11 0 4 9
05 Endocrine, nutritional or metabolic diseases Hypo-osmolality/hyponatraemia 66 42 6 24 0 1 20
09 Diseases of the visual system Macular degeneration 1718 735 211 494 1 45 398
08 Diseases of the nervous system Dystonic disorder 85 59 13 23 0 4 28
13 Diseases of the digestive system Autoimmune liver disease 42 29 16 8 0 2 14
07 Sleep-wake disorders Sleep-related breathing disorder 23 9 3 5 0 2 5
14 Diseases of the skin Hyperhidrosis 78 61 15 27 0 3 30
21 Symptoms, signs or clinical findings, not elsewhere classified concerning food/fluid intake symptom 85 69 63 12 0 6 22
11 Diseases of the circulatory system Venous thromboembolism 160 59 6 53 0 5 37
03 Diseases of the blood or blood-forming organs Blood-forming organ disease 202 83 11 65 0 7 52
02 Neoplasms Basal cell carcinoma 286 207 174 80 0 11 52
13 Diseases of the digestive system Gastric ulcer 53 43 8 16 0 1 19
09 Diseases of the visual system Nystagmus 34 27 6 10 0 1 16
21 Symptoms, signs or clinical findings, not elsewhere classified Abdominal pelvic pain 200 158 139 48 0 8 43
09 Diseases of the visual system Conjunctiva disorder 47 27 8 20 0 3 12
08 Diseases of the nervous system Brain disease 44 30 7 11 0 1 20
01 Certain infectious or parasitic diseases Zoster 77 31 8 21 0 2 16
01 Certain infectious or parasitic diseases Infectious gastroenteritis/colitis 34 27 6 10 0 1 16
02 Neoplasms Neuroendocrine carcinoma 173 101 27 59 0 7 56
13 Diseases of the digestive system Gastritis 34 27 6 10 0 1 16
08 Diseases of the nervous system Central nervous system disease 492 312 157 157 0 21 117
04 Diseases of the immune system Idiopathic inflammatory myopathy 43 7 0 12 0 1 9
22 Injury, poisoning or certain other consequences of external causes Intracranial injury 105 80 71 17 0 6 24
07 Sleep-wake disorders Circadian rhythm sleep disorder 153 122 128 26 0 8 23
08 Diseases of the nervous system Lower limb mononeuropathy 91 33 9 23 0 3 24
01 Certain infectious or parasitic diseases Dengue fever 21 15 3 8 0 1 1
13 Diseases of the digestive system Oesophagus motility disorder 34 27 6 10 0 1 16
13 Diseases of the digestive system Large intestine motility disorder 38 16 1 6 0 2 13
02 Neoplasms B-cell lymphoma 47 29 8 17 0 2 7
05 Endocrine, nutritional or metabolic diseases Testicular dysfunction 49 28 6 16 0 1 14
21 Symptoms, signs or clinical findings, not elsewhere classified Appearance/behaviour symptom 34 27 6 10 0 1 16
05 Endocrine, nutritional or metabolic diseases Insulin-resistance syndrome 15 10 1 8 0 1 2
22 Injury, poisoning or certain other consequences of external causes Eexposure to noxious substances harmful effect 47 23 2 9 0 1 7
08 Diseases of the nervous system Tension-type headache 474 207 46 146 0 22 117
13 Diseases of the digestive system Alcoholic liver disease 54 33 6 20 0 1 14
02 Neoplasms Thymoma 89 50 13 27 0 5 20
11 Diseases of the circulatory system Raynaud phenomenon 12 10 0 7 0 0 0
11 Diseases of the circulatory system Conduction disorder 25 10 3 6 0 2 5
08 Diseases of the nervous system Focal/segmental autonomic disorder 123 63 25 32 0 4 25
08 Diseases of the nervous system Trigeminal nerve disorder 9 5 0 3 0 0 2
21 Symptoms, signs or clinical findings, not elsewhere classified Dyspepsia 43 27 16 7 0 5 9
05 Endocrine, nutritional or metabolic diseases Hyper-parathyroidism 7 3 1 2 0 0 5
13 Diseases of the digestive system Pancreatic malfunction 1 1 0 0 0 0 0
14 Diseases of the skin Dermal/subcutaneous connective tissue atrophy/degeneration 23 9 3 5 0 2 5
05 Endocrine, nutritional or metabolic diseases Mineral excesses 1 1 1 0 0 1 0
15 Diseases of the musculoskeletal system or connective tissue Bone paget disease 39 25 8 16 0 2 8
21 Symptoms, signs or clinical findings, not elsewhere classified Blood/blood-forming organ sympton 29 17 6 10 0 1 3
01 Certain infectious or parasitic diseases Sexually transmitted infection 3 1 1 1 0 1 0
04 Diseases of the immune system Innate/adaptive immunodeficiency 17 12 0 8 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Cachexia 34 19 12 7 0 3 8
14 Diseases of the skin Pemphigus 11 4 0 4 0 0 2
26 Supplementary Chapter Traditional Medicine Conditions - Module I Morning sickness disorder 22 12 5 10 0 1 7
10 Diseases of the ear or mastoid process Episodic vestibular syndrome 23 12 5 10 0 1 8
11 Diseases of the circulatory system Genetic cardiac arrhythmia 10 6 0 3 0 0 3
05 Endocrine, nutritional or metabolic diseases Acidosis 77 27 4 19 0 0 13
08 Diseases of the nervous system Subarachnoid haemorrhage 46 17 4 9 1 1 9
09 Diseases of the visual system Anterior uveitis 253 175 170 55 0 10 61
24 Factors influencing health status or contact with health services General examination 34 27 6 10 0 1 16
13 Diseases of the digestive system Cholelithiasis 277 104 21 84 0 13 73
16 Diseases of the genitourinary system Prostate disease 3 2 0 1 0 0 0
02 Neoplasms Hodgkin lymphoma 334 233 177 95 0 15 73
14 Diseases of the skin Spontaneous urticaria 9 3 0 3 0 0 2
05 Endocrine, nutritional or metabolic diseases Inborn energy metabolism error 5 4 2 1 0 1 1
02 Neoplasms Urogenital cancer 66 31 8 19 0 4 22
04 Diseases of the immune system Behcet disease 1 1 0 0 0 0 1
20 Developmental anomalies Overgrowth syndrome 2 1 0 1 0 0 1
16 Diseases of the genitourinary system Cystic/dysplastic kidney disease 6 3 0 3 0 0 2
14 Diseases of the skin Pyoderma gangrenosum 1 0 0 0 0 0 0
16 Diseases of the genitourinary system Genitourinary disease 1 0 0 1 0 0 1
08 Diseases of the nervous system Movement disorder 194 157 170 41 0 10 36
05 Endocrine, nutritional or metabolic diseases Pancreatic internal secretion disorder 3 1 0 1 0 0 1
13 Diseases of the digestive system Pancreas disease 3 3 1 2 0 1 0
15 Diseases of the musculoskeletal system or connective tissue Musculoskeletal system/connective tissue disease 24 8 2 7 0 3 6
14 Diseases of the skin Extremities vasodilatation 9 5 0 3 0 0 2
01 Certain infectious or parasitic diseases Infectious meningitis 1 1 0 1 0 0 0
20 Developmental anomalies Gallbladder/bile ducts/liver structural developmental anomaly 39 23 6 12 0 4 15
09 Diseases of the visual system Vitreoretinopathy 40 22 1 9 0 0 7
13 Diseases of the digestive system Coeliac disease 2815 1171 246 775 3 65 682
12 Diseases of the respiratory system Emphysema 10 8 3 5 0 2 4
01 Certain infectious or parasitic diseases Viral encephalitis 2 1 0 1 0 0 0
20 Developmental anomalies Premature ageing appearance 2 0 0 1 0 0 0
15 Diseases of the musculoskeletal system or connective tissue Musculoskeletal disorder 9 5 0 3 0 0 2
15 Diseases of the musculoskeletal system or connective tissue Muscle calcification/ossification 2 1 0 1 0 0 0
20 Developmental anomalies Hair/hair growth developmental defect 2 1 0 0 0 0 0
11 Diseases of the circulatory system Coronary microvascular disease 1 0 0 1 0 0 1
01 Certain infectious or parasitic diseases Kinetoplastids 2 1 0 1 0 0 0
18 Pregnancy, childbirth or the puerperium Pregnancy/childbirth/puerperium maternal infection 180 92 40 44 0 10 51
23 External causes of morbidity or mortality Medical/surgical procedure injury 4 3 1 3 0 0 4
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic skin disorder 2 2 0 1 0 1 0
05 Endocrine, nutritional or metabolic diseases Hypo-glycaemia 2 0 0 1 0 0 1
11 Diseases of the circulatory system Pulmonary thromboembolism 1 1 0 0 0 0 0
12 Diseases of the respiratory system Acute laryngitis/tracheitis 1 0 0 1 0 0 1
12 Diseases of the respiratory system Acute bronchitis 1 0 0 0 0 0 0
01 Certain infectious or parasitic diseases Toxoplasmosis 1 0 0 0 0 0 0
14 Diseases of the skin Nail/perionychium infection 1 1 0 1 0 0 0
05 Endocrine, nutritional or metabolic diseases Hypo-parathyroidism 2 1 0 0 0 0 0
02 Neoplasms Rectum cancer 641 369 195 179 1 17 125
13 Diseases of the digestive system Oral mucositis 371 230 187 96 0 16 81
09 Diseases of the visual system Retinal vascular occlusion 286 188 180 76 0 12 62
04 Diseases of the immune system Neutropenia 108 81 30 42 0 3 30
11 Diseases of the circulatory system Secondary hypertension 1 1 0 1 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Heart beat abnormality 4 2 0 2 0 0 2
21 Symptoms, signs or clinical findings, not elsewhere classified Dizziness and giddiness 1 1 0 1 0 0 0
14 Diseases of the skin Urticaria 3 1 0 2 0 0 0
01 Certain infectious or parasitic diseases Staphylococcal/streptococcal disease 6 3 1 1 0 1 2
09 Diseases of the visual system Light sensitivity impairment 2 1 0 1 0 0 0
01 Certain infectious or parasitic diseases Onchocerciasis 1 1 0 1 0 0 0
03 Diseases of the blood or blood-forming organs Folate deficiency anaemia 1 0 0 0 0 0 0
22 Injury, poisoning or certain other consequences of external causes Intracranial injury, unspecified 355 203 63 124 0 15 90
22 Injury, poisoning or certain other consequences of external causes Injury of spinal cord, level unspecified 157 103 39 44 0 4 46
20 Developmental anomalies Angelman syndrome 27 20 13 6 0 1 7
09 Diseases of the visual system Impairment of binocular functions 98 51 23 19 0 4 25
14 Diseases of the skin Albinism or other specified genetically-determined hypomelanotic disorders 24 17 13 4 0 1 6
X Extension Codes Actinic keratosis 244 143 29 86 0 10 58
14 Diseases of the skin Oculocutaneousalbinism 24 17 13 4 0 1 6
21 Symptoms, signs or clinical findings, not elsewhere classified Aphasia 24 17 13 4 0 1 6
08 Diseases of the nervous system Amyotrophic lateral sclerosis 293 193 112 70 0 9 72
01 Certain infectious or parasitic diseases Giardiasis 57 30 2 18 0 1 8
X Extension Codes Septic shock 556 346 197 176 0 25 134
03 Diseases of the blood or blood-forming organs Congenital aplastic anaemia 1323 552 132 390 0 35 303
11 Diseases of the circulatory system coronary artery disease 1910 826 211 558 1 50 444
02 Neoplasms Malignant neoplasms of other or unspecified parts of mouth 1377 582 136 407 0 38 319
02 Neoplasms Adenocarcinoma of prostate 2807 1162 240 796 2 64 671
13 Diseases of the digestive system Columnar metaplastic epithelium of the oesophagus, unspecified 127 57 14 41 0 6 28
02 Neoplasms Malignant lymphoma, not elsewhere classified 456 280 192 133 0 18 110
16 Diseases of the genitourinary system Disorders of calcium or phosphate excretion 40 22 5 15 0 0 7
20 Developmental anomalies Complete trisomy 21 104 46 9 35 0 5 24
08 Diseases of the nervous system Multiple system atrophy 127 65 12 43 0 6 28
08 Diseases of the nervous system Relapsing-remitting multiple sclerosis 267 136 35 80 0 10 71
02 Neoplasms Malignant neoplasms of bladder, unspecified 598 358 194 180 1 20 123
04 Diseases of the immune system DNA repair defects other than combined T-cell or B-cell immunodeficiencies 41 23 6 15 0 1 7
02 Neoplasms Ductal carcinoma in situ of breast 186 94 30 58 0 10 45
08 Diseases of the nervous system Friedreich ataxia 256 144 27 95 0 6 47
02 Neoplasms Chronic lymphocytic leukaemia or small lymphocytic lymphoma 381 202 37 130 0 9 101
12 Diseases of the respiratory system Idiopathic pulmonary fibrosis 1347 611 142 389 2 40 322
02 Neoplasms Leukaemia 303 166 44 100 0 12 93
18 Pregnancy, childbirth or the puerperium Pre-eclampsia 2010 855 220 603 2 48 468
08 Diseases of the nervous system Duchenne muscular dystrophy 460 254 148 140 0 18 105
13 Diseases of the digestive system Obstruction of bile duct 215 159 140 59 0 8 35
16 Diseases of the genitourinary system Acute kidney failure, stage unspecified 92 48 13 26 0 2 20
08 Diseases of the nervous system Huntington disease 471 267 181 122 0 17 102
02 Neoplasms Malignant neoplasms of nasopharynx 196 103 19 66 0 10 51
14 Diseases of the skin Freckles 313 144 34 99 0 7 60
08 Diseases of the nervous system Becker muscular dystrophy 547 227 53 167 0 15 124
11 Diseases of the circulatory system Atrial fibrillation 2538 1038 229 731 3 61 583
21 Symptoms, signs or clinical findings, not elsewhere classified Haemorrhage, not elsewhere classified 409 250 176 107 0 18 105
05 Endocrine, nutritional or metabolic diseases Type1diabetesmellitus 691 382 196 198 0 25 167
X Extension Codes Dysplastic naevus 400 142 14 109 0 12 96
16 Diseases of the genitourinary system Other or unspecified ovarian cysts 2 2 0 1 0 0 1
12 Diseases of the respiratory system Pneumonia due to Respiratory syncytial virus 12 8 2 2 0 1 6
06 Mental, behavioural or neurodevelopmental disorders Unknown or unspecified psychoactive substance dependence, substance and state of remission unspecified 44 33 16 14 0 4 16
13 Diseases of the digestive system Primary sclerosing cholangitis 730 278 33 214 0 18 181
13 Diseases of the digestive system Disorders of oral mucosa 27 11 1 5 0 2 9
22 Injury, poisoning or certain other consequences of external causes Injury of lung, unspecified 274 197 176 77 0 13 56
12 Diseases of the respiratory system Bronchitis 22 8 1 5 0 2 6
20 Developmental anomalies Anomalies of pupillary function 2 2 0 1 0 0 1
01 Certain infectious or parasitic diseases Severe acute respiratory syndrome 575 321 186 154 1 16 105
08 Diseases of the nervous system Carpal tunnel syndrome 3935 1593 257 1041 3 87 956
11 Diseases of the circulatory system Ischaemic heart diseases, unspecified 735 394 196 210 0 21 167
20 Developmental anomalies Spina bifida, unspecified 316 184 168 71 0 13 69
02 Neoplasms Primary neoplasms of brain 233 155 149 57 0 13 52
02 Neoplasms Malignant neoplasm of pancreas, unspecified 586 359 196 183 1 22 142
06 Mental, behavioural or neurodevelopmental disorders Single episode depressive disorder, severe, without psychotic symptoms 431 264 185 124 0 17 106
02 Neoplasms Myelofibrosis 253 190 186 70 0 12 48
05 Endocrine, nutritional or metabolic diseases Beriberi 96 79 89 8 0 4 20
X Extension Codes Astrocytoma, anaplastic 299 198 176 78 0 12 61
X Extension Codes Oligodendroglioma, anaplastic 387 240 179 118 0 19 79
20 Developmental anomalies Structural developmental anomaly of heart or great vessels, unspecified 436 238 150 128 0 18 94
18 Pregnancy, childbirth or the puerperium Mild hyperemesis gravidarum 222 161 174 47 0 12 44
16 Diseases of the genitourinary system Recurrent pregnancy loss 226 155 167 48 0 9 45
X Extension Codes Sezary syndrome 301 193 172 68 0 11 76
12 Diseases of the respiratory system Respiratory failure 289 205 180 76 0 12 68
02 Neoplasms Peripheral T-cell lymphoma, not otherwise specified 257 172 169 55 0 10 55
20 Developmental anomalies Cleft palate 223 151 167 45 0 9 45
08 Diseases of the nervous system Infantile spasms 188 151 170 39 0 9 32
21 Symptoms, signs or clinical findings, not elsewhere classified Flushing 273 178 180 67 0 12 60
X Extension Codes Anaplastic large cell lymphoma, NOS 282 185 172 63 0 10 61
22 Injury, poisoning or certain other consequences of external causes Burn and burn infection 249 183 177 66 0 12 54
14 Diseases of the skin Melasma 244 137 135 51 0 10 60
01 Certain infectious or parasitic diseases Other specified infectious meningitis not elsewhere classified 227 156 167 49 0 9 45
20 Developmental anomalies Cleft lip 220 150 167 44 0 9 45
05 Endocrine, nutritional or metabolic diseases Argininosuccinic aciduria 223 133 134 48 0 10 50
20 Developmental anomalies Duplications of the short arm of chromosome 17 217 169 173 56 0 11 40
05 Endocrine, nutritional or metabolic diseases Mixed hyperlipidaemia 377 227 180 98 0 12 82
19 Certain conditions originating in the perinatal period Preterm newborn, unspecified 423 245 146 102 0 17 100
X Extension Codes Carcinoma of male breast 288 180 140 71 0 11 56
09 Diseases of the visual system Retinopathy of prematurity 429 241 140 105 0 17 100
08 Diseases of the nervous system Cerebrovascular diseases, unspecified 316 208 188 84 0 14 69
X Extension Codes Glioblastoma, primary, NOS 936 515 211 285 0 32 253
08 Diseases of the nervous system Hereditary sensory or autonomic neuropathy, unspecified 231 179 173 60 0 11 43
X Extension Codes Glioma, malignant 688 379 195 222 1 22 169
03 Diseases of the blood or blood-forming organs Beta thalassaemia 313 203 187 84 0 13 70
11 Diseases of the circulatory system Atherosclerotic chronic arterial occlusive disease, unspecified 273 178 180 67 0 12 60
X Extension Codes Hepatocellular carcinoma, NOS 453 290 163 133 0 14 110
15 Diseases of the musculoskeletal system or connective tissue Disorders of muscles, unspecified 228 178 174 63 0 12 46
X Extension Codes Ependymoma, NOS 192 146 139 46 0 8 31
12 Diseases of the respiratory system Pulmonary alveolar proteinosis 301 210 188 80 0 12 61
02 Neoplasms Small cell carcinoma of bronchus or lung 360 212 155 96 0 17 90
05 Endocrine, nutritional or metabolic diseases Vitamin C deficiency, unspecified 217 169 173 56 0 11 40
02 Neoplasms Malignant neoplasms of retroperitoneum 378 224 174 90 0 14 83
01 Certain infectious or parasitic diseases Tuberculosis of the respiratory system 277 177 178 66 0 12 61
10 Diseases of the ear or mastoid process Noise effects on inner ear 161 128 137 39 0 7 26
13 Diseases of the digestive system Temporomandibular joint disorders 257 202 177 77 0 12 59
02 Neoplasms Inflammatory carcinoma of breast 246 170 145 61 0 12 50
22 Injury, poisoning or certain other consequences of external causes Harmful effects of drugs, medicaments or biological substances, not elsewhere classified 299 195 172 77 0 12 59
20 Developmental anomalies Other specified syndromes with multiple structural anomalies, not of environmental origin 193 154 169 42 0 9 32
X Extension Codes Polycythaemia vera 225 176 173 62 0 11 40
19 Certain conditions originating in the perinatal period Other specified haemorrhagic or haematological disorders of fetus or newborn 67 50 52 7 0 4 17
11 Diseases of the circulatory system Asymptomatic stenosis of intracranial or extracranial artery 333 221 188 94 0 14 69
11 Diseases of the circulatory system Aortic valve stenosis 280 184 180 71 0 12 60
X Extension Codes Gliosarcoma 333 214 178 88 0 15 71
13 Diseases of the digestive system Alcoholic hepatitis 226 136 135 52 0 10 51
21 Symptoms, signs or clinical findings, not elsewhere classified Complex regional pain syndrome 226 177 175 60 0 12 46
02 Neoplasms Melanoma of skin, unspecified 272 189 146 73 0 12 52
01 Certain infectious or parasitic diseases Infectious gastroenteritis or colitis without specification of infectious agent 292 186 172 74 0 11 68
21 Symptoms, signs or clinical findings, not elsewhere classified Asphyxia 367 254 181 106 0 14 70
02 Neoplasms Neoplasms of unknown behaviour of urinary organs 254 150 58 73 1 12 44
11 Diseases of the circulatory system Acute myocardial infarction 412 250 148 122 0 13 88
X Extension Codes Craniopharyngioma 157 124 136 35 0 7 25
02 Neoplasms Malignant neoplasm metastasis in male genital organs 238 177 174 65 0 11 47
11 Diseases of the circulatory system Macro reentrant atrial tachycardia, unspecified 218 170 173 56 0 11 40
02 Neoplasms Carcinomas of ovary 260 174 147 65 0 12 56
21 Symptoms, signs or clinical findings, not elsewhere classified Shock 249 183 175 65 0 13 47
X Extension Codes Rhabdomyosarcoma, NOS 195 146 140 47 0 8 34
05 Endocrine, nutritional or metabolic diseases Galactose-1-phosphate uridyltransferase deficiency 221 132 134 47 0 10 50
X Extension Codes Clear cell renal cell carcinoma, NOS 225 171 173 58 0 11 42
05 Endocrine, nutritional or metabolic diseases Diabetic lactic acidosis 219 158 172 47 0 12 44
14 Diseases of the skin Unspecified adverse cutaneous reactions to medication 40 26 21 11 0 2 10
08 Diseases of the nervous system Hereditary sensory and autonomic neuropathy type I 91 73 74 16 0 2 19
09 Diseases of the visual system Pterygium 23 13 4 9 0 1 10
X Extension Codes Acute promyelocytic leukaemia 224 173 173 57 0 11 41
02 Neoplasms Malignant neoplasm metastasis, unspecified 193 97 20 56 0 7 59
16 Diseases of the genitourinary system Nephritic syndrome 220 114 24 68 0 5 44
06 Mental, behavioural or neurodevelopmental disorders Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional language 137 54 16 35 0 5 30
22 Injury, poisoning or certain other consequences of external causes Fracture of unspecified body region 45 25 8 14 0 4 16
11 Diseases of the circulatory system Ventricular tachycardia 255 136 19 89 0 6 65
19 Certain conditions originating in the perinatal period Neonatal withdrawal syndrome from maternal use of drugs of addiction 24 9 1 4 0 2 8
20 Developmental anomalies Hypospadias 82 58 20 29 0 5 31
15 Diseases of the musculoskeletal system or connective tissue Rotator cuff syndrome 27 12 3 5 0 2 8
11 Diseases of the circulatory system Ventricular fibrillation 24 9 2 5 0 2 5
05 Endocrine, nutritional or metabolic diseases Disorders of cholesterol synthesis 130 47 14 29 0 5 27
15 Diseases of the musculoskeletal system or connective tissue Scoliosis 24 9 1 4 0 2 8
21 Symptoms, signs or clinical findings, not elsewhere classified Renal colic 24 9 1 4 0 2 8
08 Diseases of the nervous system Other specified disorders of the nervous system 24 9 1 4 0 2 8
02 Neoplasms Benign smooth muscle or skeletal muscle tumour 19 6 1 4 0 2 5
02 Neoplasms Other specified benign neoplasm of endocrine glands 19 6 1 4 0 2 5
02 Neoplasms Neoplasms of unknown behaviour of skin 19 6 1 4 0 2 5
06 Mental, behavioural or neurodevelopmental disorders Opioid dependence, unspecified 27 12 1 6 0 2 9
04 Diseases of the immune system Anaphylaxis 19 6 1 4 0 2 5
22 Injury, poisoning or certain other consequences of external causes Fractures involving multiple body regions 24 9 1 4 0 2 8
13 Diseases of the digestive system Appendicitis 20 7 1 5 0 2 6
21 Symptoms, signs or clinical findings, not elsewhere classified Dyspnoea 89 36 6 16 0 4 23
08 Diseases of the nervous system Diseases of the musculoskeletal system or connective tissue 24 9 1 4 0 2 8
21 Symptoms, signs or clinical findings, not elsewhere classified Retention of urine 29 12 2 5 0 2 10
12 Diseases of the respiratory system Other specified acute tonsillitis 32 15 2 8 0 3 8
21 Symptoms, signs or clinical findings, not elsewhere classified Other specified abnormalities of breathing 19 6 1 4 0 2 5
21 Symptoms, signs or clinical findings, not elsewhere classified Haemoptysis 19 6 1 4 0 2 5
22 Injury, poisoning or certain other consequences of external causes Fracture of rib 24 9 1 4 0 2 8
21 Symptoms, signs or clinical findings, not elsewhere classified Gastrointestinal bleeding, unspecified 26 12 2 8 0 2 5
12 Diseases of the respiratory system Other allergic rhinitis 28 15 2 9 0 2 11
14 Diseases of the skin Porokeratoses 130 47 14 29 0 5 27
13 Diseases of the digestive system Xerostomia 520 242 68 165 0 16 138
18 Pregnancy, childbirth or the puerperium Diabetes mellitus arising in pregnancy 20 9 5 7 0 0 8
02 Neoplasms Malignant neoplasms of ill-defined sites 16 6 3 6 0 0 7
08 Diseases of the nervous system Secondary progressive multiple sclerosis 18 8 3 7 0 0 7
08 Diseases of the nervous system Primary progressive multiple sclerosis 22 11 5 10 0 1 9
02 Neoplasms Angiosarcoma 80 44 14 26 0 4 25
X Extension Codes Adenocarcinoma, endocervical type 63 33 9 22 0 5 22
16 Diseases of the genitourinary system Endometrial glandular hyperplasia 66 29 9 17 0 2 18
06 Mental, behavioural or neurodevelopmental disorders Disorders of intellectual development, unspecified 17 7 4 6 0 0 8
X Extension Codes Precursor cell lymphoblastic leukaemia, NOS 110 65 17 42 0 3 27
09 Diseases of the visual system Blindness 22 11 3 10 0 0 7
08 Diseases of the nervous system Polyneuropathy, unspecified 156 85 38 39 0 7 47
01 Certain infectious or parasitic diseases Leprosy 16 6 3 6 0 0 7
02 Neoplasms Large cell carcinoma of bronchus or lung 51 25 8 16 0 4 20
02 Neoplasms Malignant neoplasms of prostate, unspecified 51 31 11 20 0 1 9
26 Supplementary Chapter Traditional Medicine Conditions - Module I Migraine disorder(TM1) 126 71 23 33 0 6 35
05 Endocrine, nutritional or metabolic diseases Hypopituitarism 18 7 3 6 0 0 9
05 Endocrine, nutritional or metabolic diseases Central diabetes insipidus 16 6 3 6 0 0 7
02 Neoplasms Squamous cell carcinoma of oropharynx 73 39 8 23 0 4 25
02 Neoplasms Osteosarcoma of bone and articular cartilage of other specified sites 16 6 3 6 0 0 7
02 Neoplasms Malignant neoplasm metastasis in lymph nodes of head, face or neck 4173 1612 258 1106 1 91 1026
14 Diseases of the skin Lipoatrophy/lipodystrophy 16 6 3 6 0 0 7
02 Neoplasms Malignant neoplasms of anus or anal canal 68 41 5 20 0 4 22
03 Diseases of the blood or blood-forming organs Immune thrombocytopenic purpura 451 278 108 143 0 19 118
11 Diseases of the circulatory system Chronic lower extremities peripheral venous insufficiency 27 17 5 8 0 1 3
02 Neoplasms Meningioma 16 15 3 11 0 1 4
02 Neoplasms Lobular carcinoma in situ of breast 16 14 13 6 0 1 4
X Extension Codes Chronic myeloid leukaemia, NOS 167 96 25 64 0 10 35
13 Diseases of the digestive system Diseases of the digestive system, unspecified 97 64 20 31 0 6 28
03 Diseases of the blood or blood-forming organs Thrombophilia 111 63 18 41 0 5 21
19 Certain conditions originating in the perinatal period Necrotising enterocolitis of newborn 12 11 9 3 0 2 3
14 Diseases of the skin Keratosis pilaris 105 58 18 37 0 5 21
16 Diseases of the genitourinary system Heavy menstrual bleeding 27 17 5 8 0 1 3
22 Injury, poisoning or certain other consequences of external causes Concussion 163 80 23 46 0 2 31
01 Certain infectious or parasitic diseases Herpes simplex labialis 85 39 12 29 0 2 25
06 Mental, behavioural or neurodevelopmental disorders Trichotillomania 105 43 8 30 0 5 26
11 Diseases of the circulatory system Acute ST elevation myocardial infarction 239 127 15 82 0 4 56
11 Diseases of the circulatory system Stress-induced cardiomyopathy 221 117 14 77 0 4 55
11 Diseases of the circulatory system Diseases of coronary artery, unspecified 254 134 17 87 0 7 67
14 Diseases of the skin Rosacea 97 33 3 29 1 3 31
14 Diseases of the skin Periorificial dermatitis 92 29 3 26 1 3 30
21 Symptoms, signs or clinical findings, not elsewhere classified Cervical spine pain 78 38 10 16 0 4 22
05 Endocrine, nutritional or metabolic diseases Hypovolaemia 12 7 2 3 0 1 3
13 Diseases of the digestive system Acute pancreatitis 106 50 12 37 0 7 30
16 Diseases of the genitourinary system Nephrocalcinosis 246 90 19 77 0 11 63
10 Diseases of the ear or mastoid process Hearing disorder 183 111 27 73 0 10 49
01 Certain infectious or parasitic diseases Dengue with warning signs 22 10 3 4 0 1 7
16 Diseases of the genitourinary system Kidney failure, unspecified 265 108 30 84 0 11 64
13 Diseases of the digestive system Other specified disorders of teeth and supporting structures 77 37 10 16 0 4 22
X Extension Codes Nosocomial 82 43 26 15 0 3 23
19 Certain conditions originating in the perinatal period Intrauterine growth restriction, unspecified 83 46 26 18 0 3 21
05 Endocrine, nutritional or metabolic diseases Classical organic aciduria 77 41 26 14 0 3 21
21 Symptoms, signs or clinical findings, not elsewhere classified Multi organ failure 78 42 26 15 0 3 21
01 Certain infectious or parasitic diseases Clostridium difficile enterocolitis 83 44 26 15 0 3 24
08 Diseases of the nervous system Migraine with aura 66 28 6 12 0 2 15
05 Endocrine, nutritional or metabolic diseases Other specified inborn errors of energy metabolism 70 32 7 16 0 2 15
08 Diseases of the nervous system Migraine without aura 66 28 6 12 0 2 15
21 Symptoms, signs or clinical findings, not elsewhere classified Voice disturbances, unspecified 65 27 5 12 0 2 15
01 Certain infectious or parasitic diseases Infection, unspecified 76 34 7 16 0 2 16
02 Neoplasms Mantle cell lymphoma 42 26 8 15 0 1 9
02 Neoplasms Malignant neoplasm metastasis in bone or bone marrow 62 37 10 20 0 4 18
X Extension Codes Cholangiocarcinoma 167 113 44 53 0 9 43
02 Neoplasms Retinoblastoma 42 26 8 15 0 1 9
02 Neoplasms Classical Hodgkin lymphoma 43 27 8 16 0 1 10
X Extension Codes Burkitt-like lymphoma with 11q aberration 60 35 9 19 0 0 15
02 Neoplasms Malignant neoplasm of liver 29 19 5 10 0 0 5
02 Neoplasms Malignant neoplasms of ovary 76 46 12 25 0 5 21
X Extension Codes Adult T-cell leukaemia/lymphoma (HTLV-1 positive) 42 26 8 15 0 1 9
X Extension Codes Neuroblastoma, NOS 64 44 15 25 0 2 16
X Extension Codes Adenoid cystic carcinoma 31 20 5 11 0 0 5
02 Neoplasms Mature B-cell neoplasms, unspecified 42 26 8 15 0 1 9
02 Neoplasms Hereditary breast and ovarian cancer syndrome 76 47 13 27 0 4 18
02 Neoplasms Lymphoplasmacytic lymphoma 32 20 5 11 0 0 8
09 Diseases of the visual system Optic nerve disorder 43 27 8 16 0 1 10
X Extension Codes Oligoastrocytoma 52 35 9 18 0 2 6
02 Neoplasms Precursor B-lymphoblastic neoplasm 69 41 12 24 0 1 16
04 Diseases of the immune system Primary haemophagocytic lymphohistiocytosis 66 40 12 23 0 1 13
X Extension Codes Angioimmunoblastic T-cell lymphoma 33 21 5 12 0 0 9
02 Neoplasms Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated 69 41 12 24 0 1 16
X Extension Codes Carcinosarcoma, NOS 29 19 5 10 0 0 5
X Extension Codes Lymphoid leukaemia, NOS 42 26 8 15 0 1 9
X Extension Codes Oligodendroglioma, NOS 52 35 9 18 0 2 6
02 Neoplasms Choroid plexus tumours 42 26 8 15 0 1 9
02 Neoplasms Malignant neoplasms of fallopian tube, unspecified 85 51 11 28 0 4 23
X Extension Codes Malignant lymphoma, NOS 66 41 9 22 0 1 15
04 Diseases of the immune system Castlemans disease 42 26 8 15 0 1 9
X Extension Codes Burkitt lymphoma, NOS 43 27 8 16 0 1 10
02 Neoplasms Hepatoblastoma 4630 1798 262 1196 3 102 1131
X Extension Codes Transitional cell carcinoma, NOS 90 56 12 29 0 4 27
02 Neoplasms Chronic myelogenous leukaemia, BCR-ABL1-positive 32 20 5 11 0 0 8
02 Neoplasms Malignant neoplasms of corpus uteri, unspecified 5042 1922 271 1290 3 104 1230
02 Neoplasms Acute leukaemias of ambiguous lineage 55 33 9 18 0 0 11
02 Neoplasms Metastatic lung neoplasm 67 41 10 22 0 4 21
02 Neoplasms Adenocarcinoma of stomach 4428 1666 258 1173 2 95 1070
X Extension Codes Pilocytic astrocytoma 39 25 8 14 0 1 6
02 Neoplasms Extranodal NK/T-cell lymphoma, nasal type 39 25 8 14 0 1 6
05 Endocrine, nutritional or metabolic diseases Other specified amyloidosis 29 19 5 10 0 0 5
X Extension Codes Mixed tumour, malignant, NOS 64 38 10 21 0 4 18
X Extension Codes Thymic carcinoma, NOS 62 37 10 20 0 4 18
X Extension Codes Ganglioneuroblastoma 42 26 8 15 0 1 9
02 Neoplasms Other specified malignant neoplasms of kidney, except renal pelvis 5062 1917 265 1296 3 103 1234
12 Diseases of the respiratory system Other specified diseases of the respiratory system 42 14 3 4 0 2 14
01 Certain infectious or parasitic diseases Pediculosis of unspecified site or type 114 52 14 31 0 2 27
13 Diseases of the digestive system Drug-induced or toxic liver disease, unspecified 34 31 13 18 0 4 17
21 Symptoms, signs or clinical findings, not elsewhere classified Paraplegia 149 68 12 41 0 1 27
17 Conditions related to sexual health Male erectile dysfunction 24 21 9 11 0 1 8
X Extension Codes Congenital melanocytic naevus, NOS 18 16 7 8 0 1 7
X Extension Codes Alcohol beverage 30 26 11 13 0 2 9
V Supplementary section for functioning assessment Other specified neuromusculoskeletal and movement-related functions 19 17 7 8 0 1 7
13 Diseases of the digestive system Cyst of pancreas 18 16 7 8 0 1 7
08 Diseases of the nervous system Alcohol-related neurological disorders 22 20 10 8 0 2 7
21 Symptoms, signs or clinical findings, not elsewhere classified Bacteraemia 31 22 8 14 0 1 9
20 Developmental anomalies Patent arterial duct 8 7 3 4 0 2 4
21 Symptoms, signs or clinical findings, not elsewhere classified Fever of other or unknown origin 11 9 3 7 0 2 6
08 Diseases of the nervous system Mononeuropathy of unspecified site 8 7 3 4 0 2 4
14 Diseases of the skin Sunburn 12 11 6 4 0 3 4
15 Diseases of the musculoskeletal system or connective tissue Degenerative condition of spine, unspecified 9 8 3 5 0 2 5
22 Injury, poisoning or certain other consequences of external causes Fracture of shaft of tibia 9 7 3 4 0 2 4
06 Mental, behavioural or neurodevelopmental disorders Enuresis 23 20 9 10 0 3 10
19 Certain conditions originating in the perinatal period Bronchopulmonary dysplasia originating in the perinatal period 75 45 29 18 0 3 25
22 Injury, poisoning or certain other consequences of external causes Fracture of lower leg, including ankle 9 8 4 4 0 2 5
08 Diseases of the nervous system Cerebral palsy, unspecified 12 10 4 6 0 2 5
04 Diseases of the immune system Other specified functional neutrophil defects 8 7 3 4 0 2 4
13 Diseases of the digestive system Oral aphthae or aphtha-like ulceration 21 12 3 6 0 2 6
22 Injury, poisoning or certain other consequences of external causes Strain or sprain of ankle 10 8 3 4 0 2 5
01 Certain infectious or parasitic diseases Malaria due to Plasmodium vivax 11 4 1 2 0 0 5
19 Certain conditions originating in the perinatal period Congenital cytomegalovirus infection 114 59 12 35 0 1 30
01 Certain infectious or parasitic diseases Schistosomiasis 4 4 1 3 0 1 2
09 Diseases of the visual system Allergic conjunctivitis 118 54 10 42 0 4 30
02 Neoplasms Refractory anaemia with excess of blasts 36 20 7 12 0 1 7
05 Endocrine, nutritional or metabolic diseases Congenital adrenal hyperplasia 29 16 5 10 0 0 6
X Extension Codes Adrenal cortical carcinoma 71 39 12 22 0 5 20
06 Mental, behavioural or neurodevelopmental disorders Personality disorder, severity unspecified 26 14 4 8 0 0 6
02 Neoplasms Acute megakaryoblastic leukaemia 36 20 7 12 0 1 7
02 Neoplasms Mast cell leukaemia 26 14 4 8 0 0 6
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic widespread pain 50 37 13 14 0 2 11
14 Diseases of the skin Alopecia areata 26 14 4 8 0 0 6
02 Neoplasms Refractory anaemia 36 20 7 12 0 1 7
02 Neoplasms Acute erythroid leukaemia 36 20 7 12 0 1 7
X Extension Codes Acute monocytic leukaemia 36 20 7 12 0 1 7
14 Diseases of the skin Dermatitis or eczema, unspecified 26 14 4 8 0 0 6
06 Mental, behavioural or neurodevelopmental disorders Anxiety or fear-related disorders, unspecified 26 14 4 8 0 0 6
12 Diseases of the respiratory system Viral pneumonia 45 24 4 14 0 0 8
X Extension Codes Acute myelomonocytic leukaemia 36 20 7 12 0 1 7
13 Diseases of the digestive system Oral submucous fibrosis 38 23 6 14 0 1 8
04 Diseases of the immune system Graft-versus-host disease 106 58 14 34 0 2 48
02 Neoplasms Neoplasms of haematopoietic or lymphoid tissues, unspecified 125 52 10 35 0 1 51
14 Diseases of the skin Epidermolysis bullosa acquisita 76 40 8 23 0 1 39
05 Endocrine, nutritional or metabolic diseases Hypoalphalipoproteinaemia 27 9 0 5 0 0 6
06 Mental, behavioural or neurodevelopmental disorders Dementia due to cerebrovascular disease 39 20 3 8 0 0 18
08 Diseases of the nervous system Nemaline myopathy 19 14 7 8 0 2 2
08 Diseases of the nervous system Cerebral oedema 123 64 9 49 0 8 29
23 External causes of morbidity or mortality Exposure to or harmful effects of undetermined intent of other or unspecified substances chiefly nonmedicinal as to source 123 64 9 49 0 8 29
08 Diseases of the nervous system Other specified increased intracranial pressure 132 70 9 53 0 9 30
12 Diseases of the respiratory system Bronchiectasis 124 64 9 50 0 8 29
21 Symptoms, signs or clinical findings, not elsewhere classified Wheezing 123 64 9 49 0 8 29
01 Certain infectious or parasitic diseases Postherpetic polyneuropathy 135 75 11 53 0 9 31
18 Pregnancy, childbirth or the puerperium Maternal care for signs of fetal hypoxia 123 64 9 49 0 8 29
05 Endocrine, nutritional or metabolic diseases Congenital disorders of glycosylation and protein modification, unspecified 10 7 2 6 0 0 5
02 Neoplasms Malignant neoplasms of oropharynx 49 29 8 16 0 5 15
09 Diseases of the visual system Other specified disorders of the retina 3 3 0 2 0 0 1
01 Certain infectious or parasitic diseases Impetigo 3 3 0 2 0 0 1
13 Diseases of the digestive system Periapical periodontitis 4 3 0 3 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Osteomyelitis or osteitis 32 24 4 16 0 0 7
12 Diseases of the respiratory system Pneumothorax 3 3 0 2 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Chronic neuropathic pain, unspecified 9 9 2 3 0 1 3
09 Diseases of the visual system Retinal detachment 3 3 0 2 0 0 1
01 Certain infectious or parasitic diseases Cat-scratch disease 4 4 1 1 0 0 1
01 Certain infectious or parasitic diseases Superficial bacterial folliculitis 4 4 1 1 0 0 1
01 Certain infectious or parasitic diseases Plague 5 4 1 2 0 0 1
23 External causes of morbidity or mortality Ventilation associated with injury or harm in therapeutic use 14 8 1 4 0 0 4
10 Diseases of the ear or mastoid process Meniere disease 5 5 1 2 0 0 2
18 Pregnancy, childbirth or the puerperium Infection of amniotic sac or membranes 7 5 1 2 0 0 1
02 Neoplasms Malignant neoplasms of oesophagus 3799 1539 253 1002 2 82 918
14 Diseases of the skin Epidermolysis bullosa 21 16 5 9 0 0 0
03 Diseases of the blood or blood-forming organs Congenital pure red cell aplasia 17 11 9 6 0 1 4
05 Endocrine, nutritional or metabolic diseases Primary hyperoxaluria type 1 17 11 9 6 0 1 4
02 Neoplasms Malignant neoplasms of gallbladder 70 57 36 24 0 5 15
20 Developmental anomalies Common atrioventricular junction with atrioventricular septal defect 45 25 23 7 0 1 19
02 Neoplasms Sarcoma 70 57 36 24 0 5 15
05 Endocrine, nutritional or metabolic diseases Disorders of methionine cycle or sulphur amino acid metabolism 70 31 22 15 0 1 24
20 Developmental anomalies Ventricular septal defect 45 25 23 7 0 1 19
08 Diseases of the nervous system Post polio progressive muscular atrophy 45 25 23 7 0 1 19
20 Developmental anomalies Rett syndrome 17 12 2 8 0 0 7
09 Diseases of the visual system Posterior blepharitis 5 5 1 2 0 1 2
02 Neoplasms Other specified gliomas of brain 13 7 3 5 0 1 4
02 Neoplasms Tumours of neuroepithelial tissue of brain 10 6 3 4 0 1 1
02 Neoplasms Malignant neoplasms of thymus 5207 2025 275 1314 3 103 1256
X Extension Codes Seminoma, NOS 10 6 3 4 0 1 1
X Extension Codes Medulloblastoma, NOS 13 7 3 5 0 1 4
02 Neoplasms Myeloid sarcoma 10 6 3 4 0 1 1
02 Neoplasms Other specified malignant neoplasms of the ovary 45 25 8 14 0 5 14
02 Neoplasms Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach 10 6 3 4 0 1 1
02 Neoplasms Myeloproliferative and myelodysplastic disease, unclassifiable 13 8 3 6 0 1 2
X Extension Codes Waldenstrom macroglobulinemia 10 6 3 4 0 1 1
08 Diseases of the nervous system Chronic inflammatory demyelinating polyneuropathy 10 6 3 4 0 1 1
X Extension Codes Ependymoma, anaplastic 13 7 3 5 0 1 4
X Extension Codes Germinoma 47 26 8 15 0 5 14
X Extension Codes Teratoma, NOS 45 25 8 14 0 5 14
X Extension Codes Embryonal rhabdomyosarcoma, NOS 13 7 3 5 0 1 4
X Extension Codes CNS embryonal tumour, NOS 10 6 3 4 0 1 1
X Extension Codes Embryonal carcinoma, NOS 10 6 3 4 0 1 1
X Extension Codes Alveolar rhabdomyosarcoma 13 7 3 5 0 1 4
X Extension Codes Myeloproliferative neoplasm, NOS 47 30 4 16 0 2 8
X Extension Codes Small cell carcinoma, NOS 45 25 8 14 0 5 14
09 Diseases of the visual system Inappropriate saccades 10 6 3 4 0 1 1
02 Neoplasms Malignant neoplasm metastasis in mediastinum 10 6 3 4 0 1 1
X Extension Codes Nephroblastoma, NOS 13 7 3 5 0 1 4
02 Neoplasms Malignant trophoblastic neoplasms of placenta 48 27 9 16 0 5 16
02 Neoplasms Acute basophilic leukaemia 10 6 3 4 0 1 1
X Extension Codes T lymphoblastic leukaemia/lymphoma 13 7 3 5 0 1 4
02 Neoplasms Germ cell tumour of testis 5557 2076 275 1384 3 108 1356
08 Diseases of the nervous system Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cord 11 7 3 5 0 1 2
02 Neoplasms Neuroendocrine neoplasms of pancreas 36 23 4 11 0 1 6
08 Diseases of the nervous system Neuromyelitis optica 11 7 3 5 0 1 2
19 Certain conditions originating in the perinatal period Congenital human immunodeficiency virus infection 36 18 7 10 0 1 11
X Extension Codes Astrocytoma, NOS 13 10 1 4 0 1 0
05 Endocrine, nutritional or metabolic diseases Hypoglycaemia without associated diabetes 58 46 17 21 0 1 22
X Extension Codes Giant cell tumour of bone, malignant 4 4 1 3 0 0 4
13 Diseases of the digestive system Gastroparesis 58 49 19 22 0 1 20
02 Neoplasms Malignant neoplasms of corpus uteri 63 38 6 22 0 4 21
14 Diseases of the skin Skin fungal infection disorder 62 50 16 25 0 2 21
15 Diseases of the musculoskeletal system or connective tissue Lateral epicondylitis of elbow 58 49 18 22 0 2 22
11 Diseases of the circulatory system Varicose veins 53 44 16 21 0 1 20
21 Symptoms, signs or clinical findings, not elsewhere classified Vaginal discharge 64 51 16 26 0 2 21
11 Diseases of the circulatory system Unstable angina 62 49 18 23 0 2 23
13 Diseases of the digestive system Postoperative ileus 53 44 16 21 0 1 20
20 Developmental anomalies Gastroschisis 53 44 16 21 0 1 20
02 Neoplasms Malignant neoplasms of stomach, unspecified 63 38 6 21 0 5 22
05 Endocrine, nutritional or metabolic diseases Hyperkalaemia 57 44 16 21 0 1 23
13 Diseases of the digestive system Biliary disease, unspecified 4 4 1 3 0 1 4
15 Diseases of the musculoskeletal system or connective tissue Diseases of the musculoskeletal system or connective tissue, unspecified 56 47 17 23 0 1 20
13 Diseases of the digestive system Primary biliary cholangitis, unspecified 16 7 0 3 0 0 5
13 Diseases of the digestive system Intrahepatic cholestasis, not elsewhere classified 3 2 0 1 0 0 3
01 Certain infectious or parasitic diseases Chronic hepatitis D 4 2 0 2 0 0 3
02 Neoplasms Malignant neoplasms of cervix uteri, unspecified 35 19 5 10 0 4 13
X Extension Codes Sex cord-gonadal stromal tumour, NOS 35 19 5 10 0 4 13
X Extension Codes Endometrioid adenocarcinoma, NOS 35 19 5 10 0 4 13
X Extension Codes Pleomorphic adenoma 35 19 5 10 0 4 13
02 Neoplasms Other specified malignant neoplasms of oropharynx 35 19 5 10 0 4 13
11 Diseases of the circulatory system stricture 36 20 5 11 0 4 14
02 Neoplasms Penile cancer 35 19 5 10 0 4 13
02 Neoplasms Other specified carcinoma in situ of breast 35 19 5 10 0 4 13
X Extension Codes Neuroendocrine tumour, NOS 43 25 6 14 0 4 13
X Extension Codes Carcinoma, undifferentiated, NOS 35 19 5 10 0 4 13
02 Neoplasms ovarian cystadenocarcinoma 35 19 5 10 0 4 13
02 Neoplasms Intrahepatic cholangiocarcinoma 57 33 5 17 0 4 18
02 Neoplasms Uterine ligament/parametrium/uterine adnexa neoplasm 36 20 6 11 0 4 13
02 Neoplasms Malignant neoplasms of vagina 35 19 5 10 0 4 13
X Extension Codes Parathyroid carcinoma 35 19 5 10 0 4 13
02 Neoplasms Carcinosarcoma of uterus 5204 2035 277 1321 3 104 1249
02 Neoplasms Neoplasms of unknown behaviour of female genital organs 36 20 6 10 0 4 14
02 Neoplasms Malignant neoplasms of vulva 35 19 5 10 0 4 13
02 Neoplasms Mesotheliomas of peritoneum 35 19 5 10 0 4 13
05 Endocrine, nutritional or metabolic diseases Hashimoto thyroiditis 9 3 1 2 0 0 2
01 Certain infectious or parasitic diseases Bacterial meningitis 90 39 8 31 0 4 23
02 Neoplasms Malignant neoplasms of rectum, unspecified 38 25 3 12 0 1 7
02 Neoplasms Malignant neoplasms of nasal cavity 26 17 1 7 0 0 5
02 Neoplasms Neoplasms of unknown behaviour of colon 39 26 4 12 0 1 8
02 Neoplasms Malignant neoplasms of larynx, unspecified 26 17 1 7 0 0 5
02 Neoplasms Neoplasms of unknown behaviour of larynx 26 17 1 7 0 0 5
02 Neoplasms Malignant neoplasms of other or unspecified parts of biliary tract 26 17 1 7 0 0 5
X Extension Codes Mucinous adenocarcinoma 26 17 1 7 0 0 5
X Extension Codes Signet ring cell carcinoma 26 17 1 7 0 0 5
X Extension Codes Squamous intraepithelial neoplasia, high grade 26 17 1 7 0 0 5
09 Diseases of the visual system Chalazion, unspecified 28 19 2 8 0 0 6
16 Diseases of the genitourinary system Low grade squamous intraepithelial lesion of cervix uteri 38 25 3 12 0 1 7
02 Neoplasms skin carcinoma 26 17 1 7 0 0 5
04 Diseases of the immune system Familial Mediterranean fever 13 5 0 2 0 0 2
11 Diseases of the circulatory system Postcardiotomy syndrome 13 5 0 2 0 0 2
11 Diseases of the circulatory system Acute non-ST elevation myocardial infarction 19 10 0 6 0 0 2
11 Diseases of the circulatory system Acute pericarditis 13 5 0 2 0 0 2
04 Diseases of the immune system Behçet disease 13 5 0 2 0 0 2
01 Certain infectious or parasitic diseases Dermatophytosis of foot 5 4 1 2 0 0 0
08 Diseases of the nervous system Cerebral ischaemic stroke, unspecified 7 6 0 4 0 0 0
03 Diseases of the blood or blood-forming organs Disseminated intravascular coagulation 7 6 1 4 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Osteonecrosis 6 5 0 4 0 0 0
08 Diseases of the nervous system Cerebrovascular disease 16 14 2 7 0 1 5
04 Diseases of the immune system Mucocutaneous lymph node syndrome 7 6 0 5 0 0 1
09 Diseases of the visual system Retinal artery occlusions 6 5 0 4 0 0 0
11 Diseases of the circulatory system Hypertrophic cardiomyopathy 96 73 14 34 0 2 38
18 Pregnancy, childbirth or the puerperium Maternal care for fetal growth restriction 6 5 0 4 0 0 0
13 Diseases of the digestive system Leukoplakia 6 5 0 4 0 0 0
13 Diseases of the digestive system ulcer disease 7 6 0 5 0 0 0
08 Diseases of the nervous system Cerebral aneurysm, nonruptured 6 5 0 4 0 0 0
11 Diseases of the circulatory system Venous leg ulcer, unspecified 6 5 0 4 0 0 0
08 Diseases of the nervous system Late effects of cerebral ischemic stroke 7 6 0 4 0 0 0
11 Diseases of the circulatory system Chronic rheumatic heart diseases, not elsewhere classified 7 6 0 4 0 0 0
05 Endocrine, nutritional or metabolic diseases Vitamin D deficiency 22 18 11 7 0 0 5
21 Symptoms, signs or clinical findings, not elsewhere classified Other chest pain 6 5 0 4 0 0 0
16 Diseases of the genitourinary system Adenomyosis 7 6 1 5 0 0 0
05 Endocrine, nutritional or metabolic diseases Other specified disorders of urea cycle metabolism 2 1 0 1 0 0 0
05 Endocrine, nutritional or metabolic diseases Disorders of urea cycle metabolism 2 1 0 1 0 0 0
05 Endocrine, nutritional or metabolic diseases Citrullinaemia 2 1 0 1 0 0 0
16 Diseases of the genitourinary system Premenstrual tension syndrome 34 14 3 15 0 2 9
06 Mental, behavioural or neurodevelopmental disorders Stimulant dependence including amphetamines, methamphetamine or methcathinone 25 20 5 8 0 2 9
20 Developmental anomalies Marfan syndrome or Marfan-related disorders 4 2 1 1 0 0 0
13 Diseases of the digestive system Crohn disease of other specified site 2 1 0 1 0 0 0
11 Diseases of the circulatory system Cardiomegaly 3 2 1 1 0 0 0
13 Diseases of the digestive system Anal fissure/fistula 3 2 0 2 0 0 0
02 Neoplasms Hemangioma 7 3 1 2 0 0 3
18 Pregnancy, childbirth or the puerperium Placenta praevia specified as without haemorrhage 11 6 2 3 0 1 3
02 Neoplasms Adenocarcinoma of bronchus or lung 5078 1959 268 1293 3 104 1233
11 Diseases of the circulatory system Mitral valve stenosis 3 2 1 1 0 0 0
01 Certain infectious or parasitic diseases Chronic hepatitis B, unspecified 28 17 7 8 0 1 10
11 Diseases of the circulatory system Supraventricular tachyarrhythmia, unspecified 17 10 2 7 0 1 5
04 Diseases of the immune system Hereditary angioedema 15 9 1 7 0 1 5
05 Endocrine, nutritional or metabolic diseases Cerebral organic aciduria 2 2 0 0 0 0 2
20 Developmental anomalies Turner syndrome 8 6 1 4 0 0 0
16 Diseases of the genitourinary system Postmenopausal atrophic vaginitis 8 6 1 4 0 0 0
16 Diseases of the genitourinary system Premature ovarian failure 8 6 1 4 0 0 0
05 Endocrine, nutritional or metabolic diseases Gonadotropin deficiency 15 11 4 7 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Osteopenia 25 18 8 6 0 2 5
16 Diseases of the genitourinary system Amenorrhoea 17 11 3 6 0 1 3
06 Mental, behavioural or neurodevelopmental disorders Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium, without psychotic symptoms 17 11 3 6 0 1 3
01 Certain infectious or parasitic diseases Gonococcal infection, unspecified 1 0 0 1 0 0 0
14 Diseases of the skin Other specified infections of the nail or perionychium 1 0 0 1 0 0 0
01 Certain infectious or parasitic diseases Pyogenic abscess of the skin 6 2 0 2 0 0 2
01 Certain infectious or parasitic diseases Anthrax 1 0 0 1 0 0 0
16 Diseases of the genitourinary system Acute pyelonephritis 10 6 3 6 0 0 5
13 Diseases of the digestive system Abscess of liver 1 0 0 1 0 0 0
01 Certain infectious or parasitic diseases Other specified bacterial diseases 1 0 0 1 0 0 0
13 Diseases of the digestive system Alcoholic cirrhosis of liver without hepatitis 2 1 1 1 0 1 0
09 Diseases of the visual system Endophthalmitis 1 0 0 1 0 0 0
13 Diseases of the digestive system Peritonitis 6 2 0 2 0 0 2
16 Diseases of the genitourinary system Urolithiasis, unspecified 2 1 1 1 0 0 0
01 Certain infectious or parasitic diseases Tuberculosis 4 4 0 2 0 0 1
01 Certain infectious or parasitic diseases Aspergillosis 9 6 0 4 0 1 1
01 Certain infectious or parasitic diseases Meningitis due to Cryptococcus neoformans 9 6 0 4 0 1 1
12 Diseases of the respiratory system Aspergillus-induced allergic or hypersensitivity conditions 9 6 0 4 0 1 1
01 Certain infectious or parasitic diseases Blastomycosis 9 6 0 4 0 1 1
01 Certain infectious or parasitic diseases Mucormycosis 9 6 0 4 0 1 1
01 Certain infectious or parasitic diseases Candidosis 10 6 0 4 0 1 1
09 Diseases of the visual system Ocular hypertension 2 2 0 1 0 0 0
01 Certain infectious or parasitic diseases Chronic mucocutaneous candidosis 9 6 0 4 0 1 1
16 Diseases of the genitourinary system Female pelvic inflammatory diseases 2 2 0 1 0 0 0
09 Diseases of the visual system Endothelial corneal dystrophy 13 10 2 7 0 1 1
09 Diseases of the visual system Other specified conjunctivitis 7 4 0 2 0 0 2
01 Certain infectious or parasitic diseases Histoplasmosis 9 6 0 4 0 1 1
X Extension Codes Neuroma, NOS 6 6 2 1 0 1 2
12 Diseases of the respiratory system Non-allergic rhinitis 6 6 2 1 0 1 2
08 Diseases of the nervous system Painful cranial neuropathies or other facial pains 6 6 2 1 0 1 2
01 Certain infectious or parasitic diseases Acanthamoebiasis 3 1 0 1 0 0 0
01 Certain infectious or parasitic diseases Other specified pyogenic bacterial infection of skin and subcutaneous tissue 9 3 0 2 0 0 2
19 Certain conditions originating in the perinatal period Sepsis of fetus or newborn 12 7 3 2 0 1 2
08 Diseases of the nervous system Progressive supranuclear palsy 6 3 1 3 0 0 5
08 Diseases of the nervous system Spinal muscular atrophy 5 2 1 2 0 0 5
21 Symptoms, signs or clinical findings, not elsewhere classified Cramp or spasm 10 7 4 3 0 1 6
05 Endocrine, nutritional or metabolic diseases Hypophosphataemic rickets 2 2 1 0 0 0 1
X Extension Codes Giant cell tumour of bone, NOS 1 1 1 0 0 0 1
16 Diseases of the genitourinary system Penile fibromatosis 5 4 2 2 0 0 1
20 Developmental anomalies Osteogenesis imperfecta 1 1 1 0 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Paget disease of bone, unspecified 2 1 1 0 0 0 1
22 Injury, poisoning or certain other consequences of external causes Fracture of neck of femur, unspecified 6 4 2 2 0 0 1
05 Endocrine, nutritional or metabolic diseases Primary hyperparathyroidism 1 1 1 0 0 0 1
22 Injury, poisoning or certain other consequences of external causes Fracture of neck of femur 1 1 1 0 0 0 1
05 Endocrine, nutritional or metabolic diseases Calcium deficiency, unspecified 2 2 1 0 0 0 1
08 Diseases of the nervous system Acute inflammatory demyelinating polyneuropathy 1 1 0 1 0 0 0
20 Developmental anomalies Prader-Willi syndrome 3 3 1 2 0 0 1
12 Diseases of the respiratory system Other specified chronic bronchiolitis 7 5 3 3 0 0 3
16 Diseases of the genitourinary system Overactive bladder 11 9 3 6 0 0 4
16 Diseases of the genitourinary system Ovarian hyperstimulation syndrome 11 7 3 4 0 1 4
14 Diseases of the skin Lichen sclerosus of vulva 9 5 2 2 0 1 3
01 Certain infectious or parasitic diseases Influenza due to identified zoonotic or pandemic influenza virus 4 3 0 2 0 0 0
16 Diseases of the genitourinary system Urethral stricture 4 4 0 1 0 0 3
02 Neoplasms Malignant neoplasms of appendix 4 4 0 1 0 0 3
09 Diseases of the visual system Keratoconus 1637 674 136 481 2 45 375
09 Diseases of the visual system Corneal scars or opacities 4 4 0 1 0 0 3
13 Diseases of the digestive system Oesophageal obstruction 4 4 0 1 0 0 3
21 Symptoms, signs or clinical findings, not elsewhere classified Apnoea 6 6 4 2 0 1 0
05 Endocrine, nutritional or metabolic diseases Pseudohypoparathyroidism 6 6 4 2 0 1 0
20 Developmental anomalies Deletions of the long arm of chromosome 2 6 6 4 2 0 1 0
05 Endocrine, nutritional or metabolic diseases Disorders of peroxisomal alpha-, beta- or omega-oxidation 5 4 2 3 0 0 0
05 Endocrine, nutritional or metabolic diseases Hyperparathyroidism 1 0 0 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Metabolism inborn error 1 0 0 0 0 0 0
20 Developmental anomalies Neurofibromatosis type 1 6 5 2 4 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Nasal congestion 1 0 0 0 0 0 0
20 Developmental anomalies Syndromes with premature ageing appearance as a major feature 1 0 0 1 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Delirium 6 6 3 0 0 1 0
08 Diseases of the nervous system Cerebral ischaemia, unspecified 4 4 3 0 0 1 0
01 Certain infectious or parasitic diseases dengue 4 4 3 0 0 1 0
19 Certain conditions originating in the perinatal period Birth asphyxia 4 4 3 0 0 1 0
X Extension Codes Prolymphocytic leukaemia, NOS 1 0 0 0 0 0 0
15 Diseases of the musculoskeletal system or connective tissue Shoulder lesion 3 2 1 1 0 0 1
20 Developmental anomalies Other specified deletions of chromosome 22 1 1 0 1 0 0 1
04 Diseases of the immune system Granulomatosis with polyangiitis 1 1 0 1 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Oedema 1 1 0 1 0 0 1
08 Diseases of the nervous system Bell palsy 1 1 0 1 0 0 1
13 Diseases of the digestive system Drug-induced or toxic liver disease with chronic hepatitis 5 5 2 4 0 0 1
04 Diseases of the immune system IgG4 related disease 1 1 0 1 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Tenosynovitis 1 1 0 1 0 0 1
04 Diseases of the immune system Juvenile dermatomyositis 1 1 0 1 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Developmental speech or language disorders 1 1 0 1 0 0 1
03 Diseases of the blood or blood-forming organs Thrombotic thrombocytopenic purpura 5 5 2 4 0 0 1
01 Certain infectious or parasitic diseases Pneumocystosis 1 1 0 1 0 0 1
05 Endocrine, nutritional or metabolic diseases Other specified sphingolipidosis 5 5 2 4 0 0 1
03 Diseases of the blood or blood-forming organs Aplastic anaemia 1 1 0 1 0 0 1
04 Diseases of the immune system Immune dysregulation syndromes presenting primarily with lymphoproliferation 1 1 0 1 0 0 1
04 Diseases of the immune system Microscopic polyangiitis 1 1 0 1 0 0 1
06 Mental, behavioural or neurodevelopmental disorders Developmental language disorder 1 1 0 1 0 0 1
05 Endocrine, nutritional or metabolic diseases Gangliosidosis 1 1 0 1 0 0 1
11 Diseases of the circulatory system Myocarditis 2 2 1 1 0 0 2
08 Diseases of the nervous system Other specified primary disorders of muscles 5 5 2 4 0 0 1
09 Diseases of the visual system Anterior ischemic optic neuropathy 1 1 0 1 0 0 1
22 Injury, poisoning or certain other consequences of external causes Traumatic subdural haemorrhage 14 10 2 7 0 1 3
12 Diseases of the respiratory system Other specified nasal polyp 1 1 0 1 0 0 1
09 Diseases of the visual system Restrictive ophthalmopathy 1 1 0 1 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Plantar fasciitis 1 1 0 1 0 0 1
15 Diseases of the musculoskeletal system or connective tissue Axial spondyloarthritis, unspecified 2 2 1 1 0 0 2
03 Diseases of the blood or blood-forming organs Other specified qualitative platelet defects 1 1 0 1 0 0 1
08 Diseases of the nervous system Acute repetitive seizures 3 2 1 1 0 0 1
08 Diseases of the nervous system Acquired epileptic aphasia 3 2 1 1 0 0 1
08 Diseases of the nervous system Status epilepticus 4 3 2 1 0 0 2
21 Symptoms, signs or clinical findings, not elsewhere classified Urinary incontinence 3 3 0 3 0 0 1
12 Diseases of the respiratory system Pneumonia due to Staphylococcus 5 2 0 1 0 0 2
11 Diseases of the circulatory system Endocarditis 5 2 0 1 0 0 2
12 Diseases of the respiratory system Bacterial pneumonia 6 3 0 2 0 0 2
01 Certain infectious or parasitic diseases Gram-positive bacterial infection 5 2 0 1 0 0 2
01 Certain infectious or parasitic diseases Bacterial cellulitis, erysipelas or lymphangitis 5 2 0 1 0 0 2
15 Diseases of the musculoskeletal system or connective tissue Idiopathic rhabdomyolysis 4 4 2 3 0 0 0
08 Diseases of the nervous system Diseases of neuromuscular junction or muscle, unspecified 4 4 2 3 0 0 0
13 Diseases of the digestive system Hepatic veno-occlusive disease 4 4 2 3 0 0 0
13 Diseases of the digestive system Biliary atresia 4 4 2 3 0 0 0
20 Developmental anomalies Transposition of the great arteries 4 4 2 3 0 0 0
12 Diseases of the respiratory system Chronic bronchitis 4 4 2 3 0 0 0
X Extension Codes Pseudomyxoma peritonei 4 4 2 3 0 0 0
X Extension Codes Hairy cell leukaemia 8 5 1 3 0 0 4
02 Neoplasms Lentigo maligna 2 1 0 1 0 0 0
14 Diseases of the skin Stretch marks 2 1 0 1 0 0 0
01 Certain infectious or parasitic diseases Mycobacterium infection 1 1 0 1 0 0 0
16 Diseases of the genitourinary system Diseases of the urinary system, unspecified 3 1 0 0 0 0 0
08 Diseases of the nervous system Human T-cell lymphotropic virus-associated myelopathy 3 1 0 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Amnesia 1 1 0 0 0 0 1
01 Certain infectious or parasitic diseases Lyme borreliosis 1869 818 225 543 0 50 451
21 Symptoms, signs or clinical findings, not elsewhere classified Multi-drug resistant Mycobacterium tuberculosis 1 1 0 1 0 0 0
08 Diseases of the nervous system Distal myopathies 1 1 1 0 0 0 1
12 Diseases of the respiratory system Pleural effusion 1 1 1 0 0 0 1
08 Diseases of the nervous system Spinocerebellar ataxia 4 3 1 2 0 0 0
04 Diseases of the immune system Sarcoidosis 7 6 2 3 0 1 3
05 Endocrine, nutritional or metabolic diseases Tumour lysis syndrome 2 1 0 0 0 0 1
13 Diseases of the digestive system Chronic atrophic gastritis of unknown aetiology 13 9 2 6 0 1 2
08 Diseases of the nervous system Other specified mitochondrial myopathies 13 9 2 6 0 1 2
05 Endocrine, nutritional or metabolic diseases Thyrotoxicosis with diffuse goitre 1 0 0 0 0 0 0
05 Endocrine, nutritional or metabolic diseases Congenital hypothyroidism 1 0 0 0 0 0 0
13 Diseases of the digestive system Autoimmune hepatitis 2 2 1 1 0 1 1
01 Certain infectious or parasitic diseases Chlamydial conjunctivitis 2 2 1 1 0 0 1
05 Endocrine, nutritional or metabolic diseases Peripheral precocious puberty 1 1 0 1 0 0 0
13 Diseases of the digestive system Eosinophilic oesophagitis 1 1 0 1 0 0 0
15 Diseases of the musculoskeletal system or connective tissue Other specified conditions associated with the spine 1 1 0 0 0 0 0
18 Pregnancy, childbirth or the puerperium Spontaneous abortion 2 2 1 1 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Alcohol withdrawal 2 2 1 0 0 1 0
16 Diseases of the genitourinary system Pelvic organ prolapse 1 1 0 0 0 0 0
16 Diseases of the genitourinary system Azoospermia 2 2 1 1 0 0 0
15 Diseases of the musculoskeletal system or connective tissue Intervertebral disc degeneration 2 2 1 0 0 0 1
X Extension Codes Fibroma, NOS 1 1 0 0 0 0 0
20 Developmental anomalies Klinefelter syndrome 1 1 0 0 0 0 0
20 Developmental anomalies Osteopetrosis 1 1 0 0 0 0 0
18 Pregnancy, childbirth or the puerperium Preterm premature rupture of membranes 1 1 0 1 0 0 0
18 Pregnancy, childbirth or the puerperium Oligohydramnios 1 1 0 1 0 0 0
09 Diseases of the visual system contracture 1 1 0 1 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Abnormal reflex 1 1 0 1 0 0 0
05 Endocrine, nutritional or metabolic diseases Underweight in adults 2 2 1 0 0 0 1
01 Certain infectious or parasitic diseases Candidosis of lips or oral mucous membranes 1 0 0 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Haematemesis 1 1 1 0 0 0 0
01 Certain infectious or parasitic diseases Unspecified bacterial disease 1 1 1 0 0 0 0
16 Diseases of the genitourinary system Calculus of ureter 1 1 1 0 0 0 0
04 Diseases of the immune system Antiphospholipid syndrome 1 1 0 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Syncope and collapse, unspecified 2 1 1 0 0 0 0
13 Diseases of the digestive system Portal hypertension 2 1 1 0 0 0 0
20 Developmental anomalies Hereditary haemorrhagic telangiectasia 2 1 1 0 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Ascites 2 1 1 0 0 0 0
08 Diseases of the nervous system Cerebral cavernous malformation 2 1 1 0 0 0 0
24 Factors influencing health status or contact with health services Acute stress reaction 2 1 1 0 0 0 0
13 Diseases of the digestive system Oesophageal varices 2 1 1 0 0 0 0
11 Diseases of the circulatory system Lymphoedema 2 1 1 0 0 0 0
01 Certain infectious or parasitic diseases Acute hepatitis A 1 1 0 1 0 0 1
21 Symptoms, signs or clinical findings, not elsewhere classified Sciatica 2 2 0 1 0 0 0
06 Mental, behavioural or neurodevelopmental disorders Dysthymic disorder 1 1 0 0 0 0 0
02 Neoplasms Langerhans cell histiocytosis 3 1 0 1 0 0 3
05 Endocrine, nutritional or metabolic diseases Anovulation 1 1 1 1 0 0 0
13 Diseases of the digestive system Hepatopulmonary syndrome 1 1 1 1 0 0 0
02 Neoplasms Invasive lobular carcinoma of breast 1 1 1 1 0 0 0
21 Symptoms, signs or clinical findings, not elsewhere classified Bradycardia, unspecified 2 1 0 0 0 0 2
09 Diseases of the visual system Anisometropia 2 1 0 0 0 0 2
09 Diseases of the visual system Strabismus or ocular motility disorders, unspecified 2 1 0 0 0 0 2
08 Diseases of the nervous system Childhood absence epilepsy 2 2 1 0 0 0 2
08 Diseases of the nervous system Benign essential blepharospasm 1 1 1 0 0 0 1
20 Developmental anomalies Syndromes with vascular anomalies as a major feature 1 1 1 0 0 0 1
09 Diseases of the visual system Anterior uveitis, unspecified 1 1 0 1 0 0 0
09 Diseases of the visual system Purulent endophthalmitis 1 1 0 1 0 0 0
09 Diseases of the visual system Retinal oedema 1 1 0 1 0 0 0
11 Diseases of the circulatory system Thoracic aortic aneurysm 1 1 1 0 0 0 0
13 Diseases of the digestive system intestinal obstruction 2 2 1 0 0 0 2
15 Diseases of the musculoskeletal system or connective tissue Arthropathies, unspecified 1 1 1 0 0 0 1
09 Diseases of the visual system Intermediate choroiditis, unspecified 1 0 0 0 0 0 0
02 Neoplasms Serous cystadenoma,borderline malignancy of ovary 5154 2032 272 1297 3 101 1239
X Extension Codes Pheochromocytoma 4740 1855 270 1228 3 102 1145
15 Diseases of the musculoskeletal system or connective tissue Osteoarthritis, unspecified 3127 1260 236 855 3 81 738
02 Neoplasms Malignant neoplasms of biliary tract, distal bile duct 5172 2033 271 1320 3 104 1234
02 Neoplasms Diffuse large B-cell lymphomas 5662 2184 274 1410 3 109 1357
02 Neoplasms Squamous cell carcinoma of bronchus or lung 4902 1879 267 1274 3 101 1184
02 Neoplasms Adenocarcinoma of pancreas 6036 2228 278 1472 3 112 1464
02 Neoplasms Mesothelioma of pleura 5372 2069 277 1353 3 103 1297
12 Diseases of the respiratory system Pneumonia due to Pseudomonasaeruginosa 2074 869 191 582 3 52 473
02 Neoplasms Hepatocellular carcinoma of liver 4640 1804 260 1201 3 99 1131
02 Neoplasms Other specified malignant neoplasms of bronchus or lung 3739 1493 242 995 3 84 911
02 Neoplasms Urothelial carcinoma of bladder 4313 1735 264 1118 3 92 1045
01 Certain infectious or parasitic diseases Cytomegaloviral disease 4735 1863 272 1206 3 96 1146
02 Neoplasms Invasive carcinoma of breast 4101 1643 254 1067 3 89 991
02 Neoplasms Malignant neoplasms of adrenal gland 4561 1794 271 1191 3 96 1092
20 Developmental anomalies Tetralogy of Fallot 3945 1447 237 1052 3 82 949
02 Neoplasms Other specified malignant neoplasms ofcolon 4355 1654 262 1133 2 96 1084
02 Neoplasms Melanoma of skin 3402 1374 247 910 1 79 831
16 Diseases of the genitourinary system Superficial ovarian endometriosis 4523 1779 268 1174 3 92 1073
02 Neoplasms Malignant neoplasms of thyroid gland, unspecified 3906 1588 263 1042 3 94 949
01 Certain infectious or parasitic diseases Chikungunya virus disease 4330 1721 266 1142 3 87 1044
08 Diseases of the nervous system Parkinson disease 250 88 15 70 0 9 54
02 Neoplasms Glioblastoma of brain 5115 1991 272 1307 3 100 1245
X Extension Codes Renal cell carcinoma, chromophobe type 4135 1641 260 1080 3 91 1017
13 Diseases of the digestive system Inflammatory bowel diseases, unspecified 2427 1002 234 686 1 62 575
01 Certain infectious or parasitic diseases Zika virus disease 2576 1057 187 691 0 61 628
01 Certain infectious or parasitic diseases West Nile virus infection 3689 1447 254 1002 3 78 893
01 Certain infectious or parasitic diseases Malaria, unspecified 718 431 208 227 0 29 169
01 Certain infectious or parasitic diseases Human immunodeficiency virus disease without mention of tuberculosis or malaria 2610 1070 218 732 1 60 625
02 Neoplasms Gliomas of brain 3135 1265 236 854 3 73 761
02 Neoplasms Myelodysplastic syndromes, unspecified 2211 984 233 630 2 57 524
01 Certain infectious or parasitic diseases Dengue fever, unspecified 2182 898 195 607 0 49 535
08 Diseases of the nervous system Myotonic dystrophy 2664 1071 224 712 2 62 670
11 Diseases of the circulatory system Dilated cardiomyopathy 1493 636 182 429 0 38 340
01 Certain infectious or parasitic diseases Ebola virus disease 2715 1098 237 724 1 62 671
11 Diseases of the circulatory system Heart failure, unspecified 2737 1116 223 731 2 64 660
19 Certain conditions originating in the perinatal period Intrauterine growth restriction 261 145 21 94 0 6 61
02 Neoplasms Malignant neoplasms of bladder 979 496 135 309 1 26 247
13 Diseases of the digestive system Non-alcoholic steatohepatitis 300 147 27 81 0 9 77
02 Neoplasms Chronic lymphocytic leukaemia of B-cell type 4 2 0 2 0 0 2
08 Diseases of the nervous system Other specified diseases of the nervous system 5 2 0 3 0 0 2
01 Certain infectious or parasitic diseases Tuberculosis, unspecified 1 0 0 1 0 0 1